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Glaucoma is the leading cause of irreversible blindness worldwide with primary angle 
closure glaucoma (PACG) a major form of glaucoma in East Asian populations; being 
responsible for the majority of bilateral blindness in the region. The pathogenesis of 
PACG is thought to occur through the interplay of multiple anatomical and 
physiological factors. With advances in imaging technology such as the anterior 
segment optical coherence tomography (ASOCT), it is now possible to visualize and 
objectively analyse the anterior segment structures which were previously not easily 
discernible. Furthermore, the heterogeneity of PACG suggests that disease-related 
quantitative-traits could be more informative in elucidating true disease genes as the 
etiological complexity of PACG is reduced and deconstructed. We hypothesize that 
by identifying the genes that govern PACG-related quantitative-traits, we would be 
successful in identifying the genes that confer individual susceptibility to PACG. In 
this thesis, the focus is on two complimentary areas of angle closure research: 
imaging and genetics, and is aimed at uncovering novel risk markers which could help 
explain some of the mechanisms involved in the pathogenesis of angle closure. We 
anticipate that the established as well as the newly identified anatomical parameters 
will also serve as quantitative traits for angle closure.  
We identified two novel imaging-based risk factors for angle closure, namely, anterior 
chamber width (ACW), defined as the scleral spur to spur distance; and lens vault 
(LV) defined as the perpendicular distance between the anterior pole of the crystalline 
lens and the horizontal line joining the 2 scleral spurs. The two parameters were both 
independently associated with an increased risk of angle closure. ACW was 
significantly smaller in persons of Chinese ethnicity, older individuals, and in eyes 
with angle closure compared to those without. The presence of a large LV increases 
xiii 
 
the risk of having angle closure by 48 times when compared to eyes with smaller LV. 
The proposed role of these factors in the pathogenesis of angle closure is distinct, 
each resulting in worsening of anterior chamber angle crowding. In terms of their 
ability to detect subjects with angle closure, LV was found to have high area under the 
curve (AUC, 0.94; 95% confidence interval, 0.91– 0.97) with a sensitivity of 88.2%, 
and specificity of 87.5%, which was higher than that of traditional risk factors such as 
anterior chamber depth (ACD) (AUC, 0.75), axial length (AUC, 0.74), or any of the 
lens parameters (AUC ranging from only 0.58 to 0.66). LV thus has the potential to be 
utilized as a screening parameter for angle closure.   
We utilized the quantitative traits locus approach to identify novel genetic loci for 
PACG. We conducted a genome-wide association study (GWAS) on ACD on a total of 
5,308 population-based individuals of Asian descent, and observed a genome-wide 
significant association at a sequence variant within ABCC5 (rs1401999; per-allele 
effect size = - 0.045mm, P = 8.17x 10-9). This locus was also associated with an increase 
in risk of PACG in a separate case-control study of 4,276 PACG cases and 18,801 
controls (per-allele OR = 1.13 [95%CI: 1.06 – 1.22], P = 0.00046). This was the first 
reported study of a quantitative trait related to PACG and provides a genetic link 
between the disease and one of its key ocular anatomical risk factor, ACD. Our findings 
suggest that the increase in PACG risk could in part be mediated by genetic sequence 
variants influencing anterior chamber dimensions and validate the quantitative trait 
approach in identifying genes for a clinically heterogeneous condition such as PACG. 
Future work is aimed at identifying more PACG susceptibility loci using the 
quantitative-traits approach as well as other methodologies; and to develop a novel 
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1.1 Primary Angle Closure Glaucoma 
 The glaucomas are a group of heterogeneous optic neuropathies characterized 
by progressive loss of axons in the optic nerve. Glaucoma is the foremost cause of 
irreversible blindness worldwide, affecting an estimated 64.3 million people in 2013; 
the prevalence is projected to increase to 111.8 million by 2040.1 This high figure has 
important public health implications since visual loss, once established, cannot be 
reversed. Therapeutic interventions at early stages of the disease may aid in reducing 
visual morbidity associated with the condition. About 50-90% of people with 
glaucoma worldwide are unaware that they have the disease.2, 3 Glaucoma is largely 
asymptomatic except at the late stage when irreversible optic nerve damage has 
occurred. Damage to vision from glaucoma has been associated with a significant 
impact on activities of daily living, even at earlier stages of the disease well before 
blindness develops.4 As the number of elderly in the world rapidly increases, the 
number of people with glaucoma and its associated morbidity will also rise; and this 
will have an impact on the burden of health care costs for the disease.5  
 Glaucoma is classified according to the configuration of the anterior chamber 
angle (the part of the eye between the cornea and iris which is mainly responsible for 
drainage of aqueous humour) into two types: open-angle and angle closure (Figure 
1.1). Angle closure results from obstruction of the trabecular meshwork by the iris to 
the outflow of aqueous in the angle of the eye, causing an increase in intraocular 
pressure (IOP). The angle-closure type, namely, primary angle closure glaucoma 
(PACG) is a major form of glaucoma in Asia,6, 7 compared to primary open angle 
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glaucoma (POAG), which is the predominant form of the disease among Caucasians 
and Africans.8, 9  
 
 














1.1.1 Classification of Angle closure 
In the past, angle closure was classified into four categories based on the presence or 
absence of symptoms: acute, sub-acute or intermittent, chronic, and latent angle 
closure. The major limitation of this system was the inherent assumption that most 
angle closure is symptomatic. This is not the case since angle closure is 
predominantly an asymptomatic disease.10 Furthermore, the often-overlapping clinical 
presentation limited the usefulness of this classification scheme. The other major 
flaws were the absence of emphasis on the presence of loss of visual function or optic 
neuropathy.  
 
The World Glaucoma Association currently accepted classification system of angle 
closure glaucoma is based on the ideas discussed at the ISGEO (International Society 
of Geography and Epidemiology of Ophthalmology) congress held at the Netherlands 
in June 1998.10 This classification scheme postulates the natural process and 
progression of this disease by identifying three separate conceptual stages to its 
development; starting from iridotrabecular contact, to anterior segment signs of 
disease (characterized by raised intraocular pressure (IOP) and/or peripheral anterior 
synechiae (PAS), and culminating in glaucomatous optic neurpathy.10 This scheme 
has been used in recent prevalence surveys and other epidemiological research. The 
three stages of this classification system include: 
1. Primary angle closure suspects (PACS) in whom eyes have a narrow drainage angle 
(defined as the inability to visualize the pigmented posterior trabecular meshwork in 
primary gaze for >180 degrees on gonioscopy) with the absence of signs of trabecular 
damage such as PAS and/or elevated IOP, iris whorling, “glaucomfleken” lens 
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opacities, or excessive pigment deposition on the trabecular surface; and with no 
glaucomatous optic neuropathy (GON);  
2. Primary Angle Closure (PAC) with the same angle ﬁndings as PACS, but with the 
presence of signs of trabecular damage (as elucidated above), and with no GON.  
3. PACG, where there is a narrow drainage angle combined with structural and 
functional damage to the optic nerve consistent with glaucoma. As this ‘end organ 
damage’ is irreversible, it is crucial to predict disease occurrence and implement 
treatment prior to significant visual loss. 
 
The common feature in all three stages is the presence of narrow drainage angles, also 
known as occludable angles. 
 
Primary angle closure disease (PACD) is a collective term, which includes all the 
three stages of the disease spectrum from PACS, to PAC, to PACG. Acute primary 
angle closure (APAC), an ocular emergency with very high IOP, can occur at any 
stage of the spectrum of disease. The criteria for diagnosis of APAC11 include (a) 
presence of any two of the following symptoms: ocular or periocular pain, nausea 
and/or vomiting, an antecedent history of blurring of vision or haloes, a presenting 
IOP>28mmHg, and (b) presence of at least three of the following signs: conjunctival 
injection, corneal epithelial edema, mid-dilated pupils, and a shallow anterior 
chamber depth. Delay in presentation and unresponsiveness to medical treatment in 
termination of the acute attack have been shown to be associated with an unfavorable 
outcome. Singapore was reported to have the highest incidence of APAC of any 
country studied to date, with an island-wide incidence of 12.2 per 100,000 per year in 




The more severe latter stage, PACG, is potentially preventable by a prophylactic laser 
procedure, laser peripheral iridotomy (LPI) if performed in eyes with narrow angles 
(PACS) before the onset of PAC/PACG. However, after GON has developed, LPI is 
less successful and aims to lower IOP to prevent worsening of GON and visual field 
loss. 
 
1.1.2 Global Prevalence of PACG and Impact on vision 
The prevalence of PACG has been reported from many parts of the world, including 
various Asian (East Asian, South Asian, South-East Asian) populations,3, 6, 13-22 
Caucasian-derived populations,23-25 African,26-28 and amongst the Inuit people29-32 of 
the Arctic region. The prevalence of PACG increases significantly with age. 
Compared to POAG, PACG is a more damaging disease. It carries a three-fold greater 
risk of severe, bilateral visual impairment compared to POAG. Asians tend to have a 
higher prevalence of angle closure compared to Caucasians and Africans; however 
even amongst Asians, differences in prevalence rates have been reported, with the 
highest prevalence detected among persons of Burmese ethnicity.33 Interestingly, 
Inuits have been found to have a relatively higher prevalence of PACG compared to 
Western populations, with rates of 1.6% among men and 5.1% among women aged 40 
years and over.34 
Earlier studies have defined glaucoma mainly based on the level of IOP, either with or 
without evidence of structural and functional damage, and some studies did not 
involve gonioscopic assessment of the angles. Therefore, the great variability of 
disease definition and classification limits the ability to effectively compare between 
different epidemiological studies. In 2002 Foster et al described the standardized 
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scheme for classification of glaucoma for epidemiological/prevalence studies based 
on the ideas discussed at the ISGEO (International Society of Geography and 
Epidemiology of Ophthalmology) congress held in Leeuwenhorst, the Netherlands, in 
June 1998.10 The ISGEO classification scheme is based on both structural and 
functional evidence of glaucomatous neuropathy with emphasis on end organ damage 
as the defining characteristic of glaucoma. It is especially designed for 
epidemiological cross-sectional studies. Recently, many population-based studies 
have utilized the standardized ISGEO criteria to estimate the prevalence of glaucoma. 
Table 1 summarizes the prevalence of PACG and occludable angles in the different 
Asian ethnic groups.   
Indian Subcontinent (India, Nepal, Myanmar)  
The Chennai Glaucoma Study (CGS), a population-based cross-sectional study of 
4800 subjects aged 40 years and over in Chennai, Tamil Nadu, which is in the 
Southern part of India report a prevalence rate of 0.88% (95% confidence interval, CI, 
0.60–1.16) for PACG and 7.24%(95% CI, 6.38–8.02) for PACS.22 In the same study 
population, POAG was three times more common than PACG at 3.51 % (95% CI, 
2.9-4.1).35 The Aravind Comprehensive Eye Survey is another population-based study 
that was performed in Tamil Nadu, but did not utilize the ISGEO classification and 
diagnosis of PACG was based on the presence of glaucomatous optic disc damage or 
visual field defects with closed anterior chamber angles. They report a lower PACG 
prevalence of 0.5% (95% CI, 0.3-0.7) and also of POAG (1.7%, 95% CI, 1.3-2.1).36 . 
In the neighbouring state of Andhra Pradesh, (Andhra Pradesh Eye Disease Study, 
APEDS), the overall prevalence rate of PACG  at 0.94% was similar to that in the 
CGS but the prevalence of PACS was much lower  at only 2.0%. Lower prevalence of 
PACS was attributed to the likely possibilities of the use of different gonioscopy 
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lenses (2 mirror in APEDS versus. 4 mirror in the CGS) and different levels of skills 
of the examiners involved in the two studies. In the APEDS, PACG prevalence was 
found to increase from 0.56% (95% CI, 0.17–0.94) in the fourth decade to 2.5% (95% 
CI, 0.87–4.12) in the seventh decade. 37  
In a population-based survey in Meiktila district, Myanmar,33 a total of 2076 subjects 
>40 years of age were examined. The overall prevalence of PACG was 2.5% (95% 
CI, 1.5 to 3.5), higher than that of POAG which was 2.0% (95% CI, 0.9 to 3.1). 
PACG was also deemed to be responsible for 84% of all blindness due to glaucoma, 
with the majority due to the acute form of glaucoma, APAC.33  
The prevalence of the types of glaucoma and visual morbidity has also been studied in 
a Nepalese population living in the Bhaktapur district of Kathmandu, Nepal.38 Of the 
3991 subjects aged >40 years that were evaluated, the age and gender standardized 
prevalence rate for POAG was 1.24% (95% CI, 1.14–1.34) and for PACG was lower 
at 0.39% (95% CI, 0.34–0.45). The overall prevalence of glaucoma increased with 
advancing age and PACG was found to be 3 times more common in women.  
China and Mongolia 
Using the ISGEO criteria, the prevalence of PACG and POAG among urban subjects 
aged 50 years and over in the Liwan District, Guangzhou, Southern China was 1.5% 
(95% CI, 0.8%-2.1%) and 2.1% (95% CI, 1.4-2.8%) respectively.16 Although POAG 
was more prevalent, however, PACG resulted in more severe vision loss. The 
prevalence of the earlier stages of the disease namely PAC and PACS was 2.4% and 
10.2% respectively.16 In a population-based survey conducted in Northern China, 
Wang et al reported an overall glaucoma prevalence of 3.7% (95% CI, 3.1-4.2), of 
which PACG and POAG accounted for 1.0% (95% CI, 0.7-1.3) and 2.6% (95% CI, 
2.1-3.0) respectively.20 The proportion of glaucoma-related unilateral or bilateral 
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blindness was significantly higher in subjects with PACG. The Handan Eye Study39 is 
a glaucoma prevalence study carried out in a rural population in Northern China 
where total of 5480 subjects 40 years of age and older was examined. The age and 
gender standardized prevalence of PACG, PAC, and PACS were 0.5% (95% CI, 0.3-
0.7), 1.5% (95% CI, 1.2-1.8), and 10.4% (95% CI, 9.6-11.2%) respectively, similar to 
that in urban Chinese residents. Akin to other studies, the prevalence of angle closure 
was highest in the older age-groups and in female subjects. Blindness and visual 
morbidity attributed to glaucoma was also significantly higher in PACG compared to 
POAG.39 
A prevalence-based study from rural and urban locations in northern Mongolia report 
a significantly higher prevalence of PACG (1.4%) compared to POAG (0.5%).17 
However, this study was conducted prior to the establishment of the ISGEO criteria. 
PACG was defined as of the presence of acute or intermittent symptoms of angle 
closure, and in individuals with an occludable angle and an IOP of >19mmHg or a 
glaucomatous visual field. Gonioscopically occludable angles were seen in 6.4% of 
the population evaluated.17 
Japan 
The Tajimi study was carried out in an urban centre located in the central area of the 
main island of Japan in 2000-2001.21 The estimated prevalence of PACG subjects 
over 40 years was 0.6% (95% CI, 0.4%-0.9%), whilst the overall prevalence of 
glaucoma was 5.0%. 21 In this population too, women tended to be more susceptible 
to developing the disease compared to men. A later prevalence study in a rural 
population in an island in southwestern Japan, the Kumejima Study found much 
higher prevalence rates for angle closure glaucoma.18 In this study conducted in 2005-
2006, the prevalence rates for PACG, PAC and PACS were 2.0%, 3.7%, and 8.8% 
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respectively.18 Several reasons were proposed for the large discrepancy in PACG 
prevalence between the two populations in Japan. The lower myopic refraction and 
older mean age of the participants of the Kumejima Study may partly explain the 
higher prevalence of PACG. Another possibility is the likely ethnic differences 
between the people from the main island of Japan (Tajimi Study) and those in the 
Okinawa islands (Kumejima Study), since a recent genome-wide genetics study 
showed that the Japanese individuals fall onto two main clusters, those in the main 
island cluster and those in the Okinawa Island cluster.18  
Singapore 
Using the standardized ISGEO criteria, in the Tanjong Pagar Survey in Singapore 
(1997-1998), which examined ethnic Chinese persons aged over 40 years, Foster et al 
reported the age-standardized prevalence of glaucoma as 3.2% (95% CI, 2.3-4.1%) 
and that of PACG as 0.80% (95% CI, 0.4%-1.3%).3 The prevalence rate of PACG 
among the Malay ethnic group in Singapore was much lower at 0.12% (95% CI, 
0.10%-0.14%).19 The overall prevalence of glaucoma was 3.4% (95% CI, 3.3%–
3.5%). It was suggested that the relatively lower prevalence of PACG could be an 
underestimate, since gonioscopy was not performed for all study subjects. An 
assessment of the limbal ACD was used to screen for the presence of angle closure. 
Interestingly, more than 90% of persons diagnosed to have glaucoma were unaware 
that they had the disease. This has important public health implications, since 
glaucoma being largely an asymptomatic disease may remain undiagnosed until the 
late stages when irreversible visual loss has occurred. It is therefore important to 
develop effective screening strategies for the early detection of glaucoma.  The more 
recent glaucoma prevalence survey in the Indian ethnic group in Singapore report 
lower glaucoma prevalence rates.14 The age standardized prevalence of glaucoma was 
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1.95% (95% CI, 1.5-2.5%), POAG was 1.25% (95% CI, 0.89-1.73%), and for PACG 
it was much lower at 0.12% (95% CI, 0.04-0.33%).14 The glaucoma prevalence in the 
Singaporean Indian population was approximately half that of the Malay and Chinese 
ethnic groups. However, the prevalence rates are comparable to recent studies on 
individuals from the southern region of India such as the CGC and APEDS,22, 37 and 
close to 90% of the Indian population in Singapore are of South Indian ancestry. 
Western and African Populations 
Among Caucasian and African populations, the prevalence of PACG is much lower; 
0.09% in Wales,40 0.1% in Melbourne,23 0.59% in rural East Africa,28 and 0.1% 
among Zulus.26 Different diagnostic criteria were utilized for these studies since the 
studies were conducted prior to development of the ISGEO classification scheme.  
 
As illustrated in Table 1.1, the prevalence of occudable angles (PACS), which is the 
precursor stage of PACG, is much higher. The estimated prevalence varies between 
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1.1.3 Magnitude of the problem in Singapore 
A Hospital-based retrospective study conducted in Singapore between January 1964 
and December 1966 evaluated 26,900 patients attending the clinics at the Singapore 
General Hospital. A total of 364 persons were identified with glaucoma.41 Of this, the 
largest proportion had PACG (66.7%), 14.7% had POAG, 16.1% had secondary 
glaucoma and 2.8% were classified as congenital glaucoma. The study also revealed a 
greater preponderance of PACG in women (61.1% of the total) and in persons of 
Chinese ethnicity (91%) [This was higher than the proportion of Chinese in the 
national population at that time, which was 74%].41 
Importantly, the blind registry in Singapore (1953-1966) found that while glaucoma 
accounted for the highest cause of blindness (22%-25%); the cases of blindness 
caused by PACG among the Chinese population exceeded that of POAG by a factor 
of 2.5:1. The ratio was reversed for the Indian and Malay population where POAG 
was responsible for a greater proportion of blindness.42   
 
The Tanjong Pagar Survey (1997-1998) evaluated the prevalence and causes of low 
vision, blindness, and impaired visual function among Singaporean Chinese adults 
aged over 40 years.3 Glaucoma (POAG and PACG) was found to be the leading cause 
of bilateral blindness, responsible for 60% of the cases in Singapore.3 This rate is 
higher that the rates of bilateral blindness caused by glaucoma in Mongolia (34.8%)43 
and in blacks in Barbados (28%).27 The prevalence of PACG is much lower in 
persons of Indian ethnicity in Singapore, and the proportion of subjects with low 
vision (defined as logMAR, >0.30 to <1.00) was found to be equal among POAG and 
PACG. Interestingly, in the population-based study of Malay adults aged ≥40 years in 
Singapore between 2004 and 2006, the Singapore Malay Eye Study (SiMES) revealed 
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a much lower proportion of bilateral blindness attributable to glaucoma.44 The likely 
reasons that were suggested for the differences between Chinese and Malays in 
Singapore were the ethnic or genetic variations in the prevalence and risk factors of 
glaucoma.44 Bilateral blindness was defined as best corrected visual acuity (BCVA) 
worse than 3/60 in the better eye, or, constriction of the visual field to within 10° of 
fixation, in accordance with internationally accepted WHO definitions.45, 46  
 
1.1.4 Mechanisms responsible for Angle Closure 
Ritch and Lowe47 described the mechanisms of angle closure based on the forces 
acting at four anatomic levels, each one lying progressively more posterior: the iris 
(pupil block), the ciliary body (plateau iris), the lens, and forces posterior to the lens 
(e.g. malignant glaucoma) (Figure 2) 
Level 1 – Iris and pupil (Pupil block): In pupil block, considered to be the primary 
mechanism for angle closure,48, 49 there is resistance to the flow of aqueous from the 
posterior to anterior chamber at the level of the pupil. This creates a pressure gradient 
that causes anterior bowing of the peripheral iris (iris bombe´) and closure of the 
angles.  If the trabecular meshwork is substantially occluded, the normal outflow of 
the aqueous can be impeded, resulting in the elevation of IOP. The magnitude of IOP 
rise is related to the extent of iridotrabecular contact. Laser peripheral iridotomy (LPI) 
is the primary treatment option in the management of angle closure caused by 
pupillary block.50, 51 Iridotomy relieves the pressure differential, reduces the convexity 
of the iris and widens the angle.  
 
Level 2 – Ciliary body (Plateau iris): Plateau iris configuration is defined as an 
extremely narrow or closed angle on gonioscopy, with a flat iris plane and a normal 
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central anterior chamber depth (ACD).52 Such configuration is thought to occur due to 
the presence of an anteriorly positioned ciliary process that pushes the peripheral iris 
against the angle causing angle closure. As LPI either only partially opens or fails to 
open the angle, therefore, for plateau iris, laser iridoplasty is the treatment of choice. 
Iridoplasty, is a laser procedure that involves the application of low-energy laser 
burns to the peripheral iris in order to widen the anterior chamber angles. 
Plateau iris syndrome occurs when angle closure with raised IOP develops in an eye 
with plateau iris configuration despite a patent iridotomy. A review which evaluated 
angle closure glaucoma in Asians and Europeans has suggested that non-pupil block 
mechanisms such as plateau iris may be responsible for a significant proportion of 
angle closure in Asians.53 Using standardized ultrasound biomicroscopy (UBM) 
criteria, Kumar et al54, 55 found plateau iris to be a common and important mechanism 
in a sample of mostly Chinese individuals with angle closure. More than 30% of eyes 
were diagnosed to have plateau iris on UBM in the presence of a patent LPI. The 
Liwan Eye Study, a population based study in Southern China, reported a high rate of 
plateau iris configuration (in at least one quadrant) in PACS eyes.56 
 
Level 3 – Lens-induced: the lens is thought to play a crucial role in the pathogenesis 
of angle closure disease either because of an increase in its thickness or a more 
anterior position causing a decrease in ACD. Angle crowding can occur due to a 
swollen cataractous lens, or forward movement of the lens as a consequence of weak 
or loose zonules. 
 
Level 4 – Retro-lenticular: An increase in the retro-lenticular pressure can push the 
lens-iris diaphragm forward to block the angles. This type of glaucoma is referred to 
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as malignant glaucoma or ‘aqueous misdirection syndrome’. In this condition, a 
pressure differential is created between the vitreous and aqueous compartments due to 
the posterior misdirection of the aqueous humour into the vitreous cavity. The 
accumulation of fluid in the vitreous cavity results in the forward displacement of the 
lens-iris diaphragm with anterior rotation of the ciliary body causing angle closure by 
pushing the iris against the trabecular meshwork. This condition usually follows intra-
ocular surgery or may occur spontaneously; is characterized by a very shallow 
anterior chamber and raised IOP, often in the presence of a patent LPI.  
Choroidal expansion is another mechanism postulated to contribute to angle closure.57  
An increase in choroidal volume would be transmitted to the intraocular 
compartments causing the lens to move forward. Such forward movement of the lens 
could exacerbate angle crowding in an eye that is already anatomically predisposed 
towards angle closure. The anterior rotation of the ciliary body is also thought to 


















1.1.5 Known Risk Factors for Angle Closure 
Studies conducted in different ethnicities have described several demographic and 
biometric risk factors of angle closure.  
Ethnicity: The prevalence of angle closure glaucoma differs among different ethnic 
groups. Both clinic-based studies and population-based studies have confirmed the 
importance of ethnicity as an important risk factor for PACD. Persons of Asian ethnic 
background are at a greater risk to develop the disease compared to Caucasians and 
Africans. Interestingly, the prevalence of angle-closure glaucoma is also high among 
the Inuits (Eskimos),29, 32 who are anthropologically related to the Sino-Mongoloid 
people.58 The high prevalence in these populations has been attributed to the 
propensity towards shallow anterior chambers.29, 32 Nonetheless, even among Asians, 
there are variations in the prevalence rates of angle closure, with the highest 
prevalence detected among Burmese and Japanese from the Okinawa island region 
with rates of 2.5% and 2.0% respectively. Persons of Indian origin (both in India and 
Indians in Singapore) have lower rates of angle closure compared to Chinese (both 
within China and in Singapore). The prevalence rates of PACG in the different Asian 
ethnic populations is described in detail in section 1.1.2 “Global Prevalence of PACG 
and impact on vision”. Although the racial differences in the prevalence of angle 
closure is well-established, however, the mechanisms underlying these differences are 
still to be fully understood. A possible explanation postulated is a more rapid 
narrowing of the anterior chamber angles in the eyes of Chinese and Inuits due to 
development of creeping angle closure or a more rapid increase in lens thickness 
caused by factors such as diet, and increased exposure to ultraviolet B light near the 
equator (for Singaporean Chinese) or reflected from the snow (for Inuits).59 However, 
these hypotheses are yet to be proven.  
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Age and gender: Population-based studies have shown that the prevalence of angle 
closure increases with advancing age,12, 60, 61 and is also higher in females compared 
to males3, 12, 60, 61 A possible reason for the gender differences is the significantly 
narrower anterior chamber angles of female eyes compared to that of men among 
normal subjects. With age, there is a gradual shallowing of the anterior chamber and 
narrowing of the angles likely caused by an increase in lens thickness (LT) or the 
forward movement of the lens. Aging results in about 0.75 to 1.1mm increase in 
thickness and about 0.4 to 0.6mm forward movement of the anterior lens surface.47, 62  
 
Ocular biometry: The ocular biometric risk factors for angle closure include 
shallower ACD, greater LT and anterior lens position, shorter axial length (AL), and a 
more hyperopic refractive error. Several investigators have evaluated the association 
of these ocular biometric factors with angle closure. The biometric findings suggest 
that in patients with angle closure, the overall eyeball size is not only small, but the 
anterior segment is also more crowded as the lens is thicker and more anteriorly 
located. 
Anterior chamber depth 
The anterior chamber is the space within the eye which is bound by the cornea, and 
the anterior surfaces of the iris and lens. ACD is the distance measured along the 
eye’s optical axis, from the cornea to the lens surface. Shallow ACD is considered an 
important risk factor associated with an increased susceptibility to PACG. The ACD 
gradually decrease with advancing age partly due to an increase in the lens thickness 
or a forward movement of the lens.63, 64 It is shallower in females compared to males, 
and importantly, the age-related changes are more marked in women than in men.64, 65 
ACD can be easily and precisely measured by different ocular imaging techniques 
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such as A-scan ultrasound biometry, IOL Master (principle of partial coherence 
interferometry), and optical pachmetry.  
Eyes with angle closure glaucoma and occludable angles have significantly shallower 
ACD compared to eyes without angle closure.66-69  The relationship between depth of 
ACD and development of PAS was investigated in a total of 2032 subjects aged >40 
years from two East Asian populations, namely Chinese Singaporeans (N=1090) and 
Mongolians (N=942).70 In both populations, the degree of PAS increases with 
reduction in the magnitude of ACD. Interestingly, while a consistent increase in the 
extent of PAS across the range of ACD was noted in the Singaporean population; in 
the Mongolian population however, there was a noticeable threshold of 2.4mm above 
which PAS was very rare. There was also a greater likelihood of developing GON in 
persons with the shallowest anterior chambers.70  
Another population based study from Singapore of subjects aged over 50 years found 
that eyes with an ACD of less than 2.80mm were more inclined to have angle closure 
when compared to eyes with an ACD of at least 3.0mm (odds ratio, 42.5; 95% 
confidence interval, 27.4–66.2).71 In addition to shallower ACD, the other 
independent determinants of angle closure were female gender, shorter AL and 
Chinese ethnicity (as opposed to Malay or Indian ethnicity). However, the age-
adjusted ACD measurements were not different in Chinese and non-Chinese 
subjects.71    
Diurnal variation of the ACD has also been described. Using a photographic slit lamp 
(Zeiss) technique, Mapstone and Clark observed that the peripheral ACD was 
significantly shallower in the evening than in the morning, decreasing by 21.1%.72 
The findings correlated with their observations that the peak time of onset of APAC 
was during the evening hours.73 Compared with fellow eyes, the APAC-affected eyes 
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were also found to have significantly shallower ACD.74   
The diagnostic performance (sensitivity, specificity) of ACD as a screening tool for 
angle closure is variable, and depends upon the cut-off levels of ACD. Details of the 
performance of ACD at different cut-off points are described in Section 5.1.1 ‘Is there 
an appropriate and accurate screening test for Angle closure?’ 
 
The lens  
The crystalline lens is thought to play a crucial role in the pathogenesis of angle 
closure disease either due to an increase in its thickness with age or a more anterior 
position causing a decrease in ACD.69, 75 The various lens parameters that have been 
evaluated for associations with angle closure include LT, lens position (LP) and 
relative lens position. Lens position is calculated from ACD and LT and is defined as 
ACD+1/2LT. Relative LP is defined as LP/axial length.  
In an earlier study in Australia, Lowe et al76 evaluated the biometric features of eyes 
with angle closure and compared them with features from eyes of normal subjects. 
They found that while the ACD was shallower in eyes with angle closure, a major 
proportion of the difference in ACD compared to normal was attributed to a more 
anterior lens position; and the remainder to a thicker lens.76 However, a later study 
conducted on persons of Chinese ethnicity found that lens thickness was the major 
determinant of a shallow ACD; and that lens position only accounted for 4% of the 
difference between angle closure and normal eyes.77 The ratio of the LT to AL also 
increases with age and is greater in eyes with angle closure. Lim et al found no 
significant changes in LT or degree of lens opacity in APAC-affected eyes compared 
with their fellow eye.74  
Tomlinson and Leighton68 evaluated the ocular dimensions in subjects with angle 
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closure, their siblings and offspring (first-degree relatives); and compared them to age 
and gender matched normal. Compared to normal, the lens was thicker, more 
anteriorly placed, and the ACD shallower in subjects with angle closure and also in 
their siblings. However, only the LT and ACD were significantly different between 
both siblings and offspring of angle closure, when compared to normal. Additionally, 
compared to unaffected sibling, the ACD was shallower and lens thicker in subjects 
with angle closure.68 In another study on the biometric parameters in family members 
of patients with PACG, Sihota et al78 found that the ACD was shallowest, AL shortest 
and lens thickest in family members with PACG compared to family members who 
were either unaffected or were angle closure suspects. The lens position however was 
not significantly between the three groups.78  
 
Axial length 
Findings from studies in various ethnic groups have shown that eyes of subjects with 
angle closure have significantly shorter axial lengths compared to eyes with open-
angles. 79-81 Furthermore, eyes that have suffered previous APAC have significantly 
shorter axial lengths than those affected by chronic asymptomatic angle closure 
disease. The AL was also smaller in subjects with angle closure and their siblings 
compared with that of normal controls.68 
 
Hypermetropia: 
Several studies have shown the close association between hypermetropia and angle 
closure. The increased prevalence of angle closure in women probably reflects the 




1.2 Angle Closure is Not Fully Explained by Variations in the Known Biometric 
Features 
Shallower ACD and shorter AL are the predisposing characteristics for angle closure, 
and although some studies have shown that these biometric parameters can help 
distinguish between normal and angle closure subjects; however a greater 
predisposition towards angle closure susceptibility is not entirely explained by these 
biometric features alone. A large scale community-based study conducted on subjects 
aged over 50 years in Singapore demonstrated that while the strongest determinants 
for angle closure were female gender, shorter axial length, shallower anterior chamber 
depth and Chinese ethnicity; however gender and racial differences for the greater risk 
of angle closure were not fully explained by variations in AL or ACD.71  Interestingly, 
Congdon et al compared the biometric features of PACG subjects among Chinese, 
White and Black population.75 They reported that the age and gender adjusted 
population means of ACD and AL did not differ significantly between the Chinese 
(where angle closure is more prevalent), and the Whites and Blacks where angle 
closure is a comparatively rare disease.  In addition, they also found that the increased 
risk of PACG among the Chinese could not be explained by a shallower ACD.75   
These findings suggest that there could be other as yet un-identified risk factors that 
may be important in determining an increased susceptibility of certain ethnic group 
towards development of angle closure. It is therefore necessary to search for 
additional biometric risk factors that could help explain the increased risk of angle 
closure among persons of certain ethnic groups. Furthermore, the identification of 
new risk factors may be of benefit in screening and management of this potentially 




1.3 Genetic Etiology of Angle Closure 
The majority of glaucoma research has been focused on populations with a 
predominance of POAG and this has resulted in the identification of several genes for 
POAG.82-84 PACG on the other hand has been a relatively poorly researched 
condition. However, a genetic etiology for angle closure glaucoma is supported by 
several epidemiological and clinical studies which have shown familial aggregation 
and a higher risk of the disease in family members of affected individuals,85, 86 as well 
as high heritability of risk factors for PACG such as ACD87 and angle width.88 In this 
chapter, the current knowledge of the genetic basis of angle closure is described, 
including the recently identified loci for PACG.  
 
1.3.1 Evidence for the Genetic Basis of Angle Closure  
A genetic basis for PACG is supported by several findings such as the greater risk 
carried by first degree relatives of PACG patients compared to the general population, 
and the high heritability of angle closure related ocular risk factors.  
Familial predisposition  
The ocular characteristics related to angle closure glaucoma are more common in 
close relatives of affected patients than in the general population; these characteristics 
include shallower anterior chambers, thicker lens, an a more anteriorly positioned 
lens.27-31 A positive family history is another predisposing risk factor, and first-degree 
relatives of subjects with PACG have a 3-5 times greater risk of developing the 
condition compared with the general population.68, 85, 89-91 The racial differences in 
prevalence of the disease further imply a genetic predisposition to the condition.  
Amerasinghe et al explored the heritability, sibling recurrence risk (defined as the 
probability of the sibling of an affected individual also being affected), and sibling 
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relative risk (calculated by dividing the sibling recurrence risk by the population 
prevalence of narrow angles) of narrow angles among first-degree relatives of 
subjects with PAC or PACG from Singapore.86 A high heritability of narrow angles of 
almost 60% was found, even after adjusting for age and axial length. This implies that 
the presence of narrow angles was attributable largely to a genetic predisposition. The 
study also demonstrated that the sibling recurrence risk for narrow angles was nearly 
50% while the sibling relative risk was 7.57. These findings further suggests that 
family members particularly siblings of patients with PAC and PACG, are at a greater 
risk of developing narrow angles.86  
 
Heritability of PACG-related ocular biometric parameters 
Heritability is defined as the proportion of phenotypic variation in a population that is 
due to genetic variation between individuals. The heritability estimate can range from 
0 (suggests no genetic contribution) to 1 (suggests that all differences on a trait reflect 
genetic variation).  
There have been several studies which have evaluated the genetic influences for 
quantitative biometric parameters associated with angle closure disease. Studies in 
Caucasian populations have reported a heritability of 50-88% for ACD. Using data 
from 715 individuals in 189 pedigrees of the Beaver Dam Eye Study, Klein and 
colleagues92 evaluated the familial correlation and heritability estimates of several 
ocular quantitative traits including ACD and AL. Familial correlation analysis showed 
strong sibling correlation for AL (0.33 [SE 0.08] adjusted for education and height) 
and for ACD (0.32 [SE 0.09], adjusted for age, education, height, and nuclear 
sclerosis). The heritability estimates for AL and ACD were 0.67 (SE 0.14) and 0.78 
(SE 0.14) respectively, after adjustment for the same factors.92 An Australian study 
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conducted on 1224 twins (including 345 monozygotic [MZ] and 267 dizygotic [DZ] 
twin pairs) aged between 18 and 88 years, report high heritability estimates of >0.90 
for AL for both men and women, and the estimated heritability for ACD were 0.51 
and 0.78 respectively in the men and women.93 The heritability of ACD was reported 
to be greater in Chinese.87 In a study conducted on a total of 563 twin pairs (including 
357 MZ and 206 DZ twin pairs) recruited from the Guangzhou Twin Registry, He et 
al report a high heritability of 90.1% (95% CI: 88.2%-91.7%).87 
 
The heritability estimates of the other parameters range from 60% for iris thickness,94 
70% for angle width,88 and 50-70% for anterior chamber width (ACW, unpublished, 
data courtesy A/Prof Cheng Ching-Yu).   
 
Animal models for PACG 
Animal models are available for PACG including spontaneously occurring such as 
dogs, and experimentally induced such as rats and mice. The type of glaucoma that 
occurs in dogs is mainly of the closed-angle type. In a canine model of hereditary 
PACG, Grozdanic et al95 found a progressive increase in IOP with age, gradual 
narrowing of the iridocorneal angles, and destruction of the trabecular meshwork 
structure, impaired retinal ganglion cell function and optic nerve damage. The 
hereditary canine model shares features similar to some human patients with PACG 
and are potentially useful as a model to better understand glaucomatous optic nerve 
damage.95  A genetically induced mouse model of APAC has also been described.96 
These transgenic mice with over-expression of CLR (calcitonin receptor-like 
receptor), an adrenomedullin receptor demonstrated an acutely and transiently 
elevated IOP resulting from an enhanced adrenomedullin-induced relaxation of the 
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pupillary sphincter.  It was hypothesized that in humans, a defective regulation of the 
action of adrenomedullin on the pupillary sphincter may provoke the development of 
an acute attack of angle closure.96 It has been reported that the haplotype Trs840617 
Crs6759535 Trs1157699 was significantly associated with APAC. However, no 
association was found between the common variants of calcitonin receptor-like 
receptor gene (CALCRL) and PACG.97 
 
1.3.2 Potential Candidate Genes for Angle Closure 
Extracellular matrix remodelling: Extracellular matrix remodelling has been 
suggested as a likely determinant for the short axial length in relatively small eyes. 
Therefore, one of the candidate genes that have been investigated in relation to PACG 
includes the matrix metalloproteinase-9 gene (MMP9), a gene involved in the 
remodeling of extracellular matrix.98 Cong et al showed that the SNP rs2250880 
located in MMP9 might be associated with PACG in a Southern Chinese population98; 
while in an Australian Caucasian population SNPs (rs3818249 and rs17576) were 
found to be associated with PACG.99 A different SNP (rs2664538) within MMP9 was 
separately shown to be associated with susceptibility to acute PACG among 
Taiwanese patients;100 however, this was not associated in Singaporean subjects with 
PACG.101  
 
Developmental genes: The strong association of angle closure disease with smaller 
ocular dimensions makes ocular developmental genes possible candidate genes for the 
condition. Nanophthalmos and microphthalmia are ocular conditions characterized by 
short axial length, high hypermetropia and high lens-to-eye volume ratio. There is 
also a high risk of development of angle-closure in these ‘small-eyes’ that is thought 
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to occur due to the abnormal anatomical crowding of the anterior chamber. It was 
therefore thought that the genes associated with ‘small-eyes’ might also have a 
possible role in angle closure disease or PACG. Nanophthalmos can be inherited 
either as an autosomal-recessive or autosomal-dominant trait and several genetic loci 
for the condition has been identified. 
The MFRP (membrane-type Frizzled-related protein), located on chromosome 11q23 
has been found to be associated with the autosomal-recessive form of 
nanophthalmos.102 MFRP which has been shown to be expressed in the retinal 
pigment epithelium, encodes a Frizzled related protein that regulates axial length, 
thereby resulting in extreme hyperopia and nanophthalmos. Mutations in the VMD2 
(vitelliform macular dystrophy 2, also known as bestrophin) gene, located on 
chromosome 11q13 have been found in patients with the autosomal-dominant form of 
nanophthalmos.103 The gene is also associated with vitreoretinochoroidopathy. In 
addition, another locus (NNO1) on chromosome 11 has been found for autosomal 
dominant nanophthalmos associated with high hypermetropia and angle-closure 
glaucoma.104 However, the location of this gene has yet to be discovered. Mutations in 
the retinal homeobox gene CHX10 are associated with microphthalmia. 
 
However, none of these genetic polymorphisms have been convincingly replicated 
across different ethnic populations and there are also conflicting reports regarding 
their association with PACG. Furthermore, subsequent research is warranted to 
uncover the biological significance of these loci in the development of PACG since 
this is currently unknown. The disparate findings between studies suggest that further 
evaluation of PACG genetics is necessary in order to identify the genes responsible 
for the pathophysiology of this sight-threatening disorder.  
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1.3.3 Recently Identified Novel PACG Loci 
Genome-wide association studies (GWAS) are a useful and efficient study design for 
the identification of genes associated with complex diseases. This approach has been 
successful in identifying genetic variants associated with several systemic and eye 
diseases, including Type 2 diabetes,105, 106 Crohn’s disease,106, 107 heart disorders,106 
age related macular degeneration108-110 and primary open angle glaucoma.82, 84  
 
To identify the genetic determinants that confer susceptibility to PACG,111 we 
conducted a two-staged GWAS incorporating 3,771 cases and 18,551 controls. Stage 
1 (GWAS discovery) comprised 1,854 cases and 9,608 controls enrolled from 
Singapore, Hong Kong, India, Malaysia, and Vietnam. Stage 2 (replication) 
comprised a further 1,917 cases and 8,943 controls recruited independently from 
Singapore, China (1 collection from Beijing and a second from Shantou), India, Saudi 
Arabia, and the UK. We found significant associations at three novel loci; PLEKHA7 
rs11024102 (per-allele odds ratio (OR) = 1.22, P = 5.33 x 10-12), COL11A1 rs3753841 
(per-allele OR = 1.20, P = 9.22 x 10-10), and rs1015213 located between PCMTD1 
and ST18 on Chromosome 8q (per-allele OR = 1.50, P = 3.29 x 10-9).111 
 
Significant expression of PLEKHA7, COL11A1, and PCMTD1 were found in the 
ocular tissues intimately involved in the pathogenesis of PACG, namely the iris and 
trabecular meshwork of the eye. PLEKHA7 encodes for Pleckstrin-homology-domain-
containing protein 7, which is critical for the maintenance and stability of adherens 
junctions.112, 113 As adherens junctions aid in controlling para-cellular permeability,114 
it has been hypothesized that PLEKHA7 may be involved in the pathophysiology of 
angle closure related to aberrant fluid dynamics. COL11A1 encodes for one of the two 
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alpha chains of type XI collagen and being a structural protein, it may contribute 
towards anatomical risk via the sclera or iris. PCMTD1 encodes for protein-L-
isoaspartate O-methyltransferase domain-containing protein 1,115 whose function 
remains unknown.  
This study provided new perspectives into the genetic basis of PACG. It revealed that 
whilst there are genes underlying PACG, these common variants provided only a 
modicum of risks (OR in the range of 1 -1.5) as had been observed with variants 
underlying POAG.82-84 Moreover these 3 sequence variants also only explained < 2% 
of PACG risk.  Therefore it is important to build on this substantial success and 
continue to identify further susceptibility genes to elucidate the entire genetic 
architecture of PACG.  
 
1.4 Unanswered Research Questions in Angle Closure 
Angle closure is a complex disorder with multiple predisposing factors, including 
genetic predisposition that contributes to its pathogenesis. Considerable advances 
have been made with regards to the epidemiology, clinical assessment and 
understanding the genetic basis of angle closure. However, current management 
practices have undergone little change and remain similar to what it was decades ago. 
For individualized management of angle closure, there is thus a need to better 
understand the different mechanisms (including anatomical, dynamic, biomechanics 
and genetics) that contribute to the pathogenesis of the disease. Ocular biometric 
differences alone do not adequately explain the increased predisposition of certain 
ethnicities towards angle closure disease.  Additionally, the known genetic variants 
for angle closure explain only <2% of PACG risk. Other mechanisms may therefore 
likely play a role in determining the predisposition towards development of angle 
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closure. Also, there is currently a lack of a reliable, objective clinical parameter that 
can aid in the screening/detection of cases in the early asymptomatic stage prior to 
irreversible visual field damage.  
 
1.5 Technological Advances Relevant to Angle Closure 
Advances in imaging: The emergence of new imaging technology, such as anterior 
segment optical coherence tomography (ASOCT) and ultrasound biomicroscopy 
(UBM) has made it possible to visualize cross-sectional images of the anterior 
segment structures and also to perform precise quantitative measurements of these 
structures. Ultrasound biomicroscopy (UBM) uses high-frequency ultrasound to 
image the angle of the eye including structures located behind the iris such as the 
ciliary body. This makes it very useful in identifying posterior causes of angle closure 
such as plateau iris, iridociliary masses causing secondary angle closure or choroidal 
effusions. A major disadvantage of the UBM is the contact nature of the procedure 
either in the form of a scleral cup or a corneal probe. This induces discomfort for the 
patient and risks of corneal abrasion and infection, and can also result in possible 
distortion of the angles due to inadvertent indentation. Another disadvantage of the 
UBM is that it allows image acquisition of only a single quadrant at a time, which 
thereby limits its use to the evaluation of only angle and iris features.  ASOCT, on the 
other hand, is a non-contact high-resolution imaging modality that allows 
visualization of the entire anterior segment structures in a single image. With regards 
to glaucoma, the clinical applications of anterior segment imaging lie in the ability to 
visualize and assess the anatomic relationships of the angle and anterior segment 
structures; and to perform quantitative estimations of their measurements. Assessment 
of these structures may lead to the identification of new anatomical risk factors, which 
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would in turn provide a better understanding of the mechanisms involved in angle 
closure and aid in our approach to its management. In this study, we have used the 
ASOCT imaging modality to identify novel risk factors for PACG, which may in turn 
lead to more accurate diagnostic capability and improved prognostic accuracy for the 
disease. 
Details of the principles, image capture, processing and analysis, and description of 
the various quantitative ASOCT parameters is elucidated in the Methodology 
Chapter, sections 2.3 ‘ASOCT imaging’ and ‘Processing of ASOCT images’. 
 
Quantitative traits approach: Concerning the genetics of angle closure, another 
approach to identify genes that underlie certain complex traits such as PACG is to 
dissect the disease into highly heritable quantitative traits, or endophenotypes, as part 
of its overall phenotype. The genes that control these constituent endophenotypes can 
then be identified through the quantitative trait locus (QTL) approach. The approach 
of quantitative endophenotypes allows individuals to be ranked along the continuum 
of risk,116, 117 thus providing much greater information than dichotomous measures of 
affection status. Moreover, potential misclassification of individuals, between affected 
or non-affected status, is also avoided. This hypothesis-based approach of the 
interrogation of endophenotypes has been somewhat successful in the identification of 
several genes for POAG.118, 119 These include the genes for vertical cup-to-disc ratio 
(VCDR) and IOP.118, 119  
 
The heterogeneity of PACG as a diagnosis (a characteristic shared with POAG) 
means that disease-related endophenotypes could be more informative in elucidating 
true disease genes as the etiological complexity of PACG is reduced and 
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deconstructed. We therefore believe/ hypothesize that by identifying the genes that 
govern PACG-related endophenotypes, we would be successful in unraveling the 
genetic determinants that confer individual susceptibility to PACG. 
 
1.6 Study Aims 
In this study, I focus on two complimentary areas of angle closure research; namely 
imaging and genetics to uncover novel risk markers which could help explain some of 
the mechanisms involved in the pathogenesis of angle closure. I anticipate that the 
novel imaging-based anatomical parameters will also serve as quantitative traits or 
endophenotypes for angle closure. The endophenotype approach will be used to 
identify novel genetic loci for angle closure (Figure 1.3). The specific study aims are:   
a. To identify novel imaging-based anatomical risk factors for angle closure. 
b. To identify novel PACG loci using the hypothesis-based approach of the interrogation 






























1.7 Overall Study Plan  
The overall aim of this thesis is to elucidate novel markers for angle closure disease. 
To achieve this we have utilized demographic, imaging and genotyping data obtained 
from both population-based as well as hospital-based confirmed cases of angle 
closure.  
 
 The thesis is divided into two sections: Imaging and Genetic 
Chapter 2 is a description of the study populations, patient recruitment and clinical 
examinations including ASOCT imaging. The principle, image processing and 
evaluation of the ASOCT are described. The principle and requisites of GWAS is also 
described. 
Chapter 3 focuses on the Imaging aspect of the thesis. Here, we describe in detail 
two novel ASOCT-based parameters, lens vault (LV) and anterior chamber width 
(ACW) that are independently associated with angle closure disease, and also 
evaluated their performance as potential screening parameters for angle closure. The 
impact of the LV on visual acuity and refractive error and the potential clinical 
implications are also investigated. These parameters are also compared in different 
subtypes of angle closure.  
Chapter 4 focuses on the genetic determinants of quantitative traits or 
endophenotypes related to PACG. Endophenotypes are defined as heritable factors 
that are associated with a disease but by themselves do not cause the disease. The 
major endophenotype described in this chapter is anterior chamber depth (ACD).  
Chapter 5 discusses the major findings of the thesis and their clinical implications; 




SUBJECTS AND METHODS 
2.1 Study Populations 
To accomplish the aims and objectives of this research, we recruited and evaluated 
two groups of subjects:  
a. Hospital-based angle closure subjects including PACS, PAC and PACG 
b. Population-based study subjects: The population-based studies include the 
Singapore Malay Eye Study (SiMES), Singapore Indian Eye Study (SINDI), 
and the Singapore Chinese Eye Study (SCES), Beijing Eye Study (BES), and 
the community-based polyclinic study.  
 
2.1.1 Hospital-based Subjects 
Subjects aged 40 years and above, diagnosed with angle closure disease,10 classified 
as PACS, PAC, PACG, and previous APAC were recruited from glaucoma clinics of 
the Singapore National Eye Centre. Subjects with any previous intraocular surgery, or 
inability or unwillingness to give written informed consent were not included in the 
study. (Please see Chapter 1, Section 1.1.1 for the definitions of the subtypes of Angle 
closure)  
 
2.1.1 Population-based Studies 
Recruitment summary of the different population cohorts is illustrated in Table 2.1.   
Singapore Malay Eye Study (SiMES):120 this was the first of a series of population-
based studies which was conducted to determine the prevalence rate and risk factors 
of major eye diseases in Singapore. In this cross-sectional study, a total of 3,280 
Malay participants (78.7% response rate) aged between 40-79 years were recruited. 
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The Ministry of Home Affairs of Singapore provided an initial computer-generated 
list of 16.069 Malay adults aged 40-80 years of age residing in 15 residential districts 
of the south-western part of Singapore. An age-stratified random sampling was 
performed from the list, where 1400 names from each decade (namely 40-49, 50-59, 
60-69, 70-79) were selected giving a total of 5400 names. Of these, 4,168 persons (i.e. 
74.4%) were deemed eligible for participation in the study. A person was considered 
ineligible if he or she had moved residences, or, had not lived at the current address 
for more than 6 months, or was deceased, or was terminally ill. Of the 4,168 
individuals eligible for participation in the study, a total of 3,280 (response rate 
78.7%) took part in the study, conducted between August 2004 and June 2006.120  
 
Singapore Indian Eye Study (SINDI):121 SINDI was a population-based cross-
sectional study of ethnic Indians aged 40-80 years residing 15 residential districts in 
the South-western part of Singapore. The rationale and study design of the SINDI 
mirrors that of SiMES where age-stratified sampling was used to select the final 
sampling frame of 6,350 ethnic Indian residents from an initial list of 12,000 ethnic 
Indian names provided by the Ministry of Home Affairs. SINDI was conducted 
between March 2007 and December 2009 and recruited 3,400 participants with a 
response rate of 75%.  
 
Singapore Chinese Eye Study (SCES):121 Similar to SiMES and SINDI, the SCES 
was a population-based cross-sectional study of ethnic Chinese adults between 40-80 
years and residing in the South-western part of Singapore. SCES was conducted 





These cohorts are also followed-up at 5 years. The 5 year follow-up examinations for 
SiMES 2 were conducted between January 2011 to December 2013. Of a total of 
2636 eligible subjects, 1901 attended the follow-up (response rate=72%). ASOCT 
images were acquired from a larger number of individuals during this study visit. The 
5-year follow of the SINDI cohort is currently on-going and is expected to complete 
by June 2015. As of August 31, 2014, a total of 1371subjects have already been 
recruited. The recruitment for SCES 2 is scheduled to commence January 2015. For 
the 5-year follow-up visit, a person is considered ‘ineligible’ if the person is deceased 
or is terminally ill (e.g. terminal cancer), cognitively impaired, non-contactable, or 
have migrated to another country. 
   
Imaging, demographic data and DNA were also available from a population-based 
study in Beijing, China, the Beijing Eye Study (BES).  
Beijing Eye Study (BES):20 The BES was a population-based, cross-sectional study 
of Chinese subjects aged over 40 years and residing in seven communities: four 
communities in the urban district of Haidian located in the both of Central Beijing and 
three communities in the village area of Yufa of the Daxing District, located in the 
South of Beijing. At the time of the first survey in 2001, the seven communities had a 
total population of 5324 individuals aged over 40 years and deemed eligible to 
participate in the study. Of these, 4439 individuals took part in the study (response 
rate 83.4%). The 5-year follow-up study was conducted in 2006 and all the 
participants from the 2001 survey were invited to be re-examined. Blood samples 
were also taken during this time. A total of 3251 individuals participated in the 




Community-based Polyclinic Study:71, 122 In addition, imaging data of subjects 
recruited from a community-based cross-sectional study were also evaluated. In this 
study conducted between December 2005 and July 2006, a total of 2047 subjects over 
50 years of age were recruited from a government run polyclinic that provided 
primary health care services to residents living in the areas around the clinic.71, 122 In 
this study, subjects were identified by systematic sampling (every fifth patient 
registered at the polyclinic who met the study eligibility criteria). A detailed 
questionnaire was administered that included demographic and socioeconomic details, 
educational level, and medical and ocular history. Subjects with a known history of 
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  - 781 
SINDI 2* Ongoing Aug 2012 -   - 1047* 
SiMES= Singapore Malay eye Study; SINDI= Singapore Indian Eye Study; SCES= Singapore Chinese 
Eye Study; BES= Beijing Eye Study 





2.2 Clinical Examinations 
All the study subjects including both population-based and clinic-based, underwent 
standardized ocular examination and ASOCT imaging procedure.  Ocular 
examination include measurement of visual acuity, auto refraction, slit-lamp 
examination, intraocular pressure measurement by Goldmann application tonometry, 
stereoscopic optic disc examination, automated perimetry for visual field assessment, 
and gonioscopy performed in the dark using a Goldmann 2-mirror lens at high 
magnification. To further establish the presence or absence of peripheral anterior 




Visual Acuity and Auto-refraction: Visual acuity (uncorrected and best-corrected) 
was assessed using a logarithm of minimum angle of resolution chart (logMAR chart, 
Lighthouse Inc, Long Island, New York, USA) under standard lighting.  Subjects start 
reading at the 6/12 equivalent line (0.3) and if they were unable to read at least three 
letters they were then asked to read the line above. This process continued until at 
least three letters on one line was correctly read.  That line was then recorded as the 
visual acuity.  If the subject was able to read at least three letters on the first line, they 
then proceeded on to the next line below, until they were unable to read further down 
the chart. If a subject was unable to read the chart at 4m, the subject was moved to 2m 
and then 1m from the chart.  If they were still unable to see/achieve minimum 
recordable logMAR acuity, the vision was recorded as perception or non-perception 
of light.  
Refractive error was derived from the spherical equivalent of the subject’s average 
auto-refraction (Canon RK 5 Auto Ref-Keratometer; Canon, Inc, Ltd, Tochigiken, 
Japan).  
 
Slit lamp biomicroscopy: This was performed using a Haag Streit slit-lamp (Model 
BQ 900; Haag-Streit, Bern, Switzerland) to assess the conjunctiva, cornea, anterior 
chamber, lens, anterior vitreous and iris/pupil. Optic disc assessment and estimation 
of the vertical cup-to-disc ratio was done using a 78D lens.  
 
Intraocular pressure: The intraocular pressure (IOP) was measured using a 
Goldmann applanation tonometer (Haag-Streit, Switzerland) after administration of a 
single drop of topical anaesthetic (amethocaine hydrochloride 0.5%) into the inferior 
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conjunctival sac, and staining of the tear film with a dry strip of fluorescein. Care was 
taken to use just enough fluorescein to make the tonometer mires visible. 
 
Gonioscopy: Static and dynamic gonioscopy was performed to assess the anterior 
chamber angles. Under the lowest level of ambient illumination that permits a view of 
the angle and at high magnification (x 16 to x 25), the drainage angle was graded 
according to Shaffer’s convention in each quadrant. Under this convention, the angle 
width was graded ‘4’ for wide open with the ciliary body being visible, and ‘0’ when 
no angle structures were visible in the primary position. Slight tilting was permitted in 
the presence of convex iris profiles.  Dynamic indentation gonioscopy using a 
Sussman or Zeiss lens was used to detect peripheral anterior synechiae (PAS). 
 
Ocular Biometry: Ocular biometric measurements were assessed by A-Scan 
ultrasound or IOL Master. A-scan is a contact ultrasound method which measures 
axial length (AL), anterior chamber depth (ACD) and lens thickness (LT).  IOL-
Master is a non-contact optical device that measures AL and ACD. 
 
Optic Disc Imaging: Stereo-digital photographs of the optic disc were taken using 
digital fundus camera (Canon CR545NM/Nikon stereocamera) after dilatation. In 
population-based participants with narrow angles (and in whom LPI has not been 
performed), disc photos were taken without dilation.  
 
Visual Field Testing: Automated perimetry was performed with appropriate near 
refractive correction using the Humphrey Visual Field Analyzer II (model 750, Carl 
Zeiss Meditec, Dublin, CA). The Swedish Interactive Thresholding Algorithm was 
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used, and test reliability was determined by the following criteria: Fixation losses less 
than 33 %; false positive less than 20 %; and false negative less than 20 %. The visual 
field test was repeated once if deemed unreliable. 
 
2.3 ASOCT Imaging 
ASOCT imaging (Visante, Carl Zeiss Meditec, Dublin, CA) was performed for all 
study participants under standardized dark room conditions (0 lux), with the 
LCD/screen switched on. The ASOCT scans were centred on the pupil and images 
were captured along the horizontal axis i.e. nasal-temporal angles at 0 degrees-180 
degrees using the single-scan protocol. Care was taken to adjust the saturation and 
noise for each scan, and also to limit eyelid induced motion artifacts and image 
artifacts so as to obtain the best quality image for each participant. Figure 2.1 
illustrates the features that constitute a good quality ASOCT image. 
 





2.3.1 Principle of ASOCT  
The principle of ASOCT is similar to ultrasound but with the emission and reflection 
of light instead of sound. Low-coherence interferometry measures the delay and 
intensity of light reflected from tissue structures by comparing it to the light that has 
traversed a known reference path length by using a Michelson-type interferometer. 
This principle was originally employed for the retinal OCT using light of wavelength 
830 nm.123, 124 By altering the light to a longer wavelength of 1310 nm,125 it was later 
modified and refined to image the anterior segment.126 The longer wavelength 
increases the depth of penetration by reducing the amount of light scattered by the 
sclera and limbus; thereby allowing for visualization of the anterior chamber angle 
morphology in greater detail. The Visante ASOCT (Carl Zeiss Meditec Inc., Dublin, 
CA, USA) obtains scans at a rate of 2000 A-scans per second, with an axial and 
transverse resolution of 18 µm and 60 µm, respectively. It requires minimal 
experience for image acquisition.  
 
In comparison to the ultrasound biomicroscopy [UBM] another anterior segment 
imaging modality that necessitates contact with the eye, and allows visualization of 
only a single angle quadrant at a time, the major advantages of the ASOCT include: 
a. Ease of operation and rapidity of image acquisition.  
b. Non-contact method that eliminates patient discomfort and inadvertent compression 
of the globe, which is especially useful in the immediate post-operative period or after 
trauma. 
c. Allows view of both angles simultaneously and also an ability to assess the relative 
positions of the anterior segment structures. 
The development of customized image analysis software allows for quantitative 
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estimation of the various anterior segment parameters, including angle, anterior 
chamber and iris indices, lens and corneal thickness. The customized software are 
semi-automated and require the ASOCT images to be exported prior to analysis. To 
analyze the ASOCT images, we have used the Zhongshan Angle Assessment Program 
(ZAAP, Guangzhou, China) image analysis software jointly developed by researchers 
at the Singapore Eye Research Institute and the Zhongshan Ophthalmic Centre, 
Guangzhou, China.127 
 
2.3.2 Processing of ASOCT Images 
The images are stored in a JPEG format. The software automatically extracts the grey-
scale ASOCT images and after conditioning the noise and contrast, it produces a 
binary copy of the image. In the binary image, pixels are defined as 1s (tissue) and 0s 
(open space) based on a calculated brightness/ darkness threshold value. Basic edge 
arguments are used to describe the borders of the corneal epithelium, endothelium and 
anterior iris surface. The algorithm requires the subjective observer input of the 
location of the sclera spurs, following which the anterior chamber angles, iris, lens 
and anterior chamber parameters are automatically calculated. To facilitate detection 
of the sclera spur, the software also provides an ability to obtain a magnified view of 
the area of interest.  
 
2.3.3 Scleral Spur Identification in ASOCT Images 
Since the trabecular meshwork (the structure of interest for glaucoma) cannot be 
easily imaged on the ASOCT, therefore the scleral spur serves as the anatomical 
landmark for the trabecular meshwork. It has been histologically shown that the 
trabecular meshwork is located approximately 250 to 500μm anterior to the scleral 
46 
 
spur along the angle wall. 
In anterior segment imaging, sclera spur is identified as the point where there is a 
change in curvature of the inner surface of the angle wall, often appearing as an 
inward protrusion of the sclera128 (Figure 2.2). It sometimes appears as a highly 
reflective region. Non-visibility of the scleral spur can be due to several reasons. In 
open angles, the internal surface of the scleral wall can appear as a smooth continuous 
line with no inward protrusion of the sclera. In such cases, it becomes difficult to 
accurately identify the location of the scleral spur. In closed angles, the proximity of 
two highly reflective structures, sclera and iris, prevents the distinct appearance of the 
scleral spur.  
Sakata etal found that overall;129 scleral spur was visible in 72% of ASOCT images. 
However, in a quadrant-wise comparison, the scleral spur was detectable more 
commonly in the nasal and temporal quadrants (75-80%) compared to the superior 
and inferior quadrants (64-67%).129 Detection of scleral spur was also worse in 
quadrants with closed anterior chamber angles. With advances in imaging 
technologies, and availability of better quality images, the high exclusion rate due to 


















2.3.4 Anterior Segment Parameters Measured by ZAAP 
The quantitative anterior segment parameters measured by the ZAAP software are as 
follows (Figure 2.3): 
1. Angle parameters:  
a. Angle opening distance at 500μm from the sclera spur (AOD500): defined as 
the perpendicular distance between the trabecular meshwork and the iris at 
500μm anterior to the scleral spur. AOD250 and AOD750 are at 250μm and 
750μm from the sclera spur respectively.  
b. Trabecular iris space area at 500μm from the sclera spur (TISA500): defined 
as the trapezoidal area with the following boundaries: anteriorly, the AOD500; 
posteriorly, a line drawn from the scleral spur perpendicular to the plane of the 
inner scleral wall to the opposing iris; superiorly, the inner corneoscleral wall; 
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and inferiorly, the iris surface. TISA750 is at 750μm from the sclera spur 
c. Angle recess area at 500μm from the sclera spur (ARA500): defined as the 
triangular area bounded by the AOD 500 (the base), the angle recess (the 
apex), the iris surface, and the inner corneoscleral wall (sides of triangle). 
2. Anterior chamber parameters: 
a. Anterior chamber width (ACW): defined as the horizontal scleral spur-to-spur 
distance. 
b. Anterior chamber depth (ACD): the distance from the corneal endothelium to 
the anterior surface of the lens. 
c. Anterior chamber area (ACA): defined as the cross-sectional area of anterior 
segment bounded by endothelium, anterior surface of iris, and anterior surface 
of lens (within the pupil). 
d. Anterior chamber volume (ACV): the ACV is derived from ACA and it is 
generated by rotating the ACA 360° around the vertical axis through the 
midpoint (center) of the ACA. 
3. Iris parameters: 
a. Iris thickness 750 and 2000 are defined as the iris thickness measured at 750 
μm and 2000μm from the sclera spur, respectively. 
b. Iris curvature (ICurv): To calculate iris curvature, the software draws a line 
from the most peripheral to the most central points of iris pigment epithelium, 
and then a perpendicular line is extended from this line to the iris pigment 
epithelium at the point of greatest convexity. The perpendicular line is a 
measure of the ICurv. 
c. Iris cross-sectional area (IArea): It is calculated as the cumulative cross-




a. Lens vault (LV): defined as the perpendicular distance between the anterior 












2.3.5 Features of ‘Good software delineation’ on the ZAAP 
As illustrates in Figure 2.4, the features of ‘Good software delineation’ include 
well-defined borders of the corneal epithelium and endothelium, anterior lens surface 
and iris surface. The sclera spur-to-spur distance and ACD are also well defined.  
 
2.3.6 Limitations of the ZAAP software 
Inability to correctly identify the scleral spur remains the biggest limitation of the 
semi-automated ZAAP software. The other limitations include software delineation 
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errors as illustrated in Figure 2.5. In the figure, the anterior lens surface and ACD are 
inaccurately delineated. If such ‘software delineation error' occurs, the output 
generated by the software is discarded.  
 
2.3.7 Reproducibility of the ZAAP Software 
The reproducibility of the ASOCT measurements as obtained from the ZAAP 
software was performed on a random subset of 50 images by the same examiner 
(MEN) masked to the initial results.  
 












































2.4 Genome-wide Association Studies: Principle and Requisites of a Robust 
Study 
Genome-wide association study (GWAS) is an approach that involves scanning and 
analyzing DNA sequence variations (approx. 0.5 - 1 million) from across the human 
genome of a large number of people to find genetic variations associated with a 
particular disease or trait which is common in the population. The unit of genetic 
variation is the single nucleotide polymorphism or SNP.130 SNPs are single base-pair 
variations in the DNA sequence that occur normally throughout the human genome.  
They are common genetic variations among people,131 and on average occur once in 
every 300 nucleotides. Typically, a SNP has two alleles, which means that there are 
two commonly occurring base-pair possibilities for a particular SNP location. The 
frequency of a SNP in a particular population is given in terms of the minor allele 
frequency, or, the frequency of the less common allele.  
 
In a GWA study, the focus is to identify the association between these commonly 
occurring genetic variations or SNPs with a disease or trait. The ‘common disease/ 
common variants hypotheses’ states that the commonly occurring disorders in a 
population are influenced by the genetic variants that are also common in that 
population.132 
 
The International HapMap Project was designed to identify the genetic variants that 
occur across the genome.133 The HapMap is a catalogue of the common genetic 
variants that occur in humans. It describes the location of these variants in the DNA, 
and how they are distributed among individuals within populations, and also among 
different populations of the world.  
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SNP versus mutation 
SNP and point mutation are conceptually similar in that both indicate a change in the 
DNA sequence. Mutations are implicated in rare genetic disorders such as cystic 
fibrosis;134 the genetic variant induces a detrimental effect to the protein function that 
leads to the disease state. Mutations are very rarely occurring DNA sequence 
variation in the population, (frequency of <1%). SNPs on the other hand are 
commonly occurring base-pair changes where the frequency of variation at a 
particular locus in a population is at least 1-10%.  
 
2.4.1 Design and Conduct of GWA Studies 
There are several issues to consider when conducting a GWA study, including study 
design, selection of study participants, genotyping, quality control, replication and 
meta-analysis.   
 
2.4.1.1 GWA Study Designs 
There are two main primary types of GWA study designs. 
a. Case-control/ categorical studies. In this study design, allele frequencies in persons 
with the disease of interest (cases) are compared to those who are disease-free 
(controls). Both cases and controls are drawn from the same study population.135 
The cases and controls can either be matched or unmatched. Ideally some form of 
matching (such as age, gender) is desirable as it serves to improve efficiency and 
power of the study. However matching is not always practical. In an unmatched case-
control study, there is no specific requirement other than that controls should 
represent the population at risk of the disease. Therefore, to achieve adequate power 
large sample sizes are required.  
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b. Quantitative traits/ Population-based cohort studies for the assessment of continuous 
‘quantitative’ traits. Examples of quantitative traits include height, LDL cholesterol 
levels,136 central corneal thickness,137, 138 vertical cup-to-disc area.118 Some disorders 
have well established and easily measureable quantitative traits, whereas in others, the 
quantitative traits are not clearly demonstrable.  
Statistically, for common disorders, quantitative traits are preferred as the power to 
detect a genetic effect can be enhanced by evaluating the entire distribution of a trait 
rather than separating the same distribution into cases and controls. In the disorders 
with a relatively high prevalence rate in the population, there is a greater chance of 
contamination of the control group by the less extreme cases or ‘near cases’ which are 
those individuals that almost reach the diagnostic threshold for the disorder. Likewise, 
in those situations that use unselected controls, there is the possibility that some of the 
controls may indeed meet the diagnostic criteria for cases. 
 
Differences between Quantitative traits and Categorical study designs 
1. As elucidated above, a quantitative traits study design does not require an individual 
to be classified as ‘case’ or ‘control’. Many diseases have well defined and easily 
measurable quantitative traits; and others with complex clinical phenotypes may not 
have well-established quantitative traits. In such circumstances, the categorical 
approach is preferred and the cardinal component of such an approach is the use of a 
standardized clinical phenotype criteria. 
2. As with the likelihood of misclassification in the case/control status, some 
quantitative traits are also vulnerable to biases in measurements. It is therefore 
important to minimize the occurrence of such biases either by having a single rater for 
a rater-dependent measurement or having a high inter-rater agreement across multiple 
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sites.   
3. Statistical tests: Logistic regression analysis is used for categorical traits; and linear 
regression is used to test each SNP for association between the trait values and 
genotype in quantitative trait analysis.   
4. Quantitative traits analysis may be performed in the population-based studies where 
multiple quantitative measurements have been collected and where genome-wide data 
is available whereas for a categorical approach the additional collection of clinical 
cases is required. 
5. Quantitative GWA studies may help uncover plausible biological pathways and 
mechanisms by which the genes affect the disorder. 
 
2.4.1.2 Selection of Study Subjects 
The implementation of standardized and consistent diagnostic/phenotype criteria for 
selection of cases is of prime importance in GWA studies since misclassifications can 
markedly affect power and study results.135 For example, the misclassification of a 
large number of unaffected individuals as affected may tilt the results towards no 
association.139 Success therefore depends on the accurate ascertainment of affection 
status. Focusing either on extreme or familial cases can minimize heterogeneity. 
 
Controls should be drawn from the same population as the cases.135 In situations 
where the disease of interest has a high prevalence rate in the population, additional 
efforts should be made to minimize misclassification bias and ensure that the controls 
selected are truly disease free. In such circumstances of high disease prevalence, it is 
not desirable to use common population controls; the use of super-controls or persons 




Genome-wide genotyping of SNPs were made possible by the availability of chip-
based microarray technology. There are two major platforms for assaying SNPs: 
Illumina (San Diego, CA) and Affymetrix (Santa Clara, CA). Considerations for the 
selection of genotyping platform include genomic coverage, cost, population of 
interest (African, European, Asian etc), and the capacity for imputation.142  
 
2.4.1.4 Quality Control 
Stringent per-sample and per-SNP quality control measures are absolutely crucial 
otherwise false positive or spurious associations can dominate the tail end of test 
statistic distribution. To avoid systematic differences arising from the way the 
samples are handled, the collection of biological samples, DNA extraction, storage 
and subsequent genotyping should ideally be performed in the same manner for all 
samples (including cases and controls).  
 
Sample quality control measures include checks on sample identity to avoid mix-up, 
and sample-to-sample contamination (excessive heterozygosity). Related samples 
(cryptic relatedness) are removed since increased allele sharing among relatives can 
also produce erroneous association results. Individuals mismatched for sex are also 
removed. Samples that fail the minimum rate of genotyped SNPs per sample (usual 
threshold is ~90% of SNPs attempted) are removed. Low individual genotyping rates 
are generally due to poor quality DNA or low concentration.143 These samples are 
removed since the genotypes obtained for the other SNPs may be incorrect. Another 
potential cause of false negative findings of association can be attributed to 
confounding resulting from population stratification.  
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Population structure/ population stratification: This is a form of confounding in 
genetic association studies where the genetic differences between cases and controls 
are not related to the disease, but occur as a result of sampling them from populations 
of different ancestries.144 Ideally each case should have a genetically matched control 
as visualized using Principal component analysis (PCA). Programs such as Eigenstrat 
are used to perform PCA.145 Ancestry outliers should be removed. Correction for 
stratification includes genomic control where the ‘inflation factor’ λ is used to correct 
all p-values, and the principal components of each individual are also included as 
covariates in the tests for association.  
 
Further checks for genotyping errors are then performed for the individual SNPs of 
the remaining samples. The filters for genotyping errors include call rate across all 
samples, minor allele frequency, Hardy-Weinberg Equilibrium, cluster plot and q-q 
plot inspection. Quality control have been performed using the program PLINK.146 
 
SNP Call rate: This is the proportion of samples for which a SNP can be measured. 
The typical threshold is >95%. This means that SNPs which are missing in >5% of 
the samples are excluded.  
Minor allele frequency (MAF): This is the proportion of the less common of the 2 
alleles (of a particular SNP) in the population. MAF ranges between <1% to <50%. 
SNPs with very low MAF (~1-3%) are excluded. Rare SNPs (i.e. with very low 
MAF) of large effect may be important in some complex diseases, however such rare 
SNPs may cause spurious association signals if they are present in one group (e.g. 
cases) but not in another (e.g. controls), and the difference in frequency are more 
likely due to chance.  
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Hardy-Weinberg Equilibrium (HWE): In a population, the distribution of alleles and 
genotypes are stable (i.e. in equilibrium). If p and q are the frequencies of the two 
alleles (A and G) of a SNP, then the genotypes occur at frequencies of p2, 2pq, and q2 
for the major allele homozygote (AA), heterozygote (AG), and minor allele 
homozygote (GG), respectively.  
SNPs are inspected for evidence of HW disequilibrium. Gross departure from the 
HWE can indicate genotyping errors, or non-random mating or selection.  
As departure from HWE can occur due to true association where certain genotypes 
are over represented in cases, therefore, in a GWA study, HWE tests are generally 
assessed only in the controls where such departures are most usually due to poor 
genotyping. Departures from HWE in cases should be checked for the SNPs that show 
association to verify that the departure is in the expected direction of the genotyping 
association/over-representation.  
SNPs with low HW p-value (~<10 6) are excluded. 
 
2.4.1.5 Association Analyses and Correction for Multiple Testing 
Association analyses are performed after all the quality control steps are completed. 
The statistical test applied is different for quantitative traits and case-control studies. 
For quantitative traits, a linear regression model is used; and dichotomous case-
control studies are analyzed using logistic regression models.  The association can 
also be tested under different genetic models (dominant, recessive, additive, and 
multiplicative).147 Additional covariate adjustments for age, gender, clinical 
covariates and principle components145 are also incorporated to reduce spurious 




Correction for multiple testing: In a GWAS, hundreds of thousands to millions of 
tests are conducted, with each test having its own false positive probability (alpha 
value, nearly always set to 0.05). The collective likelihood of finding one or more 
false positive association is therefore much higher. To correct for the multiple tests, 
Bonferroni correction is applied.148 The assumption in the Bonferroni approach is that 
each association test is independent of all other tests. The Bonferroni correction 
adjusts the alpha value from α=0.05 to α=0.05/k, where k is the number of statistical 
tests conducted. For a GWAS that use 1 Million SNPs, the statistical significance of a 
SNP association would then be set at 5x10-8.  
Therefore, instead of the usual threshold of p=0.05, in a GWAS a critical threshold of 
5x10-8 is set as the genome-wide significance level. 
 
2.4.1.6 Visualization and Interpretation of Results 
Cluster plot and quantile-quantile (q-q) plot inspection: Cluster plots should be 
manually inspected for all top SNPs. Ideally homozygotes for either allele as well as 
heterozygotes carrying both alleles should be clearly distinguished from each other.  
 
The q-q plot is produced by plotting the observed p-values of the test statistic against 
their expected values under null hypothesis (represented as the diagonal line). 
Deviations from the diagonal line give an indication of the quality of the data in terms 
of population stratification and the strength of associations detected. Please see Figure 
4.2.4 for an illustration of q-q plot.    
 
Manhattan plot: This plot displays the association results where the -log10 of the p-
values generated by the association analysis are plotted against chromosomal location. 
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The Manhattan plot allows visualization of interesting association signals against 
background signals. Please see Figure 4.2.5 for an illustration of Manhattan plot. 
Both q-q and Manhattan plots can be generated from PLINK output files using 
programs such as Haploview or R. 
 
2.4.1.7 Replication and Meta-analysis 
Replication of results in independent population samples is a requisite for any genetic 
finding. Usually, a small subset of SNPs that surfaced from the ‘discovery’ GWAS is 
carried forward for replication. A variety of criteria are involved in the definition of 
‘replication’ of a GWAS result.149 This includes the evaluation or study of the same 
phenotype, and demonstration of a similar magnitude of effect and significance (same 
genetic model and same direction of effect) for the same SNP and allele as the initial 
‘discovery’ finding. Replication should have adequate sample size to detect the effect 
of the susceptible allele. If possible, replication should be performed on independent 
samples drawn from the same population. However, replication in additional 
populations allows for generalization of effect. Absence of genome-wide replication 
data can be a problem as it limits the ability to assess confounding population 
structure.  
SNP Replication-Sequenom: The Sequenom system allows for up to 34 SNPs to be 
typed simultaneously in a multi-plex assay. Generally 26-SNPs per pool is used or 
recommended for optimal results. For SNP genotyping, the components of each 
Sequenom assay (per-SNP) include forward polymerase chain reactions (PCR) 
primer, reverse PCR primer, and extension primer. Genotype assays for a given SNP 
is designed using Sequenom’s in-house software. The extended products are then 
spotted onto a Sequenom chip, and using Matrix-Assisted Laser Desorption/Ionization 
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Time-Of-Flight (MALDI-TOF) mass spectrometry the distinct mass of the extended 
primer identifies the SNP allele. With the MALDI-TOF mass spectrometer, which 
differentiates molecular mass, one can differentiate the SNP alleles by the different 
molecular weights of the allele-specific products.  The different product sizes are then 
translated into genotype calls on the SpectroTYPER-RT software (Sequenom 
software).  
 
The results of multiple GWA studies, or results from discovery and replication 
cohorts, can be pooled together for meta-analysis. Several software packages are 
available to facilitate meta-analysis, including METAL, STATA and GWAMA.  
The I2 index is a measure of study heterogeneity.150 This index represents the 
approximate proportion of meta-analysis variability that is attributed to heterogeneity 
between studies. The I2 values are categorized into low (<25), medium (>25 and <75) 
and high (>75) heterogeneity.      
 
2.4.1.8 Refining Genome-wide Association Signals 
The identification of a robustly replicated SNP is the crucial initial step in identifying 
disease or trait causing variant. The association analysis identifies the genomic 
location/signals that are related to the disease/trait, but not necessarily the functional 
or causal genetic variants. Identification of these causal variants is essential for 
understanding the biological process that underlies disease pathogenesis; however, 
this is a difficult task that does not guarantee a fruitful outcome in all cases. Some of 
the processes include fine mapping and resequencing of an established associated 
region,135 expression of the gene variant in tissue samples or cell lines, genetic 
manipulation in cell or animal models.151   
62 
 
2.4.2 Limitations of Genome-wide Association Studies 
Important limitations of GWA studies include the potential for false positive 
associations, requirements of a large sample size, potential biases due to sample 
selection, and lack of information on gene function. Some of the limitations can be 
minimized by following stringent diagnostic criteria for selection of individuals and 
following robust quality control measures.  
 
2.5 Genotyping and Statistical Analysis:  
Genotyping in our population-based sample collections (namely SiMES,120 SINDI,121 
SCES,121 and BES120) were performed using the Illumina 610K Quad Bead Chips. 
The Illumina Human610-Quad BeadChips assays 620,901 SNPs across the entire 
genome. 
 
We followed a selection of stringent quality control (QC) criteria to remove poorly 
performing SNPs and samples. SNPs that had missingness >5%, gross departure from 
Hardy–Weinberg equilibrium (HWE) (P-value<10-6) or were monomorphic were 
excluded from subsequent analysis. Samples with an overall call rate <95% were 
excluded from analysis. Samples were subjected to biological relationship verification 
by using the principle of variability in allele sharing according to the degree of 
relationship. Identity-by-state information was derived by PLINK.146 Those 
individuals who showed evidence of cryptic relatedness (possible either due to 
duplicated or biologically related samples) were removed before PC analysis was 
performed. 
PC analysis was undertaken using EIGENSTRAT145 to account for spurious 
associations resulting from ancestral differences of individual SNPs. PCs showing 
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significant effect on univariate analysis were used to correct for any underlying 
population substructure. Lastly, samples showing gender discrepancies between the 
clinical gender and genetically inferred gender were removed. 
It is to be noted that for the SiMES and SINDI cohorts, genotyping was performed on 
the blood samples that were collected during their baseline examination; while the 
ASOCT images were collected at their 5-year follow-up visit since they were not 
available at the baseline visit. 
PLINK: 146This is a free, open-source whole genome association analysis toolset, 
designed to perform a range of basic, large-scale analyses in a computationally 
efficient manner. PLINK is being developed at the Center for Human Genetic 
Research (CHGR), Massachusetts General Hospital (MGH), and the Broad Institute 
of Harvard & MIT. 
 The PLINK software was used for primary association testing. Individual genotypes 
were coded according to the number of copies of the variant allele present: 0 for the 
wild-type genotype, 1 for heterozygotes and 2 for homozygote variants. A trend test 
incorporated within a linear regression model was used for primary association testing 
between genotypes and the quantitative trait, adjusting for age and gender. 
 
R Software: R is available as Free Software (www.r-project.org). R is a language and 
environment for statistical computing and graphics. It provides a wide variety of 
statistical (linear and nonlinear modelling, classical statistical tests, time-series 
analysis, classification, clustering, etc) and graphical techniques.  





METAL: The METAL software is a tool for meta-analysis of genome-wide 
association datasets in a convenient, rapid and memory efficient manner. It was 
developed by Goncalo Abecasis, Yun Li and Cristen Willer in 2007.152 
The per-SNP meta-analyses were performed by METAL software with weighted 
inverse-variance approach, assuming fixed effects. A Cochran’s Q test was used to 
assess heterogeneity.  
 
Quanto Program: Quanto, developed at the University of California, is a program to 
compute sample size or power for association studies of genes, gene-environment 
interaction, or gene-gene interaction. The available study designs include the matched 
case-control, case-sibling, case-parent, and case-only designs. 

















IMAGING-BASED RISK FACTORS FOR ANGLE CLOSURE 
3.1 BACKGROUND 
Angle closure results from obstruction of the trabecular meshwork (by the iris) to the 
outflow of aqueous in the angle of the eye, causing an increase in intraocular pressure 
(IOP). Previously reported anatomical risk factors for angle closure include a shallow 
central anterior chamber depth (ACD), a thick and anterior lens position and short 
axial length (AL).70, 71, 153, 154
 
Amongst these, a shallow ACD is regarded as an 
important risk factor for the disease. However, population based data suggest that 
only a small proportion of subjects with shallow ACD ultimately develop PACG.155, 
156  Therefore, it is likely that other ocular factors relate to PACG development. The 
crystalline lens is thought to play a crucial role in the pathogenesis of angle closure 
disease either due to an increase in its thickness with age or a more anterior position 
causing a decrease in ACD.
 
The result is angle crowding and a greater predisposition 
to pupillary block due to iridolenticular apposition in eyes with small anterior 
segments.  
Lens position (LP) and relative lens positions (RLP) are axial measurements derived 
from ACD, AL and lens thickness (LT). Lens position is defined as ACD+1/2LT; and 
RLP is a ratio of LP and AL. However, there are contradictory reports on the 
importance of the various lens parameters with angle closure; with some studies 
reporting a greater tendency for angle closure eyes to have lower values of LP and 
RLP (i.e. more anteriorly located lens) and other studies reporting no such 
associations.68, 69, 78, 157-159 Tomlinson and Leighton68 evaluated the LT and RLP in 
subjects with angle closure, their siblings and offspring; and compared them to age 
and gender matched normal. The lens was thicker and more anteriorly placed in 
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subjects with angle closure, however only the LT was significantly different between 
both siblings and offspring of angle closure, compared to normal. Lowe69 also noted 
that angle closures eyes were characterized with a more anteriorly placed and thicker 
lens compared to normal; the findings were similar to the results of a study conducted 
by Marchini and colleagues157 in a Caucasian population. In a study on the biometric 
parameters in family members of patients with PACG, Sihota et al78 found that the 
ACD was shallowest, AL shortest and lens thickest in family members with PACG 
compared to family members who were either unaffected or were angle closure 
suspects. The lens position however was not significantly different between the three 
groups.78  
Previous studies have also shown that demographic factors such as women and 
Chinese have greater risk for angle closure.70, 160
 
A recent study conducted in 
Singapore investigated the determinants of angle closure and found that while the 
most important independent determinants of angle closure were female gender, 
Chinese race, shorter AL and shallower ACD; racial and gender differences in risk of 
angle closure were not fully explained by variations in AL or ACD,71, 75
 
confirming 
that other factors are involved in the predilection towards development of angle 
closure. 
 
With the emergence of the non-invasive non-contact imaging technology ASOCT, it 
is now possible to acquire high-resolution cross-sectional images of the anterior 
segment structures in-vivo in a single image (Please see Figure 2.3, Chapter2). 
ASOCT imaging also allows one to perform quantitative, novel measurements of the 
structures of the anterior segment and to assess potentially new ocular parameters 
which were previously not easily discernible either clinically by slit-lamp 
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biomicroscopy, or by ocular biometric measurement using A-scan ultrasonography. 
An ability to identify new ocular biometric parameters associated with angle closure 
could provide/lead to a better understanding of non-pupil block mechanisms, and risk 
factors that contribute to the pathogenesis of angle closure. 
Regarding the role of the lens, we hypothesize that it is the degree of the lens that is 
located anterior to the plane of the anterior chamber angles (rather than the entire lens 
thickness) that contribute to the pathogenesis of angle closure. The magnitude of this 
parameter, known as the lens vault (LV) can be accessed from ASOCT images. It is 
defined as the perpendicular distance between the anterior pole of the crystalline lens 
and the horizontal line joining the two scleral spurs in an ASOCT image (Figure 
3.1).. The line joinging the two scleral spurs is also known as the anterior chamber 
width (ACW) (Figure 3.1).  
 
 
Figure 3.1 ASOCT image illustrating the measurement of Lens vault and 







In this chapter, we investigate the association of these novel ASOCT-based 
parameters, namely LV and ACW with angle closure. We also assessed the impact of 
the LV on visual acuity and refractive error, and compared the newly identified novel 
ASOCT parameters in different subtypes of angle closure. We were fortunate that we 
could validate the role of the LV in another ethnic group, the Japanese. Our 
collaborators in Japan (with who we collaborate for our genetic studies) so kindly sent 
ASOCT images of Japanese angle closure cases and normals. We processed and 
analyzed these images and performed the analysis for validation of our findings. 
In addition, we also evaluated the distribution and association with angle closure of 
two recently described ASOCT parameters: the anterior vault, which represents the 
sum of the LV and the ACD, and the relative LV, which represents the ratio of the LV 
















3.2 SUBJECTS AND METHODS 
For the evaluation of the associations between the ASOCT parameters and angle 
closure, we have utilized data obtained from both population and community-based 
subjects as well as hospital-based angle closure subjects.  
3.2.1 Study Populations 
Please see Chapter 2, Section 2.1 for the recruitment details of the Study Populations. 
Below is a brief description of the subjects that were included for the imaging-based 
risk factor analyses: 
1. Population based study: Normal controls were selected from within the subjects 
recruited in a population-based study of Chinese adults aged over 40 years 
(Singapore Chinese Eye Study, SCES),121 based on robust clinical criteria. A 
normal control was defined as having an IOP<21 mmHg with gonioscopically 
open angles in all quadrants, healthy optic nerves and normal visual fields, and no 
previous intraocular surgery. At the time of the analysis, the population-based 
study was ongoing and the controls selected were consecutive subjects who 
fulfilled the clinical criteria. For the analysis on the LV, complete data was 
available for 176 consecutive population-based normal controls. 
2.  Community-based Polyclinic study: A total of 2047 subjects were recruited. Of 
these, incomplete clinical or imaging data were not available for the following 
reasons: 11 subjects could not undergo gonioscopy; 15 subjects could not undergo 
visual acuity examination; 87 could not undergo refraction; 62 subjects could not 
complete ASOCT examination or had poor quality ASOCT images; 42 subjects 
had software delineation errors; and 467 subjects had a scleral spur that was not 




3. Hospital based angle closure subjects: These subjects were recruited from 
glaucoma clinics of the Singapore National Eye Center, and included PACS, PAC, 
PACG, and previous APAC. Please see Chapter 1, section 1.1.1 ‘Classification of 
Angle closure’ for the detailed definition of these different subtypes of angle 
closure. Subjects with previous cataract or glaucoma surgery were excluded from 
the study, but all the subjects have previously undergone peripheral laser 
iridotomy. 
 
4. Japanese angle closure cases and controls: We collaborated with our 
collaborators Dr. Ozaki and Dr. Mizoguchi for collection of ASOCT and 
biometric data. They sent us the raw ASOCT images, which were then processed 
and analyzed here in Singapore. The subjects were recruited from two hospitals in 
Kyushu, Japan, namely Mizoguchi Eye Clinic, Sasebo, Japan and Ozaki Eye 
Hospital, Miyazaki, Japan. The control group of normal subjects (defined as IOP 
 21 mm Hg with open angles, healthy optic nerves, normal visual fields, with no 
previous surgery or family history of glaucoma) was recruited from amongst those 
attending general ophthalmology clinics in the two hospitals.   
 
3.2.2 Clinical Examinations and Biometry  
All the subjects underwent detailed ocular examination including measurement of 
visual acuity, slit-lamp examination, an assessment of the optic disc, the intra-ocular 
pressure, and gonioscopy (including indentation gonioscopy). Details of the ocular 
examination are elucidated in Chapter 2, under the section 2.2 ‘Clinical 
examinations’.  
An eye was considered to have angle closure if the posterior pigmented trabecular 
meshwork was not visible for at least 180 degrees (≥270 degrees for the Japanese 
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cases) on non-indentation gonioscopy with the eye in the primary position. 
Measurement of height and weight were performed only for the community-based 
subjects, and was used for the estimation of Body Mass Index (BMI). 
A-scan biometry was performed to obtain measurements of ACD, LT and AL; and 
they were used to calculate LP (defined as ACD + 1/2LT) and RLP (defined as 
LP/AL).  
 
Classification of visual impairment  
For all subjects, their logMAR visual acuity was classified as normal vision/minimal 
visual impairment (logMAR <0.3), mild visual impairment (0.3 < logMAR < 0.6), 
moderate/severe (logMAR > 0.6) visual impairment.  These classes are based on 
similar stratification used in previous studies.161, 162 
 
3.2.3 ASOCT imaging and analysis 
A standard protocol for acquisition and evaluation of ASOCT images was followed 
for all subjects. This is outlined in section 2.3 ‘ASOCT imaging’ of Chapter 2. In 
brief, ASOCT images were obtained under standardized light conditions after 
adjusting for saturation and noise. A single cross-sectional horizontal ASOCT image 
was analyzed for each subject using the Zhongshan Angle Assessment Program 
(ZAAP).127 As stated previously, the LV was defined as the perpendicular distance 
between the anterior pole of the crystalline lens and the horizontal line joining the two 
scleral spurs. Positive values of this parameter indicate that the anterior pole of the 
lens is located anterior to the plane of the scleral spurs; and negative values indicate 




3.2.4 Sample size estimation 
As the LV is a novel parameter, we therefore used the differences in Lens thickness 
between angle closure and controls for the estimation of sample size.80 To achieve 
91% power to detect a difference of 0.2 between the null hypothesis that both group 
means are 4.62mm and the alternative hypothesis that the mean of group 2 is 4.43mm 
with known group standard deviations of 0.30mm and 0.13mm and with a 
significance level (alpha) of 0.05 using a two-sided two-sample t-test, the total 
number estimated for each group of a case-control study was 32. 
Likewise, ACW is also a novel parameter, hence differences in horizontal corneal 
diameter between angle closure and controls was used for the estimation of sample 
size.80 To achieve 80% power to detect a difference of -0.2 between the null 
hypothesis that both group means are 11.53mm and the alternative hypothesis that the 
mean of group 2 is 11.68mm with known group standard deviations of 0.34mm and 
0.31mm and with a significance level (alpha) of 0.05 using a two-sided two-sample t-
test, the total number estimated for each group of a case-control study was 74. 
 
3.2.5 Statistical Analyses 
The statistical analyses were performed using the statistical software SPSS version 17 
(SPSS, Inc., Chicago, IL) and IBM SPSS Statistics for Windows (Version 21.0. 
Armonk, NY: IBM Corp). One eye per subject was evaluated. The right eye was used 
for the population and community based subjects. In the case of the hospital-based 
angle closure subjects, the study eye was randomly selected for bilateral cases, 
whereas the affected eye was used in unilateral cases. A p-value <0.05 was considered 
statistically significant.  
I. For parametric data, the differences in mean values were assessed by the 
73 
 
independent samples Student t-test; and for non-parametric data, the Mann-
Whitney U test was used. For categorical variables, Chi-square test was used. 
II. The associations between LV and ACW and the presence of angle closure were 
evaluated using logistic regression models to determine the odds ratio (OR) 
and 95% confidence interval (CI). For LV, multivariate adjusted OR adjusted 
for age, gender, LT, and RLP were obtained. For ACW multivariate analyses, 
two models were assessed: adjusting for age, gender, and AL in one model; 
and adjusting for age, gender, and ACD in the other model. 
III. The performances of the various biometric and ASOCT-based parameters in 
detecting angle closure were assessed after generating the receiver operator 
characteristic curves and the area under the receiver operator characteristic 
curve (AUC). The sensitivity and specificity were also calculated by using the 
optimal cutoff point as given by the maximum of the Youden index, calculated 
as J=max (sensitivity+specificity-1).  Youden index is a measure of the 
effectiveness of a diagnostic marker (parameter) and enables the selection of 
an optimal threshold value (cut-off point) for the marker (parameter). 
IV. For comparison among different subtypes of glaucoma, an analysis of variance 
(ANOVA) with Bonferroni method for multiple comparisons was used. 
V. To examine the relationship between visual acuity and LV, and that between 
spherical equivalent and LV, the mean visual acuity and spherical equivalent 
were assessed according to the degree of LV stratified by quartiles. We 







We first describe the results of the association of the various lens parameters, namely 
LV, LT, LP, and RLP with respect to angle closure by comparing eyes of subjects 
with angle closure to those with open angles; followed by the investigation of the 
relationship between LV, visual acuity and refraction in subjects with angle closure. 
We then describe the association of LV with angle closure in Japanese subjects. Next, 
we evaluated the distribution and determinants of ACW in a large sample of subjects 
recruited from a community clinic, evaluated the relationship of ACW with angle 
closure, and compared ACW measurements from this sample with those obtained 
from a hospital-based sample of subjects with angle closure. And finally, we 
investigate the distribution and relationship of AV and relative LV with angle closure; 
and compared the various ASOCT and biometric parameters in patients with different 














3.3.1 LENS VAULT, THICKNESS AND POSITION IN ANGLE CLOSURE 
This was a comparative study of Chinese subjects with angle closure recruited from 
glaucoma clinics and normal controls recruited from a population-based 
epidemiological eye study. 
Sample size estimation: c 
A total of 102 angle closure subjects (including of 29 PAC, 53 PACG and 20 APAC) 
and 176 normal controls were evaluated in the study. The subjects ranged in age from 
47 to 91 years in the angle closure group, and 44 to 81 years in the normal. The angle 
closure subjects were significantly older (65.3±9.1 years versus 54.2±7.9 years; 
p<0.001) and comprised of more females (66.7% versus 46.6%) compared to normals. 
 
 3.3.1.1 Distribution of the lens parameters by decades of age 
Table 3.3.1 shows the distribution of the lens parameters in the normal subjects. The 
LV was noted to increase significantly with advancing age (p for trend <0.001). The 
results were largely similar when the analysis was performed separately for males and 
females. Within the narrow age range of this study, we found no significant trend with 
age for LT and RLP (p=0.558 and p=0.652 respectively). Comparing between gender, 
women were noted to have significantly greater LV compared to men (379 µm versus 
260 µm; p=0.003). However, no significant gender differences were noted for LT 








Table 3.3.1: Distribution of Lens Vault, Lens Thickness, and Relative Lens Position in Subjects 
with Open Angles 
 Lens Vault Lens Thickness Relative lens Position 
AGE N Mean (SD) (µm) N 
Mean (SD) 
(mm) 
N Mean (SD) (mm) 
All persons                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
All ages 176 316 (272) 176 3.90 (0.73) 176 0.20 (0.02) 
≤ 54 years 105 265 (258) 105 3.90 (0.65) 105 0.20 (0.02) 
55-69 years 63 366 (281) 63 3.87 (0.81) 63 0.21 (0.02) 
≥ 70 years 8 581 (140) 8 4.06 (1.06) 8 0.20 (0.02) 
p for trend  0.001  0.558  0.652 
Men 
All ages 94 260 (276) 94 3.93 (0.69) 94 0.21 (0.02) 
≤ 54 years 54 214 (265) 54 3.92 (0.62) 54 0.21 (0.02) 
55-69 years 35 289 (285) 35 3.94 (0.76) 35 0.21 (0.02) 
≥ 70 years 5 554 (71) 5 4.01 (1.04) 5 0.20 (0.02) 
p for trend  0.008  0.803  0.718 
Women 
All ages 82 379 (254) 82 3.86 (0.77) 82 0.20 (0.02) 
≤ 54 years 51 319 (240) 51 3.88 (0.69) 51 0.20 (0.02) 
55-69 years 28 462 (249) 28 3.78 (0.87) 28 0.20 (0.02) 
≥ 70 years 3 626 (232) 3 4.16 (1.33) 3 0.20 (0.03) 
p for trend  0.037  0.556  0.715 





3.3.1.2 Comparison between Angle closure and Normals 
When compared to normal eyes, the eyes with angle closure were found to have 
significantly shallower ACD (2.66±0.4 mm versus 2.95±0.4 mm; p=<0.001), shorter 
AL (22.86±0.9 mm versus 23.93±1.4 mm; p<0.001), greater LV (901±265 um versus 
316±272 um, p=<0.001, and thicker lens (4.20±0.9 mm versus 3.90±0.73 mm, 
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p=0.01).There were no significant differences for LP (4.76±0.5 mm versus 4.90±0.5 
mm, p=0.34) or RLP (p=0.15) (Table 3.3.2). 
 
3.3.1.3 Association of the parameters with angle closure 
In order to quantify the association of these parameters with the presence of angle 
closure, we performed a logistic regression to determine the odds ratio. After 
multivariate analysis adjusted for age, gender, ACD, LT, and RLP, we found that  
increased LV was associated significantly with angle closure (OR, 48.1; 95% CI, 
12.8–181.3, comparing lowest with highest quartile; Table 3.3.3), but no association 
was found for LT (OR, 1.78; 95% CI, 0.76– 4.16), LP (OR, 1.94; 95% CI, 0.59 – 
6.31), or RLP (OR, 2.08; 95% CI, 0.66–6.57).  
 
 
Table 3.3.2: Comparison of Biometric parameters between Angle Closure and Normal Control 
Measures 
Angle closure 
Mean (SD)  
(n=102) 
Normal Controls 
Mean (SD)  
(n=176) 
Mean difference*  
(95% CI) 
   P value 
ACD (mm) 2.66 (0.37) 2.95 (0.37) -0.24 (-0.34, -0.13) <0.001 
AXL (mm) 22.86 (0.93) 23.93 (1.37) -0.88 (-1.23, -0.52) <0.001 
LT (mm) 4.20 (0.92) 3.90 (0.73) 0.30 (0.08, 0.56) 0.010 
LP (mm)  4.76 (0.51) 4.90 (0.54) -0.08 (-0.23, 0.08) 0.342 
RLP  0.21 (0.02) 0.20 (0.02) 0.005 (-0.002, 0.012) 0.149 
LT/AL ratio 0.18 (0.04) 0.16 (0.03) 0.02 (0.01, 0.03) <0.001 
LV (µm) 901 (265) 316 (272) 503 (425, 581) <0.001 
*Adjusted for age, gender. 
ACD= Anterior Chamber Depth; AL= Axial Length; LT= Lens Thickness; LP= Lens Position; RLP= 






Table 3.3.3: Relationship of Lens Vault, Lens thickness, Lens Position, and Relative Lens 








Age and Gender 
Adjusted 
OR (95% CI) 
Multivariate 
Adjusted+ 
OR+ (95% CI) 
Lens vault 
       1 (-278 to 226) 69 0 (0.0) -- -- 
       2 (226 to 492) 70 5 (7.1) 1.00 1.00 
       3 (492 to 818) 70 36 (51.4) 8.43 (2.88, 24.67) 7.38 (2.41, 22.63) 
       4 (818 to 1607) 69 61 (88.4) 57.25 (16.94, 193,49) 48.13 (12.78, 181.32) 
Lens thickness 
       1 (2.30 to 3.37) 70 23 (32.9) 1.00 1.00 
       2 (3.37 to 4.06) 69 18 (26.1) 0.98 (0.41, 2.37) 1.20 (0.46, 3.09) 
       3 (4.07 to 4.66) 70 21 (30.0) 1.31 (0.55, 3.09) 1.54 (0.60, 4.00) 
       4 (4.67 to 5.77) 69 40 (58.0) 2.48 (1.11, 5.57) 1.78 (0.76, 4.16) 
Lens position 
1 (4.84 to 4.48) 69 25 (36.2) 1.00 1.00 
2 (4.49 to 4.88) 70 35 (50.0) 3.23 (1.37, 7.62) 2.99 (1.23, 7.32) 
3 (4.89 to 5.22) 71 28 (39.4) 1.43 (0.61, 3.36) 1.93 (0.74, 5.05) 
4 (5.22 to 6.19) 68 14 (20.6) 0.65 (0.26, 1.63) 1.94 (0.59, 6.31) 
Relative lens position 
       1 (0.150 to 0.189) 69 24 (34.8) 1.00 1.00 
       2 (0.190 to 0.207) 71 26 (36.6) 1.00 (0.43, 2.36) 0.84 (0.33, 2.12) 
       3 (0.208 to 0.223) 70 21 (30.0) 1.30 (0.56, 3.02) 1.56 (0.60, 4.09) 
       4 (0.224 to 0.290) 68 31 (45.6) 1.23 (0.53, 2.82) 2.08 (0.66, 6.57) 











3.3.1.4 Correlation among the parameters 
We next evaluated the correlation among the various lens parameters. Lens vault and 
LT were poorly correlated (Pearson’s correlation coefficient [PCC], 0.17), as were LV 
with RLP (PCC, 0.08; Figures 3.3.1 and 3.3.2) and also LV with LP (PCC, –0.20). 
However, LT and RLP were found to be fairly correlated (PCC, 0.70; Figure 3.3.3), 
as were LT and LP (PCC, 0.68).  
 
 





















3.3.1.5 Performance characteristics for detection of angle closure 
The performance characteristics of lens parameters for detecting subjects with angle 
closure are summarized in Table 3.3.4. Among them, LV had the highest AUC (0.94; 
95% CI, 0.91– 0.97) of distinguishing gonioscopic angle-closure from open-angle 
eyes, with a sensitivity of 88.2%, and specificity of 87.5%, whereas the AUC of the 
other lens parameters ranged from only 0.58 to 0.66.  
The reproducibility of the LV measurements was excellent with a within-subject 
standard deviation of 62.7µm, a within- subject coefficient of variation of 6.4%, and 








Table 3.3.4: Area Under the Receiver Operating Characteristic Curve, sensitivity and Specificity 
for Axial length, Anterior chamber Depth and Lens parameters for Detecting Angle Closure 
Measures AUC (95% CI) Optimal 
Cutoff 
Point* 
Sensitivity† (95% CI) Specificity† (95% CI) 
ACD 0.75 (0.69, 0.81) 2.72 0.80 (0.75, 0.85) 0.68 (0.62, 0.73) 
AXL 0.74 (0.68, 0.80) 23.34 0.63 (0.57, 0.68) 0.77 (0.72, 0.82) 
LT 0.61 (0.54, 0.69) 4.61 0.43 (0.34, 0.53) 0.81 (0.75, 0.86) 
LP 0.58 (0.51, 0.65) 5.22 0.32 (0.26, 0.37) 0.86 (0.82, 0.90) 
RLP 0.55 (0.47, 0.62) 0.20 0.71 (0.61, 0.79) 0.43 (0.36, 0.51) 
LT/AL 0.66 (0.59, 0.73) 0.19 0.56 (0.46, 0.65) 0.78 (0.72, 0.84) 
LV 0.94 (0.91, 0.97) 613.30 0.88 (0.81, 0.93) 0.88 (0.82, 0.92) 
ACD=Anterior Chamber Depth; AL=Axial Length; LT=Lens Thickness; LP=Lens Position; RLP= 
Relative lens Position; LV=Lens Vault; AUC=Area Under the Receiver Operating Characteristic Curve 
*given by the maximum of the Youden index, calculated as J=max(sensitivity+specificity-1) 
†sensitivity and specificity values at the optimal cutoff point 
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3.3.1.6 Effect of lens thickness on the other lens parameters 
In order to evaluate the effect of LT on various lens parameters, we performed a sub-
analysis of the angle closure group by dividing them into two sub-groups based on 
mean LT of angle-closure eyes (i.e., >4.20 mm and ≤4.20 mm) (Table 3.3.5). No 
significant difference in LT was found between normal eyes and the angle-closure 
subgroup with thinner LT≤ 4.20 mm. However, LV was significantly greater in both 
subgroups of angle-closure eyes compared to normal controls (p<0.001).  
 
Table 3.3.5: Comparison of Ocular Biometry between Angle Closure Subgroups with Lens 
Thickness ≤ 4.20 mm and >4.20 mm with Open Angle Group 


























2.79 (0.42) 2.95 (0.37) 
-0.10 (-0.25, 
0.05) 
2.55 (0.28) 2.95 (0.37) † 
-0.33 (-0.49, -
0.17) † 
AL mm  22.74 (1.03) 23.93 (1.37) 
-0.87(-1.38, -
0.35) ‡ 
22.96 (0.84) 23.93 (1.37) 
-0.90(-1.41, -
0.39) ‡ 
LT mm 3.32 (0.58) 3.90 (0.73) 
0.03(-0.19, 
2.54) 
4.89 (0.39) 3.90 (0.73) 
0.17 (0.03, 
0.31) ║ 
LP mm 4.45 (0.53) 4.90 (0.54) 
-0.08(-0.30, 
0.14) 
5.00 (0.34) 4.90 (0.54) 
-0.24(-0.40, -
0.09) § 
RLP 0.20 (0.03) 0.20 (0.02) 
0.004(-0.005, 
0.01) 
0.22 (0.02 0.20 (0.02) 
-0.002(-0.009, 
0.01) 
LT/AL 0.15 (0.03) 0.16 (0.03) 
0.007(-0.003, 
0.02) 
0.21 (0.02) 0.16 (0.03) † 
0.015(0.007, 
0.02) † 
LV µm 870 (261) 316 (272) 
481 (382, 
579) † 
926 (268) 316 (272) † 513 (387, 638) † 
ACD= Anterior Chamber Depth; AL= Axial Length; LT= Lens Thickness; LP= Lens Position; RLP= 
Relative lens Position; LV= Lens Vault; SD= Standard Deviation 
*Adjusted for age, gender. 
† P <0.001 
‡ P =0.001 
§ P <0.01 





3.3.1.7 Comparison between Angle closure subtypes  
The parameters were compared between the different subtypes of angle closure. No 
significant differences were observed in biometric parameters between the 3 clinical 
subgroups of angle closure except for LV, which was significantly greater in those 
with a prior APAC episode, compared with those with PAC (P = 0.003) and PACG 
(P = 0.001; Table 3.3.6).  
 
Table 3.3.6: Ocular Biometric Differences in Angle Closure Subtypes 
Measures 
Mean (SD)      
Primary Angle 
Closure* (N=29) 
Mean (SD)  
Primary Angle Closure 
Glaucoma*(N=53) 
Mean (SD)     
Previous Acute Angle 
Closure*(N=20) 
ACD (mm) 2.64 (0.28) 2.63 (0.35) 2.75 (0.50) 
AL(mm) 22.87 (0.94) 22.94 (1.01) 22.65 (0.67) 
LT (mm) 4.17 (0.90) 4.24 (0.94) 4.12 (0.92) 
LP (mm) 4.73 (0.55) 4.75 (0.52) 4.81 (0.46) 
RLP  0.21 (0.03) 0.21 (0.02) 0.21 (0.02) 
LT/AL ratio 0.18 (0.04) 0.19 (0.04) 0.18 (0.04) 
LV (µm) 858 (219)† 861 (264)† 1071 (271) 
*Adjusted for age, gender. 
†significant differences in LV between PAC and Acute Glaucoma (p=0.003) and between PACG and 
Acute Glaucoma (p=0.001) 
ACD= Anterior Chamber Depth; AL= Axial Length; LT= Lens Thickness; LP= Lens Position; RLP= 











3.3.2 THE IMPACT OF LENS VAULT ON VISUAL ACUITY AND 
REFRACTIVE ERROR 
The LV is a surrogate measurement of the amount of lens that is located anterior to 
the plane of the anterior chamber angles. It is the ASOCT risk factor for angle closure 
that is most analogous to the lens component. Studies have shown that for cases of 
visually significant cataract and PACG, cataract extraction results in deepening of the 
anterior chamber and widening of the angles, and in some cases, may lower IOP and 
reduce the likelihood of progression.163, 164 However, there is a lack of consensus on 
the role of lens extraction in eyes with PACG or PAC with good visual acuity.  
 
In light of the importance and strong association of LV with angle closure, we 
therefore sought to investigate the impact of LV on visual acuity since we believe that 
this would have a bearing on the approach towards management of eyes with angle 
closure. Whereas good visual acuity may naturally preclude cataract surgery, an 
increased LV may support the decision to proceed with cataract surgery even with a 
visual acuity that was considered ‘normal’ for surgical intervention.  
In this study, the subjects evaluated were those that were recruited as part of the 
community-based polyclinic study. Details of the subjects that were included in the 
analysis have been described under section 3.1.2 ‘Study Population’ of this Chapter.  
 
3.3.2.1 Patient demographics 
Of the 1372 subjects (67.0%) who were included for the final analysis, 752 (54.8%) 





Table 3.3.7 shows the distribution of the various parameters amongst eyes with angle 
closure and those without angle closure. Subjects with angle closure were 
significantly older (64.6±7.4 vs 61.8±7.4 years, p<0.001) and had significantly shorter 
AL (23.07±0.88mm vs 24.15±1.37mm, p<0.001), smaller ACD (2.69±0.22 vs 
3.20±0.33mm, p<0.001), and greater LV (775±188 vs 388µm ±252, p<0.001) but no 
significant differences were noted in the visual acuity amongst the 2 groups 
(0.39±0.20 vs 0.37±0.22, p=0.12). The majority of subjects had normal visual acuity/ 
mild visual impairment (86.3 – 86.8%) in both groups. 
 
 
Table 3.3.7 Demographic and clinical data of the Study subjects 
Measures 
No Angle Closure 
N = 1077 
Angle Closure 
N = 295 
p-value 
Age, years (SD) 61.8 (7.4) 64.6 (7.4) <0.001 
Women, number (%) 559 (51.9%) 193 (65.4%) <0.001 
Race (Chinese), number (%) 949 (88.1) 284 (96.3%) <0.001 
Visual acuity, logMAR, mean (SD)  0.37 (0.22) 0.39 (0.20) 0.12 
Axial length, mm, mean (SD) 24.15 (1.37) 23.07 (0.88) <0.001 
Spherical equivalent, D, mean (SD) +0.37 (2.78) +2.04 (1.78) <0.001 
ACD, mm, mean (SD) 3.20 (0.33) 2.69 (0.22) <0.001 
Lens Vault, microns (SD) 388 (252) 775 (188) <0.001 
Visual Acuity   
0.41 
Normal vision / mild visual 
impairment 
929 (86.3%) 256 (86.8%) 
Moderate/Severe visual impairment 147 (13.7%) 39 (13.2%) 
SD= standard devoiation; Normal vision = logMAR <0.3; mild visual impairment 0.3 < 






3.3.2.2 Visual acuity and spherical equivalent stratified by Lens vault 
The distribution of mean visual acuity by quartiles of LV is shown in Table 3.3.8. A 
significant association between increasing LV and worsening VA was observed only 
in the eyes without angle closure (p=0.02); in the angle closure group the trend 
analysis showed no association between LV and VA (p=0.83). It is interesting to note 
that for subjects with LV in the top quartile (>667 μm), the mean logMAR visual 
acuity recorded was 0.40 ± 0.20 for angle closure subjects and 0.41±0.22 for subjects 
without angle closure, suggesting that even for those with the highest LVs, the visual 
acuity remained relatively good. Figure 3.3.4 exemplifies this lack of association 
between LV and VA in eyes with angle closure. Fig 1A shows an eye with a high LV 




Table3.3.8: Mean visual acuity (logMAR) stratified by lens vault quartiles 
Quartile 










Q1    <272.2 343 0.36±0.22 0 - 
Q2   272.2 – 462.5 330 0.36±0.22 14 0.41±0.23 
Q3  462.5 – 667.6 272 0.36±0.21 74 0.36±0.19 
Q4 >667.6 132 0.41±0.22 223 0.40±0.20 








Figure 3.3.4: ASOCT images illustrating the measurement of Lens Vault as 
determined by the ZAAP. Figure A is the image of an eye with a large LV and 
good visual acuity (LogMAR 0.14); and Figure B of an eye with a small LV and 











A similar trend analysis of spherical equivalent with quartiles of LV (Table 3.3.9) 
showed no association in the angle closure group (p=0.64). The mean spherical 






3.3.2.3 Linear regression for association with Lens vault 
When multiple linear regression analysis of associations with LV was performed after 
adjusting for age, gender, AL and ACD, no significant association was found between 
LV and visual acuity (p=0.35), or between LV and spherical equivalent (p=0.06) in 
eyes with angle closure (Table 3.3.10). Figures 3.3.5 and 3.3.6 are the scatter plots 
depicting the correlation between LV and VA (r2=0.003), and, LV and spherical 





Table 3.3.9: Mean spherical equivalent stratified by lens vault quartiles 
Quartile 
(Lens vault μm) 
 
N 
No Angle Closure 





Q1    <272.2 343 -0.68±3.08 0 - 
Q2   272.2 – 462.5 330 +0.37±2.49 13 +1.82±2.31 
Q3  462.5 – 667.6 272 +1.16±2.51 72 +2.00±1.64 
Q4 >667.6 132 +1.45±2.22 210 +2.07±1.80 
P trend  <0.001  0.64 
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Table 3.3.10: Multiple Linear Regression for associations with Lens Vault (microns) in 
eyes with Angle closure (N=295) 
Measures B  95% CI of B p value 
Visual acuity (logMAR) 33.2 -67.7, 134.2 0.35 
Spherical equivalent (Dioptre) -11.5 -23.3, 0.3 0.06 
Axial length (mm) -24.5 148.9, -0.09 0.05 





Figure 3.3.5 Scatter plot showing the correlation between visual acuity and lens 








Figure 3.3.6: Scatter plot showing the correlation between spherical equivalent 


















3.3.3 INCREASED LENS VAULT AS A RISK FACTOR FOR ANGLE 
CLOSURE: CONFIRMATION IN A JAPANESE POPULATION 
We performed a case-control study of Japanese subjects with angle closure and 
normal. The subjects were recruited from two hospitals in Kyushu, Japan. 
Please see section 3.1 ‘Subjects and Methods’ at the beginning of this Chapter for a 
description of patient recruitment, clinical examination and image analysis. 
 
A total of 124 Japanese subjects with angle closure and 80 normal controls were 
recruited. Complete data were available for 109 angle closure subjects (consisting of 
65 PAC and 44 PACG subjects) and 68 controls after excluding 13 cases and 10 
control subjects with ASOCT software delineation errors, indeterminate scleral spurs 
on ASOCT scans, or missing data.  
 
There was no significant difference between angle closure eyes and normal controls 
for age (73.5±7.0 vs 72.6±7.3 years, p=0.37), or spherical equivalent (p=0.81). There 
were a greater proportion of females in both the groups (88% vs 69%, p=0.002). 
Compared to normal eyes, eyes with angle closure had significantly shallower ACD 
(p=<0.000), shorter AL (p=<0.000), greater LV (p=<0.000) and LT (p=<0.000), and a 













Mean (SD)  
(n=109) 
Normal Controls 
Mean (SD)  
(n=68) 
Mean difference*  
(95% CI) 
   P 
value 
ACD (mm) 2.51 (0.39) 3.14 (0.35) -0.64 (-0.79,-0.50) 0.00 
AL (mm) 22.22 (0.77) 23.28 (0.81) -1.04 (-1.34,-0.74) 0.00 
LT (mm) 4.91 (0.54) 4.54 (0.47) 0.35 (0.16,0.54) 0.00 
LP (mm) 4.96 (0.32) 5.38 (0.44) -0.47 (-0.59,-0.35) 0.00 
RLP 0.224 (0.015) 0.231 (0.019) -0.010 (-0.016,-0.004) 0.019 
LV (μm) 1034 (257) 419 (236) 600 (509,691) 0.00 
*Adjusted for age, gender. 
ACD= Anterior Chamber Depth; AL= Axial Length; LT= Lens Thickness; LP= Lens Position; 
RLP= Relative lens Position; LV= Lens Vault 
 
After multivariate analysis adjusted for age, gender, ACD, LT, and RLP, increased 
LV was associated significantly with angle closure (OR, 24.2; 95% confidence 
interval [CI], 2.3- 250.5, comparing lowest with highest quartile; Table 3.3.12), but 
no association was found for LT (OR, 2.59; 95% CI, 0.48-13.85).  
 
There was fair correlation between LV and LT (Pearson’s correlation coefficient 
[PCC], 0.42). However, LV and RLP were poorly correlated (PCC, -0.26). In terms of 
distinguishing angle-closure subjects from normal subjects, LV had the highest AUC 
(0.96; 95% CI, 0.92–0.98), a sensitivity of 85.3%, and specificity of 94%, whereas the 
















Age and gender 
adjusted 
OR (95% CI) 
Multivariate 
adjusted+ 
OR+ (95% CI) 
LT 
1 (3.03 – 4.50) 45 16 (35.6) 1.00 1.00 
2 (4.51 – 4.85) 44  21 (47.7) 1.5 (0.63 – 3.6) 0.47 (0.15 – 1.46) 
3 (4.86 – 5.11) 46  34 (73.9) 5.9 (2.3 – 15.3) 0.99 (0.29 – 3.40) 
4 (5.12 – 5.90) 41  38 (92.7) 29.8 (7.3 – 121.7) 2.59 (0.48 – 13.85) 
LP 
1 (3.91 – 4.87) 44 41 (93.2) 53.8 (13.1 – 221.5)  
2 (4.88 – 5.12) 44 38 (86.4) 24.4 (7.5 – 79.5)  
3 (5.13 – 5.42) 45 22 (48.9) 3.9 (1.4 – 10.5)  
4 (5.43 – 6.37) 43 8 (18.6) 1.00  
LV 
1 (41 – 506.7) 44 0 (0) - - 
    2 (506.8 – 840.9) 44 24 (54.5) 1.00 1.00 
   3 (841 – 1072.8) 44 42 (95.5) 18.5 (3.7 – 90.9) 6.6 (1.1 – 38.9) 
     4 (1072.9 – 1722) 44 43 (97.7) 34.9 (4.2 – 288.5) 
24.2 (2.3 – 250.5) 
RLP 
1 (0.176 – 0.218) 43  (74.5) 5.4 (2.1 – 14.1)  
2 (0.219 – 0.227) 44  (77.1) 6.8 (2.6 – 18.1)  
3 (0.228 – 0.237) 44  (66.7) 2.8 (1.1 – 6.9)  
4 (0.238 – 0.271) 43  (38.3) 1.00  
*Adjusted for age, gender, ACD, LT and RLP for LV 
*Adjusted for age, gender, and ACD for LT. 
LT= Lens Thickness; LP= Lens Position; RLP= Relative lens Position; LV= Lens Vault; OR=Odds 










In order to evaluate the effect of LT on various lens parameters, we performed a sub-
analysis of the angle closure group by dividing them into 2 sub-groups based on mean 
LT of angle closure eyes (i.e. >4.91mm and <4.91mm) (Table 3.3.14). No significant 
difference in LT was found between normal eyes and the angle closure subgroup with 
thinner LT<4.91 mm. However, LV was significantly greater in both subgroups of 
angle closure eyes compared to normal controls (p=0.00).   Results were largely 
similar when the median LT (5.01mm) was chosen as a cut-off to examine the effect 




Table 3.3.13: Area Under the Receiver Operating Characteristic Curve, sensitivity and 
Specificity for Axial length, Anterior chamber Depth and Lens parameters for Detecting 
Angle Closure 








ACD 0.90 (0.85 , 0.94) 2.65 76.2 (67.0 – 83.8) 95.6 (87.6 – 99.1) 
AL 0.83 (0.77 , 0.88) 22.87 83.5 (75.2 , 89.9) 71.6 (59.3 , 82.0) 
LT 0.75 (0.69 , 0.81) 4.81 71.6 (62.1, 79.8) 74.6 (62.5, 84.5) 
LP 0.85 (0.79 , 0.90) 5.13 73.4 (64.1, 81.4) 85.3 (74.56, 92.7) 
RLP 0.68 (0.61 , 0.75) 0.232 77.1 (68.0, 84.6) 58.2 (45.5, 70.2) 
LV 0.96 (0.92 , 0.98) 762 85.3 (77.3 , 91.4) 94.0 (85.4 , 98.3) 
ACD= Anterior Chamber Depth; AL= Axial Length; LT= Lens Thickness; LP= Lens Position; 
RLP= Relative lens Position; LV= Lens Vault; AUC= Area Under the Receiver Operating 
Characteristic Curve 






Table 3.3.14: Biometric parameters between Angle Closure and Normal Control Eyes, with Angle Closure Subgroups Categorized by Lens thickness 
Measure 
Mean (SD) in 




Mean (SD) in 
Normal 











Mean (SD) in 
Normal 





ACD (mm) 2.71 ± 0.49 3.14 ± 0.35 -0.49 (-0.69,-0.30) 0.00 2.38 ± 0.23 3.14 ± 0.35 -0.76 (-0.87, -0.66) 0.00 
AL (mm) 22.23 ± 0.79 23.29 ± 0.81 -0.99 (-1.40,-0.59) 0.00 22.20 ± 0.77 23.29 ± 0.81 -1.08 (-1.43, -0.74) 0.00 
LT (mm) 4.41 ± 0.52 4.54 ± 0.47 -0.07 (-0.29,0.14) 0.50 5.21 ± 0.23 4.54 ± 0.47 0.65 (0.49, 0.77) 0.00 
LP (mm) 4.92 ± 0.42 5.42 ± 0.33 -0.54 (0.72,-0.35) 0.00 4.99 ± 0.23 5.42 ± 0.33 -0.45 (-0.56, -0.34) 0.00 
RLP 0.221 ± 0.02 0.233 ± 0.02  -0.013 (-0.023,-0.004) 0.006 0.225 ± 0.01 0.233 ± 0.02  -0.009 (-0.015, 0.003) 0.004 
LV (μm) 943 ± 272 419 ± 236 527 (407,646) 0.00 1092 ± 232 419 ± 236 659 (569, 749) 0.00 
*Adjusted for age and gender 
ACD= Anterior Chamber Depth; AL= Axial Length; LT= Lens Thickness; LP= Lens Position; RLP= Relative lens Position; LV= Lens Vault; SD=Standard deviation 
 96 
3.3.4 ANTERIOR CHAMBER WIDTH AND ANGLE CLOSURE 
The identification of new ocular biometric risk factors for angle closure may lead to a 
better understanding of the disease mechanism and also aid in the development of 
cost-effective population-based screening strategies. Customized software allows 
quantitative estimation of anterior segment structures from ASOCT images. One of 
the ocular parameter that has not been previously studied is the anterior chamber 
width (ACW), defined as the horizontal scleral spur-to-spur distance, as measured by 
ASOCT (Figure 3.1).  
In this study, we evaluated the distribution and determinants of ACW in a large 
sample of subjects recruited from a community clinic, evaluated the relationship of 
ACW with angle closure, and compared ACW measurements from this sample with 
those obtained from a hospital-based sample of subjects with primary angle closure. 
 
3.3.4.1 Patient demographics 
Of the 1465 subjects (71.6%) who were included for the final analysis, 793 (54.1%) 
were female and 1318 (90.0%) were Chinese (Table 3.3.15). The included subjects 
were significantly younger, had shallower ACD, and were more likely to be female. 
There were also a higher proportion of subjects with angle closure on gonioscopy 



















Age, years (SD) 62.7 (7.7) 64.4 (8.4) < 0.001 
Women, number (%) 793 (54.1) 284 (48.8) 0.029 
Race, number (%)    
       Chinese 1318 (90.0) 513 (88.1) 
0.507 
       Malay 27 (1.8) 15 (2.6) 
       Indian 102 (7.0) 48 (8.2) 
       Others 18 (1.2) 6 (1.0) 
IOP, mm Hg, mean (SD)  14.74 (2.40) 14.80 (2.43) 0.632 
Axial length, mm, mean (SD) 23.91 (1.34) 23.92 (1.29) 0.937 
Central ACD, mm, mean (SD) 3.08 (0.38) 3.12 (0.36) 0.018 
SD = standard deviation; IOP= intraocular pressure; ACD = anterior chamber depth 
 
3.3.4.2 Distribution of Anterior chamber width by age and gender 
In the community sample, women were found to have a significantly smaller ACW 
compared to men (11.70 mm vs. 11.81 mm, respectively, P<0.001, Table 3.3.16). 
The ACW was found to decrease significantly with advancing age (P for trend 
<0.001) at an average of 0.05 mm per decade for all persons. The results were largely 
similar when the analysis was performed separately for male and female patients. In a 
comparison between Chinese and non-Chinese subjects, the subjects of Chinese 
ethnicity were found to have a shorter ACW (P = 0.003) compared with non-Chinese.  
 
3.3.4.3 Relationship of systemic and ocular factors with Anterior chamber width 
The relationship between selected ocular and systemic factors with ACW is presented 
in Table 3.3.17. After controlling for age and gender, the final predictors of smaller 
ACW were lower educational level (P<0.001), lower BMI (P<0.001), shorter AL 
(P<0.001), and shallower central ACD (P<0.001). 
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Table 3.3.16: Distribution of Anterior Chamber Width by Age and Gender, Community 
group 
 
                               
Age 















All persons         
All ages 1465 11.75 (0.39)  315 11.57 (0.37)  1150 11.80 (0.38) 
50-59 years 638 11.80 (0.37)  94 11.64 (0.33)  544 11.83 (0.36) 
60-69 years 548 11.72 (0.41)  135 11.52 (0.39)  413 11.79 (0.40) 
≥ 70 years 279 11.70 (0.38)  86 11.58 (0.36)  193 11.75 (0.38) 
p for trend  < 0.001   0.278   0.007 
Men         
All ages 672 11.81 (0.40)  112 11.62 (0.39)  560 11.85 (0.39) 
50-59 years 253 11.88 (0.38)  24 11.66 (0.39)  229 11.90 (0.38) 
60-69 years 265 11.80 (0.41)  50 11.62 (0.40)  215 11.84 (0.40) 
≥ 70 years 154 11.71 (0.39)  38 11.59 (0.39)  116 11.76 (0.38) 
p for trend  < 0.001   0.519   0.002 
Women         
All ages 793 11.70 (0.37)  203 11.55 (0.35)  590 11.76 (0.36) 
50-59 years 385 11.75 (0.35)  70 11.63 (0.32)  315 11.78 (0.35) 
60-69 years 283 11.65 (0.40)  85 11.46 (038)  198 11.73 (0.38) 
≥ 70 years 125 11.67 (0.37)  48 11.57 (0.34)  77 11.74 (0.38) 
p for trend  0.003   0.232   0.142 
SD= Standard Deviation; ACW= Anterior Chamber Width 
 
 
Of the 1465 subjects in the community sample, 315 (21.5%) were diagnosed as 
having angle closure on gonioscopy. The mean ACW was significantly smaller in 
eyes with angle closure compared with those without angle closure (11.60 vs. 11.80, 
P<0.001). A correlation analysis was performed to assess the relationship between 
ACW and ACD, ACW and AL, and ACD and AL, and a linear relationship (r = 0.41– 
0.54) was found between them (Table 3.3.18) (Figures 3.3.7 and 3.3.8). 
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p value  N 
Mean ACW   
(SD) mm 





   No formal education 265 11.63 (0.41) < 0.001  82 11.48 (0.40) 0.510  183 11.69 (0.40) < 0.001 
   Primary 401 11.76 (0.37)   93 11.63 (0.34)   308 11.79 (0.36)  
   Secondary/ Technical 504 11.77 (0.39)   86 11.58 (0.36)   418 11.80 (0.38)  
   A Level/ Polytechnic 164 11.82 (0.35)   31 11.63 (0.32)   133 11.86 (0.35)  
   Tertiary 131 11.86 (0.39)   23 11.54 (0.43)   108 11.93 (0.35)  
Race 
     Chinese 1318 11.74 (0.38) 0.003  303 11.56 (0.37) 0.621  1015 11.79 (0.37) 0.037 
      Malay 27 11.85 (0.43)   5 11.73 (0.51)   22 11.87 (0.41)  
      Indian 102 11.85 (0.42)   5 11.76 (0.46)   97 11.86 (0.42)  
      Others 18 11.97 (0.32)   2 11.62 (0.03)   16 12.01 (0.31)  
BMI, kg/m2            
      Underweight <18.5 77 11.69 (0.37)   27 11.48 (0.37)   50 11.80 (0.33)  
      Normal ≥ 18.5, < 25 895 11.73 (0.39) < 0.001  196 11.56 (0.38) 0.067  699 11.78 (0.38) 0.010 
    Overweight ≥ 25, <30 398 11.79 (0.38)   76 11.59 (0.35)   322 11.83 (0.37)  
      Obese (>30) 94 11.84 (0.37)   16 11.72 (0.34)   78 11.87 (0.38)  
Axial Length, mm            
  1st Quartile ≤ 23 357 11.51 (0.35)   150 11.43 (0.37)   207 11.56 (0.33)  
  2nd Quartile >23, ≤23.7 363 11.71 (0.33) < 0.001  88 11.69 (0.32) < 0.001  275 11.72 (0.34) < 0.001 
  3rd Quartile >23.8, 
≤24.6 
358 11.85 (0.34)   52 11.69 (0.24)   306 11.88 (0.35)  
 100 
 4th Quartile >24.7 358 11.95 (0.36)   17 11.80 (0.41)   341 11.96 (0.36)  
Central ACD, mm            
 1st Quartile ≤ 2.81 375 11.56 (0.37)   225 11.52 (0.35)   151 11.62 (0.39)  
 2nd Quartile >2.82, ≤3.07 367 11.71 (0.35) < 0.001  80 11.66 (0.38) < 0.001  287 11.73 (0.34) < 0.001 
 3rd Quartile >3.08, ≤3.34 357 11.77 (0.36)   10 11.91 (0.40)   347 11.76 (0.36)  
 4th Quartile >3.34 365 11.97 (0.36)   0 -   365 11.97 (0.36)  
SD= Standard Deviation; ACW= Anterior Chamber Width; ACD= Anterior Chamber Depth; BMI=Body Mass Index 
 
 
     
Table 3.3.18: Correlation between Anterior Chamber Width and Anterior Chamber Depth and 









Pearson Correlation -- .413 .436 
P value  <0.001 <0.001 
ACD 
Pearson Correlation .413(**) -- .544 
P value <0.001  <0.001 
** Correlation is significant at the 0.01 level (2-tailed) 
ACW=Anterior Chamber Width; ACD= Anterior Chamber Depth; AL=  Axial Length  
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Figure 3.3.7: Scatter plot showing correlation between anterior chamber width 





Figure 3.3.8: Scatter plot showing correlation between anterior chamber width 





3.3.4.4 Association of Anterior chamber width with Angle closure 
Additional analyses were performed to assess the role of ACW, AL, and ACD in 
determining the risk of angle closure (Table 3.3.19). The age- and gender-adjusted 
ORs for the highest quartile compared with the lower 3 quartiles of ACW, AL, and 
ACD with the presence of angle closure were 3.4 (95% CI, 2.3–5.0), 6.3 (95% CI, 
3.8–10.5), and 46.8 (95% CI, 24.5–89.3), respectively (P for trend <0.001 for all). 
Upon further multivariate analysis adjusted for age, gender, and AL, it was found that 
ACW had significant ORs with angle closure (P for trend of 0.001); the results were 
similar when adjusted for ACD (P = 0.05) (Table 3.3.19). The performance of ACW, 
AL, and ACD as determinants for detecting angle closure is summarized in Table 
3.3.20, which shows AUCs of 0.62, 0.68, and 0.82, respectively, with best cutoff 
values of 11.7 mm, 23.5 mm, and 2.9 mm for ACW, AL, and ACD, respectively. 
Table 3.3.19: Relationship of Anterior Chamber Width, Axial Length and Anterior Chamber 
Depth, and Narrow Angles 
 Quartile N 
Narrow 
Angles 































4 365 31 (8.5) 1.0 1.0 1.0 1.0 








1.7 (0.9, 3.1) 
 4 358 17 (4.7) 1.0 1.0 













p trend   < 0.001 < 0.001 
ACW=Anterior Chamber Width; ACD= Anterior Chamber Depth; AL=  Axial Length  
OR= Odds Ratio; CI= Confidence Interval 
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Table 3.3.20: Sensitivity, Specificity, Positive Predictive Value, Negative Predictive Value, and Area 
Under the Curve Analysis of Anterior Chamber Width, Axial length and anterior Chamber Depth In 
Identifying Angle Closure 
Measures Sensitivity (%) Specificity (%) PPV NPV AUC 
     ACW ≤ 11.7 64.4 60.5 30.9 86.2 0.63 
Axial length ≤ 23.5 74.3 63.6 35.7 90.1 0.69 
ACD ≤ 2.9 84.4 80.3 54.0 95.0 0.82 
ACW = Anterior chamber width;  ACD = Anterior Chamber Depth; PPV = positive predictive value; 
NPV = negative predictive value; AUC = area under curve 
 
3.3.4.5 Comparison with hospital-based subjects  
A total of 126 hospital-based subjects with PAC/PACG were recruited. Of them, the 
scleral spur could not be identified in 15, leaving 111 subjects in the final analysis. 
Seventy-five subjects (67.6%) were female, and the majority of subjects were of 
Chinese ethnicity (91.9%). The subjects ranged in age from 47 to 91 years, with a 
median age of 66 years. Forty- seven subjects (42.3%) had PAC, and 64 subjects 
(57.7%) had PACG. Compared to those subjects with angle closure from community-
based subjects, the hospital-based subjects with angle closure had shorter AL (P = 
0.01) and higher IOP (P = 0.001), whereas there was no statistically significant 
difference in age (P = 0.5), gender (P = 0.5), race (P = 0.23), or ACD (P = 0.63) 
(Table 3.3.21) between these 2 groups.  
 
The ACW of hospital-based subjects with PAC/ PACG was significantly smaller than 
both the open-angle (11.80 mm vs. 11.33 mm, P<0.001) and angle closure (11.60 mm 
vs. 11.33 mm, P<0.001) groups from the community-based sample. 
The reproducibility of the ACW measurements was excellent with a within-subject 
standard deviation of 0.13 mm, a within- subject coefficient of variation of 1.18%, 
and an intra-class correlation coefficient of 0.92 (95% CI, 0.85 – 0.95). 
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Age, years (SD) 64.8 (7.5) 65.4 (8.8) 0.509 
Women, number (%) 203 (64.4) 75 (67.6) 0.552 
Race, number (%)    
       Chinese 303 (96.2) 102 (91.9) 
 
0.237 
       Malay 5 (1.6) 3 (2.7) 
       Indian 5 (1.6) 3 (2.7) 
       Others 2 (0.6) 3 (2.7) 
IOP, mm Hg, mean (SD)  15.34 (2.39) 16.33 (3.33) 0.001 
Axial length, mm, mean (SD) 23.09 (0.88) 22.84 (0.96) 0.014 


















3.3.5 LENS VAULT RELATED PARAMETERS AND ANGLE CLOSURE 
Recently, Kim et al165 described novel ASOCT-based biometric parameter: the 
anterior vault, which represents the sum of the LV and the ACD (Figure 3.3.9), and 
the relative LV, which represents the ratio of the LV to the anterior vault. They 
hypothesized that in an eye with a deep anterior chamber, the presence of a large lens 
vault may have a lower likelihood of precipitating angle closure. They therefore 
suggested that the relative LV (i.e. relative to the anterior chamber) might be better 
related to the risk of angle closure than the absolute LV value.165 In their study 
performed on subjects of Korean ethnicity, they noted significant differences in terms 
of LV and relative LV between normal and eyes with angle closure; and the relative 
LV also performed better in distinguishing between angle closure and normal eyes 
(area under the receiver operator characteristic curve: 0.97 vs. 0.92, P = 0.032).165  
We therefore aimed to investigate the distribution and relationship of these newly 
described biometric parameters with angle closure in our subject cohort. Furthermore, 
as it is not known how these newly identified novel ASOCT parameters differ in the 
subtypes of angle closure, we also aimed to compare these parameters in patients with 
















For the first objective, we analyzed the data obtained from subjects that were recruited 
as part of the community polyclinic study. Details of the study have been described 
under section 2.1 ‘Study Population’ in Chapter 2. 
For the second objective, subjects diagnosed with angle closure disease, classified as 
PACS, PAC, PACG, and previous APAC, which were recruited from glaucoma 
clinics of the Singapore National Eye Center were assessed. Details of the definition 
of the different subtypes of angle closure are given in Chapter 1, section 1.1.1 






3.3.5.1 Demographics and association of Lens vault-related parameters with 
Angle closure 
Of a total of 2057 subjects recruited for the community study, 583 were excluded 
leaving 1464 subjects with complete data that were available for analysis. Of these, 
315 (21.5%) had angle closure. Significant differences between open-angles and 
angle-closure eyes were found for LV (0.39±0.25mm vs 0.77±0.19mm, p<0.001), 
anterior vault (3.12±0.17mm vs 2.98±0.16mm, p<0.001), and relative LV (0.124±0.08 
vs 0.260±0.06, p<0.001(Table 3.3.22).  
 
The LV and relative LV were noted to increase significantly with advancing age (p 
for trend <0.001 for both), but no significant trend was noted for anterior vault 
(p=0.13). The results were largely similar when the analyses were performed 
separately for eyes with open angles and those with angle closure (Table 3.3.22).  
 
There was low correlation between anterior vault and LV (Pearson’s correlation 
coefficient [PCC], -0.08), but moderate correlation between anterior vault and ACW 






























N Mean (SD) mm  
All ages 1464 3.09 (0.18) 315 2.98 (0.16) 1149 3.12 (0.17) <0.001 
50-59 years 638 3.10 (0.19) 94 2.98 (0.15) 544 3.13 (0.18)  
60-69 years 548 3.06 (0.18) 135 2.96 (0.17) 413 3.10 (0.17)  
≥ 70 years 278 3.08 (0.16) 86 3.01 (0.15) 192 3.11 (0.15)  
p for trend  0.13  0.14  0.53  






N Mean (SD) mm  
All ages 1464 0.47 (0.29) 315 0.77 (0.19) 1149 0.39 (0.25) <0.001 
50-59 years 638 0.39 (0.27) 94 0.73 (0.16) 544 0.33 (0.24)  
60-69 years 548 0.50 (0.28) 135 0.26 (0.06) 413 0.41 (0.24)  
≥ 70 years 278 0.60 (0.27) 86 0.82 (0.19) 192 0.50 (0.24)  
p for trend  <0.001  0.001  <0.001  
Relative 
Lens Vault 
N Mean (SD) N Mean (SD) N Mean (SD)  
All ages 1464 0.153 (0.094) 315 0.260 (0.060) 1149 0.124 (0.080) <0.001 
50-59 years 638 0.126 (0.089) 94 0.243 (0.052) 544 0.106 (0.079)  
60-69 years 548 0.164 (0.094) 135 0.264 (0.063) 413 0.132 (0.077)  
≥ 70 years 278 0.194 (0.089) 86 0.272 (0.062) 192 0.160 (0.077)  





























1 -.081** .994** -.860** -.104** 
Sig. (2-tailed)  .002 .000 .000 .000 





-.081** 1 -.173** .578** .637** 
Sig. (2-tailed) .002  .000 .000 .000 




.994** -.173** 1 -.902** -.163** 
Sig. (2-tailed) .000 .000  .000 .000 




-.860** .578** -.902** 1 .411** 
Sig. (2-tailed) .000 .000 .000  .000 




-.104** .637** -.163** .411** 1 
Sig. (2-tailed) .000 .000 .000 .000  
N 1464 1464 1464 1464 1464 











After multivariate analysis adjusting for age, gender, axial length, and anterior 
chamber width, a smaller anterior vault was significantly associated with angle-
closure (odds ratio [OR] 10.1 and 95% confidence interval [CI], 5.7-17.6), comparing 
highest to lowest quartile). Likewise, larger relative LV (OR 81.6 and 95% CI, 37.8-
176.1, comparing lowest to highest quartile) was significantly associated with angle-
closure (Table 3.3.24).  
 
The performance characteristics of these parameters for detecting subjects with angle 
closure are summarized in Table 3.3.25, which shows AUCs of 0.89, 0.72, and 0.91, 
respectively, with best cutoff values of 567μm, 3.10 mm, and 0.20 for LV, anterior 
vault, and relative LV respectively.  
Within this population, ACW, LV and anterior vault demonstrates a generally normal 






















Age and Gender 
Adjusted 
OR (95% CI) 
Multivariate 
Adjusted† 
OR (95% CI) 
Multivariate 
Adjusted‡ 
OR (95% CI) 
Anterior vault 
1 (2.54-2.96) 151 (47.9) 8.0 (5.1, 15.5) 6.9 (4.3, 10.9) 10.1 (5.7, 17.6) 
2 (2.97-3.09) 85(27.0) 3.5 (2.2, 5.5) 3.5 (2.2, 5.6) 4.4 (2.6, 7.5) 
3 (3.10-3.20) 51 (16.2) 1.8 (1.1, 2.9) 1.7 (0.9, 2.8) 1.9 (1.2, 3.3) 
4 (3.21-3.67) 28 (8.9) Ref Ref Ref 
Lens Vault 
1 (-0.39-0.27) 0 - - - 
2 (0.28-0.46) 15 Ref Ref Ref 
3 (0.47-0.67) 74 5.7 (3.2, 10.1) 5.5 (2.9, 10.2) 6.1 (3.2, 11.5) 
4 (0.68-1.58) 226 36.7 (20.9, 64.4) 31.7 (17.2, 58.3) 49.1 (25.8, 93.4) 
Relative Lens Vault 
1 (-0.12-0.088) 0 - - - 
2 (0.089-0.149) 10 Ref Ref Ref 
3 (0.150-0.220) 67 7.7 (3.9, 15.2) 8.1 (3.8, 17.4) 8.6 (4.0, 18.5) 







OR= Odds Ratio ; CI= Confidence Interval 
†Adjusted for age, gender, axial length 

















Table 3.3.25: Area Under the Receiver Operating Characteristic Curve, sensitivity and 
Specificity for Anterior chamber Depth, Anterior Chamber Width and Lens Vault 
Related parameters for Detecting Angle Closure 
Measures AUC (95% CI) Optimal Cutoff Point* Sensitivity† Specificity† 
ACD mm 0.82 (0.79, 0.84) ≤2.90mm 80.3 53.9 
ACW mm 0.67 (0.64, 0.69) ≤11.7mm 64.4 60.5 
LV  µm 0.89 (0.88, 0.91) >576µm 85.7 77.5 
AV mm 0.72 (0.70, 0.75) ≤3.10mm 78.7 52.5 
RLV 0.91 (0.89, 0.93) >0.20 85.4 82.9 
ACD= Anterior Chamber Depth;  ACW=Anterior chamber width; LV= Lens Vault;  
AV=Anterior Vault; RLV= Relative lens vault; AUC= Area Under the Receiver Operating 
Characteristic Curve 
*given by the maximum of the Youden index, calculated as J=max(sensitivity+specificity-1) 
†sensitivity and specificity values at the optimal cutoff point 
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Figure 3.3.11: Distribution of Lens vault 
 




3.3.5.2 Comparison between subtypes of Angle closure 
We then evaluated the characteristics of these parameters including ACW in the 
different subtypes of angle closure. A total of 427 angle closure subjects were 
recruited, which included 143 PACS (33.5%), 75 PAC (17.6%), 165 PACG (38.6%), 
and 44 previous APAC (10.3%). Majority of the subjects were of Chinese ethnicity 
(N= 394; 92.3%), and there were more women (n = 275; 64.4%). The subjects’ ages 
ranged from 41 to 93 years, and the mean age was 65.6 years (standard deviation 
[SD], 8.8 years; Table 3.3.26). 
 
Patients with APAC had the shortest AL. There was no significant difference in lens 
thickness among the subtypes of angle closure disease (Table 3.3.26). When 
compared with the other groups, there was a significant difference between mean 
ACD value of APAC and the rest of the other subtypes of angle closure disease (all 
with P < 0.001) with the APAC group having the smallest mean ACD. There was a 
significant difference in mean ACW between PACS and PACG (p=0.016) (Table 
3.3.26). LV and rLV were found to be the greatest in the APAC group, with a 
significant difference between APAC and PACS, PAC, PACG (all with P < 0.001). 





















Proportion 33.5% 17.6% 38.6% 10.3%  
Age (SD), years 63.1 (7.6) 66.0 (8.1) 68.4 (9.4) 62.2 (7.9) <0.001a 
Race, Chinese, N (%) 135 (94.4%) 66 (88.0%) 151 (91.5%) 42 (95.5%) 0.323 
Gender, Female, N (%) 105 (73.4%) 47 (62.7%) 92 (55.8%) 31 (70.5%) 0.010b 
ACD mm(SD) 2.16 (0.26) 2.12 (0.30) 2.17 (0.29) 1.79 (0.24) <0.001c 
AL mm (SD) 22.75 (1.12) 22.70 (0.89) 23.05 (1.02) 22.48 (0.74) 0.002d 
LT mm (SD) 4.32 (0.90) 4.01 (0.92) 4.27 (0.95) 4.39 (0.91) 0.08 
LV mm (SD) 0.80 (0.25) 0.87 (0.25) 0.83 (0.27) 1.15 (0.30) <0.001e 
AV mm (SD) 2.97 (0.20) 2.99 (0.20) 3.00 (0.19) 2.94 (0.18) 0.21 
Relative LV 0.270 (0.08) 0.290 (0.08) 0.277 (0.09) 0.389 (0.09) <0.001f 
ACW mm (SD) 11.24 (0.39) 11.36 (0.42) 11.38 (0.42) 11.30 (0.35) 0.02g 
PACS: primary angle closure suspect; PAC: primary angle closure; PACG: primary angle closure 
glaucoma; APAC: previous acute primary angle closure; SD: Standard Deviation; ACD: Anterior 
Chamber Depth;  AL: axial length; LT: Lens thickness; LV= Lens Vault;  AV=Anterior Vault; 
ACW=Anterior chamber width 
a Non-Chinese ethnicity includes Malays, Indians, Sikhs, Eurasians, Burmese,  and Filipino 
a Significant pair-wise comparisons:  p<0.001 for PACG vs PACS, APAC 
b Significant pair-wise comparisons: p=0.002 for PACS vs PACG (chi square test) 
c Significant pair-wise comparisons: p<0.001 for APAC vs PACS, PAC, PACG 
d Significant pair-wise comparisons: p=0.006 for APAC vs PACG 
e Significant pair-wise comparisons:  p<0.001 for APAC vs PACS, PAC, PACG 
f Significant pair-wise comparisons:  p<0.001 for APAC vs PACS, PAC, PACG 












Lens vault is a novel ASOCT-based parameter that measures the amount of lens that 
is located anterior to the plane of the scleral spurs. As the scleral spur is the surrogate 
marker for the location of the anterior chamber angles in an ASOCT image, therefore 
the LV can also be considered to be a measurement of the amount of lens located 
anterior to the anterior chamber angles. Our study supports the concept that increased 
thickness and bulk of the lens anterior to the plane of the scleral spur pushes the 
peripheral iris against the trabecular meshwork, worsening angle crowding in an 
already predisposed eye i.e. an anatomically small eye. Increased LV likely increases 
the amount of irido-lenticular contact, leading to a more pronounced iris curvature, 
pupil block, and angle crowding. 
 
3.4.1 Len Vault: A better marker for the assessing the role of the lens in angle 
closure 
The associations between various lens biometric properties and angle closure have 
been inconsistent. While some studies report a greater predisposition for angle closure 
in eyes with thicker and more anteriorly placed lens,68, 69 others have found no such 
association.78 Lim et al74 reported a more anteriorly placed lens (i.e. a smaller LP 
measurement) in the attack eyes of APAC subjects compared to the fellow eyes; they 
attributed their findings to a shallower ACD resulting from a short AL in the APAC 
eyes. Sihota et al78 found no differences in RLP when comparing PACG patients with 
family members. They suggested that the occurrence of angle closure was largely 
related to shorter AL and thicker lens, resulting in a shallower ACD. In our study we 
found that eyes with angle closure had significantly thicker lenses with a 
corresponding greater LV. However, LP and RLP were similar both in open- and 
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closed-angle eyes.  
A possible reason for the variable findings could be that LP, calculated from two 
anterior segment parameters, ACD and LT (both are axial parameters derived from A-
scan measurements), estimates the position of the center of the lens (lenticular mid- 
point) from the central cornea rather than in relation to the angles. It does not indicate 
whether the centre of the lens is anterior or posterior to the anterior chamber angles 
(Figure 3.3.13). Furthermore, the 2 factors ACD and LT (which are used to compute 
LP) seem to be interdependent and to compensate for each other. In contrast, the new 
parameter, LV is a single quantitative parameter which measures the portion of the 
lens in relation to the plane of the scleral spurs, with the scleral spurs being a 
surrogate marker of the posterior limit of the anterior chamber angle. Therefore, we 
postulate that LV may capture better the role of the lens in angle closure. 
 
 






3.4.2 Concept and mechanism of the Lens vault 
Interestingly, Tiedeman described a parameter similar in concept to the LV 
previously166 back in 1991 in an article which described the mathematical model that 
predicts the profile of the iris in angle closure. The parameter ‘Z distance’ was 
defined as the anterior displacement of the plane of the pupil from the plane of the iris 
root as obtained from biometric photographs. With an increasing value of Z, there was 
a greater likelihood of occlusion of the trabecular meshwork. The authors 
hypothesized that this increase in ‘Z value’ results in an increase in the angle made by 
the iris take-off from the iris root (described as angle 𝜃). The importance of this 
parameter was validated in other studies.167, 168 
Lowes and Mapstone proposed a vector model of pupil block mechanism. They 
explained that the co-contraction of iris sphincter and dilator muscles, as well as the 
iris elasticity, will generate a resultant force that is perpendicular to the lens surface, 
thereby causing either relative or absolute obstruction of aqueous flow in the pupil 
region.169-171 In eyes with forward movement of the lens–iris diaphragm, the contact 
between iris and anterior lens surface is anterior positioned; thus, it decreases the 
angle between the respective vectors, and thus increases the resultant force on the lens 
surface and resistance to aqueous flow from the posterior to anterior chambers.  
 
With the advent of imaging modalities such as ASOCT, it is now possible to acquire 
cross-sectional in-vivo images of the entire anterior chamber in a single scan, and thus 
permit visualization of the relative position of the various anterior segment structures. 
Our results further suggest that the position (relative to scleral spurs) of the anterior 
lens surface appears to be more important than lens thickness and position itself in 
angle closure. We hypothesize that a larger LV would occupy more space in the 
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anterior chamber, causing crowding of the anterior segment and aggravation of the 
pupil block component, resulting in narrowing of the angle. The LV is an easily 
obtained parameter once an ASOCT image is at hand. 
 
3.4.3 Characteristics of the Lens vault in normals 
In the normal control group, we found that LV was greater in females and increased 
with advancing age. Theoretically, the increase in LV observed with advancing age 
may be related to zonular laxity or increased LT. However, with a poor correlation 
found between LV and LT, it is likely that the increase in LV with age may be 
associated with changes in zonular laxity with age. 
The increasing magnitude of LV with age may be a contributory factor to the greater 
incidence of angle closure in older adults. However, the lens is not likely to be the 
only component in angle closure, and therefore we do not expect changes in LV to 
exactly mirror the incidence in APAC. It is possible that once a threshold has been 
reached, further increases in the LV do not add further to the risk of disease.  
Lens vault was also found to be greater in women; this may again explain the 
occurrence of increased prevalence of angle closure among women.  
 
3.4.4 Characteristics of the Lens vault in Angle closure 
Interestingly, although the 3 subtypes of angle closure (PACG, PAC, and APAC) had 
similar biometric parameter measurements (e.g., ACD and AL), LV was different and 
was significantly greater in those eyes that have had previous APAC compared with 
the PAC (P = 0.003) and PACG (P = 0.001) subgroups. This together with the 
findings of a greater LV in women may help to explain the previously reported 
increased incidence of APAC in women and also may help explain in part why APAC 
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develops in certain eyes and not in others.  
 
3.4.5 Lens vault is independent of Lens thickness 
Since we noted that LV was only fairly correlated with LT (PCC = 0.17), we 
hypothesized that it was potentially likely that an eye with a thick lens need not 
necessarily have a large LV and vice versa. We have illustrated this hypothesis in 
Figure 3.3.14 which shows similar magnitude of LV but different measures of LT. 
Therefore, to determine the effect of LT on the lens parameters, we divided angle-
closure eyes (based on mean LT value) into two groups (>4.20 mm and ≤4.20 mm) 
and compared them separately versus normal control eyes (Table 3.3.5). It was 
interesting to note that although there was no significant difference in LT between 
normal controls and the angle- closure sub-group with thinner lens, the LV, however, 
was significantly greater in both the angle closure subgroups. The LV was also poorly 
correlated with LT (PCC: 0.17). This shows that LV, although being a part of the lens, 
is not entirely dependent on LT, and is likely to be more representative of the role of 












 Figure 3.3.14: Diagrammatic illustration of eyes with similar magnitude of LV 







3.4.6 Confirmation of the importance of the LV in another ethnic population 
Compared to the thickness and position of the lens, only the LV was found to be 
significantly associated with angle closure in the Japanese, similar to the effect in the 
Chinese. Although the lens was thicker and more anteriorly located in eyes with angle 
closure, after multivariate adjustments, the other lens parameters were not 
significantly associated with angle closure.  
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It was interesting to note that in comparison to the Chinese, the Japanese angle 
closure subjects (as well as the normal controls) had thicker lenses (4.20 vs 4.91mm 
in angle closure; and 3.90 vs 4.54mm in normals) and greater LV (901 vs 1034µm in 
angle closure; and 316 vs 419 µm in normals). Also, ACD and AL were smaller in 
Japanese eyes (both angle closure and normal groups). Thus it is likely that the lens 
occupies a greater volume in the eye and may play a major role in contributing to the 
pathogenesis of angle closure in persons of Japanese ethnicity. 
 
Also, similar to the findings in Chinese subjects, when we determined the effect of LT 
on the lens parameters by dividing the angle closure eyes (based on mean LT value) 
into two groups, we noted that although there was no significant difference in LT 
between normal controls and the angle closure sub-group with thinner lens, the LV 
however, was significantly greater in both the angle closure subgroups. This finding 
reinforces the point that the LV is not entirely dependent on LT and is likely a better 
measure for representing the role of the lens in angle closure.  
 
3.4.7 Is the lens vault a good screening parameter for angle closure?  
In terms of the ability to differentiate angle closure eyes for the purpose of screening, 
the LV performed most favorably with the AUC for LV (0.94) being higher than any 
other lens parameters (AUC range, 0.58–0.66) or previously used screening 
parameters such as ACD (AUC, 0.75) and AL (AUC, 0.74). We also found that the 
optimum sensitivity and specificity was highest for the LV. With an excellent ability 
to predict eyes with angle closure confirmed in two different ethnic groups, as well as 
its ability to quantify the relationship of the lens with respect to the anterior chamber 
angle or its structures, LV has the potential to be utilized as a screening and diagnostic 
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parameter for angle closure. Description of the currently available screening tools/ 
parameters for angle closure is detailed in Chapter 5, section 5.1 ‘Angle closure 
screening ‘.  
 
3.4.8 The magnitude of the Anterior Vault remains stable with age  
An important feature highlighted by our study is that the anterior vault, which 
represents the portion of the anterior segment that is located anterior to the plane of 
the angles, is significantly smaller in eyes with angle closure, and its magnitude 
remains stable with advancing age (within our limited age range). While a prospective 
study is necessary to validate this finding, however, our findings suggest that one of 
the factors that determines predisposition towards angle closure is the dimension of 
the anterior segment. In such predisposed eyes, development of angle closure likely 
occurs due to the gradual age-related increase in the size of the lens, and 
corresponding shallowing of the anterior chamber depth. Therefore, anterior vault 
may be another parameter that may aid in identifying early, eyes that are at risk of 
angle closure.  
 
3.4.9 Lens extraction in Angle closure: Is there a role for the Lens vault in the 
management of angle closure?  
Laser peripheral iridotomy (LPI) is the established first line treatment for angle 
closure as it eliminates pupillary block. However, LPI does not open up the angle in 
all cases, and evidence of progression of PACG in the presence of a patent iridotomy 
has been reported.49, 172 Plausible reasons for the persistence of iridotrabecular contact 
have been attributed to mechanisms other than pupillary block, such as plateau iris 




The lens plays an important role in the pathogenesis of PACG.68, 69, 159 In addition to a 
relief of the anatomical situation, phacoemulsification of the lens in angle closure 
eyes is known to have an IOP lowering effect believed to occur due to better access 
for the outflow of aqueous through the trabecular meshwork.163, 164, 173 LV is the 
ASOCT risk factor for angle closure that is most analogous to the lens component. 
Although an increased LV may either represent an aged lens, an intumescent lens or 
subluxed lens, the targeted removal of this component converges to a lens extraction.    
However, there is currently a lack of consensus on the role of lens extraction in eyes 
with PACG or PAC with good visual acuity. In the absence of visually significant 
cataract, whether to extract the lens in cases of PACG is currently being investigated 
by an ongoing multi-centered randomized controlled trial, the effectiveness in Angle 
Closure Glaucoma of Lens Extraction (EAGLE) study,174 with particular reference to 
quality of life metrics. This study is investigating whether early lens extraction in 
PACG improves patient-reported outcomes and cost effectiveness compared with 
standard care.174 
 
While LT can be biometrically determined and was initially studied as a possible 
contributory factor, the data suggesting an association between LT and angle closure 
remains inconsistent.69, 78, 158 On the other hand, we have shown that LV which 
represents the magnitude of the lens that is anterior to the plane of the anterior 
chamber angles (ie anterior to the level of the scleral spurs), is independently 
associated with angle closure. LV has also been shown to have a greater ability to 
differentiate eyes with angle closure (AUC 0.94 - 0.96) compared to LT (AUC 0.61-
0.75) or ACD (AUC 0.75-0.90). As greater LV carries a higher risk of angle closure, 
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it follows therefore that lens removal in patients with greater LV is likely to reduce 
this risk significantly. In our study we examined a large community based population 
group and found no association between the degree of LV and extent of visual 
impairment in subjects with angle closure. As illustrated in figure 3.3.4A, the LV 
may be considerable whilst the visual acuity remains good.  In such eyes with a large 
LV, even if visually asymptomatic, lens extraction may be of benefit as the lens 
related aspect would be refractory to an iridotomy.  
 
Many elderly PACG patients will develop cataracts in the near future and will require 
surgery. This includes both those with naturally ageing cataract and in some cases 
from the effect of conventional glaucoma treatment.175-177 Whilst it may be tempting 
to speculate that lens extraction is preferable to LPI throughout the angle closure 
spectrum in the presence of borderline visually significant cataracts, realistically this 
scenario depends on each individual case. Moreover, lens extraction in the 
management of PACG must be balanced against the small but real risk of 
endophthalmitis related to surgery. An assessment of LV may be useful in the 
education of patients and to guide in the decision making process. Of note, this study 
showed that increasing LV in angle closure eyes is not associated with either a 
myopic shift in refraction or a decrease in VA. This permits the ASOCT to be more 
useful from a mechanistic view rather than a simple interpretation of whether the 
angles are open or closed. An estimation of the LV if available is useful as it better 
defines the role of the lens directly in relation to the anterior chamber angles. An 
added advantage is the ability to visualize the relative positions of the anterior 




3.4.10 Anterior chamber width: Effect on the anterior chamber drainage region 
We found that the ACW was significantly smaller in Chinese compared with other 
races. A smaller ACW was also observed in eyes with angle closure, shallower ACD, 
and in eyes with shorter AL. These findings suggest that angle crowding caused by a 
smaller ACW may be an important factor predisposing Chinese eyes to angle closure.  
 
The ACW can be regarded as the diameter of the anterior chamber of the eye. As the 
circumference of a circle is estimated as diameter times pi (value of 3.14), therefore, a 
unit change in the width (diameter) of the anterior chamber of the eye (if assumed to 
be a circle) would result in a circumferential change of 3.14 units (Figure 3.3.15). For 
example, a 1-mm decrease in the ACW from 12 mm would result in a 3.14-mm 
decrease in the circumference of the anterior chamber drainage region, which is 
equivalent to an 8.3% reduction. A smaller ACW also implies a smaller anterior 
chamber volume, and this may further facilitate the angle-crowding mechanism. 
Because this was a cross-sectional study, we were unable to confirm a causal 
relationship between ACW and angle closure. In future studies, it would be important 
to prospectively study this association, as well as our hypothesis that ACW may play 










Figure 3.3.15: Illustration of the relationship between diameter (ACW) and 







3.4.11 Anterior chamber width: Associations with Age, BMI and Educational 
level 
In our cross-sectional study, the findings that ACW decreased as a linear function of 
age may help explain the angle narrowing that is observed with increasing age. Kanai 
and Kaufman178 observed that with aging, the sclera undergoes a progressive 
degeneration of collagen. Rada and colleagues179 found that glycosaminoglycans, a 
constituent of collagen responsible for providing mechanical support, decreases in the 
anterior scleral tissue with age. This age- related reduction of glycosaminoglycans 
may result in paucity of support to the scleral spur, which may be reflected by a 
smaller ACW. Another possible explanation for a smaller ACW could be a decrease 
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in ciliary body tone, which occurs with advancing age. However, these hypotheses 
can only be confirmed in a long-term prospective study evaluating the change in 
ACW (and other ocular parameters) with age and with the development of narrow 
angles. Such a study may help us correctly predict the eyes that have the highest 
chance for developing narrow angles. 
 
Our study also revealed an interesting association between smaller ACW and lower 
BMI is interesting. It has been previously reported that adult height in a Chinese 
population was independently related to ocular dimensions even after controlling for 
age, gender, education, occupation, income, housing type, and weight; namely, 
shorter people had shorter ALs and shallower anterior chambers.180, 181 Persons of 
smaller body constitution have lower BMI and thus proportionately smaller ocular 
size and ACW.  
Another finding of the present study is the association of smaller ACW with lower 
educational level. There have been several studies that have reported on the 
relationship between axial myopia and educational level.182-184 Our findings could 
therefore be explained by the fact that less-educated patients were probably more 
hyperopic with proportionately smaller ocular size. 
 
3.4.12 Anterior chamber width and Angle closure 
Anterior chamber width was significantly smaller in the hospital-based subjects with 
angle closure disease (consisting of PAC and PACG) compared with the community- 
based subjects with open angles and, notably, even smaller than the community-based 
subjects with angle closure. A probable reason for this observation is that the subjects 
recruited from the hospital were either symptomatic or had a more advanced stage of 
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angle-closure disease; thus, they were more likely to present to a hospital. 
When we investigated the performance of the different biometric parameters in 
screening for angle closure, we found that ACW performed worse than ACD or AL, 
suggesting that ACW by itself cannot be used for screening in the general population. 
However, it is not known whether ACW may be useful in certain subgroups of 
patients with angle closure, such as those with plateau iris, because central ACD is 
often normal in such eyes.  
 
3.4.13 Characteristics of ASOCT parameters in subtypes of angle closure 
Interestingly, comparison among subtypes of angle closure showed that whilst the 
APAC group had the smallest anterior segment dimensions with a large LV, the 
PACS eyes, which represent the earliest stage of the angle closure disease spectrum, 
had the most spacious anterior chambers characterized by larger anterior vault, deeper 
ACD, and a smaller LV compared with the other subgroups. This suggests that PACG 
disease progression may be associated with changes in anterior segment dimensions: 
decreasing anterior chamber volume with increasing severity of disease. However, 
definitive association between progression and biometric alterations can only be 
established by a prospective longitudinal study. 
 
Studies have reported ACD as a risk factor in the development of PACG. 71, 185, 186 
Moreover, some have proposed that the shallower the ACD, the higher the risk for an 
acute attack.185 Lan et al. studied the biometric differences in acute and chronic 
PACG and found that the ACD of eyes with acute angle closure as well as the fellow 
eyes were significantly shallower than chronic angle closure.187 Likewise, in an 
ASOCT study of the subtypes of PAC, Moghimi185 noted that the mean ACD was 
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smallest in the acute eyes followed by the fellow eyes, with the chronic group having 
the deepest anterior chambers. This further emphasizes the importance of a shallow 
ACD in the predisposition to an acute attack. In a population-based study, Sng and co-
workers showed that LV was a major determinant of ACD contributing to 58% of its 
variability.186 While we have established the role of the LV in angle closure; however 






















3.5 SUMMARY & CONCLUSIONS 
In summary, we found that eyes with angle closure have thicker lenses with a greater 
LV, smaller ACW and anterior vault, shallower ACD, and shorter AL. The LV and 
relative LV were associated strongly and independently with angle closure and 
distinguished eyes with angle closure from those with open angles better than 
traditional biometric parameters. Our findings also suggest that there is a significant 
population of angle closure individuals with a large LV but good visual acuity. The 
clinical relevance of LV may lie in aiding decision making in those for whom LPI or 
phacoemulsification may be equally acceptable treatment options. Cataract surgery 
may be a consideration in those cases with large LV in the absence of visually 
significant cataract. 
With good ability to predict eyes with angle closure confirmed in two different ethnic 
groups, as well as its ability to quantify the relationship of the lens with respect to the 
anterior chamber angle or its structures, LV has the potential to be utilized as a 
screening and diagnostic parameter for angle closure. In future studies, it would be 
important to prospectively evaluate the association of changes in LV with angle 











3.6 STRENGTHS OF THE IMAGING STUDIES 
1. Well-characterized study participants  
Appropriate case definition is the cornerstone of epidemiological research. In 
this research we followed strict criteria for categorization of cases and 
controls. We used the World Glaucoma Association accepted ISGEO 
classification to classify primary angle closure cases into PACS, PAC and 
PACG. The ISGEO is a conceptually simple classification scheme based on 
both structural and functional evidence of glaucomatous neuropathy and is 
especially designed for epidemiological cross-sectional studies. By giving 
emphasis to end organ damage as the defining characteristic of glaucoma, it 
divides primary angle closure to the three separate stages. Unlike the prior 
symptomatology-based classification of angle closure, the ISGEO places 
emphasis on features that indicate trabecular obstruction as well as functional 
visual loss. In this classification scheme, the three stages share the anatomical 
characteristic of ‘occludable angles’. 
Evaluation of study subjects were performed using identical instruments and 
imaging devices under standardized examination conditions. 
 
2. Standardized examination protocol  
Keeping in mind the possibilities of alterations in quantitative measurements 
with change in lighting conditions, we have captured all our ASOCT scans 
under standardized lighting conditions of 0 lux  (as measured by a light-
meter). We followed meticulous imaging protocols for image capture and 
image analysis. Furthermore, by evaluating non-angle ASOCT-derived 
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parameters, our findings are less likely to vary across meridional scans, and 
therefore more effectively capture the role of the parameters in angle closure.  
 
3. Large sample size 
We have incorporated large sample sizes in our research; both population-
based and hospital-based subjects. Additionally our hospital-based population 
encompassed the entire spectrum of angle closure disease from PACS to 




















3.7 OVERALL STUDY LIMITATIONS  
The limitations of the study can be categorized as follows: 
1. Related to ASOCT imaging 
The use of semi-automated image analysis software and exclusion of a large 
number of images (mainly due to undetectable scleral spurs) are the main 
limitations. However, with improvements in ASOCT imaging technology and 
subsequent availability of fully automated image analysis techniques may help 
reduce the exclusion rates. Another limitation was that we only utilized 1 
meridional scan and it is not known if multiple scans in various meridia will 
further improve accuracy. 
 
2. Extrapolation of findings 
Majority of the subjects evaluated for the imaging-based studies were Chinese; 
therefore caution is warranted when trying to extrapolate the results to other 
ethnic groups. We were fortunate that we could validate the role of the LV in 
another ethnic group, the Japanese. As the studies were cross-sectional in 
nature; hence, it is difficult to establish temporal or causal relationships. A 
prospective longitudinal study is needed to address the cause and effect 
relationship between the novel ASOCT parameters and angle closure. 
 
3. Potential effect of Cataract 
The association of lens parameters with cataract type or severity was not 
investigated as we did not have data on the cataract grades of the subjects. It is 
possible that the degree and type of cataract may influence LT and LV. Also, 
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the availability of such data would enhance our understanding of the effect of 
cataractogenesis on LV and visual acuity. 
 
4. Others 
Factors such as accommodation, lighting, and previous laser iridotomy, 
cataract severity, which may induce changes in the various anterior segment 





















3.8 CAN THE ESTABLISHED AND NOVEL ANATOMICAL RISK FACTORS 
BE CONSIDERED AS INTERMEDIATE PHENOTYPE FOR ANGLE 
CLOSURE? 
In this study, we have identified novel anatomical risk factors, ACW and LV, which 
are independently associated with an increased risk for angle closure. These 
parameters are normally distributed, and eyes with angle closure were found to have 
smaller ACW, larger LV, and also smaller anterior vault compared to eyes without 
angle closure. Together with the established angle closure risk factors such as 
shallower ACD and thicker lens, these quantitative parameters can be considered as 
intermediate phenotype or endophenotype for angle closure disease. Therefore, these 
parameters can be utilized to find novel genes for PACG through the endophenotype 
or quantitative traits loci approach. Please see the next section (section 4.1) for a 
















GENETIC LOCI FOR ANGLE CLOSURE 
 
4.1 ENDOPHENOTYPE APPROACH TOWARDS IDENTIFICATION OF 
PACG SUSCEPTIBILITY LOCI 
We anticipate that as with many late-onset common diseases such as heart disease,106 
type 2 diabetes105, 106 and others, the genetic basis of angle closure disease will also be 
complex and non-Mendelian, and more likely attributable to multiple genes/ loci each 
of which explains a small proportion/ percentage of disease risk. Technological 
advances have enabled identification and characterization of common genetic 
variations across the entire human genome;130, 133 and large-scale genome-wide 
association (GWA) studies have improved our understanding of the genetic basis of 
many complex diseases. The “common disease/common variants (CDCV)” 
hypothesis postulates that common diseases are likely governed by the combined 
effect of multiple genetic variants, which are common in the population, and with 
each individual variant contributing a small effect to the overall disease risk/ 
phenotype.132  
 
4.1.1 Genome-wide approaches for the identification of genetic variants for 
complex diseases 
There are two primary approaches for GWA studies:   
Case-control/ Categorical traits– Affected versus un-affected/Normal or extremes 
of phenotypes. 
Quantitative traits/ Endophenotypes – Height, LDL-cholesterol levels, Central 




Case-control/ Categorical traits GWAS approach 
In the case-control GWA studies, the focus is on qualitative traits and involves the 
comparison of allele frequencies of cases versus controls. Controls are often chosen 
from population-based studies irrespective of disease status, or from among 
individuals without the disease. Large scale GWAS have successfully led to the 
discovery of several susceptibility loci/variants across the entire genome for common, 
complex diseases such as type 2 diabetes (T2D), heart disease, schizophrenia,105, 106 
and recently, this methodology was used to successfully identify three common 
genetic variants for PACG. The number of loci robustly implicated in some of these 
diseases has climbed steadily over the last decade. The GWAS findings indicate that 
multiple genes of modest effect sizes affect these complex disorders.132  
 
An understanding of the mechanisms by which each of these genes affect the disorder 
has led to the disorder being thought of in terms of its quantitative traits. Some 
diseases have well-established quantitative measures, such as high-density lipoprotein 
(HDL) and low-density lipoprotein (LDL) cholesterol levels as predictors of 
cardiovascular disease. HDL and LDL may be considered as intermediate quantitative 
traits or endophenotypes of cardiovascular disease.136 Similarly, fasting blood glucose 
may be considered an endophenotype for Diabetes.105  
 
4.1.2 What is an endophenotype? 
Intermediate quantitative traits or endophentypes are factors that are associated with a 




a. It must be heritable 
b. It should be associated with a disease in the general population 
c. It is primarily state-independent i.e. it should manifest in the individuals regardless of 
the disease state 
d. In families with the disease, high (or low) levels of the trait must occur in the unaffected 
family members at a rate higher than in the general population i.e. disease risk is 
correlated genetically with the endophenotype.  
 
 
4.1.3 Identifying disease genes through the quantitative traits/ endophenotype 
approach 
Quantitative phenotypes allow individuals to be viewed along the continuum of risk, 
and may provide additional information which could complement dichotomous 
measures of affection status. For some common complex diseases such as Type 2 
Diabetes (T2D), coronary artery disease and Crohn’s disease, the analysis of 
endophenotyes or the quantitative trait approach has been successful in identifying a 
range of genes and loci for the conditions. Such findings have led to refinements and 
modifications in the definitions of certain diseases.105, 106, 136  
 
Type 2 Diabetes: In the case of T2D, by studying the genetic variants controlling 
levels of fasting blood glucose and hyperglycemia, the approach has been successful 
in identifying genes associated with disease susceptibility. For example, IRS1 
(encoding the insulin receptor substrate-1) had been found to be associated with T2D 
as well as fasting glucose, fasting insulin and development of hyperglycemia.188 A 
meta-analysis of 10 cohorts comprising > 40,000 individuals identified rs10830963 at 
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MTNR1B to be associated with both with fasting glucose (P=3.2×10−50) and T2D 
(P=3.3×10−7);189 and another study found a different variant (rs1387153) near 
MTNR1B associated with T2D, fasting glucose and glycated hemoglobin (HbA1C).
190 
MTNR1B, which encodes the melatonin receptor MT2, is postulated to influence 
insulin secretion and glucose levels. Its endogenous ligand melatonin is a 
neurohormone that mediates circadian rhythmicity.190 Additionally, several other 
GWAS for fasting glucose as a quantitative trait have identified genetic variants for 
T2D.191, 192 
 
Coronary Artery Disease (CAD): The same rationale has been put forth to identify 
genes for coronary artery disease through genetic variants controlling lipid traits.116, 
136, 193-195 Some of the heritable markers for CAD include plasma concentrations of 
total cholesterol, HDL cholesterol, Triglycerides (TG), and LDL cholesterol. A 
genome-wise association study on >100,000 subjects of European ancestry revealed 
95 loci that showed significant association (p<5x10-8) with at least one of these four 
lipid traits.136 While this quantitative traits approach not only identified the known 
loci previously determined by candidate-gene and dichotomous GWAS approaches; it 
also identified 59 novel genome-wide significant loci.136 Some of the newly identified 
loci were near known lipid regulators such as CYP7A1, NPC1L1 and SCARB1; while 
others were in areas not previously implicated in lipid metabolism.136 Individuals with 
and without CAD were then evaluated for association with these lipids associated 
loci. Several loci were also found to be significantly associated with CAD. Some loci 
are within genes that have clear biological and clinical relevance such as LDLRAP1 
(responsible for autosomal recessive hypercholesterolemia), SCARB1 (which is a 
receptor for selective uptake of HDL-C), NPC1L1 (an established drug target), 
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MYLIP (regulator of LDL-C), and PPP1R3B (regulator of HDL-C). These 
associations demonstrate the likelihood that several quantitative mechanisms may 
underlie a complex disease.136  
 
POAG: More importantly, in relation to eye disease the same quantitative trait or 
endophenotype-based approach has been successfully used to map genes for primary 
open angle glaucoma (POAG) through those that control vertical cup-to-disc ratio 
(VCDR), a measurement of the magnitude of optic disc cupping and intraocular 
pressure (IOP).118, 119 Heritability studies conducted in twins, sib ships, small 
pedigrees and isolated populations have shown that these quantitative traits for POAG 
have a genetic basis196-198 with heritability estimates ranging from 0.29-0.5 for IOP, 
and from 0.48 to 0.80 for VCDR.198-201 In the study by Charlesworth and colleagues, 
both of these traits exhibited significant genetic correlations with disease risk, 
suggesting substantial overlap of genes that jointly influence variation in these 
quantitative phenotypes and disease status.118 
A genome wide association study on optic disc area and VCDR, using data over 
11,000 Caucasians identified three loci for optic disc area and another six for 
VCDR.119 The genes for optic disc area were CDC7/TGFBR3 on chromosome 1p22, 
ATOH7 on chromosome 10q21.3-22.1 and SALL1 on chromosome 16q12. The genes 
for VCDR were, CDKN2B on chromosome 9p21, SIX1 on chromosome 14q22-23, 
SCYL1 on chromosome 11q13, CHEK2 on chromosome 22q12.1, ATOH7 on 
chromosome 10q21.3-22.1, DCLK1 on chromosome 13q13, and the borderline 
significance gene BCAS3 on chromosome 17q23.119 ATOH7 gene is therefore 
involved in both optic disc area and VCDR, independently. 202 These loci were then 
evaluated for association with POAG. Of them, three of the loci associated with 
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VCDR and the ATOH7 were also found to be associated with an increased risk for 
POAG.202 
 
Based on the successes of quantitative traits approach to effectively identify novel 
genetic variants for complex disorders, we believe that the heterogeneity of PACG (a 
characteristic shared with POAG) means that disease-related endophenotypes/ 
quantitative traits could be more informative in elucidating true disease genes as the 
etiological complexity of PACG is reduced and deconstructed. 
 
4.1.4 Identification of PACG genes through the Endophenotype approach 
As PACG has constituent intermediate phenotypes such as shallow ACD, and the 
newly identified phenotypes described in the thesis such as smaller ACW, smaller AV 
and larger LV, therefore, the Endophenotype approach can be used to identify novel 
susceptibility genes for PACG. We believe that by identifying the genes that govern 
these PACG-related quantitative traits, we would be successful in unraveling the 
genetic determinants that confer individual susceptibility to PACG, a condition 
responsible for the majority of irreversible visual loss worldwide.  
 
In this proposal we aim to identify the genetic variants that influence PACG-related 








4.2 GENETIC DETERMINANTS OF ANTERIOR CHAMBER DEPTH 
Smaller anterior segment dimensions are a hallmark of PACG, with shallower anterior 
chamber depth (ACD), the cardinal feature associated with increased susceptibility to 
PACG.203, 204 Eyes with an ACD of less than 2.80mm were more inclined to have 
angle closure when compared to eyes with an ACD of at least 3mm (odds ratio (OR), 
42.5; 95% confidence interval (CI), 27.4–66.2).71 There is also a greater likelihood of 
developing glaucomatous optic neuropathy in persons with the shallowest anterior 
chambers.70 ACD (Figure 4.2.1), an easily and precisely quantified measure by ocular 
imaging techniques, is a normally distributed quantitative trait within the general 
population.  
 









4.2.1 Evidence for genetic basis for ACD 
Heritability of ACD: Twin-based heritability studies conducted in Caucasian and 
Chinese individuals have shown that ACD displays high heritability with estimates 
ranging from 51-88% in Caucasians92, 93 and >90% in Chinese,88 and can be 
considered an endophenotype/intermediate trait for PACG. Data from the Beaver 
Dam Eye Study reports heritability estimates of 0.78 (SE 0.14) for ACD, after 
adjustment for age, education, height, and nuclear sclerosis.92 An Australian study 
conducted on 1224 twins (including 345 monozygotic [MZ] and 267 dizygotic [DZ] 
twin pairs) aged between 18 and 88 years, report heritability estimates of 0.51 and 
0.78 respectively in the men and women.93 The heritability of ACD was reported to be 
greater in Chinese.87 In a study conducted on a total of 563 twin pairs (including 357 
MZ and 206 DZ twin pairs) recruited from the Guangzhou Twin Registry, He et al 
report a high heritability of 90.1% (95% CI: 88.2%-91.7%).87 
Normal distribution of ACD: Within the general population, ACD is a normally 
distributed quantitative trait.87, 205 The ACD in our Singapore Malay Eye Study 
(SiMES) and the Singapore Indian Eye Study (SINDI cohorts also follow a normal 
distribution (Figures 4.2.2 and 4.2.3). 
Developmental genes: As described earlier under Section 1.5.2 (Potential candidate 
genes for angle-closure), previous molecular genetics studies have mapped recessive 
nanophthalmos to a locus at chromosome 11q23.3 and identified four independent 
mutations in the MFRP gene.102 Another locus on chromosome 11 has also been 
mapped to autosomal dominant nanophthalmos.103, 104  
Nanophthalmos is a rare disorder of eye development resulting in small eyes that are 
predisposed to angle closure glaucoma due to the crowding of the anterior chamber. 
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The eyes are characterized by short axial length, extreme hyperopia, high lens-to-eye-
ratio and a corresponding shallow ACD.  
 
 
Figure 4.2.2: Distribution of anterior chamber depth in the Singapore Malay Eye 












Figure 4.2.3: Distribution of anterior chamber depth in the Singapore Indian 




4.2.2 Aims of the study 
As with any quantitative trait, ACD is likely to be determined by a number of 
genes/loci of varying effect sizes. The available evidences suggest that ACD has a 
strong genetic basis; therefore a well-designed GWAS approach would be ideal to 
uncover genes associated with this trait. Therefore, the aim of this study is to identify 
genetic variants that significantly influence ACD, and to determine if such genes (if 
any) affect PACG risk. We conducted a two-staged study, first a GWAS on a total of 
4,484 population-based individuals of Indian and Malay ethnicity from Singapore, 
and Chinese from Beijing, China. Secondly, the identified QTLs for ACD were 
assessed for association in PACG case cohorts.  
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4.2.3 Materials and Methods 
Sample collections analyzed for Anterior Chamber Depth 
We obtained ACD measurements from three population based samples: SiMES,120 
SINDI121 and the Beijing Eye Study (BES).20  Please see Chapter 2, Section 2.1 for a 
description of the study design, sampling method, recruitment, and evaluation of the 
subjects’ recruited for the above studies.  
 
 Measurement and Analysis of Anterior Chamber Depth (ACD): 
ACD was measured using the IOLMaster (Carl Zeiss Meditec, Dublin, CA). Five 
readings were obtained and the average computed. The signal-to-noise ratio for all 
readings were >2.0, which indicate that a clear signal was obtained when performing 
the measurement. All the readings were within 0.05 mm of the one with the highest 
signal-to-noise ratio.  
 
The ACD measurements that were used in the GWAS analyses excluded any 
measurements from any eye which were pseudophakic or aphakic. For collections 
with data from two phakic eyes (namely, SiMES and SINDI), individuals were 
excluded if the ACD measurements between the two eyes differed by more than 
0.2mm (which represented the top ~20th percentile of symmetrical data). This 
resulted in a good correlation between the left and the right eye measurements (r2 > 
0.95 in both SiMES and SINDI). However, BES only had measurements for the right 
eye; thus in the final meta-analysis we used ACD measurements that were taken from 





PACG case-control cohorts 
The subjects for the PACG case-control study were compiled from 11 independent 
sample collections enrolled from 8 different countries. These were subjects recruited 
as part of a then concurrent case-control study (of which I was also actively involved 
in patient recruitment and phenotyping) that aimed to identify PACG-related genetic 
variants using the case-control GWAS methodology.111 Furthermore, for the current 
study, an additional PACG case-control collection from Japan (136 cases and 419 
controls) as well as an additional 436 PACG cases from the Beijing site were included 
for the analyses. The PACG cases and population-based controls were defined using 
the same criteria as described previously under section 1.1.1, Chapter 2. 
 
Selection of controls without angle closure 
In an attempt to minimize the misclassification of controls, we selected controls that 
were clinically vetted to have open angle as controls with closed / narrow angles are 
at increased risk of PACG compared to controls with open angles. These ‘super 
controls’ were selected from within the population-based samples based on robust 
clinical criteria. The criteria for defining as eye as ‘super control’ were an IOP < 21 
mmHg, open angles (on gonioscopy) in all quadrants, healthy optic nerves, normal 
visual fields, and no previous intraocular surgery. 
 
Genotyping  
ACD GWAS: Genotyping in the following sample collections (SiMES, N = 1752; 
SINDI, N = 1860; BES1, N = 872) was performed using the Illumina 610K Quad 
BeadChips following manufacturer instructions after genomic DNA were extracted 
from participants using standard laboratory techniques. Genotyping of SNP ABCC5 
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rs1401999 in an additional 824 participants from the Beijing Eye Study (termed 
BES2) was performed using direct capillary sequencing.  
 
PACG sample collections: Genome-wide genotyping was performed for a total of 
1,854 PACG cases and 9,608 controls using Illumina SNP-arrays. A further 1,917 
PACG cases and up to 8,943 controls were genotyped using the Sequenom 
MassArray and Taqman real-time PCR method.   
 
4.2.4 Statistical analysis 
1. A selection of stringent quality control (QC) filters were applied to remove 
poorly performing SNPs and samples using tools implemented in PLINK 
version 1.7.146 Please see section 2.4.1.4 for a description of the QC measures 
for both SNPs and samples. The QC criteria were as follows: SNPs that had > 
5% of missing genotypes, gross departure from Hardy-Weinberg equilibrium 
(test for HWE showing P < 10-6) or were of minor allele frequency below 1% 
were excluded from downstream analysis. For sample QC, samples with an 
overall genotyping call rate of < 95% were excluded from analysis. Principal 
component (PC) analysis was undertaken to account for spurious associations 
resulting from ancestral differences of individual SNPs. PC plots were 
performed using the R statistical program package (www.r-project.org/). 
2. Genome-wide per-cohort and meta-analysis of ACD for all three sample 
collections was performed using standard procedures as previously 
described.138, 206, 207 For the GWAS on ACD, linear regression was performed 
to test for association between SNP genotypes and ACD as implemented by 
PLINK (version 1.07). Individual SNP genotypes were coded according to the 
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number of copies of the minor allele present: 0 for the wild-type genotype, 1 
for heterozygotes, and 2 for homozygote variants. A trend test using linear 
regression was used for primary association testing between genotypes and 
ACD as a quantitative trait, adjusting for age, gender, and the significant axes 
of genetic stratification.  
3. Meta-analysis across SiMES, SINDI and BES was performed using the 
inverse-variance, fixed effects model in order to obtain a combined point 
estimate of the overall effect size (β) coefficients and its corresponding 
standard error (SE). Inter-cohort heterogeneity was assessed with the 
Cochran’s Q statistic and its accompanying I2 index. Quantile-quantile (QQ) 
and Manhattan plots were created using the software R (www.r-project.org). 
After sample and genotyping QC, a combined total of 4484 individuals with 
complete data for ACD measurements, age and gender were available for 
SiMES, SINDI and BES individual GWAS. The overall genomic inflation 
factor for the meta-analysis of the three sample collections was minimal (λgc 
= 1.036; see Figure 4.2.4). We considered P < 5 x 10-8 as genome-wide 
significant, and the previously used threshold for genome-wide significance 
(P < 5x107) as ‘highly suggestive evidence of association.208 
4. For the association between ABCC5 rs1401999 and PACG, the analysis was 
carried out using logistic regression modeled for a trend-per-copy effect of the 







Figure 4.2.4: Quantile-quantile plot of P-values from the meta-analysis of ACD 
across the three independent sample collections with genome-wide genotyping 






















4.2.5.1 Identification of a quantitative trait locus for anterior chamber depth 
After sample and genotyping QC, a total of 1752 (SiMES), 1860 (SINDI), and 872 
(BES) individuals (combined total=4484) with complete data for ACD measurements, 
age and gender were available for GWA analysis. Table 4.2.1 shows the baseline 
characteristics of sample collections. We measured the association between ACD and 
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individual SNP genotypes using linear regression, modeling for a trend-per-copy 
effect on the minor allele. Additional adjustments were made for age, gender, and the 
significant axes of genetic stratification.  
We noted a significant excess of small P-values at the extreme tail of the quantile-
quantile distribution (Figure 4.2.4) accompanied by a background of minimal 
genomic inflation, thus indicating that there could be genuine associations between 
SNP genotypes and ACD. Highly suggestive evidence of association (P = 1.92 x 10-7) 
was observed at a sequence variant within ABCC5 (rs1401999) on Chromosome 3 as 
depicted in the Manhattan plot (Figure 4.2.5).  
 
 
Table 4.2.1: Baseline characteristics of sample collections 
 SiMES SINDI BES1 BES2 
N 1752 1860 872 824 
%Male (%) 49.43 50.97 37.16 40.66 
Age 1 [yr] 57.72 (10.84) 56.45 (9.12) 58.10 (9.35) 62.38 (9.99) 
ACD 1 [mm] 3.13 (0.36) 3.13 (0.37) 2.41 (0.32) 2.41 (0.34) 











Figure 4.2.5: Manhattan plot for genome-wide meta-analysis of anterior 
chamber depth in three populations with genome-wide genotyping data ((SiMES, 






We were able to replicate of this observation in a further 824 population-based 
samples from the BES, Beijing, China (which we refer to as BES2), (P = 0.011) using 
Sanger sequencing. Upon meta-analysis of all 5,308 population-based samples, we 
obtained a genome-wide significant association with ACD (β = -0.045 mm ACD per-





Table 4.2.2. Quantitative trait analysis between ABCC5 rs1401999 and anterior chamber 




β SE Pgc MAF 
SIMES 1752 C -0.056 0.0149 1.76 x 10-4 0.15 
SINDI 1860 C -0.041 0.0115 3.97 x 10-4 0.41 
BES1 872 C -0.026 0.0196 0.19 0.16 
BES2 824 C -0.058 0.0227 0.011 0.16 
All BES 1696 C -0.040 0.0148 0.0075 0.16 
Meta-
analysis* 
5308 C -0.045 0.00775 8.17 x 10-9  
SIMES: Singapore Malay Eye Study (typed with Illumina 610K GWAS chip) 
SINDI: Singapore Indian Eye Study (typed with Illumina 610K GWAS chip) 
BES1: Beijing Eye Study typed with Illumina 610K GWAS chip. 
BES2: Beijing Eye Study typed with direct sequencing.  
β: Per-allele effect size of ABCC5 rs1401999 on anterior chamber depth.  
SE: Standard error for β 
Pgc: Genomic control corrected P-value 
MAF: Minor allele frequency 





4.2.5.2 Association between ABCC5 rs1401999 and PACG 
For the second analysis, we examined if this variant was associated with PACG. We 
analyzed 1,854 PACG cases and 9,608 controls from 5 cohorts (Table 4.2.3), all 
genotyped with Illumina SNP-arrays, and a further 2,422 cases and up to 9,193 
controls from 7 independent collections genotyped using the Sequenom MassArray or 
Taqman platforms. As significant heterogeneity was noted for the effect of ABCC5 
rs1401999 and PACG risk between the 12 sample collections (Pheterogeneity = 0.0047, 
I2-index = 60.6%; Figure 4.2.6 and Table 4.2.4), we looked for sources of possible 
heterogeneity within the sample collections,209 the most obvious of which are the use 
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of clean, open angle controls in some collections (Please see  ‘Selection of controls 
without angle closure’ in section 4.2.3 Materials and Methods), and un-ascertained 
population-based controls in others. This could be important in the context of this 
study as the prevalence of at-risk population with inherent angle closure, is as high as 
10% in Asian populations.3, 16  
Overall, we noted modest evidence of association (per-allele odds ratio = 1.13, 95% 
confidence interval = 1.06 - 1.22; P = 0.00046) between the minor allele (C allele) of 
rs1401999 and PACG when all 12 case-control collections were considered. 
Interestingly, this association was augmented when we only included pre-specific 
sample collections where the controls had definite open angles (N = 3,458 PACG 
cases and N = 3,831 controls, per-allele OR = 1.30, P = 7.45 x 10-9; Figure 4.2.6 and 



























Singapore (Chinese) 984 Illumina 610K 943 Illumina 610K 
Hong Kong (Chinese) 297 Illumina 610K 1,044* Illumina 610K 
Malaysia (Malays) 83 Illumina 610K 3,065* Illumina 610K 
India (Indians) 337 
Illumina 610K 
and 660W 
2,538* Illumina 610K 
Vietnam (Vietnamese) 153 Illumina 610K 2,018* Illumina 60W 
All Stage 1 1,854  9,608  










Singapore (Chinese) 242 Sequenom 1,479* Illumina 610K 
Beijing (Chinese)† 1,428 Sequenom 1,503 Sequenom 
Saudi (Middle Eastern descent) 165 Sequenom 175* Sequenom 
UK (European descent) 127 Sequenom 4,703* Illumina 1.2M 
India (Indians) 80 Sequenom 309 Sequenom 
Shantou (Chinese) 244 Taqman 605* Taqman 
Japan 136 Taqman 419 Taqman 
All Stage 2 2,422  9,193  
All samples 4,276  18,801  
* denotes population-based controls.  
aClinically certified open-angled controls are not accompanied by * 
† PACG patients were recruited from the Beijing Tongren Hospital and controls were recruited from 







Table 4.2.4: Association analysis between ABCC5 rs1401999 and PACG in all chip-typed sample 
collections (top panel), de-novo genotyped sample collections (middle panel), and PACG cases 
and clinically certified controls with open angles (bottom panel) 
Stage 1 (Chip-typed sample collections) 
Collection MAF case MAF control OR P 
Singapore 0.135 0.109 1.27 0.017 
Hong Kong 0.147 0.132 1.16 0.38 
India 0.493 0.408 1.29 2.83 x 10-5 
Malaysia* 0.175 0.150 1.21 0.38 
Vietnam 0.143 0.121 1.21 0.25 
Meta-analysis (Stage 1)   1.23 
9.84 x 10-5 
(I2=0.0%) 
* Results here are presented based on raw minor allele frequency counts without further adjustment 
Stage 2 (De-novo genotyped sample collections) 
Collection MAF case MAF control OR P 
China (Beijing) ** 0.173 0.139 1.29 0.00045 
Singapore 0.120 0.143 0.82 0.17 
China (Shantou) 0.131 0.150 0.85 0.31 
Japan 0.136 0.113 1.23 0.32 
India 0.477 0.442 1.15 0.41 
Saudi Arabia 0.432 0.484 0.83 0.16 
United Kingdom 0.412 0.453 0.85 0.22 
Meta-analysis  (Stage 2)   1.06 
0.23  
(I2 = 67.5%) 
Meta-analysis (Stages 1 and 2)  1.13 
0.00046  
(I2 = 60.6%) 
ABCC5 rs1401999 genotyped in PACG cases and clinically certified open-angled controls only 
Collection MAF case MAF control OR P 
Singapore 0.132 0.109 1.24 0.026 
Hong Kong 0.159 0.103 1.64 0.012 
India 0.489 0.429 1.28 0.0047 
Beijing** 0.173 0.139 1.29 0.00045 
Japan 0.136 0.113 1.23 0.32 
Meta-analysis     1.30 
7.45 x 10-9  
(I2 = 0.0%) 
MAF case: Minor allele frequency in PACG cases; MAF control: Minor allele frequency in controls 
OR: Odds ratio; P: P-value for association with PACG.  
I2: I-squared index for between-collection heterogeneity.  
**PACG patients were recruited from the Beijing Tongren Hospital and controls were recruited from 





Figure 4.2.6: Association analysis between ABCC5 rs1401999 and susceptibility 




The vertical line represents a per-allele odds ratio of 1.00. The oblongs represent point 
estimates (referring to the per-allele odds ratio), with the height of the oblongs 
inversely proportional to the standard error of the point estimates. Horizontal lines 
indicate the 95% confidence interval for each point estimate. Meta-analyses of 
samples are reflected by blue diamonds. The width of the diamonds indicates their 
95% confidence intervals. All point estimates in Stage 1 have been adjusted for the 







4.2.5.3 What is the effect of age and gender? 
As PACG is more prevalent amongst females and the elderly, we formally adjusted 
the association for age and gender using logistic regression in populations for which 
demographic data are available (e.g. Singapore). We observed no significant change 
in the association when the adjustment for age is performed singly or in tandem. This 
strongly suggests that the association between ABCC5 rs1401999 and PACG is 
independent of age and gender. (Table 4.2.5) 
 
 
Table 4.2.5: Age and gender adjusted analyses 
CHR SNP Effect Allele OR P Additional adjustments 
3 rs1401999 G 1.269 0.01657 Unadjusted 
   1.337 0.02356 Age only 
   1.276 0.01784 Gender only 
   1.339 0.02368 Age and Gender 
   1.17 9.59E-105 Statistics for Age* 
   1.61 5.67E-07 Statistics for Gender** 
* Each PACG case is, on average, 1.17 years older compared to the controls 
** Females have on average 1.61-fold elevated risk of PACG compared to males 












4.2.5.4 Conditional analysis with recently identified PACG loci 
We also performed conditional analyses of the ABCC5 variant with the previously 
implicated PACG loci,111 namely PLEKHA7 rs11024102, COL11A1 rs3753841, and 
rs1015213 located between PCMTD1 and ST18 on Chromosome 8q. No change in 
either the odds ratio or p-values of the association were observed. (Table 4.2.6)   
Table 4.2.6: Association analysis between ABCC5 rs1401999 and PACG in the GWAS collections 
CHR SNP BP A1 OR P Collection Adjustments 
3 rs1401999 185161036 G 1.27 0.01657 Singapore unadjusted 
3 rs1401999 185161036 G 1.28 0.01374 Singapore adjusted for rs11024102 
3 rs1401999 185161036 G 1.28 0.01469 Singapore adjusted for rs3753841 
3 rs1401999 185161036 G 1.28 0.01269 Singapore adjusted for rs1015213 
3 rs1401999 185161036 G 1.13 0.3683 Hong Kong unadjusted 
3 rs1401999 185161036 G 1.13 0.3812 Hong Kong adjusted for rs11024102 
3 rs1401999 185161036 G 1.13 0.3777 Hong Kong adjusted for rs3753841 
3 rs1401999 185161036 G 1.13 0.3701 Hong Kong adjusted for rs1015213 
3 rs1401999 185161036 G 0.98 0.9411 Malays unadjusted 
3 rs1401999 185161036 G 0.97 0.8914 Malays adjusted for rs11024102 
3 rs1401999 185161036 G 0.99 0.9635 Malays adjusted for rs3753841 
3 rs1401999 185161036 G 0.99 0.9566 Malays adjusted for rs1015213 
3 rs1401999 185161036 G 1.32 0.001171 Indians unadjusted 
3 rs1401999 185161036 G 1.32 0.000991 Indians adjusted for rs11024102 
3 rs1401999 185161036 G 1.31 0.001418 Indians adjusted for rs3753841 
3 rs1401999 185161036 G 1.32 0.001173 Indians adjusted for rs1015213 
3 rs1401999 185161036 G 1.22 0.2405 Vietnam unadjusted 
3 rs1401999 185161036 G 1.21 0.2497 Vietnam adjusted for rs11024102 
3 rs1401999 185161036 G 1.23 0.2199 Vietnam adjusted for rs3753841 
3 rs1401999 185161036 G 1.21 0.25 Vietnam adjusted for rs1015213 
3 rs1401999 185161036 G 1.24 5.02E-05 meta unadjusted 
3 rs1401999 185161036 G 1.24 4.44E-05 meta adjusted for rs11024102 
3 rs1401999 185161036 G 1.24 5.19E-05 meta adjusted for rs3753841 
3 rs1401999 185161036 G 1.25 4.20E-05 meta adjusted for rs1015213 
Additional adjustments compensating for the allelic dosages at PLEKHA7 rs11024102, COL11A1 rs3753841, and rs1015213 




4.2.5.5 The effect of rs1401999 when using the left eye ACD measurement  
Furthermore, attesting to the robustness of our findings, we observed a similar 
magnitude of association when using left eye ACD measurements of SiMES and 
SINDI cohorts (β = -0.051, P = 8.15 x 10-4 and β = -0.045, P = 8.11 x 10-5 
respectively), where left eye ACD data were also available. BES cohort had only right 
eye data. 
 
4.2.5.6 What is the effect of ABCC5 rs1401999 on axial length? 
As both ACD and AL are distance measurements on the axial direction of the eye 
globe, previously described to share genetic factors to a certain degree,210 we also 
assessed the effect of ABCC5 rs1401999 on AL. We noted that the association 
between rs1401999 and AL was much weaker compared to that observed with ACD 
(P-meta = 0.000615, Table 4.2.7). 
  




β SE Pgc MAF 
SiMES 2136 C -0.02783 0.04205 0.51 0.15 
SINDI 2089 C -0.1158 0.03139 0.000231 0.41 
BES 634 C -0.0662 0.09079 0.41 0.16 
Meta-analysis 4859 C -0.08303 0.02424 0.000615*  
SiMES: Singapore Malay Eye Study 
SINDI: Singapore Indian Eye Study 
BES: Beijing Eye Study 
N: Number of individuals with complete genotyping and axial length data. 
β: Per-allele effect size of ABCC5 rs1401999 on axial length (in mm)  
SE: Standard error for β 
Pgc: Genomic control corrected P-value 
MAF: Minor allele frequency 




4.2.5.7 Expression of ABCC5 in eye tissues 
The RT-PCR analysis on human ocular tissues demonstrated that ABCC5 is expressed 
in the anterior segment structures relevant to PACG such as the iris, ciliary body, and 
lens (Figure 4.2.7). Additionally, Abcc5 message and protein were confirmed in 
mouse ocular tissues using in situ hybridization and immunohistochemistry (Figures 
4.2.8 and 4.2.9).  
We would like to acknowledge and thank Professor Simon John (and team), Howard 
Hughes Medical Institute, The Jackson Laboratory, Bar Harbor, Maine, USA, for 
helping to perform the in situhybridization and immunohistochemistry in mouse 
ocular tissues for Abcc5. 
 
 
Figure 4.2.7: Expression analysis of ABCC5 in human ocular tissues:  
 
The ABCC5 specific 249bp RT-PCR product was observed for anterior sclera (AS), 
cornea (cornea epithelium, CE; corneal stroma, CS and cornea endothelium, CEn), 
iris (I), trabecular meshwork (TM), ciliary body (CB), lens (L), lens capsule (LC), 
retina and retinal pigment epithelium (R), optic nerve head (ONH) and optic nerve 
(ON). The ubiquitously expressed gene, ACTB was used as the normalizing control. A 
no template sample acted as the negative control (NC) to ensure non-contamination of 









Figure 4.2.8: Abcc5 is expressed in multiple ocular tissues that may participate in 
the pathogenesis of PACG.  
RNA In situ hybridization with an antisense probe (AS) shows that Abcc5 mRNA is 
expressed in: (A) iris (I), (B) ciliary body (CB) (C)cornea and (D) in the outer nuclear 
layer (ONL) inner nuclear layer (INL) and ganglion cell layer (GCL) of the retina. 
The middle panel shows a merged image of AS staining and DAPI. In situ 









Figure 4.2.9: Immunohistochemical localization of ABCC5 in ocular tissues:  
 
Cryosections of whole eyes from wild-type A/J mice were imaged using fluorescence 
microscopy. ABCC5 is present in: (A)iris (I), cornea (C)(B) ciliary body (CB) and (C) 
retina, in the inner segment (IS), inner nuclear layer (INL) and Muller cell processes 
in the inner plexifom layer (IPL). The right panel shows images with 







4.2.5.8 Power Calculations 
A power calculation was conducted for bringing forward genome-wide significant 
SNPs from the ACD quantitative trait analysis to the PACG case control analysis (for 
4,276 cases and 18,801 controls) (Table 4.2.8). The power calculation is consistent 
with our findings.  
 
Table 4.2.8. Study power as a function of minor allele frequency and per-allele odds ratios. 
    OR       
   1.05 1.1 1.15 1.2 1.25 
 0.1 0.40% 8.00% 42.44% 84.20% 98.50% 
MAF 0.15 0.80% 17.30% 68.70% 97% >99% 
 0.2 1.3% 27.40% 83.70% >99% >99% 
 0.25 1.80% 36.60% 91.20% >99% >99% 
 0.3 2.30% 44% 94.80% >99% >99% 

















In this study we used an endophenotype approach to identify genetic variants that 
predispose one to develop PACG. PACG is a clinically heterogeneous disease that 
develops through three stages i.e PACS, PAC and PACG (please see Section 1.1.1 for 
a description of the conceptual stages of angle closure glaucoma). We first performed 
a GWAS of ACD in Singaporean Indians and Malays and Chinese from Beijing 
China, where we found rs1401999 within ABCC5 to contribute to the normal 
variation of ACD, a quantitative trait relevant to PACG. We then demonstrated the 
association of rs1401999 with PACG using case-control cohorts from multiple 
populations across Asia. Importantly this association with PACG surpassed GWAS 
significance when the analysis was confined to control pre-selected to have open 
angles. 
This same rationale of identification of disease genes through the quantitative traits or 
endophenotype approach has been put forth to identify genes for coronary artery 
disease through genetic variants controlling lipid traits116, 117, 136, 193 as well as genes 
for POAG genes through those that control VCDR.118, 119 It has been extensively 
demonstrated that eyes with shallower ACD were more inclined to have narrow 
angles/angle closure, therefore we believe ACD to be a true endophenotype for PACG 
validating this approach.  
 
4.2.6.1 ABCC5 gene: Does it have a possible role in eye development? 
ABCC5, also known as multidrug resistance protein 5 (MRP5), has been shown to 
participate in tissue defense and cellular signal transduction through efflux of 
anticancer drugs, toxicants and a second messenger cGMP.211-213 In addition, it has 
also been reported to play an active role in the embryonic development of zebrafish 
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through the regulation of intracellular cGMP levels.214 It is expressed in most human 
tissues, including the cornea,215 retinal pigment epithelium and retina of the eye.216 
We also noted ABCC5 expression in ocular structures relevant to PACG such as the 
iris, ciliary body, and lens. However, its exact role in the context of PACG is not yet 
known.  
The significant association between ABCC5 rs1401999 with a shallower ACD argues 
favorably for a role in eye growth, particularly that of the anterior segment. 
Intriguingly, a study in zebrafish suggested that Abcc5 may play an active role in eye 
development through the regulation of intracellular cGMP levels. Zebrafish Abcc5, 
which shares 73% amino acid sequence identity with human ABCC5, is highly 
expressed in the lens of the developing eye.214 Notably, the blockage of endogenous 
ABCC5 activity by its dominant-negative was shown to retard development, 
producing smaller eyes as well as overall reduction of body length and pigmentation 
of embryos.214 Abcc5 knockout mice have been generated but an evaluation of their 
eyes was not reported.217 A developmental role for ABCC5 in mammalian eyes 
therefore remains to be defined and will require further detailed studies in model 
organisms. 
 
In addition, the linkage disequilibrium (LD) block that includes rs1401999 and 
ABCC5, also includes the presenilin-associated rhomboid-like (PARL) gene, 5-
hydroxytryptamine receptor 3D (HTR3D) gene and the 5-hydroxytryptamine receptor 
3C (HTR3C) gene (Figure 4.2.7). It is thus possible that rs1401999 might simply be 
in LD with an as yet unidentified causal variant, and it remains unclear whether the 
causal alleles or group of alleles influence ABCC5 or any of the neighboring genes to 
influence ACD. However, the clear expression within ocular tissues and a possible 
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role in eye development make ABCC5 a rather attractive candidate gene for ACD. 
Indeed, re-sequencing of the region will be necessary to identify novel potentially 
functional polymorphisms related to PACG pathogenesis. 
 
Figure 4.2.10: Regional linkage disequilibrium (LD) plot for ABCC5 and its 
flanking region (Chr. 3).This is plotted using the D’ algorithm.ABCC5 rs1401999 






The other top hit in the genome-wide analysis 
While SNP rs4148479 was the top hit, however the assay (since some samples were 
subjected to direct Sanger sequencing for increased level of veracity) for rs1401999 
was much easier to design, and thus it was taken up for further replication. Moreover, 
the r2 coefficient between rs4148479 and rs1401999 = 1.00, and they are perfect 





4.2.6.2 Strength of association improves with the use of pre-selected ‘Super-
controls’ 
The prevalence of the pre-cursor stage of PACG, namely PACS, is about 10% in 
many Asian populations, 3, 16, 18, 22, 39 (Please see Table 1.1 for the prevalence of 
glaucoma, including the PACS stage in Asian populations). Given the association 
between angle closure and shallow ACD66-69, 71 it is therefore appropriate to remove 
the ‘at-risk individuals’ from the control population in order to assess the true 
relationship between ACD QTLs and PACG. Unsurprisingly, the evidence of 
association between rs1401999 and PACG was augmented when we only included 
sample collections where the controls had definite open angles. Similar observations 
have also been seen with recent studies on Alzheimer’s disease, where the inclusion 
of general population-based controls resulted in significant underestimation of the 
odds ratio conferred by the disease-associated SNP compared to when properly 
matched, risk-free controls were applied.140, 141, 218 As Alzheimer’s is a late-onset 
commonly occurring condition, therefore the population-based control group was 
more likely to have a sizable proportion of individuals with Alzheimer’s. Therefore, it 
was more informative to use a specially selected control group of individuals who 
were cognitively intact at age 85; the odds ratio (OR) increased from 4.24 (when 
using population-based controls) to 7.52 with the specially selected controls.140 
Likewise, in our study, we found not only an enrichment of the strength of association 
(OR 1.30, p=7.45 x 10-9) but also a reduction in heterogeneity (I2 = 0.0%) when using 
only clinically certified open-angled controls, compared to the use of unselected 





4.2.6.3 Modest effect size of ABCC5  
We caution that the modest statistical evidence reported here for rs1401999, when 
examined in a total of 4,276 PACG cases and 18,801 controls, is at least 5 orders of 
magnitude below that of the three recently identified PACG-associated variants.111 
Clinical studies have shown that ACD is only a modest determinant of angle width.219  
Therefore, this may explain why an ACD controlling gene such as ABCC5 would only 
confer a relatively small effect on PACG disease itself.  Incidentally, the proportion of 
PACG risk explained by ABCC5 rs1401999 is 0.35% (95% confidence interval = 0.01 
to 1.2%). Our study highlights the fact that even larger sample sizes may be necessary 
to dissect and conclusively identify the possible modifiers of genetic risk conferred by 
variants of modest effects, particularly when they exert their action on disease 
pathogenesis via endophenotypes. Furthermore, it is also likely that genetic variants 
that influence the stronger determinants of angle width such as anterior chamber area, 
width and lens vault may confer a greater magnitude of effect on PACG.   
 
4.2.6.4 ABCC5 more strongly associated with Malays and Indians 
It was somewhat surprising that the evidence of association observed was slightly 
weaker (per-allele β = -0.04, P = 0.0075) in the Chinese samples which we assessed 
compared to that observed in Malays (per-allele β = -0.056, P = 1.76 x 10-4) and 
Indians (per-allele β = -0.041, P = 3.97 x 10-4) since PACG is relatively more 
prevalent among the Chinese. However, there was no heterogeneity (P-value for 
heterogeneity = 0.59, I2 = 0.0%) when data from the Chinese, Indians, and Malays 
were meta-analyzed, thus suggesting that the observed differences in statistical 
significance between the three ethnic groups for rs1401999 and ACD could be due to 
chance. We were thus cautious about drawing firm conclusions from this limited data 
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regarding ethnic specific differences. However, as is now increasingly well-
documented, there are clear ethnic-specific differences in signal strengths of genetic 
associations for complex traits, with a recent example being a common polymorphism 
in COL8A2 and central corneal thickness. This genetic polymorphism (rs96067) 
shows very strong association (N = 6,963; P = 2.3 x 10-11) in Asians, but much weaker 
association in Europeans (N = 13,057; P = 0.042), likely suggesting that the 
underlying genetic architecture could differ between the different ethnic groups.220 
 
The following observations can also be drawn from this study. It is important that all 
sample collections are included and assessed transparently especially when drawn 
from diverse populations. Secondly, despite the broad-based success in the use of 
large numbers of unselected, population-based controls in genetic studies106, 221-225the 
deployment of controls with proper clinical phenotyping and documentation will often 
assist in more definitive identification of susceptibility genes. A comprehensive 
examination of all variation around ABCC5 using targeted deep re-sequencing is now 
necessary to parse the true association signal in an effort to more completely 
understand the role of this gene in ACD and PACG.  
 
In summary our study identified a common genetic variant within ABCC5 as being 
significantly associated with ACD, which was also associated with a modest risk of 
PACG. Our findings are largely in keeping with the anatomical risk factors of 
individual susceptibility to PACG in the eye, whereby shallower ACD is a cardinal 
clinical and pathogenic feature, predisposing the eye to more ‘crowded’ anterior 
segment and thus increasing the risk of PACG. Our study provides further clues to 
genetic mechanisms underlying this major global cause of blindness. 
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4.3 ASSOCIATION OF THE THREE PACG LOCI WITH ANTERIOR 
CHAMBER DEPTH AND AXIAL LENGTH 
 
Three susceptibility loci for PACG were recently identified: PLEKHA7 rs11024102, 
COL11A1 rs3753841, and rs1015213 located in the intergenic region between 
PCMTD1 and ST18.111 However, it is not clear how these three loci contribute to the 
pathogenesis of PACG or whether these genetic variants act via any known 
anatomical risk factors for PACG.  
 
4.3.1 Purpose 
We therefore aimed to investigate the association of these three PACG susceptibility 
loci with the anatomical risk factors ACD and axial length (AL). We evaluated this 




ACD and AL measurements were derived from four population based samples: 
SiMES, SINDI, SCES and BES.  Please see Section 2.1, Chapter 2 for a description 
of the study design, sampling method, recruitment, and evaluation of the subjects’ 
recruited for the above studies.  
Measurement of ACD and AL 
ACD and AL were measured using the IOLMaster (Carl Zeiss Meditec, Dublin, CA). 
Five readings were obtained and the average computed. Readings from an eye that 
was pseudophakic or aphakic were excluded. As there was good correlation between 
the biometric data from the two eyes, therefore analysis was performed using data 
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from the right eye only. In the Beijing cohort, AL was measured by optical low-
coherence reflectometry (Lenstar 900 Optical Biometer; Haag-Streit) for only the 
right eyes of study participants, and ACD measurements were obtained from ASOCT 
images. Since BES only had measurements for the right eye; final meta-analysis used 
ACD and AL measurements taken from the right eye in all four cohorts.  
 
Genotyping  
Methods of genotyping and data quality control (QC) for SiMES, SINDI, SCES, and 
BES have been described previously in Chapter 2, section 2.4 ‘Genotyping and 
Statistical Analysis’. Final number of subjects passing quality checks was 2542, 2538, 
1949, and 927 for SiMES, SINDI, SCES, and BES, respectively. Genotype at the 
three loci of interest (rs3753841, rs1015213, and rs11024102) was analyzed using 
PLINK (version 1.07). 
 
4.3.3 Statistical Analysis  
Individual SNP genotypes were coded according to the number of copies of the 
variant allele present: 0 for the wildtype genotype, 1 for heterozygous, and 2 for 
homozygous variants. A trend test incorporated within a linear regression model was 
used for primary association testing between genotypes and ACD/AL as quantitative 
traits, adjusting for age, sex, and population admixture (reflected by principal 
components).  
Meta-analysis was performed with PLINK (version 1.07) using the fixed effects 
model on primary analysis and was verified with the random effects model when 
significant heterogeneity was observed. For the meta-analysis, a combined point 
estimate of the overall effect size (β coefficient) and its corresponding P value were 
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obtained. The Cochran’s Q and accompanying I2 statistic were used to assess inter-
cohort heterogeneity. For the final analysis, a Bonferroni correction factor of 3 was 
applied to correct for number of loci studied, resulting in a P value threshold of 0.017 
to be considered statistically significant experiment-wide. 
 
4.3.3 Results  
Table 4.3.1 summarizes the descriptive statistics of all cohorts after genotyping and 
sample QC. A total of 7245, 7243, and 7239 subjects who had complete genotype and 
ACD (including covariates) measurement data were tested for association between the 
three PACG susceptibility loci (rs3753841, rs1015213, and rs11024102) and ACD, 
respectively (Table 4.3.2).  
 
We found nominal evidence of association between SNP rs1015213 (PCMTD1-ST18) 
and a shallower ACD when all data were meta-analyzed (β= -0.033, P = 0.021). There 
was no significant heterogeneity of the effect size across all sample collections 
(Pheterogeneity = 0.87, I
2 = 0). The observation was not statistically significant when 
multiple testing was considered. No significant association was also found between 










Table 4.3.1. Characteristics of the study population 
 SiMES SINDI SCES BES 
Na 2542 2538 1949 927 
Ageb 
59.09 (11.04);  
40-80 
58.04 (10.01);  
43-80 
58.99 (9.98);  
44-111 
53.11 (9.35);  
40-81 
Gender (female %) 0.51 0.49 0.49 0.63 
Anterior chamber 
depth b 
3.10 (0.38);  
1.78-4.25 
3.22 (0.46);  
1.74-5.39 
2.95 (0.37);  
1.99-5.09 
2.41 (0.32);  
1.29-3.61 
Axial length b 
23.57 (1.05);  
20.61-30.53 
23.38 (1.11);  
19.14-32.76 
23.61 (1.37);  
20.39-33.27 
23.03 (1.11);  
19.90-30.36 
a Number of subjects with genotype data after quality check; b Mean (standard deviation); range 
 
Table 4.3.2. Association results between three PACG susceptibility loci and ACD 
Chr SNP BP A1 Cohort n EAF beta SE P Phet I2 
1 rs3753841 103152506 G SCES 1690 0.32 0.006 0.014 0.67    
     SIMES 2209 0.2889 0.019 0.011 0.094    
     SINDI 2520 0.4377 -0.003 0.013 0.802    
     BES 826 0.2983 0.014 0.016 0.392    
        All 7245   0.0093   0.16 0.76 0 
Chr SNP BP A1 Cohort n EAF beta SE P Phet  I2 
8 rs1015213 53050094 A SCES 1690 0.011 -0.041 0.064 0.52    
     SIMES 2207 0.04055 -0.021 0.025 0.404    
     SINDI 2520 0.1222 -0.033 0.02 0.089    
     BES 826 0.02427 -0.068 0.046 0.139    
        All 7243   -0.033   0.021 0.87 0 
Chr SNP BP A1 Cohort n EAF beta SE P Phet  I2 
11 rs11024102 16965181 G SCES 1690 0.37 
-
0.0007 
0.013 0.96    
     SIMES 2205 0.37 -0.014 0.011 0.19    
     SINDI 2518 0.303 0.002 0.014 0.893    
     BES 826 0.4326 -0.023 0.015 0.119    
        All 7239   -0.009   0.148 0.65 0 
Chr, chromosome number; SNP, SNP ID; BP, base-pair position; A1, effect allele; n, number of subjects 
included in the analysis; EAF, effect allele frequency; β, per-allele change in ACD/AL; SE, standard 
error for ascertainment of β; P, P-value for association; Phet, P-value for heterogeneity between cohorts; 




In the association testing between the three PACG susceptibility loci (rs3753841, 
rs1015213, and rs11024102) and AL, a total of 6902, 6900, and 6896 subjects who 
had complete genotype and AL (including covariates) measurement data were 
included, respectively (Table 4.3.3). We found that locus rs11024102 (PLEKHA7) 
was significantly associated with longer AL in the meta-analysis of all collections 
using the fixed effects model (β= 0.051, P = 0.009). However, as significant 
heterogeneity of effect sizes was observed (Pheterogeneity=0.01, I
2=69.19%), therefore 
meta-analysis using the random effects model was conducted. The results did not 
show significant association between rs11024102 (PLEKHA7) and AL (Prandom effects = 
0.38). No significant association was also found between the other two loci 
(rs3753841 and rs1015213) and AL in individual cohorts or in the meta- analysis of 
















Table 4.3.3. Association results between three PACG susceptibility loci and AL 
Chr SNP BP A1 Cohort n EAF beta SE P Phet I2 
1 rs3753841 103152506 G SCES 1613 0.32 -0.096 0.051 0.06    
     SIMES 2210 0.2889 0.07 0.034 0.039    
     SINDI 2488 0.4377 0.043 0.03 0.151    
     BES 591 0.2983 -0.019 0.069 0.783    
        All 6902   0.0265   0.18 0.081 51.8 
Chr SNP BP A1 Cohort n EAF beta SE P Phet I2 
8 rs1015213 53050094 A SCES 1613 0.011 -0.19 0.24 0.41    
     SIMES 2208 0.0405 -0.112 0.075 0.137    
     SINDI 2488 0.1222 -0.048 0.046 0.301    
     BES 591 0.0242 -0.1 0.203 0.622    
        All 6900   -0.07   0.067 0.766 0 
Chr SNP BP A1 Cohort n EAF beta SE P Phet I2 
11 rs11024102 16965181 G SCES 1613 0.37 -0.015 0.052 0.77    
     SIMES 2206 0.37 0 0.032 0.99    
     SINDI 2486 0.303 0.138 0.032 <0.001    
     BES 591 0.4326 0.016 0.064 0.801    
     All 6896  0.051  0.009 0.01 69.2 
        
All (random effects) 
  
0.035   0.384     
Chr, chromosome number; SNP, SNP ID; BP, base-pair position; A1, effect allele; n, number of subjects included in 
the analysis; EAF, effect allele frequency; β, per-allele change in ACD/AL; SE, standard error for ascertainment of 
















We conducted a candidate gene association study between the three recently 
identified PACG susceptibility loci and anatomical quantitative trait risk factors for 
angle closure (ACD and AL) using four population-based samples totalling 
approximately 7000 individuals of Asian descent.  
 
4.3.4.1 Lack of association with ACD and AL in Asian cohorts 
Overall, none of the novel PACG loci showed significant association with ACD or 
AL, which suggests disease mechanisms that act independently of shallower anterior 
chamber and shorter eyeball length. We directly examined association between the 
three PACG loci and the anatomical quantitative trait risk factors in sample 
collections of the same ethnicity (Chinese, Malays, and Indians) as in the initial 
PACG case-control GWAS. Such an approach minimizes ethnic heterogeneity as a 
reason for our non-significant observations.  
 
We have utilized well-characterized population-based studies that encompass three 
major ethnic groups of Asia in which PACG is a predominant blinding condition. 
With the current sample size, for SNPs rs3753841 (COL11A1) and rs11024102 
(PLEKHA7), which have an effect allele frequency of more than 0.3, we have more 
than 95% power for detecting differences among the wild-type, heterozygous, and 
homozygous groups assuming an underlying true effect size of 0.2 (delta/sigma) or 
larger. For SNP rs1015213 (PCMTD1-ST18), which has a lower effect allele 
frequency, we still have approximately 80% power for detecting differences if we 
assume an underlying true effect size of 1.1 (delta/sigma) or larger.  
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As angle closure is a heterogeneous condition with multiple anatomical and 
physiological risk factors including novel imaging-based risk factors, therefore 
although not correlated with ACD or AL, these PACG-associated loci may be 
associated with these other parameters. 
4.3.4.2 Are the PACG loci associated with other anatomical traits?  
We therefore sought to examine the association between the three PACG-
predisposing SNPs and other ocular anatomical traits including the novel ASOCT 
traits anterior chamber width (ACW), lens vault (LV), and anterior vault (AV) in 
addition to the iris parameter, iris thickness (Tables 4.3.4 to 4.3.7).  
 
We did not observe significant association (P > 0.0.017 for all comparisons) between 
the 3 SNP markers and ACW, LV, AV, and iris thickness within our sampling frame, 
although modest evidence of association were noted between SNP rs1015213 and a 
larger LV (β=0.038mm, P=0.028); also between SNPs rs1015213 and rs11024102 with a 
smaller AV (β=-0.01mm, P=0.045 and β=-0.012mm, P=0.045 respectively). Given the 
smaller sample size of subjects with ASOCT data (N~3400) compared to those with 
ocular biometric data (N~7000), we are therefore underpowered to detect association 
with the ASOCT-derived quantitative traits. With availability of a larger ASOCT 
dataset (as data collection is currently on-going), we will re-analyze the association of 










Table 4.3.4: Association results between three PACG susceptibility loci and anterior chamber width (ACW)  
  CHR SNP BP A1 TEST NMISS BETA SE P I2 
SiMES 1 rs3753841 103152506 G ADD 591 0.001236 0.02686 0.9633   
SINDI      752 -0.000227 0.02097 0.9991   
SCES      1372 -0.01856 0.0173 0.2835   
BES      729 0.007847 0.0273 0.7739   
All      3444 -0.00592  0.5858 0 
  CHR SNP BP A1 TEST NMISS BETA SE P   
SiMES 8 rs1015213 53050094 T ADD 591 -0.05662 0.06211 0.3623   
SINDI      752 -0.06022 0.03371 0.07445   
SCES      1372 -0.1249 0.08507 0.1424   
BES      729 0.03657 0.07792 0.639   
All      3444 -0.05446  0.03874 0 
  CHR SNP BP A1 TEST NMISS BETA SE P   
SiMES 11 rs11024102 16965181 C ADD 590 -0.01319 0.02491 0.5967   
SINDI      753 -0.003867 0.02334 0.8684   
SCES      1372 -0.001465 0.01673 0.9302   
BES      729 -0.00112 0.02459 0.9996   














Table 4.3.5: Association results between three PACG susceptibility loci and lens vault (LV) 
  CHR SNP BP A1 TEST NMISS BETA SE P I2 
SiMES 1 rs3753841 103152506 G ADD 591 0.003439 0.01741 0.8435   
SINDI     ADD 752 -0.00218 0.01298 0.8662   
SCES     ADD 1372 0.01036 0.01152 0.3687   
BES     ADD 729 0.004619 0.01585 0.7709   
  All         3444 -0.0033   0.6805 0 
  CHR SNP BP A1 TEST NMISS BETA SE P   
SiMES 8 rs1015213 53050094 T ADD 591 -0.00948 0.0403 0.814   
SINDI     ADD 752 0.04576 0.02084 0.02845   
SCES     ADD 1372 0.0949 0.05661 0.09392   
BES     ADD 729 0.044414 0.04522 0.3293   
  All         3444 0.038   0.02832 0 
  CHR SNP BP A1 TEST NMISS BETA SE P   
SiMES 11 rs11024102 16965181 C ADD 590 0.01242 0.01616 0.4426   
SINDI     ADD 753 -0.00428 0.01444 0.767   
SCES1     ADD 1372 0.003099 0.01114 0.7808   
BES     ADD 729 0.02434 0.01426 0.0883   
















Table 4.3.6: Association results between three PACG susceptibility loci and anterior vault (AV)  
  CHR SNP BP A1 TEST NMISS BETA SE P I2 
SiMES 1 rs3753841 103152506 G ADD 591 -0.001627 0.01317 0.9017   
SINDI      752 -0.005277 0.01002 0.5985   
SCES      1372 -0.009555 0.008093 0.2379   
BES      729 -0.001228 0.01271 0.923   
All      3444 -0.0044  0.475 0 
  CHR SNP BP A1 TEST NMISS BETA SE P   
SiMES 8 rs1015213 53050094 T ADD 591 -0.01668 0.03047 0.5842   
SINDI      752 -0.006513 0.01615 0.6869   
SCES      1372 -0.02314 0.03982 0.5613   
BES      729 -0.01467 0.03626 0.6858   
All      3444 -0.01  0.04537 0 
  CHR SNP BP A1 TEST NMISS BETA SE P   
SiMES 11 rs11024102 16965181 C ADD 590 -0.008357 0.01223 0.4945   
SINDI      753 -0.008175 0.01115 0.4636   
SCES      1372 -0.01422 0.007817 0.06909   
BES      729 -0.01772 0.01143 0.1216   






4.3.4.3 Other likely reasons for the lack of significant associations between the 
PACG loci with anterior chamber depth and axial length 
Recent evidence suggests that dynamic physiological factors such as changes in iris 
volume with dilation and choroidal expansion/effusion may have a role in angle-
closure pathogenesis.226-228 We speculate that at least one of the PACG-associated 
variants confers risk via these dynamic (as opposed to static or anatomical) 
mechanisms. One of the susceptibility genes, PLEKHA7, encodes a plekstrin 
homology domain containing protein, proposed to regulate apical junctional 
complexes (AJCs).112, 113 As AJCs control epithelial and endothelial paracellular 
permeability,114 PLEKHA7 may be involved in the pathophysiology of angle closure 
related to aberrant fluid dynamics. While it may be worthwhile to investigate the 
Table 4.3.7: Association results between three PACG susceptibility loci and iris thickness  
  CHR SNP BP A1 TEST NMISS BETA SE P I2 
SiMES 1 rs3753841 103152506 G ADD 591 -0.000788 0.00499 0.8746   
SINDI      752 0.003865 0.00395 0.3282   
SCES      1372 -0.004399 0.004024 0.2745   
All      2715 -0.0003  0.8914 7.36 
  CHR SNP BP A1 TEST NMISS BETA SE P   
SiMES 8 rs1015213 53050094 T ADD 591 -0.01692 0.01152 0.1424   
SINDI      752 -0.006129 0.006384 0.3373   
SCES      1372 -0.005195 0.02015 0.7966   
All      2715 -0.00844  0.1178 0 
  CHR SNP BP A1 TEST NMISS BETA SE P   
SiMES 11 rs11024102 16965181 C ADD 590 0.001948 0.004631 0.6742   
SINDI      753 0.001994 0.004396 0.6502   
SCES      1372 -0.00172 0.003884 0.658   
All      2715 0.0005  0.8437 0 
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association between PACG susceptibility loci and the physiological risk factors of 
angle closure, however, the evaluations of dynamic factors are currently limited by 
the difficult nature of procedures for image capture and measurements. It is hoped that 
advances in imaging technology and image analysis techniques will lead to 
development of newer modalities that capture high-resolution dynamic images of 






















4.4 GENETIC DETERMINANTS OF ANTERIOR CHAMBER WIDTH 
In section 3.4, we had described the distribution and determinants anterior chamber 
width (ACW), a novel imaging-based anatomical risk factor for angle closure. It is 
defined as the sclera spur-to-spur distance on horizontal ASOCT images. ACW is 
analogous to the diameter of the anterior chamber of the eye (Figure 3.4.1). 
Therefore, a smaller ACW implies a smaller anterior chamber circumference (defined 
as diameter times pi) and volume. This could facilitate the angle-crowding mechanism 
in angle closure disease, and can also result in a corresponding reduction of the 
circumferential drainage region of the anterior chamber. The ACW was found to be 
significantly smaller in persons of Chinese ethnicity, in women, and in those eyes 
with angle closure compared to those without angle closure.  
 
4.4.1 Heritability, distribution and reproducibility of ACW 
The heritability estimates for ACW range from 50% to 70% (Tables 4.4.1 and 4.4.2, 
unpublished, data courtesy A/Prof Cheng Ching-Yu). Within the three population 
cohorts in Singapore (SCES, SINDI and SiMES), ACW follows a normal distribution 
(Figures 4.4.1-4.4.3). ACW is a highly reproducible measurement with a repeatability 
coefficient of 0.11 mm, and an excellent intra-class correlation coefficient of 0.970 






Table 4.4.1. Clinical characteristics of the study subjects 
    Relationship to Proband 
Characteristics n Total n Proband n Child n Parents n Sibling 
Age, yr 451 55.3 (13.5) 98 65.7 (9.9) 169 43.7 (8.5) 10 80.5 (5.5) 147 57.8 (9.6) 
Gender, male (%) 451 188 (42%) 98 24 (24%) 169 80 (47%) 10 1 (10%) 147 65 (44%) 




Table 4.4.2. Calculation of the heritability of anterior chamber width (ACW) 
 Estimates Using FCOR  Estimates Using SOLAR 


















Figure 4.4.1: Distribution of anterior chamber width (ACW) in the Singapore 
Chinese Eye Study (SCES) cohort 
 
Figure 4.4.2: Distribution of anterior chamber width (ACW) in the Singapore 




Figure 4.4.3: Distribution of anterior chamber width (ACW) in the Singapore 






As with ACD, the ACW can also be considered as an endophenotype/quantitative trait 
for PACG. Furthermore, although it has not been demonstrated, we believe that the 
ACW is a stable measurement that is less likely to be affected by changes in lighting 
conditions and accommodation. It represents a structural measurement of a dimension 
of the anterior chamber. We therefore choose to investigate the genetic determinants 




To identify the genetic markers responsible for the variation of ACW, we conducted a 
population-based GWAS of ACW in four well characterized population-based 
studies: SINDI,121 SiMES,120 SCES121 and the BES,20 respectively. 
 
4.4.2 Methods 
Measurement and Analysis of Anterior Chamber Width 
ACW measurements were obtained from the four population-based studies. Please see 
Section 2.1, Chapter 2 for a description of the study design, sampling method, 
recruitment, and evaluation of the subjects’ recruited for the above studies.  
Measurements of ACW were obtained from horizontal ASOCT scans using 
customized-software, the Zhongshan Angle Assessment Program (ZAAP, 
Guangzhou, China). The ACW measurements used in the GWAS analysis excluded 
any measurements from eyes that were pseudophakic or aphakic. Individuals were 
also excluded whose ASOCT images were not analyzable due to a poor quality, or 
software delineation errors, or indeterminate sclera spurs. Furthermore, for the 
Singapore cohorts (SiMES, SINDI, SCES), scans from the right eye were first 
evaluated. If the images were not analyzable, or the eyes were pseudophakic/aphakic 
then the images from the left eye were assessed for measurement of ACW. However, 
for BES, only right eye measurements were available.  
 
Genotyping  
Genotyping for the participants of all four studies was performed using the Illumina 
610K Quad BeadChips (Illumina, Inc., San Diego,CA) following manufacturer 
instructions after genomic DNA were extracted from participants using standard 
laboratory techniques. Samples were excluded if they had a per sample call rate <95% 
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or showed evidence of admixture, cryptic relatedness, high heterogeneity, or gender 
discrepancy. (Please see section 2.4.1.4 for a description of the QC measures for both 
SNPs and samples). Final number of subjects passing quality checks were 2542, 2538, 
1949, and 927 for SiMES, SINDI, SCES, and BES, respectively. After sample and 
genotyping QC, a combined total of 3472 individuals with complete data for ACW 
measurements, age and gender were available for SCES, SINDI, SiMES, and BES.  
 
4.4.3 Statistical analysis 
For the GWAS on ACW, linear regression was performed to test for association 
between SNP genotypes and ACW as implemented by PLINK (version 1.07). 
Individual SNP genotypes were coded according to the number of copies of the minor 
allele present: 0 for the wild-type genotype, 1 for heterozygotes, and 2 for 
homozygote variants. Meta-analysis across SiMES, SINDI, SCES and BES was 
performed using the inverse-variance, fixed effects model in order to obtain a 
combined point estimate of the overall effect size (β) coefficients and its 
corresponding standard error (SE). Inter-cohort heterogeneity was assessed with the 
Cochran’s Q statistic and its accompanying I2 index. Quantile-quantile (QQ) and 
Manhattan plots were created using the software R (www.r-project.org). The overall 
genomic inflation factor for the meta-analysis of the three sample collections was 
minimal (λgc = 1.036).  
 
4.4.4 Results 
4.4.4.1 Identification of the genetic determinants for anterior chamber width 
After quality checks, 1371 SCES, 782 SINDI, 590 SiMES and 729 BES samples 
remained with both genotype and phenotype data including age and gender; and these 
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were used for GWA analysis. We measured the association between ACW and 
individual SNP genotypes using linear regression, modeling for a trend-per-copy effect 
on the minor allele. Additional adjustments were made for age, gender, and the 
significant axes of genetic stratification.  
 
Meta-analysis of ACW data in the four sample collections (overall N=3472) showed a 
significant excess of small P-values at the extreme tail of the quantile-quantile 
distribution (Figure 4.4.4) and we identified several regions showing promising SNPs 
of borderline significance (Figure 4.4.5), with the most significant associations being 
at a locus on chromosome 1q43, which is a gene-desert region (Pmeta = 1.16x10-6 β 
meta = 0.05mm per-copy of the minor allele, Phet=0.11); and  another locus (Pmeta = 
2.40x10-6 , β meta = -0.049mm per-copy of the minor allele, Phet=0.41) was observed 













Figure 4.4.4: Quantile-quantile plot of P-values from the meta-analysis of ACW 
across the four independent sample collections with genome-wide genotyping 














Figure 4.4.5: Manhattan plot for genome-wide meta-analysis of anterior 
chamber width in four populations with genome-wide genotyping data (SiMES, 
















4.4.4.2 Power of the currently available data and sample size required to achieve 
adequate power 
Based on this preliminary QTL analysis for ACW (sample size of 3472), for the 
genetic effect (beta) of 0.05mm per risk allele based on an additive effect model for 
an effective allele frequency of 0.4 (α = 5 x10-8), the power of the current study is 
41.5% (assuming a population mean and standard deviation of 11.50mm and 0.40mm 
respectively).  
 
To achieve 80% power at a genetic effect (beta) of 0.05mm per risk allele based on an 
additive effect model for an effective allele frequency of 0.3 (α = 5 x10-8), the sample 
size required for analysis of the ACW quantitative trait  (assuming a population mean 
and standard deviation of 11.50mm and 0.40mm respectively) is ~6000.  
 





  70% 75% 80% 85% 90% 
0.1 12,156 12,787 13,509 14,376 15,505 
0.15 8575 9021 9530 10,142 10,938 
0.2 6830 7185 7591 8078 8712 
0.25 5826 6128 6475 6890 7431 
0.3 5200 5470 5779 6150 6633 
0.35 4798 5048 5333 5675 6121 









4.4.4.3. The regions that shows promising SNPS 
Genetic variants within chromosomes 1 and 13 were found to have potential statistical 
evidence for association with ACW. While the top SNPs within chromosome 1 were 
in the gene desert region, those top SNPs within chromosome 13 were located with 
the MBNL2 gene.  
 
 
4.4.4.4 Can MBNL2 be a potential gene for ACW? 
Since ACW is the surrogate measurement of the size of the anterior chamber of the 
eye; therefore it is likely that genetic variants/genes that control variations in ACW 
may be developmental genes. 
The MBNL2 gene is a member of the muscleblind protein family which was initially 
described in Drosophila melanogaster.229 The human genome contains three 
muscleblind-like genes including MBNL1 (also known as MBNL), MBNL2 (also 
known as MBLL) and MBNL3 (also known as MBXL/MBLX/CHCR).  While MBNL1 
is highly expressed in skeletal muscle, MBNL2 is ubiquitously expressed in similar 
level in all tissues including the brain and retina; and MBNL3 is detected primarily in 
the placenta. MBNL2 may play a role in myotonic dystrophy pathophysiology (DM). 
The MBNL1, MBNL2 and MBNL3 proteins bind to double stranded (ds) CUG RNA, 
and evidence suggests that there is a link between expression of mutant DM1 
(Myotonic dystrophy type 1) transcripts and nuclear sequestration of the muscleblind 
proteins. The muscleblind proteins MBNL1, MBNL2 and MBNL3 are required for the 
terminal differentiation of muscle and photoreceptor tissues. Therefore, it has been 
suggested that nuclear sequestration of the human proteins might impair their normal 
function in muscle and eye development and maintenance. 
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Kanadia et al230 analyzed the expression pattern of the mouse Mbnl1, Mbnl2, and 
Mbnl3 genes during embryonic development using whole-mount in situ hybridization 
between 7.5 and 13.5 dpc (days post conception). At 9.5 dpc, all three muscleblind 
genes were expressed in the developing head region with prominent expression of 
Mbnl2 and Mbnl3 in the mandibular and maxillary components of the first branchial 
arch and the neural tube. They also noted variable expression of these genes in the 
frontonasal prominence, optic eminence and otic vesicle.230  
While MBNL2 may have a role in eye development in mouse, however its 
developmental role in mammalian eyes remains to be defined.   
 
4.4.4.5 Are there genetic determinants for the other ASOCT-based risk factors 
for angle closure? 
In addition to ACW, we have also performed the QTL analyses for other angle 
closure related traits, namely, (Lens vault) and Anterior Vault (AV). LV represents 
the measurement of the magnitude of the lens that is located anterior to the angles and 
a larger LV was found to be independently associated with an increased risk for angle 
closure. AV on the other hand represents the axial size of the anterior segment that is 
located anterior to the angles. While this parameter was found to be significantly 
smaller in eyes with angle closure compared to normals, importantly however, its 
magnitude was found to remain stable with advancing age. It could thus be a 
potentially important PACG-related quantitative trait. 
 
Genetic determinants for the variation of these parameters were explored. However, 
akin to the ACW findings, our analyses for these parameters are currently 
underpowered, with the most significant levels of association being in the range of 
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5x10-4 to 5x10-6.  The sample sizes used for the analyses were similar to the ones for 
ACW (~3400).  
Given the current lack of substantial association with the available sample size, we 
have not presented the data in this thesis. However, as we have collected (and are also 
currently collecting) more ASOCT data, we do plan to re-analyze in a larger cohort of 
subjects once genotyping data is additionally available. This is elaborated further in 






















GENERAL DISCUSSION AND IMPLICATIONS 
There are two aspects to the Research presented in this thesis. First, to expand the 
spectrum of imaging-based anatomical risk factors for angle closure, and, second, to 
identify novel susceptibility loci associated with primary angle closure glaucoma 
(PACG) disease through the interrogation of its quantitative traits or endophenotypes. 
 
5.1 MAIN FINDINGS OF THE IMAGING DATA 
For the first part of the research, the objective was to evaluate new quantitative 
parameters to identify novel imaging-based features that are associated with an 
increased risk for angle closure and that may also explain the likely mechanism of 
disease occurrence.   
 
We found two novel risk independent risk factors for angle closure, lens vault (LV) 
and anterior chamber width (ACW). The ACW was significantly smaller in persons of 
Chinese ethnicity, older individuals, and in eyes with angle closure compared to those 
without. In our case-control comparison on lens parameters, we found that the 
presence of a large LV increases the risk of having angle closure by 48 times when 
compared to eyes with smaller LV; and this finding was independent of lens thickness 
(LT) or lens position. Interestingly, the poor correlation between LV and LT (PCC: 
0.17) as well as our sub-analysis (stratified based on the mean LT) showed that even 
though LV is a part of the overall LT, however, its magnitude is not entirely 
dependent on LT. As LV represents that portion of the lens that lie in front of the 
anterior chamber angles, therefore it is likely to be more representative of the role of 
the lens as an indicator of the risk for angle closure. In addition, we also found that 
199 
 
the Anterior Vault (AV) (defined as the anterior chamber depth (ACD) + LV) which 
represents the portion of the anterior segment that is anterior to the plane of the 
angles, is not only significantly smaller in eyes with angle closure compared to 
normal, but more importantly, the magnitude of this parameter remains stable with 
advancing age. The relative LV on the other hand, is a derived parameter (ratio of LV 
to AV), which captures the proportion of the LV relative to the size of the anterior 
segment that is anterior to the angles. 
 
The proposed role of these factors in the pathogenesis of angle closure is distinct, 
each resulting in worsening of anterior chamber angle crowding. While a smaller 
ACW implies a smaller anterior chamber circumference and volume; it has been 
proposed that an increased LV pushes the peripheral iris against the trabecular 
meshwork so occluding aqueous outflow in a mechanism involving relative pupil 
block and increased iris curvature in an eye with a pre-existing narrow angles.  
 
The high prevalence of angle closure glaucoma in Asia,3, 16, 18, 33 coupled with its often 
aggressive and potentially blinding nature have prompted the need for an effective 
screening tool to combat the condition by identifying people with early stages of 
disease. Laser peripheral iridotomy (LPI) is the established first line treatment for 
angle closure. However, studies have found that treatment with LPI may arrest the 
progression of angle closure only if the procedure is done early enough, such as in 
eyes with occludable angles or primary angle closure suspect (PACS)  stage before 
the onset of peripheral anterior synechiae (PAS) or glaucomatous damage.49
 
Detection 
of the early stage of disease (latent stage) is thus a key component of any screening 
program to prevent PACG. Gonioscopy is the clinical reference standard for assessing 
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the angle and diagnosing angle closure. However, it is based upon a subjective at best 
semi- quantitative assessment
231, 232
that requires considerable skill and experience by 
an ophthalmologist, and involves contact with the cornea, thus making it an 
inappropriate initial screening test. Please see the following section (Section 5.1.2) 
for a discussion of the currently available screening modality for angle closure.  
 
Development of an objective-screening test that is clinician-independent, quick, non-
contact, cost-effective, and with good diagnostic capabilities would likely be more 
effective and convenient for screening. 
 
5.1.1 Is there an appropriate and accurate screening test for Angle closure? 
The aim of any screening program for a disease is to detect cases early in the 
asymptomatic or precursor stage, which should be followed by an intervention to 
prevent progression of the disease to the stages associated with increased morbidity or 
mortality. While definitive data on the natural course of angle closure disease are 
lacking; there are however sufficient evidence to suggest that it is a progressive 
disease, which, if left untreated, can lead to acute angle closure, chronic glaucomatous 
optic nerve damage, and blindness.  
 
The requirements of screening modalities (tests) differ depending upon the intended 
application i.e. either for population-based (Universal) or clinic-based (Opportunistic) 
screening. For universal population-based screening purposes, high specificity levels 
are preferable; whereas, for opportunistic clinic-based case identification, a higher 
sensitivity is more appropriate. The overall performance or accuracy of a screening 
test can be measured by the area under the receiver operating characteristic curve 
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(ROC), which is also known as the area under the curve (AUC). In terms of angle 
closure, the positively identified subjects (either from the population or clinic) can 
undergo further diagnostic investigations and evaluations by a glaucoma specialist. 
Prophylactic laser iridotomy performed as the first-line treatment for PACS may 
arrest the progression of the angle closure process and prevent development of 
PACG,233 however, it is less effective in controlling the intraocular pressure (IOP) if 
optic nerve damage with PAS has already occurred.49, 234 For PACG, a targeted or 
opportunistic screening of at-risk populations such as older individuals, females, 
people of Asian ancestry, and those with a family history of PACG can increase case 
detection rates. 
 
A number of potential screening tests are available for detection of angle closure. The 
diagnostic accuracy, ease of administration, and cost-effectiveness vary depending on 
the test/modality. To date, there is no single test or a combination of tests that have 
been identified as the ‘optimal screening test’ for angle closure glaucoma.  
 
Gonioscopy: Gonioscopy, the current reference standard for diagnosing angle closure 
is a highly subjective technique and with only moderate agreement reported among 
observers.3, 17 Although cost-effective, the time and expertise required to perform 
gonioscopy as well as the large degree of variability in assessment makes it an 
unsuitable tool for population-based screening of angle closure.   
 
Peripheral ACD: Estimation of the limbal or peripheral ACD by the oblique 
flashlight test or the slit-lamp based van Herick technique (including the modified 
grading scheme described by Foster et al namely, 0%, 5%, 15%, 25%, 40%, 75%, and 
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>100% as a proportion to the corneal thickness) have also been evaluated as screening 
modalities for angle closure.204 While Congdon et al154 reported sensitivity and 
specificity of 80% and 69% respectively for the detection of angle closure using the 
flashlight test, the performance of the modified grading scheme of Foster performed 
better. With the <15% cut-off value for limbal ACD, the sensitivity and specificity for 
detection of angle closure was 83.7% and 85.7%  respectively;204 and at the higher 
ACD cut-off of <25%, the sensitivity rose to 99.2%, while the specificity dropped to 
65.5%. The test showed similar results when it was evaluated in a population-based 
study of Chinese residents in Singapore, yielding a sensitivity of 83.0%, a specificity 
of 88.1% for the detection of gonioscopic angle closure.235  
 
Central ACD: The performance of central ACD as a screening test has also been 
assessed. At a cut-off value of <2.22mm, Devereux et al found that the optical 
pachymetry method had a sensitivity of 85% and a specificity of 84% to detect 
gonioscopic angle closure.203 The sensitivity and specificity of the ACD as measured 
by A-scan ultrasound or IOL Master biometry varies between 15-97% and 65-99% 
respectively, depending on the cut-off values.122, 154, 235, 236 The low specificity levels 
obtained for corresponding sensitivity levels hinders the use of these modalities as 
effective screening tools for angle closure.  
 
Other Instruments: Scanning peripheral anterior chamber depth analyzer (SPAC, 
Takagi, Nagano, Japan) is a newer instrument that uses an optical system to 
quantitatively assess the peripheral ACD. The SPAC scans the ACD from the optical 
axis to the temporal limbus and yields numerical and categorical grades. The numeric 
grades are from 1-12, with 12 representing the deepest ACD and categorical grades 
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for risk of angle closure are ‘S’ which is for ‘suspect angle closure’; ‘P’ for ‘potential 
angle closure’; and an absence of suffix for ‘normals’. A community-based study in 
Singapore evaluated the effectiveness of the IOL Master and SPAC instruments as 
screening tools for angle closure in a total of 2,052 subjects aged over 50 years.236 At 
a cut-off level of <5 on the SPAC numeric scale, the sensitivity and specificity of 
SPAC to detect gonioscopic angle closure was 90.0% and 76.6% respectively, with an 
AUC of 0.83.122, 236 The AUC for IOL Master at the ACD cut-off of <2.87mm was 
also 0.83, sensitivity 87.7% and specificity 77.7%.122 Table 5.1 summarizes results of 
performance of the various screening modalities from previous published data.  
 
While some of these instruments are easy and quick to perform, with requirement of 
minimal expertise (with the exception of gonioscopy), however the relatively modest 
performances of these modalities limits their usefulness as effective screening tools 
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 5.1.2 Can the novel parameters be useful as potential screening tools for angle 
closure? 
The imaging modality evaluated in this research is the anterior segment optical 
coherence tomography (ASOCT), a non-contact imaging device that rapidly acquires 
high-resolution images of the anterior segment structures including the angles. There 
is good reproducibility in the measurement of the various ASOCT parameters with 
intra-class and inter-class correlations ranging from 0.88 to 0.97. 
 
We found two novel risk independent risk factors for angle closure, LV and ACW. In 
terms of their ability to detect subjects with angle closure, LV was found to have the 
highest AUC (0.94; 95% CI, 0.91– 0.97) with a sensitivity of 88.2%, and specificity 
of 87.5%. This was higher than the traditional risk factors such as ACD (AUC, 0.75), 
axial length (AL) (AUC, 0.74), or any of the lens parameters (AUC ranging from only 
0.58 to 0.66). The performance of ACW was less satisfactory with an AUC of 0.62. 
Therefore, with an excellent ability to predict eyes with angle closure as well as its 
ability to quantify the magnitude of the lens with respect to the anterior chamber 
angle, LV has the potential to be utilized as a screening parameter for angle closure.  
Interestingly, the other parameter derived from the LV, namely the relative LV, which 
is a ratio that quantifies the proportion of the anterior segment occupied by the LV, is 
also an excellent potential screening parameter. ACW on the other hand may be 
useful in certain subgroups of patients with angle closure, such as those with plateau 
iris, because central ACD or the overall magnitude of the anterior segment is often 




While ease of operation, rapid image acquisition, ability for objective structural 
assessment, and being clinician-independent make the ASOCT appealing as a 
potential tool for screening of angle closure, however, at present the high cost of the 
instrument may limit the feasibility of using this device for universal population-
based screening. Nonetheless, as an opportunistic (clinic-based) screening modality 
for at-risk populations such as older individuals, females, persons of Asian ancestry or 
positive family history, the ASOCT can assist clinicians in increasing case detection 
rates. Furthermore, with advances in ASOCT imaging technology and development of 
fully automated image analysis software, the potential applications of this imaging 
device can be further improved. 
 
5.2 CLINICAL IMPLICATIONS AND PROGRESS MADE FROM THE 
FINDINGS OF THIS THESIS 
The identification of these new risk factors have enhanced our understanding of the 
mechanisms involved in the angle closure disease process, suggesting that non-pupil 
block mechanisms also play a role in the pathogenesis of angle closure disease.  
In addition to ACW and LV, the other novel angle closure risk factors recently 
identified include the iris parameters (iris curvature, thickness and area) and anterior 
chamber area and volume (ACA and ACV).237-239 These parameters were evaluated 
separately and each was shown to be independently associated with angle closure. As 
a follow-up to the identification of these new risk factors, we subsequently assessed 
the contributions of each of these individual factors collectively to determine the 
predominant mechanism(s) involved and also to identify the most clinically useful set 




5.2.1 Determinants of Angle Width 
The width of the anterior chamber angle is the key anatomical feature that determines 
the categorization of the eye into either open angle or angle closure. As there was 
paucity of information regarding the determinants of the angles width, we therefore 
wanted to quantitatively evaluate the factors that contribute to variations of this 
anatomical feature. For a description of the various quantitative anterior segment 
parameters obtained from an ASOCT image, please see section 2.3.4 “Anterior 
segment parameters measured by ZAAP”. In this study, the quantitative angle 
measurements, angle opening distance (AOD) and trabecular iris space area (TISA) 
were selected as surrogates for the angle width. ASOCT and ocular biometric data 
obtained from two large population-based studies were evaluated. To find the subsets 
of independent variables that best predicts a dependent variable, a linear regression 
modeling using the R2 best subsets selection method was performed with TISA and 
AOD as dependent variables.219 
 By incorporating all the established as well as the newly identified anatomical risk 
factors, we found that ACA, ACV, and LV were the 3 most important determinants of 
angle width (Table 5.2.1), across both angle width parameters and both populations. 
Interestingly, the established ocular biometric parameters namely, ACD, AL and LT 
performed less favorably than the ASOCT parameters.219  
Furthermore, we found that a model including only 6 quantitative ASOCT parameters 
- namely ACA, ACV, ACW, LV, iris thickness (IT), and iris area (IArea) explained 
more than 80% of the variability in angle width (Tables 5.2.2).219 
The identification of factors that determine the angle width is an important initial step 
towards a better understanding of the mechanisms that lead to the development of 
angle closure.  
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Table 5.2.1: Linear regression models showing R-square value of single predictors of 
TISA750 and AOD750 in the population-based sample 
















ACV 0.51 0.51 0.47 0.54 0.54 0.52 
ACA 0.49 0.50 0.46 0.55 0.55 0.53 
LV 0.47 0.47 0.46 0.56 0.55 0.55 
ACD 0.39 0.38 0.38 0.46 0.45 0.46 
I-Curv 0.36 0.41 0.27 0.48 0.51 0.41 
AL 0.27 0.24 0.25 0.30 0.25 0.32 
LP 0.23 0.24 0.20 0.27 0.29 0.24 
RLP 0.04 0.06 0.03 0.06 0.08 0.04 
Age 0.04 0.04 0.06 0.06 0.06 0.09 
ACW 0.03 0.02 0.05 0.03 0.01 0.04 
IT750 0.03 0.04 0.04 0.06 0.07 0.07 
IT2000 0.01 0.01 0.02 0.01 0.01 0.01 
I-Area 0.01 0.02 0.00 0.02 0.04 0.01 
LT 0.01 0.01 0.00 0.01 0.02 0.00 
Anterior chamber volume (ACV), anterior chamber area (ACA), lens vault (LV), anterior 
chamber depth (ACD), iris curvature (I-Curv), axial length (AL), lens position (LP), 
relative lens position (RLP), anterior chamber width (ACW), iris thickness (IT), iris area 















Table 5.2.2: Linear Regression Models showing Best R-square selection models (N=1008) 
No. of variables 
in model 







ACV (0.51, 0.55) 
ACW (0.11, 0.13) 
0.62 0.68 
3 
ACV (0.51, 0.55) 
ACW (0.11, 0.13) 
IT750 (0.06, 0.10) 
0.68 0.78 
4 
ACV (0.51, 0.55) 
ACW (0.11, 0.13) 
IT750 (0.06, 0.10) 
I-Area (0.04, 0.03) 
0.72 0.81 
5 
ACV (0.51, 0.05) 
ACW (0.11, 0.08) 
IT750 (0.06, 0.10) 
I-Area (0.06, 0.04) 
ACA (0.05, 0.56) 
0.79 0.83 
6 
ACV (0.51, 0.05) 
ACW (0.11, 0.08) 
IT750 (0.06, 0.10) 
I-Area (0.06, 0.02) 
ACA (0.05, 0.56) 
LV (0.03, 0.04) 
0.81 0.85 
7 
ACV (0.51, 0.05) 
ACW (0.11, 0.08) 
IT750 (0.06, 0.10) 
I-Area (0.06, 0.02) 
ACA (0.05, 0.56) 
LV (0.03, 0.04) 
I-Curv (0.00, 0.01) 
0.81 0.87 
8 
ACV (0.51, 0.05) 
ACW (0.11, 0.08) 
IT750 (0.06, 0.10) 
I-Area (0.06, 0.02) 
ACA (0.05, 0.56) 
LV (0.03, 0.04) 
I-Curv (0.00, 0.01) 
RLP (0.00, 0.00) 
0.81 0.87 
Anterior chamber volume (ACV), anterior chamber area (ACA), lens vault (LV), anterior chamber 
depth (ACD), iris curvature (I-Curv), axial length (AL), lens position (LP), relative lens position 







5.2.2 Classification algorithms for detection of Angle Closure and the ‘Angle 
closure Score’ 
 Being largely asymptomatic, PACG is often recognized only in the late stages when 
irreversible visual field loss has occurred. The high prevalence of angle closure in 
Asia and its potential blinding course highlight the need for an effective screening 
tool for identifying eyes with angle closure. We therefore considered six different 
classification algorithms (stepwise logistic regression with Akaike information 
criterion, Random forest, multivariate adaptive regression splines, support vector 
machine, naïve Bayes’ classification, and recursive partitioning) to comprehensively 
evaluate the diagnostic accuracy of a set of predictors including demographic, 
biometric and ASOCT parameters to detect gonioscopic angle closure.240  
We found that a classification algorithm based on stepwise logistic regression that 
used a combination of the 6 parameters obtained from a single horizontal ASOCT 
scan, identified nearly all cases of gonioscopic angle closure with an AUC of 0.95240 
(Table 5.2.3).  
This suggests that we are able to detect cases of angle closure with high precision. 
The algorithm performed equally well in a second independent sample of patients 
attesting to the robustness of the algorithm.  
We also assessed the relative importance of the variables in each predictive model. 
The LV, ACA and ACV were found to be the top 3 important variables across the 











As a follow-up to this study, we next sought to develop an objective, clinician-
independent, imaging-based ‘angle closure score’ for the detection of eyes with 
angle closure. Stepwise logistic regression model with Akaike information criterion 
was used to generate the ‘score’, which was then converted to an estimated 
probability of the presence of gonioscopic angle closure.241 The estimated probability 
was computed as escore/(1 +escore).In addition, we also assessed the possibility of 
identifying the important parameter(s) associated with angle closure in a particular 
individual. Figure 5.1 illustrates the graphical representation of 6 subjects randomly 
chosen from amongst the 1368 community-based samples. In each plot, the 
components to the score for the respective individual are graphically represented to 
allow for an objective assessment of the likely contributing mechanism(s) (Figure 
Table 5.2.3: Estimated estimation accuracies by algorithm for the data set consisting of 6 
variables 
 Testing data 10-fold cross-validation 
Prediction 
Algorithm 
AUC 95% CI AUC 95% CI Sensitivity Specificity 
Stepwise Logistic 
Regression 
0.962 0.948, 0.975 0.954 0.942, 0.966 0.957 0.767 
Random Forest 0.948 0.928, 0.969 0.953 0.930, 0.975 0.942 0.784 
MARS 0.952 0.932, 0.972 0.948 0.930, 0.966 0.968 0.717 
SVM 0.926 0.897, 0.955 0.926 0.883, 0.969 0.930 0.830 
Naïve Bayes 0.952 0.936, 0.968 0.945 0.932, 0.958 0.962 0.786 
Recursive 
Partitioning 
0.905 0.876, 0.933 0.860 0.790, 0.930 0.883 0.828 
AUC= area under the receiver operator characteristic curve; CI=confidence interval; MARS= 
Multivariate Adaptive Regression Splines; SVM= Support Vector Machine 
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5.1).241 As can be seen in the figure, and as one would expect, the estimated 
probability for those eyes without angle closure was lower than for those with angle 
closure. Furthermore, for those eyes with angle closure, the largest contributors were 








Therefore, by first identifying novel angle closure risk factors, we have been able to 
develop a more objective method to assess for the predominant mechanism(s) 
involved. This has a potential towards personalized approach to management that can 





5.3. MAIN FINDINGS OF THE DETERMINATION OF GENETIC LOCI FOR 
ANGLE CLOSURE 
The usefulness of genome-wide association studies is their hypothesis-free approach 
that is not constrained by prior knowledge of disease/trait, etiology/mechanism or 
genetic associations. GWAS permits interrogation of hundreds of thousands of 
markers of the entire human genome in thousands of unrelated individuals to yield 
promising signals of association between human traits and genetic variants. GWAS 
thus have the potential to unravel the genetic architecture of a disease and reveal 
genes not previously suspected to be associated with the disease.  
 
We have utilized the quantitative traits approach to effectively identify a novel 
genetic variant for PACG. We conducted a GWAS on ACD on a total of 5,308 
population-based individuals of Asian descent, and observed a genome-wide 
significant association at a sequence variant within ABCC5 (rs1401999; per-allele 
effect size = - 0.045mm, P = 8.17x 10-9). This locus was also associated with an 
increase in risk of PACG in a separate case-control study of 4,276 PACG cases and 
18,801 controls (per-allele OR = 1.13 [95%CI: 1.06 – 1.22], P = 0.00046).  
 
This was the first reported study of a quantitative trait related to PACG and provides a 
genetic link between the disease and one of its key ocular anatomical risk factor, 
ACD. Our findings suggest that the increase in PACG risk could in part be mediated 
by genetic sequence variants influencing anterior chamber dimensions and validate 
the quantitative trait approach in identifying genes for a clinically heterogeneous 
condition such as PACG. The quantitative trait/ endophenotype approach allows one 
to deconstruct the etiological complexity of a common complex disease so as to 
214 
 
simplify the search for causative genes. This approach has been successful in 
elucidating disease genes for common complex diseases such as the study of genetic 
variants controlling lipid traits and susceptibility to coronary artery disease,116, 136, 193 
and genetic variants controlling fasting blood glucose levels and Type 2 diabetes.188, 
189, 191  
 
We also found that utilizing a subgroup of controls with clinically certified open 
angles, the association was strengthened (per-allele OR = 1.30, P = 7.45 x10-9; 3,458 
cases vs. 3,831 controls), suggesting that the deployment of controls with proper 
clinical phenotyping will assist in more definitive identification of susceptibility 
genes. This was done to minimize the possibility of mis-classification bias arising 
from the fact that narrow or occludable angles is prevalent in about 10% in many 
Asian populations. Therefore, in order to assess the true relationship between ACD 
genetic loci and PACG given the association between angle closure and shallow 
ACD, it was therefore appropriate to remove these ‘at-risk individuals’ from the 
control populations. Such an approach of utilizing risk-free controls have been 
employed in studies on Alzheimer’s disease where it was shown to improve the odds 
ratio conferred by the disease-associated SNP compared to when using general 
population-based controls.140, 141, 218 
 
5.3.1 What are the other endophenotypes for PACG? 
The (highly) heritable traits for angle closure include ACD,87, 92, 93 angle width,88 iris 
thickness,94 and anterior chamber width (ACW); and these can be considered 
endophenotypes for PACG. Heritability estimates range from 60% for iris thickness,94 
70% for angle width,88 50-70% for ACW (unpublished, data courtesy A/Prof Cheng 
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Ching-Yu), and the highest heritability has been shown for ACD, 51-88% in 
Caucasians92, 93 and >90% in Chinese.87 The high heritability (50-90%) demonstrated 
for these PACG-related traits suggest a strong genetic contribution for these traits, 
Once sufficient sample size of subjects with both phenotype and genotype data are 
available, we will evaluate the association between the other PACG-related 
quantitative endophenotypes and genotypes from population-based cohorts, using 
quantitative trait locus (QTL) analysis.   
 
5.3.2 What is the role of the PACG associated genes identified to date? 
All novel genes identified thus far have the potential to provide insights into PACG 
disease mechanisms. PLEKHA7 encodes for Pleckstrin-homology-domain-containing 
protein 7, which is critical for the maintenance and stability of adherens junctions21. 
In adult tissues, adherens junctions maintain tissue homeostasis and along with tight 
junctions control epithelial and endothelial para-cellular permeability22. It is 
speculated that PLEKHA7 may be involved in the pathophysiology of angle closure 
related to aberrant fluid dynamics. COL11A1 encodes for one of the two alpha chains 
of type XI collagen and being a structural protein, it may contribute towards 
anatomical risk. Interestingly, mutations in COL11A1 have been described in patients 
with Stickler syndrome.8 PCMTD1 encodes for protein-L-isoaspartate O-
methyltransferase domain-containing protein 1, whose function remains unknown. 
The exact role of ABCC5, encoding ATP-binding cassette sub-family C member 5 
protein, in the eye is not known. The strong association between ABCC5 variants with 
a shallower ACD (P < 5 x 10-8) however argue favorably for a role in eye growth, 




5.4 IMPLICATIONS OF THE NEW BIOMARKERS FOR ANGLE CLOSURE 
GLAUCOMA 
As glaucoma is largely a painless and progressive disease with irreversible end-organ 
optic nerve damage, therefore an ability to predict the presence of disease prior to 
significant visual loss is critical. With better objective markers for predicting the risk 
of disease occurrence and appropriate prophylaxis, more people with PACG could 
avoid blindness. The current research, which is focused on identifying novel 
biomarkers (imaging and genetics) for PACG may have many implications including 
screening, risk assessment and economic relevance. It is hoped that such markers 
would lead to a better understanding of the disease pathophysiology and 
susceptibility.  In the future such knowledge/findings could lead to development of 
novel screening tests/ prediction algorithms for the condition. 
 
5.4.1 Improved screening and prevention of blindness  
The advent of the anterior segment optical coherence tomography (ASOCT) imaging 
modality has allowed both an ability to visualize the anterior segment structures in a 
single image as well as to perform precise quantitative measurements of these 
structures. In this research study, we have shown that eyes with angle closure have 
significantly larger LV, and smaller ACW and anterior vault (AV). In addition to 
these novel ASOCT parameters, I have also been closely involved in the identification 
of the other new ASOCT parameters associated with angle closure including ACA, 
ACV, and the various iris parameters (thickness, area and curvature).   
 
The identification of several novel risk parameters suggests that angle closure is a 
heterogeneous disease, which can be caused by the absolute or relative deviations in 
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either one, or a combination of the different risk factors for the condition. Therefore, 
an evaluation of these risk factors could assist in either clinic-based assessments to 
help clinicians identify the likely mechanisms causing angle closure; or, in a 
population-based setting to screen for angle closure.  
Each of these different parameters has not only been evaluated individually, but their 
concurrent and collective assessments have led towards finer approaches for 
determination of the predominant anatomical mechanism involved (see section 5.2 
above), and could lead to a more personalized approach in angle closure management.  
 
As glaucoma is a potentially blinding condition, the ability to predict disease 
occurrence prior to significant visual loss is critical. Furthermore, development of or 
progression to PACG may potentially be prevented by therapeutic interventions such 
as prophylactic laser iridotomy if performed at an early stage of the disease. With 
effective screening, early detection and appropriate prophylaxis, more people with 
PACG could avoid blindness.  
 
6.4.2 Expand the spectrum of genetic loci associated with PACG disease 
Through the interrogation of ACD-a key ocular anatomical risk factor and a PACG-
related endophenotype, a novel locus (ABCC5) for PACG was identified. This new 
locus adds to the currently limited spectrum of the genetic determinants of PACG that 
at present includes only the three susceptibility loci that were recently identified. The 
new PACG locus identified through the ACD QTL approach suggest that the increase 
in PACG risk could in part be mediated by genetic sequence variants influencing the 
anterior chamber dimensions and validate the quantitative trait approach in 
identifying genes for PACG. Therefore, by identifying more susceptibility loci 
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through the endophenotype/ QTL approach, the genetic constituents of PACG genetic 
would be further elucidated and could provide insights into the pathways responsible 
for disease pathogenesis, which would facilitate development of novel therapies for 
the condition. 
 
6.4.3 Improved Risk Assessment for PACG 
Accumulating evidence suggests that the pathobiology of PACG is complex with 
multiple contributory factors including demographic, anatomical/biometric, 
dynamic/physiological and genetic factors. It is therefore possible that the newly 
identified novel phenotypic and genetic risk factors will have the potential to 
influence clinical guidelines for the screening, diagnosis and management of PACG 
and thus have broad public health impact. By identifying more genetic variants for 
PACG and combining with the novel anatomical risk factors and 
established/traditional risk factors, it could be possible in the future to provide a risk 
assessment of PACG that will be profoundly useful in clinical practice to help 
clinicians identify the predominant mechanism involved, assess progression risk and 
aid in deciding the appropriate therapy.  
 
6.4.4 Economic Implications 
With almost half of the world’s glaucoma sufferers being Asians, and PACG the 
major form of glaucoma, it is anticipated that the disease will have important public 
health implications, the consequences of which are likely to affect the individual, 
society and health care systems. Moreover, about 50-90% of people with glaucoma 
worldwide are unaware they have the disease.2, 3  The economic burden is further 
increased since end stage glaucoma causes blindness, and moderate to severe 
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glaucoma causes significant morbidity including limitations of physical and social 
abilities. Therefore, ability to early detection of those at risk and performing 
prophylactic treatment may reduce the rate of blindness, progression of disease, and 

























In this research, we have been successful in unraveling novel ocular biometric and 
genetic risk markers for PACG. Building on these successes, we plan to continue to 
identify further susceptibility genes/loci to increase the genetic information for PACG. 
Furthermore, we have expanded our imaging work on the novel risk factors to develop 
an algorithm (with excellent diagnostic performance) for detection of angle closure (but 
not angle closure glaucoma per-se) (see section 5.2). We therefore plan to extend on 
this to develop a predictive model for the prediction of PACG risk by incorporating 
anatomical factors (both established and novel), demographics (gender, ethnicity and 
age), and the risk associated validated genetic loci from our current and future genetic 
discoveries. 
On the imaging aspect, our classification algorithm and ‘angle closure score’ (Section 
5.2) has the potential to be integrated easily into ASOCT image analysis software to 
alert clinicians to the presence of gonioscopic angle closure. We envisage to work 
towards incorporating the ‘angle closure score’ and corresponding graphical output 
(of contributing variables) into ASOCT image analysis software, so that in addition to 
the individual ASOCT parameter measurements, the output will provide a more 
objective assessment, including a likelihood index for angle closure.  
As regards angle closure genetics, our future work is aimed at identifying as many 
PACG susceptibility loci/candidate genes by using both the hypothesis-free GWAS 
methods including ExomeWAS and whole genome sequencing as well as the 
hypothesis-based endophenotype approaches; and also to develop a novel PACG risk 




6.1 To identify further susceptibility loci for PACG 
In our efforts to elucidate the full allelic spectrum of PACG, we plan to utilize the 
following methodologies:  
6.1.1 Quantitative endophenotype approach using ASOCT-based quantitative 
traits  
With the sample size that is available to date (ie ~3400 as of August 31, 2014), we are 
currently underpowered to detect genome-wide significant genetic markers responsible 
for the variation of anterior chamber width (ACW) and other ASOCT parameters 
including anterior vault (AV), lens vault (LV), iris thickness and angle width. Therefore, 
the next step would be to re-analyze the data in a larger cohort of subjects (discovery) 
followed by replication of the findings of the discovery cohort by genotyping of 
(experimentally significant) SNPs in independent cohorts. The GWAS significant 
SNPs/ loci identified for each endophenotype will be tested for their association with 
PACG 
Study subjects with PACG-related quantitative traits and genotyping data: The 
additional subjects/ cohorts for discovery and replication include participants of 
SINDI 2 (those subjects recruited from September 01, 2014 onwards, for whom 
GWAS data and ASOCT data are already available), and the following cohorts for 
which genome-wide data is not yet available (but ASOCT images are available):  
1) Angle closure glaucoma polyclinic study (~2100) 
2) Beijing Eye Study (BES, referred to as BES2, ~1000) 
3) Handan Eye Study (~1400).  
ASOCT images from the participants of these studies will be analyzed for the 
estimation of ACW and other ASOCT parameters including AV, LV, iris thickness 
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and angle width. Genotyping including GWAS will also be performed for these 
cohorts. 
SINDI 2:  This will include the subjects that were recruited from September 01, 2014 
onwards. Approximately 1000 additional subjects are expected to be recruited by June 
2015.  It is important to note that GWAS genotyping data is already available for 
these subjects as it was performed when they were recruited for the baseline study 
visit 6 years previously. 
Angle Closure Glaucoma Polyclinic study: ~2100 community-based subjects aged 
50 years were recruited between June 2013 and September 2013 from a polyclinic in 
Singapore. The aim of the study was to validate the newly developed angle closure 
detection software and to identify the optimal method for angle closure detection in 
the population. Imaging by ASOCT was performed and DNA samples were also 
collected from the subjects. 
BES2: DNA is also available for an additional 1000 individuals recruited for the BES 
who have clinical, ocular biometry and ASOCT images. These are in addition to the 
900 subjects (BES1) for which GWAS data is already available.  
The Handan Eye Study (HES) is a population-based study of eye diseases in rural 
Chinese persons aged ≥ 30 years. Clinical, biometry, ASOCT images and DNA are 
available for approximately 1400 individuals from from HES.   
 
We anticipate that these cohorts will contribute an additional ~4500 subjects having 
both gradable ASOCT, and genotyping data passing stringent quality checks. 
Genome-wide genotyping is planned for some cohorts and Sequenom genotyping will 




Meta-analysis: Primary association testing between genotypes and the PACG-related 
endophenotypes will be performed to identify the genetic variants for these 
quantitative traits. Those SNPs that show suggestive evidence of association (P < 1 x 
10-4) with each endophenotype in the discovery cohorts will be taken forward for 
replication in independent cohorts. The genotyping of the associated SNPs in the 
Replication cohorts will be done by using Sequenom MassArray platform 
(www.sequenom.com).  
A combined meta-analysis of the discovery and replication cohorts will then be 
performed to identify susceptibility loci/genes for the endophenotypes.  
 
Examine whether the top SNPs/GWAS significant SNPs are associated with PACG: 
The top SNPs/GWAS significant SNPs associated with each PACG-related 
endophenotype will be assessed for associations in PACG case-control cohorts for 
who genome-wide genotyping data is already available (Please see Table 4.2.3, 
Chip-genotyped cases). This will inform whether the genetic variants controlling 
ocular biometric traits are also PACG disease genes. 
 
6.1.2 Other methodologies to identify PACG susceptibility loci 
Large scale PACG case-control meta-analysis: Efforts will also be made to identify 
more PACG susceptibility loci by expanding the discovery PACG cohorts and through 
the conduct of PACG case-control meta-analyses. We are augmenting our sample 
collection to include clinical and genetic data from multiple international collaborators. 





ExomeWAS and whole genome sequencing:  As rarer variants of higher penetrance 
may confer a significant level of risk and explain a large proportion of the inter-
individual heritability of PACG, we also plan to supplement the traditional GWAS 
methodology with the ExomeWAS and whole genome sequencing approaches. The 
exome array genotyping allows us to specifically explore the possible contribution of 
potentially functional coding variants in disease susceptibility.242 This has a high 
chance of uncovering functional genetic mutations of higher penetrance than those 
discovered via GWAS, thus explaining more of the proportion of PACG risk.  
 
6.2 Refining GWAS signals  
Since only a fraction of the approximately 10 million common genetic variants are 
directly genotyped by the GWA platforms, it is therefore likely that the most 
significantly associated signals are merely correlated markers and not necessarily 
causal markers. It is therefore important to refine these signals in order to identify the 
causal variant for the phenotype or trait as the identification of these variants may 
improve predictive models of disease risk.  However, finding the causal variant is not 
always straight-forward and can be a challenging and difficult task. One of the methods 
to identify causal risk variants for PACG would be to deep sequence the previously 
identified PACG genes as well as the genes associated with the disease endophenotypes.  
 
6.3 Develop/ construct a predictive risk model for PACG 
Our eventual aim is to develop a risk prediction model for PACG, a potentially 
blinding condition more prevalent in persons of Asian ethnicity. Being largely 
asymptomatic, PACG is often recognized only in the late stages when irreversible 
visual field loss has occurred. Although, we have found that our imaging-based model 
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alone has a high accuracy for detecting angle closure, however, not all angle closure 
patients go on to develop glaucomatous optic neuropathy and visual impairment. 
Therefore an ability to detect early those subjects at high risk for progression to 
PACG would be invaluable not only in a clinic-based setting but also at a population-
wide level.  
We therefore aspire to develop or construct a novel PACG risk prediction algorithm 
combining ocular imaging and genetic markers to detect at-risk patients. We 
hypothesize that such an algorithm can be useful not only as an adjunctive diagnostic 
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Lens Vault, Thickness, and Position in
Chinese Subjects with Angle Closure
Monisha E. Nongpiur, MD,1 Mingguang He, MD, PhD,2 Nishani Amerasinghe, MRCOphth,1,3
David S. Friedman, MD, PhD,4 Wan-Ting Tay, BSc,1 Mani Baskaran, MS,1 Scott D. Smith, MD, MPH,5
Tien Yin Wong, MD, PhD,1,6 Tin Aung, FRCS(Ed), PhD 1,6
Purpose: To investigate the association of lens parameters—specifically, lens vault (LV), lens thickness (LT),
and lens position (LP)—with angle closure.
Design: Prospective, comparative study.
Participants: One hundred two Chinese subjects with angle closure (consisting of primary angle closure,
primary angle-closure glaucoma, and previous acute primary angle closure) attending a glaucoma clinic and 176
normal Chinese subjects with open angles and no evidence of glaucoma recruited from an ongoing population-
based cross-sectional study.
Methods: All participants underwent gonioscopy and anterior-segment optical coherence tomography (AS
OCT; Carl Zeiss Meditec, Dublin, CA). Customized software was used to measure LV, defined as the perpen-
dicular distance between the anterior pole of the crystalline lens and the horizontal line joining the 2 scleral spurs,
on horizontal AS OCT scans. A-scan biometry (US-800; Nidek Co, Ltd, Tokyo, Japan) was used to measures LT
and to calculate LP (defined as anterior chamber depth [ACD] 1/2 LT) and relative LP (RLP; defined as LP/axial
length [AL]).
Main Outcome Measures: Lens parameters and angle closure.
Results: Significant differences between angle-closure and normal eyes were found for LV (901265 vs.
316272 m; P0.001), LT (4.200.92 vs. 3.900.73 mm; P  0.01), LT-to-AL ratio (0.180.04 vs.
0.160.03; P0.001), ACD (2.660.37 vs. 2.950.37 mm; P0.001), and AL (22.860.93 vs. 23.921.37
mm; P0.001), but no significant differences were found for LP (4.760.51 vs. 4.900.54 mm; P  0.34) or
RLP (0.210.02 vs. 0.200.02; P  0.14). After adjusting for age, gender, ACD, LT, and RLP, increased LV
was associated significantly with angle closure (odds ratio [OR], 48.1; 95% confidence interval [CI],
12.8 –181.3, comparing lowest to highest quartile), but no association was found for LT (OR, 1.78; 95% CI,
0.76 – 4.16), LP (OR, 1.94; 95% CI, 0.59 – 6.31), or RLP (OR, 2.08; 95% CI, 0.66 – 6.57). There was low
correlation between LV and LT (Pearson’s correlation coefficient [PCC], 0.17), between LV and RLP (PCC,
0.08), or between LV and LP (PCC, 0.2).
Conclusions: Eyes with angle closure have thicker lenses with greater LV compared with normal eyes. The
LV, which represents the anterior portion of the lens, is a novel parameter independently associated with angle
closure after adjusting for age, gender, ACD, and LT.
Financial Disclosure(s): Proprietary or commercial disclosure may be found after the references.











(Primary angle-closure glaucoma remains a major cause
of blindness, particularly in Asian countries. Previous
studies have demonstrated that ocular risk factors for
angle-closure glaucoma are shallow anterior chamber
depth (ACD), short axial length (AL), and increased lens
thickness (LT).1– 4 Among these parameters, the lens is
thought to play a crucial role in the pathogenesis of angle
closure disease either because of an increase in its thick-
ness or a more anterior position causing a decrease in
ACD. The result is angle crowding and a greater predis-
position to pupillary block resulting from iridolenticular
apposition in eyes with small anterior segments. How-
ever, the association of various lens parameters such as
the lens position (LP; defined as ACD 1/2 LT), relative a
474 © 2011 by the American Academy of Ophthalmology
Published by Elsevier Inc.ens position (RLP; defined as LP/axial length), and
T-to-AL (LT/AL) ratio have not been established con-
lusively, and there have been conflicting reports on the
mportance of LP and RLP with angle closure.5–10
It is now possible to capture in a single image the
ntire anterior chamber using anterior-segment optical
oherence tomography (AS OCT). This allows better
maging of the lens relative to other structures. The
uthors hypothesize that the degree of lens that is located
nterior to the plane of the angles plays a role in the
athogenesis of angle closure. One way to quantify the
agnitude of this parameter is to calculate the lens vault
LV), defined as the perpendicular distance between the
nterior pole of the crystalline lens and a horizontal line















































Nongpiur et al  Lens Features in Chinese Subjects with Angle Closurejoining the 2 scleral spurs. The aim of the present study
was to evaluate the relative importance of lens parame-
ters (LV, LT, LP, and RLP) with respect to angle closure
by comparing eyes with angle closure with eyes of pa-
tients with open angles.
Patients and Methods
This was a prospective, comparative study of Chinese subjects
with angle closure attending a glaucoma clinic and of normal
control subjects recruited from an ongoing population-based
study.11 Written informed consent was obtained from all sub-
jects, and the study had the approval of the Institutional Review
Board of Singapore Eye Research Institute and was performed
in accordance with the tenets of the Declaration of Helsinki.
A case of angle closure was defined as primary angle closure
(PAC), primary angle-closure glaucoma (PACG), or previous
acute primary angle closure (APAC) in subjects recruited from
clinics at Singapore National Eye Center. Primary angle closure
was defined as the presence of appositional angle closure for
180 degrees or more with peripheral anterior synechiae, raised
intraocular pressure, or both, but without glaucomatous optic
neuropathy. Primary angle-closure glaucoma was defined as
eyes with PAC associated with glaucomatous optic neuropathy
(defined as loss of neuroretinal rim with a vertical cup-to-disc
ratio of 0.7 or an intereye asymmetry of 0.2, and/or notch-
ing attributable to glaucoma). Previous APAC was defined as
the presence of at least 2 of the following symptoms: ocular or
periocular pain, nausea or vomiting or both, and an antecedent
history of intermittent blurring of vision with haloes; a present-
ing intraocular pressure of more than 28 mmHg on Goldmann
applanation tonometry; and the presence of at least 3 of the
following signs: conjunctival injection, corneal epithelial
edema, middilated unreactive pupil, and shallow anterior cham-
ber.12 Patients diagnosed with secondary angle closure (such as
neovascular or uveitic glaucoma), patients who had corneal
abnormalities that would affect imaging, and patients who had
previous laser iridoplasty or intraocular surgery history were
excluded. All subjects with angle closure previously had un-
dergone laser peripheral iridotomy.
The control group of normal subjects (defined as intraocular
pressure 21 mmHg with open angles, healthy optic nerves and
normal visual fields, no previous surgery, and no family history
of glaucoma) were recruited from an ongoing population-based
study of Chinese persons aged 40 years and older (the Singa-
pore Chinese Eye Study), described in detail elsewhere.11,13,14
For this report, complete data were available for 176 consecu-
tive normal Chinese study subjects, and they were included as
population controls.
All subjects underwent a detailed eye examination that in-
cluded visual acuity measurement using a logarithm of minimum
angle of resolution chart (Lighthouse, Inc., Long Island, NY),
slit-lamp examination (Model BQ 900; Haag-Streit, Bern, Swit-
zerland), stereoscopic optic disc examination with a 78-diopter
lens (Volk Optical, Inc., Mentor, Ohio), intraocular pressure mea-
surement by Goldmann applanation tonometry (Haag-Streit,
Koniz, Switzerland), and gonioscopy, performed in the dark using
a Goldmann 2-mirror lens at high magnification (16). Indenta-
tion gonioscopy with the Sussman 4-mirror lens was used to
establish the presence or absence of peripheral anterior synechiae.
A-scan biometry (Model US-800; Nidek Co, Ltd., Tokyo, Japan)
was used to measure AL, ACD, and LT, and these results were
used to calculate LP (defined as ACD 1/2LT) and RLP (defined
as LP/AL). Anterior-Segment Optical Coherence Tomography
ll subjects underwent imaging with AS OCT (Visante; Carl
eiss Meditec, Dublin, CA) performed in dark room conditions
0 lux) by an operator who was masked to the results of the
linical ophthalmic examination. Scans were centered on the
upil and were obtained along the horizontal axis (nasal-
emporal angles at 0°–180°) using the standard anterior-
egment single-scan protocol. To obtain the best quality image,
he examiner adjusted the saturation and noise and optimized
he polarization for each scan during the examination. Because
everal scans are acquired by the AS OCT device, the examiner
hose the best image, with no motion artefacts or image arte-
acts resulting from the eyelids.
One cross-sectional horizontal AS OCT scan of the nasal
nd temporal angle was evaluated for each subject. These
mages were processed using customized software, the Zhong-
han Angle Assessment Program (ZAAP, Guangzhou, China),15
y a single observer (MEN) who was masked to clinical data.
or each image, the only observer input was to determine the
ocation of the 2 scleral spurs. The algorithm then automatically
alculated the LV, defined as the perpendicular distance be-
ween the anterior pole of the crystalline lens and the horizontal
ine joining the 2 scleral spurs (Fig 1). Positive values indicate
hat the anterior pole of the lens is located anterior to the sclera
pur line, whereas negative values occur when the anterior pole of
he lens is posterior to the sclera spur line. The reproducibility for this
lgorithm was performed on 60 consecutive patients with PAC cho-
en from a research clinic at the Zhongshan Ophthalmic Center
ospital. The AS OCT images of the right eyes were analyzed by the
ame experienced grader (MH) twice on separate days using the
hongshan Angle Assessment Program software. The lens vault was
.7230.196 mm in these selected images. The test–retest difference
or lens vault was –0.0220.055 mm (P  0.06). The test–retest
oefficient of variation was 7.6%.
tatistical Analysis
tatistical analysis was performed using SPSS software version
7 (SPSS, Inc., Chicago, IL). Differences in mean values of
arametric data among eyes of different subjects were exam-
ned using the independent samples Student t test. For nonpara-
etric data, a Mann–Whitney U test was used to compare
eans of independent samples. The difference between angle
losure cases and normal subjects in lens parameters was eval-
ated using logistic regression models to determine the odds
atio (OR) and 95% confidence interval (CI). Multivariate ad-
usted ORs were obtained after adjustment for age, gender, LT,
igure 1. Anterior segment optical coherence tomography image illustrating
he measurement of Lens Vault as determined by the Zhongshan Angle










































Ophthalmology Volume 118, Number 3, March 2011and RLP. Receiver operator characteristic curves were gener-
ated, and the area under the receiver operator characteristic
curve (AUC) was used to assess the performance of the various
parameters in detecting angle closure. The sensitivity and spec-
ificity were calculated using the optimal cutoff point given by
the maximum of the Youden index,16 calculated as J  max
(sensitivityspecificity1). A P value less than 0.05 was con-
sidered statistically significant.
Results
A total of 102 angle-closure subjects (consisting of 29 PAC, 53
PACG, and 20 previous APAC subjects) and 176 normal control
subjects were recruited for the study. All subjects were of Chinese
ethnicity. Angle-closure subjects were older (65.39.1 years vs.
54.27.9 years; P0.001), and there were proportionately more
females (66.7% vs. 46.6%; P  0.001) compared with normals. For
the normal control group, LV increased significantly with advancing
age (P0.001, for trend; Table 1, available at http://aaojournal.org).
The results were largely similar when the analysis was performed
separately for males and females. Within the limited age range of this
study, no significant trend with age was noted for LT and RLP.
Women had significantly greater LV compared with men (379.07 m
vs. 260.09m; P 0.003), but no significant gender differences were
noted for LT (P  0.5) or RLP (P  0.06).
Significant differences between the angle closure and control
groups were found for LV (901265 m vs. 316272 m;
P0.001), LT (4.200.92 mm vs. 3.900.73 mm; P  0.01),
LT/AL ratio (0.180.04 vs. 0.160.03; P0.001), ACD (2.660.37
mm vs. 2.950.37 mm; P0.001), and AL (22.860.93 mm vs.
23.921.37 mm; P0.001), but no significant differences were found
for LP (4.760.51 mm vs. 4.900.54 mm; P  0.34) or RLP
(0.210.02 vs. 0.200.02; P  0.14; Table 2). After multivariate
analysis adjusted for age, gender, ACD, LT, and RLP, increased
LV was associated significantly with angle closure (OR, 48.1; 95%
CI, 12.8–181.3, comparing lowest with highest quartile; Table 3),
but no association was found for LT (OR, 1.78; 95% CI, 0.76–
4.16), LP (OR, 1.94; 95% CI, 0.59–6.31), or RLP (OR, 2.08; 95%
CI, 0.66–6.57). Furthermore, LV and LT were poorly correlated
(Pearson’s correlation coefficient [PCC], 0.17), as were LV with
RLP (PCC, 0.08; Figs 2 and 3 available at http://aaojournal.org)
and LV with LP (PCC, –0.20). However, LT and RLP were fairly
correlated (PCC, 0.70; Fig 4, available at http://aaojournal.org), as
were LT and LP (PCC, 0.68).
In terms of distinguishing angle-closure subjects from open-
angle subjects, LV had the highest AUC (0.94; 95% CI, 0.91–
Table 2. Comparison of Biometric Parameters b
Measures
Angle Closure Mean
(SD) (n  102)
Normal Con
(SD) (n
ACD (mm) 2.66 (0.37) 2.95
AL (mm) 22.86 (0.93) 23.93
LT (mm) 4.20 (0.92) 3.90
LP (mm) 4.76 (0.51) 4.90
RLP 0.21 (0.02) 0.20
LT/AL ratio 0.18 (0.04) 0.16
LV (m) 901 (265) 316
ACD  anterior chamber depth; AL  axial length;
thickness; LV  lens vault; RLP  relative lens positio
*Adjusted for age, gender.0.97), a sensitivity of 88.2%, and specificity of 87.5%, whereas r
476he AUC of the other lens parameters ranged from only 0.58 to
.66 (Table 4, available at http://aaojournal.org). Finally, no
ifferences were observed in biometric parameters between the
clinical subgroups of angle closure except for LV, which was
ignificantly greater in those with a prior APAC episode, com-
ared with those with PAC (P  0.003) and PACG (P  0.001;
able 5).
iscussion
s far as the authors are aware, this is the first study to
escribe the LV as a unique and possibly independent
cular parameter associated with angle closure. This sup-
orts the concept that increased thickness and bulk of the
ens anterior to the plane of the scleral spur pushes the
eripheral iris against the trabecular meshwork, worsening
ngle crowding in an already predisposed eye. Increased LV
ikely increases the amount of iridolenticular contact, lead-
ng to a more pronounced iris curvature, pupil block, and
ngle crowding.
Findings related to lens biometric properties and angle
losure have been inconsistent. Although a more anteri-
rly located lens has been described as a predisposing
actor for angle closure by some authors,5–10 others have
ot found any difference when comparing eyes with
ngle closure with those with open angles.9 Lim et al17
eported a more anteriorly placed lens in attack eyes of
AC subjects than in fellow eyes; they attributed their
ndings to a shallower ACD resulting from a short AL in
he AAC eyes. Sihota et al9 found no differences in RLP
hen comparing PACG patients with family members.
hey suggested that the occurrence of angle closure was
argely related to shorter AL and thicker lens, resulting in
shallower ACD. The present study found that eyes with
ngle closure had significantly thicker lenses with a cor-
esponding greater LV. However, LP and RLP were
imilar both in open- and closed-angle eyes. After mul-
ivariate analysis adjusted for age, gender, ACD, LT, and
LP, increased LV was associated significantly with
ngle closure, but no association was found for LP, RLP,
r LT. It seems that previously used parameters such as
P, which is dependent on the 2 variables (LT and ACD)
or its calculation, may not be an accurate predictor for
en Angle Closure and Normal Control Groups
Mean
6) Mean Difference* (95% CI) P Value
) 0.24 (0.34, 0.13) 0.001
) 0.88 (1.23, 0.52) 0.001
) 0.30 (0.08, 0.56) 0.010
) 0.08 (0.23, 0.08) 0.342
) 0.005 (-0.002, 0.012) 0.149
) 0.02 (0.01, 0.03) 0.001
503 (425, 581) 0.001


























Nongpiur et al  Lens Features in Chinese Subjects with Angle Closurevariables seem to be interdependent and to compensate
for each other. In contrast, the new parameter, LV, is a
single measured value that may capture better the role of
the lens in angle closure.
Interestingly, a parameter similar in concept to the LV
was described previously by Tiedeman18 in an article that
explained the mathematical model that predicts the pro-
file of the iris in angle closure. The parameter Z distance
was defined as the anterior displacement of the plane of
the pupil from the plane of the iris root as obtained from
biometric photographs. With an increasing value of Z,
there was a greater likelihood of occlusion of the trabec-
ular meshwork. The authors hypothesized that this in-
crease in Z value results in an increase in the angle made






1 (278 to 226) 69 0 (0.0)
2 (226 to 492) 70 5 (7.1)
3 (492 to 818) 70 36 (51.4)
4 (818 to 1607) 69 61 (88.4)
LT
1 (2.30 to 3.37) 70 23 (32.9)
2 (3.37 to 4.06) 69 18 (26.1)
3 (4.07 to 4.66) 70 21 (30.0)
4 (4.67 to 5.77) 69 40 (58.0)
LP
1 (4.84 to 4.48) 69 25 (36.2)
2 (4.49 to 4.88) 70 35 (50.0)
3 (4.89 to 5.22) 71 28 (39.4)
4 (5.22 to 6.19) 68 14 (20.6)
RLP
1 (0.150 to 0.189) 69 24 (34.8)
2 (0.190 to 0.207) 71 26 (36.6)
3 (0.208 to 0.223) 70 21 (30.0)
4 (0.224 to 0.290) 68 31 (45.6)
—  absence of value in those cells; ACD  anterior ch
LT  lens thickness; LV  lens vault; OR  odds rat
*Adjusted for age, gender, ACD, LT, and RLP.
Table 5. Ocular Biometric Diffe
Measures
Mean (SD) Primary Angle
Closure* (n  29)
Me
Clos
ACD (mm) 2.64 (0.28)
AL(mm) 22.87 (0.94)
LT (mm) 4.17 (0.90)
LP (mm) 4.73 (0.55)
RLP 0.21 (0.03)
LT/AL ratio 0.18 (0.04)
LV (m) 858 (219)†
ACD  anterior chamber depth; AL  axial length;
PAC  primary angle closure; PACG  primary ang
standard deviation.
*Adjusted for age, gender.
†Significant differences in LV between PAC and Acu
Glaucoma (P  0.001).y the iris take-off from the iris root (described as angle
). The importance of this parameter was validated in
ther studies.19,20 Furthermore, more recent studies have
roposed novel mechanisms for angle closure such as
horoidal effusion21,22 and dynamic differences in iris
ovement in light and dark.23,24 Further studies explor-
ng the interactions and interplay of LV with such dy-
amic components are warranted to identify the contri-
utions of anatomic variations of the entire eye, instead
f just the small region of the anterior chamber angle, in
he development of angle closure.
In the normal control group, we found that LV was
reater in females and increased with age. Theoretically, the
ncrease in LV observed with advancing age can be related








.43 (2.88, 24.67) 7.38 (2.41, 22.63)
.25 (16.94, 193,49) 48.13 (12.78, 181.32)
1.00 1.00
.98 (0.41, 2.37) 1.20 (0.46, 3.09)
.31 (0.55, 3.09) 1.54 (0.60, 4.00)
.48 (1.11, 5.57) 1.78 (0.76, 4.16)
1.00 1.00
.23 (1.37, 7.62) 2.99 (1.23, 7.32)
.43 (0.61, 3.36) 1.93 (0.74, 5.05)
.65 (0.26, 1.63) 1.94 (0.59, 6.31)
1.00 1.00
.00 (0.43, 2.36) 0.84 (0.33, 2.12)
.30 (0.56, 3.02) 1.56 (0.60, 4.09)
.23 (0.53, 2.82) 2.08 (0.66, 6.57)
r depth; CI  confidence interval; LP  lens position;
P  relative lens position.
es in Angle Closure Subgroups
D) Primary Angle
laucoma* (n  53)
Mean (SD) Previous Acute
Angle Closure* (n  20)
2.63 (0.35) 2.75 (0.50)
2.94 (1.01) 22.65 (0.67)
4.24 (0.94) 4.12 (0.92)
4.75 (0.52) 4.81 (0.46)
0.21 (0.02) 0.21 (0.02)
0.19 (0.04) 0.18 (0.04)
861 (264)† 1071 (271)
lens position; LT  lens thickness; LV  lens vault;
sure glaucoma; RLP  relative lens position; SD 




































Ophthalmology Volume 118, Number 3, March 2011to zonular laxity or increased LT. However, with a poor
correlation found between LV and LT, it is likely that the
increase in LV with age may be associated with changes in
zonular laxity with age.
Interestingly, although the 3 subtypes of angle closure
(PACG, PAC, and previous AAC) had similar biometric
parameter measurements (e.g., ACD and AL), LV was
different and was significantly greater in the previous
APAC group, compared with the PAC (P  0.003) and
PACG (P  0.001) subgroups. This together with the find-
ings of a greater LV in women may help to explain the
previously reported increased incidence of APAC in women
and also may help explain in part why APAC develops in
certain eyes and not in others.
In terms of the ability to differentiate angle closure eyes for
the purpose of screening, when the performance of the various
parameters in detecting angle closure was assessed, LV had the
highest AUC (0.94), higher than any other lens parameters
(AUC range, 0.58–0.66) or previously used screening param-
eters such as ACD (AUC, 0.75) and AL (AUC, 0.74). Further
research is warranted to examine the use of measuring LV in
screening for angle closure in the population.
One of the limitations to this study was that the groups
were not age or gender matched. The angle closure group
was significantly younger and had more females. Second,
this was a cross-sectional study; hence, it is difficult to
establish temporal or causal relationships. Third, the asso-
ciation of lens parameters with cataract type or severity was
not investigated. It is possible that the degree and type of
cataract may influence LT and LV. Factors such as accom-
modation, lighting, and previous laser iridotomy, which
may induce changes in the various lens parameters, were not
evaluated. The study population was Chinese, and it is not
known if the results would be the same in other racial
groups. Finally, the relatively small sample size may have
affected the ability to detect subtle differences in biometric
and lens characteristics.
In summary, this study found that eyes with angle
closure have thicker lenses with a greater LV, shallower
ACD, and shorter AL. Lens vault was associated strongly
and independently with angle closure and distinguished
eyes with angle closure from those with open angles
better than traditional biometric parameters. In contrast,
no differences were noted in the position of the lens or
RLP between eyes with and without angle closure. Lens
vault therefore is a potential novel marker associated
with angle closure.
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Novel Association of Smaller Anterior
Chamber Width with Angle Closure
in Singaporeans
Monisha E. Nongpiur, MD,1 Lisandro M. Sakata, MD, PhD,2 David S. Friedman, MD, PhD,3
Mingguang He, MD, PhD,4 Yiong-Huak Chan, PhD,5 Raghavan Lavanya, MD,1
Tien Yin Wong, FRCS, PhD,1,5 Tin Aung, PhD, FRCS(Ed)1,5
Purpose: To describe variations in anterior chamber width (ACW) and investigate its association with the
presence of narrow angles.
Design: Cross-sectional study.
Participants: We recruited 2047 subjects aged 50 years or more from a community polyclinic and 111
subjects with primary angle closure (PAC) or primary angle closure glaucoma (PACG) from an eye hospital in
Singapore.
Methods: All participants underwent gonioscopy, anterior chamber depth (ACD) and axial length (AL)
measurement (IOLMaster; Carl Zeiss, Jena, Germany), and anterior-segment optical coherence tomography
(AS-OCT, Visante, Carl Zeiss Meditec, Dublin, CA). Customized software was used to measure the ACW, defined
as the distance between the scleral spurs in the horizontal (nasal-temporal) axis of AS-OCT scans. An eye was
deemed to have narrow angles if the posterior trabecular meshwork was not visible for at least 180 degrees on
non-indentation gonioscopy with the eye in the primary position.
Main Outcome Measures: Anterior chamber width and narrow angles.
Results: Data on 1465 community-based subjects were available for analysis. Anterior chamber width was
significantly smaller in women compared with men (11.70 mm vs. 11.81 mm, respectively, P0.001) and
decreased significantly with age (P for trend 0.001). Significant predictors of smaller ACW were lower
educational level, lower body mass index, shorter AL, shallower ACD, and Chinese race. Of the 1465 subjects,
315 (21.5%) had narrow angles on gonioscopy. Mean ACW was smaller in eyes with narrow angles compared
with those without narrow angles (11.60 mm vs. 11.80 mm, P0.001). The age- and gender-adjusted odds ratio
for the highest quartile compared with the lower 3 quartiles of ACW with the presence of narrow angles was 3.4
(95% confidence interval, 2.3–5.0; P for trend 0.001). Hospital-based subjects with PAC/PACG had even
smaller ACW than community subjects with narrow angles (11.33 mm vs. 11.60 mm, P0.001).
Conclusions: In this cross-sectional study, ACW was smaller in women, Chinese persons, and older
persons, and was associated with narrow angles in 2 different study populations. These data suggest that a
smaller ACW may represent a novel risk indicator for angle closure.
Financial Disclosure(s): Proprietary or commercial disclosure may be found after the references.
Ophthalmology 2010;117:1967–1973 © 2010 by the American Academy of Ophthalmology.Identifying new ocular biometric parameters that are
associated with angle closure is important for under-
standing mechanisms of disease and for designing cost-
effective population-based screening strategies. Previous
reports have identified ocular risk factors for primary
angle-closure glaucoma (PACG), such as a shallow an-
terior chamber depth (ACD), thick and anteriorly placed
lens, and short axial length (AL).1– 4 A recent cross-
sectional study in Singapore investigated determinants of
angle closure and demonstrated that the strongest predic-
tors for the disease were female gender, shorter AL,
shallower ACD, and Chinese race/ethnicity.2 However,
gender and racial differences for risk for angle closure
were not fully explained by variations in AL or ACD
alone.2 Anterior-segment optical coherence tomography
© 2010 by the American Academy of Ophthalmology
Published by Elsevier Inc.(AS-OCT) is a recently introduced technology that per-
mits imaging of the entire cross-section of the anterior
segment in 1 image frame. Anterior-segment optical co-
herence tomography imaging allows one to make novel
measurements of the anterior segment and to assess po-
tential new ocular parameters.
One ocular parameter that has not been well studied is
the anterior chamber width (ACW), defined as the horizon-
tal scleral spur-to-spur distance, as measured by AS-OCT.
This study evaluated the distribution and determinants of
ACW in a large sample of subjects recruited from a com-
munity clinic, evaluated the relationship of ACW with nar-
row angles, and compared ACW measurements from this
sample with those obtained from a hospital-based sample of
subjects with primary angle closure (PAC).
1967ISSN 0161-6420/10/$–see front matter
doi:10.1016/j.ophtha.2010.02.007
Ophthalmology Volume 117, Number 10, October 2010Materials and Methods
Approval for the study was granted by the Singapore Eye Research
Institute institutional review board. The study was conducted in
accordance with the Declaration of Helsinki. Written informed
consent was obtained from all subjects before enrollment.
Two groups of subjects were evaluated in this study: a community-
based population sample and eye hospital-based patients with
glaucoma. For the former, subjects aged 50 years or older were
recruited from a government-run polyclinic that provides primary
health care services for residents living in the area around the
clinic. The details of the study have been described.2,5 Briefly, sub-
jects were identified by systematically sampling (every fifth patient
who was registered at the polyclinic) and met the study eligibility
criteria. A detailed questionnaire was administered that included de-
mographic and socioeconomic details, education level, and medical
and ocular history. No subjects had ophthalmic symptoms, and indi-
viduals with a history of glaucoma, previous intraocular surgery,
previous laser treatment, penetrating eye injury, or corneal disorders
preventing anterior chamber assessment were excluded.
All subjects underwent measurement of height and weight, and
a detailed eye examination that included visual acuity measure-
ment using a logarithm of minimum angle of resolution chart
(Lighthouse Inc., Long Island, New York), slit-lamp examination
(Model BQ 900, Haag-Streit, Bern, Switzerland), stereoscopic
optic disc examination with a 78 diopter lens (Volk Optical Inc,
Mentor, OH), and intraocular pressure (IOP) measurement with
Goldmann applanation tonometry (Haag-Streit, Koniz, Switzer-
land). Axial length and central ACD were measured by IOLMaster
(Carl Zeiss, Jena, Germany). Gonioscopy was performed in the
dark using a Goldmann 2-mirror lens at high magnification (16).
Indentation gonioscopy with the Sussman 4-mirror lens (Ocular
Instruments Inc., Bellevue, WA) was used to establish the presence
or absence of peripheral anterior synechiae. An eye was considered
to have narrow angles if the posterior pigmented trabecular mesh-
work was not visible for at least 180 degrees on non-indentation
gonioscopy with the eye in the primary position.
Hospital subjects were recruited from glaucoma clinics at the
Singapore National Eye Center and underwent similar ocular ex-
amination as detailed above. We recruited subjects with PAC or
PACG.6 Primary angle closure was defined as the presence of
narrow angles with peripheral anterior synechiae and/or increased
IOP 21 mm Hg. Eyes with PAC and evidence of glaucomatous
optic neuropathy (defined as loss of neuroretinal rim with a vertical
cup: disc ratio of 0.7 or an inter-eye asymmetry of 0.2, or
notching attributable to glaucoma) were diagnosed as PACG.
Subjects with previous cataract or glaucoma surgery were ex-
cluded, but all subjects with PAC/PACG had previously under-
gone laser iridotomy.
Anterior-Segment Optical Coherence Tomography
Imaging
All subjects underwent imaging with AS-OCT (Visante, Carl Zeiss
Meditec, Dublin, CA) under standardized conditions of light (20
lux) by an operator who was masked to the results of the clinical
ophthalmic examinations. Scans were centered on the pupil and
taken along the horizontal axis (nasal-temporal angles at 0–180
degrees) using the standard anterior segment single-scan protocol.
To obtain the best-quality image, the examiner adjusted the satu-
ration and noise and optimized the polarization for each scan
during the examination. Because several scans are acquired by the
AS-OCT device, the examiner chose the best image, with no
motion artefacts or image artefacts caused by the eyelids.
One cross-sectional horizontal AS-OCT scan of the nasal and
temporal angle was evaluated for each subject. These images were
1968processed using customized-software, the Zhongshan Angle As-
sessment Program (ZAAP, Guangzhou, China),7 by a single
fellowship-trained glaucoma specialist (LMS) who was masked to
clinical data. For each image, the only observer input was to
determine the location of the 2 scleral spurs. The algorithm then
automatically calculated the ACW, defined as the distance between
the sclera spurs in the nasal and temporal quadrants (Fig 1).
Statistical Analysis
Right eyes were used for analysis. Statistical analysis was per-
formed using STATA9.2 (StataCorp LP, College Station, TX).
The following analyses were performed for the community-based
subjects. A multivariate regression analysis using educational sta-
tus, race, body mass index (BMI, calculated as weight in kilograms
divided by height in meters squared), AL, and central ACD was
used to determine predictors of ACW. The association between
ACW and the presence of narrow angles was evaluated using
logistic regression models to determine the odds ratio (OR) and
95% confidence interval (CI), adjusting for age and gender. Mul-
tivariate adjusted OR calculations (with 95% CI) were then per-
formed to evaluate the association of ACW, AL, and ACD with
risk for narrow angles. The correlation among ACW, ACD, and
AL was calculated. Independent t test was used for the comparison
of ACW measurements in the community-based subjects and
hospital subjects. A P value less than 0.05 was considered statis-
tically significant.
The intraobserver reproducibility of ACW measurements was also
assessed in a random subset of 101 eyes by a single examiner (LMS)
who was masked to the other test results. The measurements were
performed in 2 sessions separated by an interval of 1 week.
Results
A total of 2047 community-based subjects were recruited from the
polyclinic, of whom 582 were excluded for the following reasons:
Eleven subjects could not undergo gonioscopy examination; 62
subjects could not complete AS-OCT examination or had poor
quality AS-OCT images; 42 subjects had software delineation
errors; and 467 subjects had a scleral spur that was not clearly
visible on AS-OCT images. Of the 1465 subjects (71.6%) who
were included for the final analysis, 793 (54.1%) were female and
1318 (90.0%) were Chinese (Table 1). Included subjects were
Figure 1. Anterior segment-optical coherence tomography image illus-
trating the measurement of anterior chamber width. Bold arrows indicate
the position of the scleral spur.significantly younger, had shallower ACD, and were more likely to
Nongpiur et al  Smaller ACW with Angle Closure in Singaporeansbe female. There was also a higher proportion of subjects with
narrow angles on gonioscopy in the included subjects compared
with excluded subjects (P0.001).
In the community sample, women had a significantly smaller
ACW than men (11.70 mm vs. 11.81 mm, respectively, P0.001,
Table 2). Anterior chamber width was found to decrease significantly
with advancing age (P for trend 0.001) at an average of 0.05 mm
per decade for all persons. The results were largely similar when the
analysis was performed separately for male and female patients.
Chinese people were found to have a shorter ACW (P  0.003)
compared with non-Chinese people. Table 3 shows the relationship
between selected ocular and systemic factors with ACW. After con-
trolling for age and gender, the final predictors of smaller ACW were
lower educational level (P0.001), lower BMI (P0.001), shorter
AL (P0.001), and shallower central ACD (P0.001).
Of the 1465 subjects in the community sample, 315 (21.5%)
were diagnosed as having narrow angles on gonioscopy. The mean
ACW was smaller in eyes with narrow angles compared with those








(N  582) P Value
Age, yrs (SD) 62.7 (7.7) 64.4 (8.4) 0.001
Women, No. (%) 793 (54.1) 284 (48.8) 0.029
Race, No. (%)
Chinese 1318 (90.0) 513 (88.1)
Malay 27 (1.8) 15 (2.6)
Indian 102 (7.0) 48 (8.2)
Others 18 (1.2) 6 (1.0) 0.507
IOP, mmHg, mean (SD) 14.74 (2.40) 14.80 (2.43) 0.632
AL, mm, mean (SD) 23.91 (1.34) 23.92 (1.29) 0.937
Central ACD, mm, mean (SD) 3.08 (0.38) 3.12 (0.36) 0.018
ACD  anterior chamber depth; AL  axial length; IOP  intraocular
pressure; SD  standard deviation.
Table 2. Distribution of Anterior Chamber
Age
All Persons P
N Mean ACW (SD) mm N
All person
All ages 1465 11.75 (0.39) 315
50–59 yrs 638 11.80 (0.37) 94
60–69 yrs 548 11.72 (0.41) 135
70 yrs 279 11.70 (0.38) 86
P for trend 0.001
Men
All ages 672 11.81 (0.40) 112
50–59 yrs 253 11.88 (0.38) 24
60–69 yrs 265 11.80 (0.41) 50
70 yrs 154 11.71 (0.39) 38
P for trend 0.001
Women
All ages 793 11.70 (0.37) 203
50–59 yrs 385 11.75 (0.35) 70
60–69 yrs 283 11.65 (0.40) 85
70 yrs 125 11.67 (0.37) 48
P for trend 0.003ACW  anterior chamber width; SD  standard deviation.without narrow angles (11.60 vs. 11.80, P0.001). An analysis
was performed on the relationship between ACW and ACD, ACW
and AL, and ACD and AL, and a linear relationship (r  0.41–
0.54) was found between them (Table 4) (Figs 2 and 3).
Further analysis was performed to assess the role of ACW, AL,
and ACD in determining the risk of narrow angles (Table 5). The
age- and gender-adjusted ORs for the highest quartile compared
with the lower 3 quartiles of ACW, AL, and ACD with the
presence of narrow angles were 3.4 (95% CI, 2.3–5.0), 6.3 (95%
CI, 3.8–10.5), and 46.8 (95% CI, 24.5–89.3), respectively (P for
trend 0.001 for all). With multivariate adjustment for age, gen-
der, and AL, it was found that ACW had significant ORs with
narrow angles (P for trend of 0.001); the results were similar when
adjusted for ACD (P 0.05) (Table 5). The performance of ACW,
AL, and ACD as determinants for detecting narrow angles is
summarized in Table 6, which shows AUCs of 0.62, 0.68, and
0.82, respectively, with best cutoff values of 11.7 mm, 23.5 mm,
and 2.9 mm for ACW, AL, and ACD, respectively.
Of 126 hospital-based subjects with PAC/PACG, the scleral
spur could not be identified in 15, leaving 111 subjects in the final
analysis. Seventy-five subjects (67.6%) were female, and the ma-
jority of subjects were Chinese (91.9%). The subjects ranged in
age from 47 to 91 years, with a median age of 66 years. Forty-
seven subjects (42.3%) had PAC, and 64 subjects (57.7%) had
PACG. The hospital-based subjects with angle closure had shorter
AL (P  0.01) and higher IOP (P  0.001) compared with those
with narrow angles from the community-based sample, whereas there
was no statistically significant difference in age (P  0.5), gender
(P  0.5), race (P  0.23), or ACD (P  0.63) (Table 7) between
these 2 groups. The ACW of hospital-based subjects with PAC/
PACG was significantly smaller than both the open-angle (11.80 mm
vs. 11.33 mm, P0.001) and narrow-angle (11.60 mm vs. 11.33 mm,
P0.001) groups from the community-based sample.
The reproducibility of the ACW measurements was excellent
with a within-subject standard deviation of 0.06 mm, a within-
subject coefficient of variation of 0.5%, a repeatability coefficient
of 0.11 mm, and an intra-class correlation coefficient of 0.970
(95% CI, 0.956–0.980).
th by Age and Gender, Community Group
ns with Narrow Angle Persons without Narrow Angle
Mean ACW (SD) mm N Mean ACW (SD) mm
11.57 (0.37) 1150 11.80 (0.38)
11.64 (0.33) 544 11.83 (0.36)
11.52 (0.39) 413 11.79 (0.40)
11.58 (0.36) 193 11.75 (0.38)
0.278 0.007
11.62 (0.39) 560 11.85 (0.39)
11.66 (0.39) 229 11.90 (0.38)
11.62 (0.40) 215 11.84 (0.40)
11.59 (0.39) 116 11.76 (0.38)
0.519 0.002
11.55 (0.35) 590 11.76 (0.36)
11.63 (0.32) 315 11.78 (0.35)
11.46 (038) 198 11.73 (0.38)
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Biometric1–4 and ethnic factors8–12 are well-known predis-
posing factors for angle-closure disease. Of these, shallow
ACD and shorter AL have been reported to be the most
consistent risk factors.1,13,14 To our knowledge, no other
study has examined the distribution and determinants of
ACW in an Asian population and evaluated its association
with narrow angles. We found that ACW was significantly
smaller in Chinese compared with other races. A smaller
ACW was observed in eyes with narrow angles, shallower






(SD) mm P Value
Education
No formal education 265 11.63 (0.41) 0.001
Primary 401 11.76 (0.37)
Secondary/technical 504 11.77 (0.39)
A level/polytechnic 164 11.82 (0.35)
Tertiary 131 11.86 (0.39)
Race
Chinese 1318 11.74 (0.38) 0.003
Malay 27 11.85 (0.43)
Indian 102 11.85 (0.42)
Others 18 11.97 (0.32)
BMI, kg/m2
Underweight 18.5 77 11.69 (0.37)
Normal 18.5, 25 895 11.73 (0.39) 0.001
Overweight 25, 30 398 11.79 (0.38)
Obese (30) 94 11.84 (0.37)
AL, mm
First quartile 23 357 11.51 (0.35)
Second quartile 23, 23.7 363 11.71 (0.33) 0.001
Third quartile 23.8, 24.6 358 11.85 (0.34)
Fourth quartile 24.7 358 11.95 (0.36)
Central ACD, mm
First quartile 2.81 375 11.56 (0.37)
Second quartile 2.82, 3.07 367 11.71 (0.35) 0.001
Third quartile 3.08, 3.34 357 11.77 (0.36)
Fourth quartile 3.34 365 11.97 (0.36)
ACD  anterior chamber depth; ACW  anterior chamber width; BMI
Table 4. Correlation between Anterior Chamber Width and








Pearson correlation — 0.413 0.436
P value 0.001 0.001
ACD
Pearson correlation 0.413* — 0.544
P value 0.001 0.001
ACD  anterior chamber depth; ACW  anterior chamber width; AL
axial length.
*Correlation is significant at the 0.01 level (2-tailed).
1970ACD, and shorter AL. These findings could indicate that
angle crowding caused by a narrower ACW may be an
important factor predisposing Chinese eyes to angle closure.
The circumference of a circle is estimated as diameter times
pi (value of 3.14). Therefore, a unit change in the width
(diameter) of the anterior chamber of the eye (if assumed to
nder by Selected Ocular, Systemic, and Demographic Factors,
Group
Persons with Narrow Angle Persons without Narrow Angle
N
Mean ACW
(SD) mm P Value N
Mean ACW
(SD) mm P Value
82 11.48 (0.40) 0.510 183 11.69 (0.40) 0.001
93 11.63 (0.34) 308 11.79 (0.36)
86 11.58 (0.36) 418 11.80 (0.38)
31 11.63 (0.32) 133 11.86 (0.35)
23 11.54 (0.43) 108 11.93 (0.35)
03 11.56 (0.37) 0.621 1015 11.79 (0.37) 0.037
5 11.73 (0.51) 22 11.87 (0.41)
5 11.76 (0.46) 97 11.86 (0.42)
2 11.62 (0.03) 16 12.01 (0.31)
27 11.48 (0.37) 50 11.80 (0.33)
96 11.56 (0.38) 0.067 699 11.78 (0.38) 0.010
76 11.59 (0.35) 322 11.83 (0.37)
16 11.72 (0.34) 78 11.87 (0.38)
50 11.43 (0.37) 207 11.56 (0.33)
88 11.69 (0.32) 0.001 275 11.72 (0.34) 0.001
52 11.69 (0.24) 306 11.88 (0.35)
17 11.80 (0.41) 341 11.96 (0.36)
25 11.52 (0.35) 151 11.62 (0.39)
80 11.66 (0.38) 0.001 287 11.73 (0.34) 0.001
10 11.91 (0.40) 347 11.76 (0.36)
0 — 365 11.97 (0.36)
dy mass index; SD  standard deviation.





2ACW anterior chamber width; CACD central anterior chamber depth.
Nongpiur et al  Smaller ACW with Angle Closure in Singaporeansbe a circle) would result in a circumferential change of 3.14
units. For example, a 1-mm decrease in the ACW from 12
mm would result in a 3.14-mm decrease in the circumfer-
ence of the anterior chamber drainage region, which is
equivalent to an 8.3% reduction. A smaller ACW also
implies a smaller anterior chamber volume, and this may
facilitate the angle-crowding mechanism. Because this was
a cross-sectional study, we were unable to confirm a causal
relationship between ACW and angle closure. In future
studies, it would be important to prospectively study this
association, as well as our hypothesis that ACW may play a
role in the differential rates of angle closure in the Chinese.
Anterior chamber width decreased as a linear function of
age in this cross-sectional study, which may help explain the
angle narrowing that is observed with increasing age. Kanai
and Kaufman15 observed that with aging, the sclera under-
goes a progressive degeneration of collagen. Rada and col-
leagues16 found that glycosaminoglycans, a constituent of
collagen responsible for providing mechanical support, de-
creases in the anterior scleral tissue with age. This age-
related reduction of glycosaminoglycans may result in pau-
Figure 3. Scatter plot showing correlation between ACW and AL. ACW
anterior chamber width; AXL  axial length.
Table 5. Relationship of Anterior Chamber Width, Axi
Measures Quartile N n (%)
Age and Gender OR
(95% CI)
ACW 1–3 1100 284 (25.8) 3.4 (2.3–5.0)
4 365 31 (8.5) 1.0
P trend 0.001
AL 1–3 1078 290 (26.9) 6.3 (3.8–10.5)
4 358 17 (4.7) 1.0
P trend 0.001
ACD 1–2 743 305 (41.0) 46.8 (24.5–89.3)
3–4 722 10 (1.4) 1.0
P trend 0.001ACD  anterior chamber depth; ACW  anterior chamber width; AL  axicity of support to the scleral spur, which may be reflected by
a smaller ACW. Another possible explanation for a smaller
ACW could be a decrease in ciliary body tone, which occurs
with advancing age. However, these hypotheses can only be
confirmed in a long-term prospective study evaluating the
change in ACW (and other ocular parameters) with age and
with the development of narrow angles. Such a study may
help us correctly predict the eyes that have the highest
chance for developing narrow angles.
Our finding of the association between smaller ACW
and lower BMI is interesting. A previous study by our
group reported that adult height in a Chinese population
was independently related to ocular dimensions even
after controlling for age, gender, education, occupation,
income, housing type, and weight; namely, shorter people
had shorter ALs and shallower anterior chambers.17,18
Persons of smaller body constitution have lower BMI and
thus proportionately smaller ocular size and ACW. An-
other finding of the present study is the association of
smaller ACW with lower educational level. There have
been several studies that have reported on the relation-
ship between axial myopia and educational level.19 –21
Our findings could therefore be explained by the fact that
less-educated patients were probably more hyperopic
with proportionately smaller ocular size.
Anterior chamber width was significantly smaller in the
hospital-based subjects with angle closure disease (consist-






Gender, and ACD ORc
(95% CI)
Adjusted for Age, Gender,
AL, and ACD ORc
(95% CI)









Table 6. Sensitivity, Specificity, Positive Predictive Value,
Negative Predictive Value, and Area Under the Curve Analysis
of Anterior Chamber Width, Axial Length, and Anterior





(%) PPV NPV AUC
ACW  11.7 64.4 60.5 30.9 86.2 0.63
AL  23.5 74.3 63.6 35.7 90.1 0.69
ACD  2.9 84.4 80.3 54.0 95.0 0.82
ACD  anterior chamber depth; ACW  anterior chamber width;
AUC  area under curve; NPV  negative predictive value; PPV 




33al length; CI  confidence interval; OR  odds ratio.
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Ophthalmology Volume 117, Number 10, October 2010ing of PAC and PACG) compared with the community-
based subjects with open angles and, notably, even smaller
than the community-based subjects with narrow angles. The
probable reason for this observation is that the subjects
recruited from the hospital were either symptomatic or had
a more advanced stage of angle-closure disease; thus, they
were examined in the hospital.
When we investigated the performance of the different
biometric parameters in screening for narrow angles, we
found that ACW performed worse than ACD or AL, sug-
gesting that ACW by itself cannot be used for screening in
the general population. However, it is not known whether
ACW may be useful in certain subgroups of patients with
angle closure, such as those with plateau iris, because cen-
tral ACD is often normal in such eyes.
Study Limitations
The main limitation of our study was the high exclusion
rate, with approximately one quarter of subjects excluded
from the analysis mainly because of problems identifying
the scleral spur. Subjects in whom the scleral spur could
not be identified may thus have differed from those
included in the study. Manual identification of the sclera
spur is not ideal, and the development of a completely
automated measurement algorithm for ACW measure-
ment is needed in future studies. The results from this
study cannot be directly extrapolated to the entire Singa-
pore population because subjects were not population-
based but selected from polyclinics. However, we believe
that this community-based population is likely to be
fairly representative of all Singaporeans in this age range.
Further research validating these findings in a popula-
tion-based study may be useful. We did not assess the
variation of ACW with accommodation and different
lighting conditions. It is possible that quantitative param-
eters, such as ACW, would have varying measurements
because of the effect of light and accommodation. An-
other possible limitation is the accurate placement of the









(N  111) P Value
Age, years (SD) 64.8 (7.5) 65.4 (8.8) 0.509
Women, number (%) 203 (64.4) 75 (67.6) 0.552
Race, number (%)
Chinese 303 (96.2) 102 (91.9)
Malay 5 (1.6) 3 (2.7)
Indian 5 (1.6) 3 (2.7)
Others 2 (0.6) 3 (2.7) 0.237
IOP, mm Hg, mean (SD) 15.34 (2.39) 16.33 (3.33) 0.001
Axial length, mm, mean (SD) 23.09 (0.88) 22.84 (0.96) 0.014
Central ACD, mm, mean (SD) 2.68 (0.23) 2.66 (0.38) 0.638
SD  standard deviation; IOP  intraocular pressure; ACD  anterior
chamber depth.cross-sectional scan beam on AS-OCT. The examiner
1972attempted to obtain the scan on the widest horizontal
diameter (middle of the pupil); however, the scan may
have been obtained slightly off axis in some participants.
Again, this would be expected to be as equally likely to occur
with open or closed angles and should not affect the associa-
tions found.
In conclusion, our study shows that smaller ACW was
associated with the presence of narrow angles, indepen-
dently of age, gender, and AL. Eyes with PAC and PACG
were also found to have small ACW. Our study suggests
that ACW could be another risk indicator for angle
closure.
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Abstract
Purpose A thicker lens vault (LV), measured by anterior
segment optical coherence tomography (ASOCT), was re-
cently identified as a novel risk factor for angle closure in
Chinese Singaporeans. The purpose of our study was to
investigate the association of LV with angle closure in
Japanese subjects.
Design Case–control study
Methods One hundred and twenty-four subjects with prima-
ry angle-closure disease and 80 controls were recruited. All
participants underwent ASOCT, and customized software
was used to measure LV, defined as the perpendicular dis-
tance between the anterior pole of the lens and a horizontal
line joining the two scleral spurs. A-scan biometry was used
to measure lens thickness (LT) and to calculate lens position
(LP) and relative lens position (RLP).
Results Eyes with angle closure had significantly shallower
anterior chamber depth (ACD), shorter axial length, greater
LV and LT (p<0.001 for all), and anteriorly positioned
lenses (LP, p<0.001; RLP, p00.019). After multivariate
analysis adjusted for age, gender, ACD, LT, and RLP, in-
creased LV was significantly associated with angle closure
(odds ratio [OR] 24.2; 95 % confidence interval [CI], 2.3–
250.5, comparing lowest with highest quartile), but no as-
sociation was found for LT (OR 2.59; 95 %CI, 0.48–13.85).
In a sub-analysis evaluating the effect of LT on LV, LV was
significantly greater in both the angle-closure group with
thinner lens (LT≤4.91 mm) and angle-closure group with
thicker lens (LT>4.91 mm) compared to normal controls
(p<0.001 for both).
Conclusions In Japanese eyes, LV was independently asso-
ciated with angle closure. These results corroborate the
recent findings from Singapore on LV as a risk factor for
angle closure.
Keywords Lens vault . Anterior segment optical coherence
tomography . Angle closure glaucoma
Introduction
There are considerable differences in the prevalence of
primary angle-closure glaucoma (PACG) among different
ethnic groups. Higher prevalence rates have been reported
in Asians, including Chinese [1–3], Mongolians [4], and
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Burmese [5, 6] compared to Caucasians and Africans [7, 8],
in whom primary open-angle glaucoma is the predominant
form of glaucoma. Even amongst the various Asian ethnic
groups, differences in prevalence have been demonstrated,
and the mechanisms underlying these differences are not
entirely understood. Untreated angle closure is often pro-
gressive, and potentially blinding. Therefore, there is a need
for effective screening for the condition in order to identify
people at risk, with subsequent initiation of appropriate
prophylaxis and therapy.
The ability to acquire cross-sectional images of the ante-
rior segment of the eye with anterior segment optical coher-
ence tomography (ASOCT) has recently led to the
identification of several anatomical risk factors that may
contribute to the pathogenesis of the angle-closure disease.
These factors include thicker irides with greater iris area and
curvature [9], smaller anterior chamber width [10], area, and
volume [11], as well as greater lens vault (LV) [12]. With a
high prevalence of PACG in persons of Asian ethnicity
[1–6], it is necessary to evaluate and understand the role of
these factors in different races.
Defined as the perpendicular distance between the ante-
rior pole of the lens and a horizontal line joining the two
scleral spurs (Fig. 1) [12], measurements of the LV can be
easily obtained from ASOCT scans by using customised
software. In a recent study that investigated the relationship
of various lens parameters with angle closure in Chinese
subjects, it was reported that eyes with angle closure had
significantly thicker lens and greater LV, while lens position
(LP) and relative lens position (RLP) were not significantly
different between angle-closure eyes and normal controls.
Moreover, only the LV was noted to be independently
associated with angle closure, after multivariate analysis
adjusted for age, gender, ACD, LT, and RLP. Comparing
the lowest with the highest quartile of LV, the presence of a
larger LV increased the risk of angle closure by 48 times
compared to eyes with smaller LV. LV is a measurement that
represents the relationship of the anterior pole of the lens
with respect to plane of the anterior chamber angles
(represented by the scleral spurs on ASOCT images). Larger
positive values of LV indicate that a greater bulk of the lens
is located anterior to this plane. A larger LV would thus
probably worsen the angle crowding in an already at-risk
eye [12].
The purpose of our study was to investigate the associa-
tion of LV with angle closure in another ethnic group, the
Japanese.
Methods
This was a comparative study of Japanese subjects with
angle closure and normal control subjects recruited from
two hospitals in Kyushu, Japan. Written informed consent
was obtained from all subject,s and the study had the ap-
proval of the Institutional Review Board of the hospitals and
was performed in accordance with the tenets of the Decla-
ration of Helsinki.
Subjects with either primary angle closure (PAC) or
PACG were recruited. PAC was defined as the presence of
appositional angle closure for ≥270 degrees with peripheral
anterior synechiae and/or raised intraocular pressure (IOP)
but without glaucomatous optic neuropathy. PACG was
defined as eyes with PAC associated with glaucomatous
optic neuropathy (defined as loss of neuroretinal rim with
a vertical cup:disc ratio of >0.7 or an inter-eye asym-
metry of >0.2, and/or notching attributable to glaucoma).
Patients diagnosed with secondary angle closure (such as
neovascular or uveitic glaucoma), patients who had corneal
abnormalities that would affect imaging, and patients who had
previous laser iridoplasty or intraocular surgery history were
excluded. All subjects with angle closure had previously
undergone laser peripheral iridotomy (LPI).
The control group of normal subjects (defined as
IOP ≤21 mm Hg with open angles, healthy optic nerves,
normal visual fields, with no previous surgery or family
history of glaucoma) were recruited from amongst those at-
tending general ophthalmology clinics.
All subjects underwent a standardized eye examination
that included visual acuity measurement, slit-lamp exami-
nation (Model BQ 900, Haag–Streit, Bern, Switzerland),
stereoscopic optic disc examination with a 78 dioptre lens
(Volk Optical Inc, Mentor, OH, USA), IOP measurement by
Goldmann applanation tonometry (Haag–Streit, Köniz,
Switzerland) and gonioscopy, performed in the dark using
a Goldmann 2-mirror lens at high magnification (x16).
Indentation gonioscopy with the Sussman 4-mirror lens
was used to establish the presence or absence of peripheral
anterior synechiae. A-scan biometry (Model US-800, Nidek
Co LTD, Japan) was used to measure axial length (AL),
anterior chamber depth (ACD), and lens thickness (LT), and
these results were used to calculate lens position (LP,
Fig. 1 Anterior segment optical coherence tomography image illus-
trating the measurement of lens vault as determined by the Zhongshan
Angle Assessment Program. Bold arrows indicate the position of the
scleral spur
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defined as ACD + 1/2LT), and relative lens position (RLP,
defined as LP/AL).
Anterior segment optical coherence tomography
(ASOCT)
All subjects underwent imaging with ASOCT (Visante, Carl
Zeiss Meditec, Dublin, CA, USA) performed in dark-room
conditions (0 lux) by operators who were masked to the
results of the clinical ophthalmic examination. Scans were
centred on the pupil and taken along the horizontal axis
(nasal-temporal angles at 0°–180°) using the standard ante-
rior segment single-scan protocol. To obtain the best quality
image, the examiner adjusted the saturation and noise, and
optimized the polarization for each scan during the exami-
nation. As several scans are acquired by the ASOCT device,
the examiner chose the best images, with no motion arte-
facts or image artefacts due to the eyelids.
One cross-sectional horizontal ASOCT scan of the nasal
and temporal angle was evaluated for each subject. These
images were processed using customized-software, the
Zhongshan Angle Assessment Program (ZAAP, Guangz-
hou, China) [13] by a single observer (MEN), masked to
clinical data. For each image, the only observer input was to
determine the location of the two scleral spurs, defined as
the point where there was a change in curvature of the inner
surface of the angle wall, often appearing as an inward
protrusion of the sclera. The algorithm then automatically
calculated the LV, defined as the perpendicular distance
between the anterior pole of the crystalline lens and the
horizontal line joining the two scleral spurs. Positive values
indicate that the anterior pole of lens is located anterior to
the sclera spur line, whereas negative values occur when the
anterior pole of the lens is posterior to the sclera spur line.
Statistical analysis
Statistical analysis was performed using the statistical package
SPSS Version 17 (SPSS, Chicago, IL, USA). Differences in
mean values of parametric data among eyes of different sub-
jects were examined using independent samples Student’s t-
test. The difference between angle-closure cases and normal
subjects in lens parameters was evaluated using logistic re-
gression models to determine the odds ratio (OR) and 95 %
confidence interval (CI). Multivariate adjusted ORs were
obtained after adjustment for age, gender, ACD, LT, and
RLP. Receiver operator characteristic (ROC) curves were
generated, and the area under the ROC curve (AUC) was used
to assess the performance of the various parameters in detect-
ing angle closure. The sensitivity and specificity were calcu-
lated using the optimal cut-off point given by the maximum of
the Youden index [14], calculated as J 0 max (sensitivity +
specificity−1). A p-value less than 0.05 was considered statis-
tically significant.
Results
A total of 124 Japanese subjects with angle closure and 80
normal controls were recruited. Complete data were avail-
able for 109 angle-closure subjects (consisting of 65 PAC
and 44 PACG subjects) and 68 controls, after excluding 13
cases and ten control subjects with ASOCT software delin-
eation errors, indeterminate scleral spurs on ASOCT scans,
or missing data. There was no significant difference between
angle-closure eyes and normal controls for age (73.5±7.0 vs
72.6±7.3 years, p00.37), or spherical equivalent (p00.81).
There was a greater proportion of females in both the groups
(88 % vs 69 %, p00.002). Compared to normal eyes, eyes
with angle closure had significantly shallower ACD
(p<0.001), shorter AL (p<0.001), greater LV (p<0.001)
and LT (p<0.001), and a more anteriorly positioned lens (LP,
p<0.001; RLP, p00.019) (Table 1). After multivariate analysis
adjusted for age, gender, ACD, LT, and RLP, increased LV was
associated significantly with angle closure (OR, 24.2; 95 %
confidence interval [CI], 2.3–250.5, comparing lowest with
highest quartile; Table 2), but no association was found for
LT (OR, 2.59; 95 % CI, 0.48–13.85).
There was fair correlation between LV and LT (Pearson’s
correlation coefficient [PCC], 0.42). However, LV and RLP
were poorly correlated (PCC, −0.26). In terms of distinguish-
ing angle-closure subjects from normal subjects, LV had the
highest AUC (0.96; 95 % CI, 0.92–0.98), a sensitivity of
85.3 %, and specificity of 94 %, whereas the AUC of the
other lens parameters ranged from 0.68 to 0.85 (Table 3).
In order to evaluate the effect of LT on various lens param-
eters, we performed a sub-analysis of the angle closure group
by dividing them into two sub-groups based on mean LT of
angle-closure eyes (i.e., >4.91 mm and ≤4.91 mm) (Table 4).
No significant difference in LT was found between normal
eyes and the angle-closure subgroup with thinner LT≤
4.91 mm. However, LV was significantly greater in both
subgroups of angle-closure eyes compared to normal controls
(p<0.001). Results were largely similar when the median LT
(5.01 mm) was chosen as a cut-off to examine the effect of
lens thickness on various lens parameters (Table not shown).
Discussion
LV is a recently described ASOCT parameter which meas-
ures the amount of lens that is located anterior to the plane
of the scleral spurs. A greater LV has been found to be
strongly associated with an increased risk of angle closure
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in persons of Chinese ethnicity, suggesting its potential role
in screening for the condition [12]. In this study, we wished
to confirm the role of this parameter in another ethnic group,
the Japanese. Compared to the thickness and position of the
lens, only the LV was found to be significantly associated
with angle closure in the Japanese, similar to the effect in the
Chinese. Although the lens was thicker and more anteriorly
located in eyes with angle closure, after multivariate adjust-
ments the other lens parameters were not significantly asso-
ciated with angle closure.
It was interesting to note that in comparison to the Chi-
nese [12], the Japanese angle-closure subjects (as well as the
normal controls) had thicker lenses (4.20 vs 4.91 mm in
angle closure; and 3.90 vs 4.54 mm in normals) and greater
LV (901 vs 1034 μm in angle closure; and 316 vs 419 μm in
normals). Also, ACD and AL were smaller in Japanese eyes
(both angle-closure and normal groups). Thus it is likely that
the lens occupies a greater volume in the eye, and may play
a major role in contributing to the pathogenesis of angle
closure in persons of Japanese ethnicity.
Since LV was only fairly correlated with LT (PCC00.42),
it was potentially likely that an eye with a thick lens need
not necessarily have a large LVand vice versa. Therefore, to
determine the effect of LT on the lens parameters, we divid-
ed angle-closure eyes (based on mean LT value) into two
groups (>4.91 mm and ≤4.91 mm) and compared them
separately versus normal control eyes (Table 4). It was
interesting to note that although there was no significant
Table 1 Comparison of biometric parameters between angle closure and normal control groups
Measures Angle closure mean (SD) (n0109) Normal controls mean (SD) (n068) Mean differencea (95 % CI) P value
ACD (mm) 2.51 (0.39) 3.14 (0.35) −0.64 (−0.79, −0.50) <0.001
AL (mm) 22.22 (0.77) 23.28 (0.81) −1.04 (−1.34, −0.74) <0.001
LT (mm) 4.91 (0.54) 4.54 (0.47) 0.35 (0.16, 0.54) <0.001
LP (mm) 4.96 (0.32) 5.38 (0.44) −0.47 (−0.59, −0.35) <0.001
RLP 0.224 (0.015) 0.231 (0.019) −0.010 (−0.016, −0.004) 0.019
LV (μm) 1034 (257) 419 (236) 600 (509, 691) <0.001
a Adjusted for age, gender
ACD 0 anterior chamber depth; AL 0 axial length; LT 0 lens thickness; LP 0 lens position; RLP 0 relative lens position; LV 0 lens vault
Table 2 Relationship of
lens vault, lens thickness, lens
position, and relative lens
position
*Adjusted for age, gender, ACD,
LT and RLP for LV
*Adjusted for age, gender, and
ACD for LT.
LT 0 lens thickness; LP 0 lens
position; RLP 0 relative lens
position; LV 0 lens vault; OR 0
odds ratio; CI 0 confidence
interval
Quartile No Angle closure no (%) Age- and gender-adjusted
OR (95 % CI)
Multivariate-adjusted*
OR (95 % CI)
LT
1 (3.03–4.50) 45 16 (35.6) 1.00 1.00
2 (4.51–4.85) 44 21 (47.7) 1.5 (0.63–3.6) 0.47 (0.15–1.46)
3 (4.86–5.11) 46 34 (73.9) 5.9 (2.3–15.3) 0.99 (0.29–3.40)
4 (5.12–5.90) 41 38 (92.7) 29.8 (7.3–121.7) 2.59 (0.48–13.85)
LP
1 (3.91–4.87) 44 41 (93.2) 53.8 (13.1–221.5)
2 (4.88–5.12) 44 38 (86.4) 24.4 (7.5–79.5)
3 (5.13–5.42) 45 22 (48.9) 3.9 (1.4–10.5)
4 (5.43–6.37) 43 8 (18.6) 1.00
LV
1 (41–506.7) 44 0 (0) - -
2 (506.8–840.9) 44 24 (54.5) 1.00 1.00
3 (841–1,072.8) 44 42 (95.5) 18.5 (3.7–90.9) 6.6 (1.1–38.9)
4 (1,072.9–1,722) 44 43 (97.7) 34.9 (4.2–288.5) 24.2 (2.3–250.5)
RLP
1 (0.176–0.218) 43 (74.5) 5.4 (2.1–14.1)
2 (0.219–0.227) 44 (77.1) 6.8 (2.6–18.1)
3 (0.228–0.237) 44 (66.7) 2.8 (1.1–6.9)
4 (0.238–0.271) 43 (38.3) 1.00
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difference in LT between normal controls and the angle-
closure sub-group with thinner lens, the LV, however, was
significantly greater in both the angle closure subgroups.
The LV was also only fairly correlated with LT (PCC0
0.42). This shows that LV, although being a part of the lens,
is not entirely dependent on LT, and is likely to be more
representative of the role of the lens as an indicator of risk
for angle closure.
The association of LP and LT with angle closure is not
established. While some studies report a greater tendency
for angle closure in eyes with thicker and more anteriorly
placed lens [15, 16], others have found no such association
[17]. A possible reason could be that LP, calculated from
two anterior segment parameters, ACD and LT, (which are
axial parameters derived from A-scan measurements) esti-
mates the position of the centre of the lens (lenticular mid-
point) from the central cornea. It does not indicate whether
the centre of the lens is anterior or posterior to the anterior
chamber angles. Newer imaging modalities such as ASOCT
facilitate image acquisition of the entire anterior chamber in
a single scan, and permit visualization of the relative posi-
tion of the various anterior segment structures. LV is a
quantitative parameter which measures the portion of the
lens in relation to the plane of the scleral spurs, with the
scleral spurs being a surrogate marker of the posterior limit
of the anterior chamber angle. It is an easily obtained pa-
rameter once an ASOCT image is at hand. Lowes and Map-
stone proposed a vector model of pupil block mechanism:
the co-contraction of both iris sphincter and dilator muscle,
as well as the iris elasticity, will generate a resultant force
perpendicular to the lens surface, causing relative or abso-
lute obstruction of aqueous flow in the pupil region [18–20].
In eyes with forward movement of the lens–iris diaphragm,
the contact between iris and anterior lens surface is anterior
positioned; thus, it decreases the angle between the respec-
tive vectors, and thus increases the resultant force on the
lens surface and resistance to aqueous flow from posterior to
anterior chambers. Our results further suggest that the posi-
tion (relative to scleral spurs) of the anterior lens surface
appears to be more important than lens thickness and
Table 3 Area under the receiver operating characteristic curve, sensitivity and specificity for axial length, anterior chamber depth and lens
parameters for detecting angle closure
Measures AUC (95 % CI) Optimal cutoff pointa Sensitivityb (95 % CI) Specificityb (95 % CI)
ACD 0.90 (0.85–0.94) 2.65 76.2 (67.0–83.8) 95.6 (87.6–99.1)
AL 0.83 (0.77–0.88) 22.87 83.5 (75.2–89.9) 71.6 (59.3–82.0)
LT 0.75 (0.69–0.81) 4.81 71.6 (62.1–79.8) 74.6 (62.5–84.5)
LP 0.85 (0.79–0.90) 5.13 73.4 (64.1–81.4) 85.3 (74.56–92.7)
RLP 0.68 (0.61–0.75) 0.232 77.1 (68.0–84.6) 58.2 (45.5–70.2)
LV 0.96 (0.92–0.98) 762 85.3 (77.3–91.4) 94.0 (85.4–98.3)
ACD 0 anterior chamber depth; AL 0 axial length; LT 0 lens thickness; LP 0 lens position; RLP 0 relative lens position; LV 0 lens vault; AUC 0
area under the receiver operating characteristic curve
a,b sensitivity and specificity values at the optimal cutoff point
Table 4 Biometric parameters between angle-closure and normal control eyes, with angle-closure subgroups categorized by lens thickness
























ACD (mm) 2.71±0.49 3.14±0.35 −0.49 (−0.69, −0.30) 0.00 2.38±0.23 3.14±0.35 −0.76 (−0.87, −0.66) <0.001
AL (mm) 22.23±0.79 23.29±0.81 −0.99 (−1.40, −0.59) 0.00 22.20±0.77 23.29±0.81 −1.08 (−1.43, −0.74) <0.001
LT (mm) 4.41±0.52 4.54±0.47 −0.07 (−0.29, 0.14) 0.50 5.21±0.23 4.54±0.47 0.65 (0.49, 0.77) <0.001
LP (mm) 4.92±0.42 5.42±0.33 −0.54 (0.72, −0.35) 0.00 4.99±0.23 5.42±0.33 −0.45 (−0.56, −0.34) <0.001
RLP 0.221±0.02 0.233±0.02 −0.013
(−0.023, −0.004)
0.006 0.225±0.01 0.233±0.02 −0.009
(−0.015, 0.003)
0.004
LV (μm) 943±272 419±236 527 (407, 646) 0.00 1092±232 419±236 659 (569, 749) <0.001
a Adjusted for age and gender
ACD 0 anterior chamber depth; AL 0 axial length; LT 0 lens thickness; LP 0 lens position; RLP 0 relative lens position; LV 0 lens vault; SD 0
standard deviation
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position itself in angle closure. We hypothesize that a larger
LV would occupy more space in the anterior chamber,
causing crowding of the anterior segment and aggravation
of the pupil block component, resulting in narrowing of the
angle. With good ability to predict eyes with angle closure
confirmed in two different ethnic groups, as well as its
ability to quantify the relationship of the lens with respect
to the anterior chamber angle or its structures, LV has the
potential to be utilized as a screening and diagnostic param-
eter for angle closure. In future studies, it would be impor-
tant to prospectively evaluate the association of changes in
LV with angle-closure progression. In terms of detecting
angle closure, the AUC for LV (0.96) is greater than all
the other lens parameters (0.68–0.85) as well as the estab-
lished risk factors of angle closure such as ACD (0.90) and
AL (0.83). These findings are similar to those observed in
the Chinese population [12]. However, future studies in
other ethnicities are warranted to confirm this and also to
precisely determine normal and abnormal values for LV.
One of the limitations to our study was the cross-
sectional nature of the study. Hence, it was not possible to
establish temporal or causal relationships. A prospective
longitudinal study is needed to address the cause and effect
relationship between LV and angle closure. Second, we did
not look at the association of the lens parameters with
cataract status or height of the individual. It is possible that
the degree of cataract may be associated with size and vault
of the lens. Taller individuals are known to have longer AL,
which may have an impact on the size of the lens relative to
the size of the eye. Third, factors such as accommodation
and lighting, which may induce changes in lens parameters,
were not evaluated. Fourth, since our study was aimed at
evaluating the association of various lens parameters with
angle closure, the role of other ASOCT derived parameters
such as iris and anterior chamber parameters will be
reported in a separate paper that is currently under
preparation.
In conclusion, this study on Japanese subjects confirms
that a thicker LV is associated with angle closure, and
supports its possible role in screening for the condition.
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PURPOSE. Three susceptibility loci for primary angle-closure glaucoma (PACG) were recently
identified: PLEKHA7 rs11024102, COL11A1 rs3753841, and rs1015213 located in the
intergenic region between PCMTD1 and ST18. The purpose of this study was to investigate
the associations of these loci with the ocular biometric parameters anterior chamber depth
(ACD) and axial length (AL).
METHODS. Genotype and ocular biometric data were available for four population-based
studies, including three from Singapore (Singapore Chinese Eye Study, Singapore Malay Eye
Study, and Singapore Indian Eye Study) and one from China (Beijing Eye Study), exceeding
7000 participants. ACD and AL were measured using the IOLMaster for the Singapore cohorts
and optical low-coherence reflectometry (Lenstar 900 Optical Biometer) for the Beijing
cohort. Five readings were obtained for each participant and the average was computed.
Analysis excluded any eye that was pseudophakic or aphakic.
RESULTS. ACD measurements and genotype data of the three loci were available for 7245,
7243, and 7239 subjects, respectively. We noted nominal evidence of association between
single nucleotide polymorphism (SNP) rs1015213 (PCMTD1-ST18) and a shallower ACD
when all data were meta-analyzed (b ¼ 0.033, P ¼ 0.021). When multiple testing was
considered, the observation was nonsignificant. There was no association between ACD and
rs11024102 (PLEKHA7) or rs3753841 (COL11A1). We did not observe significant
associations between AL and any of the three SNPs.
CONCLUSIONS. The lack of association between the PACG susceptibility loci with ACD or AL
suggests that predilection to PACG may be mediated by factors other than shallow anterior
chamber or short eyeball length.
Keywords: genetic, association, glaucoma, quantitative trait, anterior segment OCT
Primary angle-closure glaucoma (PACG) is responsible forsubstantial visual loss in many Asian countries, such as
Singapore,1 China,2,3 Mongolia,4 and India.5,6 PACG has long
been suspected to have a substantial hereditable component.
This was proven recently in a genome-wide association study
(GWAS) of PACG conducted in five sample collections across
Asia with validation in a further six sample collections
worldwide.7 Genome-wide significant association (P < 5 3
108) with PACG was found in three new susceptibility loci
(rs3753841 in COL11A1, rs1015213 located between PCMTD1
and ST18, and rs11024102 in PLEKHA7). However, it is not
clear how these three loci contribute to the pathogenesis of
PACG or whether these genetic variants act via any known
anatomical risk factors for PACG.
Previous studies have demonstrated that ocular biometric
parameters such as a shallow anterior chamber depth (ACD)
and short axial length (AL) are strong risk factors for PACG.8–11
In a community-based study of older Singaporeans, eyes with
ACD less than 2.80 mm were 42.5 times more likely to have
angle closure than eyes with ACD of at least 3.00 mm.10
Likewise, a shorter AL is also associated with an increased risk
for angle closure. Reports have shown that eyes of Chinese
patients who had acute angle closure had shorter AL than those
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affected by chronic asymptomatic angle closure, and that both
groups had shorter AL than the control group.12,13
The aim of this study was to investigate the association of
these three PACG susceptibility loci with the anatomical risk
factors ACD and AL. To this end, we sought to test this
association in large population-based samples of Asian descent.
METHODS
Descriptions of Study Populations
Ethical approval was obtained from the Singapore Eye
Research Institute Institutional Review Board and the Medical
Ethics Committee of the Beijing Tongren Hospital for the
Singapore and Beijing cohorts, respectively. Written informed
consent was obtained from all study participants, and the study
adhered to the Declaration of Helsinki.
Singapore Cohorts. Data from the Singapore Malay Eye
Study (SiMES), Singapore Indian Eye Study (SINDI), and
Singapore Chinese Eye Study (SCES) were analyzed. SiMES,
SINDI, and SCES were population-based, cross-sectional studies
of ethnic Malay (aged 40–79 years), Indian (aged from 40–80þ
years), and Chinese (aged from 40–80þyears) adults residing in
the southwestern part of Singapore. Details of the study design,
sampling plan, and methods have been previously reported for
these studies.14,15 In brief, these three studies were designed to
determine the prevalence and impact of major eye diseases in
Singaporeans of different ethnicities. An age-stratified (by 10-
year age group) random sampling strategy was employed for
subject selection from a computer-generated list provided by
the Ministry of Home Affairs, Singapore. SiMES was conducted
from August 2004 to June 2006 and recruited 3280 participants
(78.7% response rate). SINDI was conducted from March 2007
to December 2009 and recruited 3400 participants (75%
response rate). SCES was conducted from February 2009 to
December 2011 and recruited 3353 participants. The final
number of subjects who were genotyped was 3072, 2953, and
1952 for SiMES, SINDI, and SCES, respectively.
Beijing Cohort. The Beijing Eye Study (BES) was a
population-based, cross-sectional study of Chinese adults
(aged 40þ years) in urban communities in the Haidian district
in the north of central Beijing and in rural communities in the
village area of Yufa of the Daxing district, south of Beijing.16
In the year 2001 when the first survey was carried out, 4439
participants were recruited (83.4% response rate). The BES
was repeated in 2006 and 2011. In 2011, when ACD and AL
were measured, the study included all participants from the
previous two surveys and added subjects who fulfilled the
eligibility criteria of age of 50þ years, who lived in the study
region, and who had not participated in the previous surveys.
A total of 3468 participants (78.8% response rate) were
recruited in the 2011.17 The final number of subjects who
were genotyped was 988. Measurement of ACD and AL was
performed using optical low-coherence reflectometry (Len-
star 900 Optical Biometer; Haag-Streit, Koeniz, Switzerland).
The examination was performed by experienced clinical
technicians. Five measurements were performed, and the
mean value was taken for further statistical analysis.
Measurements of Ocular Parameters
Singapore Cohorts. ACD and AL were measured by
noncontact partial-coherence laser interferometry (IOLMaster,
Carl Zeiss Meditec, Dublin, CA). Five readings were obtained,
and the mean value was used for analysis. The biometric
measurements were excluded from any eye that was pseudo-
phakic or aphakic. As there was good correlation between
biometric data for the two eyes, analysis was performed using
only data for the right eyes.
Beijing Cohort. ACD and AL were measured by optical
low-coherence reflectometry (Lenstar 900 Optical Biometer;
Haag-Streit) for the right eyes of study participants in the
survey in 2011. Five measurements were performed, and the
mean value was used for analysis.17 Good correlation between
IOLMaster and Lenstar measurements for ACD/AL has been
demonstrated, and no statistical differences in ACD/AL
measurements were observed in a previous study.18 Therefore,
the use of different measurement devices is unlikely to affect
the result of analysis.
Genotyping and Data QC
Methods of genotyping and data quality control (QC) for SiMES,
SINDI, SCES, and BES have been described previously.19–22 In
brief, participants of all four studies were genotyped using the
Illumina Human610-Quad BeadChip (Illumina, Inc., San Diego,
CA) with the following QC criteria: Samples were excluded if
they had a per sample call rate <95% or showed evidence of
admixture, cryptic relatedness, high heterogeneity, or sex
discrepancy. Final number of subjects passing quality checks
was 2542, 2538, 1949, and 927 for SiMES, SINDI, SCES, and
BES, respectively. Genotype at the three loci of interest
(rs3753841, rs1015213, and rs11024102) was analyzed using
PLINK (version 1.0723).
Statistical Analysis
Linear regression was performed for primary association
testing using a commercially available statistical software
package (SPSS for Windows, version 20.0; IBM-SPSS, Chicago,
IL). Individual SNP genotypes were coded according to the
number of copies of the variant allele present: 0 for the wild-
type genotype, 1 for heterozygous, and 2 for homozygous
variants. A trend test incorporated within a linear regression
model was used for primary association testing between
genotypes and ACD/AL as quantitative traits, adjusting for
age, sex, and population admixture (reflected by principal
components).
Meta-analysis was performed with PLINK (version 1.0723)
using the fixed effects model on primary analysis and was
verified with the random effects model when significant
heterogeneity was observed. For the meta-analysis, a combined
point estimate of the overall effect size (b coefficient) and its
corresponding P value were obtained. The Cochran’s Q and
accompanying I2 statistic were used to assess intercohort
heterogeneity. For the final analysis, a Bonferroni correction
factor of 3 was applied to correct for number of loci studied,
resulting in a P value threshold of 0.017 to be considered
statistically significant experiment-wide.
RESULTS
Table 1 summarizes the descriptive statistics of all cohorts after
genotyping and sample QC.
A total of 7245, 7243, and 7239 subjects who had
complete genotype and ACD (including covariates) measure-
ment data were tested for association between the three
PACG susceptibility loci (rs3753841, rs1015213, and
rs11024102) and ACD, respectively (Table 2). We found
nominal evidence of association between SNP rs1015213
(PCMTD1-ST18) and a shallower ACD when all data were
meta-analyzed (b ¼ 0.033, P ¼ 0.021). There was no
significant heterogeneity of the effect size across all sample
collections (Pheterogeneity ¼ 0.87, I2 ¼ 0). The observation was
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statistically nonsignificant when multiple testing was con-
sidered. No significant association was found between the
other two loci (rs3753841 and rs11024102) and ACD in the
meta-analysis (Table 2). The regional association analysis for
the three loci and ACD is illustrated in Supplementary
Figures S1, S2, and S3.
In the association testing between the three PACG suscepti-
bility loci (rs3753841, rs1015213, and rs11024102) and AL, a total
of 6902, 6900, and 6896 subjects who had complete genotype
and AL (including covariates) measurement data were included,
respectively (Table 3). We found that locus rs11024102
(PLEKHA7) was significantly associated with longer AL in the
meta-analysis of all collections using the fixed effects model (b¼
0.051, P ¼ 0.009). However, significant heterogeneity of effect
sizes was observed (Pheterogeneity¼ 0.01, I2¼ 69.19%). Therefore
meta-analysis using the random effects model was conducted; the
results did not show significant association between rs11024102
(PLEKHA7) and AL (Prandomeffects ¼ 0.38). No significant
association was found between the other two loci (rs3753841
and rs1015213) and AL in individual cohorts or in the meta-
TABLE 1. Characteristics of the Study Population
SiMES SINDI SCES BES
n* 2542 2538 1949 927
Age† 59.09 (11.04), 40–80 58.04 (10.01), 43–80 58.99 (9.98), 44–111 53.11 (9.35), 40–81
Sex‡ 0.51 0.49 0.49 0.63
ACD† 3.10 (0.38), 1.78–4.25 3.22 (0.46), 1.74–5.39 2.95 (0.37), 1.99–5.09 2.41 (0.32), 1.29–3.61
AL† 23.57 (1.05), 20.61–30.53 23.38 (1.11), 19.14–32.76 23.61 (1.37), 20.39–33.27 23.03 (1.11), 19.90–30.36
* Number of subjects with genotype data after quality check.
† Mean (standard deviation), range.
‡ % female.
TABLE 2. Association Results Between Three PACG Susceptibility Loci and ACD
Chr SNP BP A1 Cohort n EAF b SE P Phet I2
1 rs3753841 103152506 G SCES 1690 0.32 0.006 0.014 0.67
SiMES 2209 0.2889 0.019 0.011 0.094
SINDI 2520 0.4377 0.003 0.013 0.802
BES 826 0.2983 0.014 0.016 0.392
All 7245 0.0093 0.16 0.76 0
8 rs1015213 53050094 A SCES 1690 0.011 0.041 0.064 0.52
SiMES 2207 0.04055 0.021 0.025 0.404
SINDI 2520 0.1222 0.033 0.02 0.089
BES 826 0.02427 0.068 0.046 0.139
All 7243 0.033 0.021 0.87 0
11 rs11024102 16965181 G SCES 1690 0.37 0.0007 0.013 0.96
SiMES 2205 0.37 0.014 0.011 0.19
SINDI 2518 0.303 0.002 0.014 0.893
BES 826 0.4326 0.023 0.015 0.119
All 7239 0.009 0.148 0.65 0
Chr, chromosome number; SNP, SNP ID; BP, base-pair position; A1, effect allele; n, number of subjects included in the analysis; EAF, effect allele
frequency; b, per-allele change in ACD/AL; SE, standard error for ascertainment of b; P, P value for association; Phet, P value for heterogeneity
between cohorts; I2, I2 index for heterogeneity between cohorts.
TABLE 3. Association Results Between Three PACG Susceptibility Loci and AL
Chr SNP BP A1 Cohort n EAF b SE P Phet I2
1 rs3753841 103152506 G SCES 1613 0.32 0.096 0.051 0.06
SiMES 2210 0.2889 0.07 0.034 0.039
SINDI 2488 0.4377 0.043 0.03 0.151
BES 591 0.2983 0.019 0.069 0.783
All 6902 0.0265 0.18 0.081 51.79
8 rs1015213 53050094 A SCES 1613 0.011 0.19 0.24 0.41
SiMES 2208 0.04055 0.112 0.075 0.137
SINDI 2488 0.1222 0.048 0.046 0.301
BES 591 0.02427 0.1 0.203 0.622
All 6900 0.07 0.067 0.766 0
11 rs11024102 16965181 G SCES 1613 0.37 0.015 0.052 0.77
SiMES 2206 0.37 0 0.032 0.99
SINDI 2486 0.303 0.138 0.032 <0.001
BES 591 0.4326 0.016 0.064 0.801
All 6896 0.051 0.009 0.01 69.19
All (random effects) 0.035 0.384
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analysis of all cohorts (Table 3). The regional association analysis
for the three loci and AL is illustrated in Supplementary Figures
S4, S5, and S6.
DISCUSSION
We conducted a candidate gene association study between
three established PACG susceptibility loci and anatomical
quantitative trait risk factors for angle closure (ACD and AL)
using four population-based samples totaling approximately
7000 individuals of Asian descent. Overall, none of the novel
PACG loci showed significant association with ACD or AL,
which suggests disease mechanisms that act independently of
shallower anterior chamber and shorter eyeball length. A
notable strength of this study is that it directly examined
association between the PACG loci and the anatomical
quantitative trait risk factors in sample collections of the same
ethnicity (Chinese, Malays, and Indians) as in the initial PACG
case–control GWAS. Such an approach minimizes ethnic
heterogeneity as a reason for our nonsignificant observations.
Indeed, several explanations can be given for this result.
Angle closure is a heterogeneous condition that can result from
one or a combination of anatomical and/or physiological
changes of the anterior and posterior segment structures.24 In
addition to ACD and AL, there are several novel imaging-based
anatomical risk factors for angle closure, including smaller
anterior chamber width25; smaller anterior chamber area and
volume26; greater iris thickness, area, and curvature27; and
larger lens vault.28 Although not correlated with ACD or AL,
these PACG-associated loci may be associated with these other
anatomical parameters. Recent evidence also suggests that
dynamic physiological factors such as changes in iris volume
with dilation29,30 and choroidal expansion/effusion31 may have
a role in angle-closure pathogenesis. We speculate that at least
one of the PACG-associated variants confers risk via these
dynamic (as opposed to static) mechanisms. One of the
susceptibility genes, PLEKHA7, encodes a plekstrin homology
domain containing protein, proposed to regulate apical
junctional complexes (AJCs).32,33 As AJCs control epithelial
and endothelial paracellular permeability, PLEKHA7 may be
involved in the pathophysiology of angle closure related to
aberrant fluid dynamics. With the identification of newer
ocular biometric and dynamic risk factors, there is a better
understanding of the mechanisms involved in the disease
process. Therefore, the association between PACG susceptibil-
ity loci and other anatomical and physiological risk factors of
angle closure is worthy of further investigation. Functional
characterization of these genes in tissues and cells relevant to
PACG is also likely to provide further insights into associated
disease mechanisms.
We have utilized well-characterized population-based studies
that encompass three major ethnic groups of Asia in which
PACG is a predominant blinding condition. Our study is further
strengthened by a large sample size. For SNPs rs3753841
(COL11A1) and rs11024102 (PLEKHA7), which have an effect
allele frequency of more than 0.3, we have more than 95%
power for detecting differences among the wild-type, heterozy-
gous, and homozygous groups assuming an underlying true
effect size of 0.2 (delta/sigma) or larger. For SNP rs1015213
(PCMTD1-ST18), which has a lower effect allele frequency, we
still have approximately 80% power for detecting differences if
we assume an underlying true effect size of 1.1 (delta/sigma) or
larger. While we evaluated the correlation between PACG
susceptibility loci and only two ocular anatomical features, the
association with other PACG-related quantitative traits such as
lens, iris, and anterior chamber characteristics should also be
investigated in future analyses. Another limitation of our study
was that we were able to control only for age, sex, and
population stratification in the analysis. A previous study
reported that lens vault and posterior corneal arc length were
responsible for approximately 75% of the variation of ACD in a
Singaporean Chinese cohort.34 It is likely that such factors could
confound the results of the study. However, in the current study,
the confounding effect of these determinant factors could not be
investigated due to the nonavailability of data.
In summary, this candidate gene study investigated the
possibility that three PACG susceptibility loci could contribute
to the pathogenesis of PACG by looking at their association
with the most obvious anatomical risk factors of angle closure:
ACD and AL. The lack of association with both phenotypes
suggests that the pathogenesis of PACG involves risk factors
other than ACD and AL. Future research investigating the
association between PACG susceptibility loci and other risk
factors for angle closure and progression in angle-closure
disease should now be performed.
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Abstract
Anterior chamber depth (ACD) is a key anatomical risk factor for primary angle closure glaucoma (PACG). We conducted a
genome-wide association study (GWAS) on ACD to discover novel genes for PACG on a total of 5,308 population-based
individuals of Asian descent. Genome-wide significant association was observed at a sequence variant within ABCC5
(rs1401999; per-allele effect size =20.045 mm, P= 8.1761029). This locus was associated with an increase in risk of PACG in
a separate case-control study of 4,276 PACG cases and 18,801 controls (per-allele OR= 1.13 [95% CI: 1.06–1.22], P= 0.00046).
The association was strengthened when a sub-group of controls with open angles were included in the analysis (per-allele
OR= 1.30, P= 7.4561029; 3,458 cases vs. 3,831 controls). Our findings suggest that the increase in PACG risk could in part be
mediated by genetic sequence variants influencing anterior chamber dimensions.
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Introduction
Primary angle closure glaucoma (PACG) remains a major cause
of irreversible blindness, particularly in Asian countries such as
China [1], Mongolia [2], Singapore [3], and India [4] with up to
80% of the estimated 15 million people afflicted with PACG
resident in Asia [5]. We recently conducted a genome-wide
association study (GWAS) on PACG with 3,771 PACG cases and
18,551 controls, and identified 3 strongly associated genetic
variants: rs11024102 in PLEKHA7, rs3753841 in COL11A1 and
rs1015213 located between PCMTD1 and ST18 on Chromosome
8q [6]. As these 3 sequence variants only explained ,2 percent of
PACG risk, we looked into other methodologies besides the
GWAS based approaches to identify more genes that underlie
PACG susceptibility. The clinical heterogeneity of PACG suggests
that disease-related endophenotypes/quantitative traits may help
elucidate true disease genes. Quantitative phenotypes allow
individuals to be viewed along the continuum of risk, and may
provide additional information which could complement dichot-
omous measures of affection status [7], [8]. Such an approach has
been used in the study of genetic variants controlling lipid traits
and susceptibility to coronary artery disease [7], [8].
Smaller anterior segment dimensions are a hallmark of PACG,
with shallower anterior chamber depth (ACD), the cardinal feature
associated with increased susceptibility to PACG [9], [10]. Eyes with
an ACD of less than 2.80 mm were more inclined to have angle
closure when compared to eyes with an ACD of at least 3 mm (odds
ratio (OR), 42.5; 95% confidence interval (CI), 27.4–66.2) [11].
There is also a greater likelihood of developing glaucomatous optic
neuropathy in persons with the shallowest anterior chambers [12].
ACD, an easily and precisely quantified measure by ocular
imaging techniques, is a normally distributed quantitative trait
within the general population. It displays high heritability with a
coefficient as high as 0.90 [13], [14], and can be considered an
endophenotype for PACG.
To identify genetic variants that significantly influence ACD, and
to determine if such genes (if any) affects PACG risk, we conducted a
two-staged study, first a GWAS on a total of 4,484 population-based
individuals of Indian and Malay ethnicity from Singapore, and
Chinese from Beijing, China. Secondly, the identified QTLs for
ACD were assessed for association in PACG case cohorts.
Results
Identification of a QTL for ACD
After sample and genotyping QC, a total of 1752 (Singapore
Malay Eye Study, SiMES), 1860 (Singapore Indian Eye Study,
SINDI), and 872 (Beijing Eye Study, BES) individuals with com-
plete data for ACD measurements, age and gender were available
for GWA analysis. We measured the association between ACD
and individual SNP genotypes using linear regression, modeling
for a trend-per-copy effect on the minor allele. Additional ad-
justments were made for age, gender, and the significant axes of
genetic stratification. We noted a significant excess of small P-
values at the extreme tail of the quantile-quantile distribution
(Figure S1) accompanied by a background of minimal genomic
inflation, thus indicating that there could be genuine associations
between SNP genotypes and ACD. Highly suggestive evidence of
association (P=1.9261027) was observed at a sequence variant
within ABCC5 (rs1401999) on Chromosome 3 (Figure S2). We
were able to replicate of this observation in a further 824
population-based samples of Chinese descent from Beijing, China
(P=0.011) using Sanger sequencing, leading to genome-wide
significant association with ACD upon meta-analysis of all 5,308
population-based samples (b=20.045 mm ACD per-copy of the
minor allele (C allele), P=8.1761029; Table 1). Furthermore,
attesting to the robustness of our findings, we observed a similar
magnitude of association when using left eye ACD measurements
of SiMES and SINDI cohorts (b=20.051, P= 8.1561024 and
b=20.045, P= 8.1161025 respectively), where left eye ACD data
were also available.
Additionally, as both ACD and axial length are distance
measurements on the axial direction of the eye globe, previously
described to share genetic factors to a certain degree [15], we also
assessed the effect of ABCC5 rs1401999 on axial length. We found
the association between rs1401999 and axial length to be much
weaker compared to that observed with ACD (P-meta = 0.000615,
Table S1).
Association between ABCC5 rs1401999 and PACG
For the second analysis, we examined if this variant was
associated with PACG, and proceeded to conduct analysis of 1,854
PACG cases and 9,608 controls from 5 cohorts (Table S2), all
genotyped with Illumina SNP-arrays, and a further 2,422 cases
and up to 9,193 controls from 7 independent collections
genotyped using the Sequenom MassArray or Taqman platforms.
As there was significant heterogeneity for the effect of ABCC5
rs1401999 and PACG risk between the 12 sample collections
(Pheterogeneity = 0.0047, I
2-index = 60.6%; Figure 1 and Table 2),
we looked for sources of possible heterogeneity within the sample
collections [16], the most obvious of which are the use of
clean, open angle controls in some collections (see ‘Selection of
controls without angle closure’ in methods), and un-ascertained
population-based controls in others. This could be important in
the context of this study as the prevalence of at-risk population
with inherent angle closure is as high as 10% in Asian populations
[3], [17]. Overall, we noted modest evidence of association (per-
allele odds ratio = 1.13, 95% confidence interval = 1.06–1.22;
P=0.00046) between the minor allele (C allele) of rs1401999
and PACG when all 12 case-control collections were considered,
and this association was augmented when we only included pre-
selected sample collections where the controls had definite open
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angles (N= 3,458 PACG cases and N=3,831 controls, per-allele
OR=1.30, P=7.4561029; Figure 1 and Table 2).
We also performed conditional analyses of the ABCC5 variant
with the previously implicated PACG loci [6] and observed no
change in either the odds ratio or p-values of the association.
(Table S3).
Expression of ABCC5 in eye tissues
RT-PCR analysis on human ocular tissues demonstrated that
ABCC5 is expressed in anterior segment structures relevant to
PACG such as the iris, ciliary body, and lens (Figure S3).
Additionally, Abcc5 message and protein were confirmed in mouse
ocular tissues using in situ hybridization and immunohistochem-
istry (Figure S4, S5).
Discussion
In this study, a GWAS of ACD in Singaporean Indians and
Malays and Chinese from Beijing China found rs1401999 within
ABCC5 to contribute to the normal variation of ACD, a
quantitative trait relevant to PACG. Interestingly, none of the
previously identified PACG-associated genetic variants [6] were
significantly associated with ACD [18]. We also demonstrated the
association of rs1401999 with PACG using case-control cohorts
from multiple populations across Asia. Importantly this association
surpassed GWAS significance when the analysis was confined to
control pre-selected to have open angles.
ABCC5, also known as multidrug resistance protein 5 (MRP5),
has been shown to participate in tissue defense and cellular signal
transduction through efflux of anticancer drugs, toxicants and a
second messenger cGMP [19]. [20], [21]. It is expressed in
most human tissues, including the cornea [22], retinal pigment
epithelium and retina of the eye [23]. We also noted ABCC5
expression in ocular structures relevant to PACG such as the iris,
ciliary body, and lens. However, its exact role in the context of
PACG is not yet known. The significant association between
ABCC5 rs1401999 with a shallower ACD argues favorably for a
role in eye growth, particularly that of the anterior segment.
Intriguingly, a study in zebrafish suggested that Abcc5 may play an
active role in eye development through the regulation of
intracellular cGMP levels. Zebrafish Abcc5, which shares 73%
amino acid sequence identity with human ABCC5, is highly
expressed in the lens of the developing eye [24]. Notably, the
blockage of endogenous ABCC5 activity by its dominant-negative
was shown to retard development, producing smaller eyes as well
as overall reduction of body length and pigmentation of embryos
[24]. Abcc5 knockout mice have been generated but an evaluation
of their eyes was not reported [25]. A developmental role for
ABCC5 in mammalian eyes therefore remains to be defined and
will require further detailed studies in model organisms.
In addition, the linkage disequilibrium (LD) block that includes
rs1401999 and ABCC5, also includes the presenilin-associated
rhomboid-like (PARL) gene, 5-hydroxytryptamine receptor 3D
(HTR3D) gene and the 5-hydroxytryptamine receptor 3C
(HTR3C) gene (Figure S6). It is thus possible that rs1401999
might simply be in LD with an as yet unidentified causal variant,
and it remains unclear whether the causal alleles or group of alleles
influence ABCC5 or any of the neighboring genes to influence
ACD. However, the clear expression within ocular tissues and a
possible role in eye development make ABCC5 a rather attractive
candidate gene for ACD. Indeed, re-sequencing of the region will
be necessary to identify novel potentially functional polymor-
phisms related to PACG pathogenesis.
The prevalence of the pre-cursor stage of PACG, namely
narrow angles, is about 10% in many Asian populations [3], [17].
Given the association between angle closure and shallow ACD
[11] it is therefore appropriate to remove the ‘at-risk individuals’
from the control population in order to assess the true relationship
between ACD QTLs and PACG. Unsurprisingly, the evidence of
association between rs1401999 and PACG was augmented when
we only included sample collections where the controls had
definite open angles. Similar observations have also been seen with
very recent studies on Alzheimer’s disease, where the inclusion of
general population-based controls resulted in significant underes-
timation of the odds ratio conferred by the disease-associated SNP
compared to when properly matched, risk-free controls were
applied, [26]. [27], [28]. We caution that the modest statistical
evidence reported here for rs1401999, when examined in a total of
4,276 PACG cases and 18,801 controls, is at least 5 orders of
magnitude below that of the three PACG-associated variants from
our recent GWAS study [6]. Clinical studies have shown that
ACD is only a modest determinant of angle width [29]. Therefore,
this may explain why an ACD controlling gene such as ABCC5
would only confer a relatively small effect on PACG disease itself.
Incidentally, the proportion of PACG risk explained by ABCC5
rs1401999 is 0.35% (95% confidence interval = 0.01 to 1.2%). Our
study highlights the fact that even larger sample sizes may be
necessary to dissect and conclusively identify the possible modifiers
of genetic risk conferred by variants of modest effects, particularly
when they exert their action on disease pathogenesis via
endophenotypes. The following observations can also be drawn
from this study. It is important that all sample collections are
included and assessed transparently especially when drawn from
diverse populations. Secondly, despite the broad-based success in
the use of large numbers of unselected, population-based controls
in genetic studies [30], [31], [32], [33], [34], [35] the deployment
of controls with proper clinical phenotyping and documentation
will often assist in more definitive identification of susceptibility
genes. A comprehensive examination of all variation around
ABCC5 using targeted deep re-sequencing is now necessary to
parse the true association signal in an effort to more completely
understand the role of this gene in ACD and PACG.
In summary our study identified a common genetic variant
within ABCC5 as being significantly associated with ACD, which
was also associated with a modest risk of PACG. Our findings are
Author Summary
The anterior chamber is the space within the eye which is
bound by the cornea, and the anterior surfaces of the iris
and lens. Anterior chamber depth (ACD) is the distance
measured along the eye’s optical axis, from the cornea to
the lens surface. ACD is an important risk factor for primary
angle closure glaucoma (PACG), a major cause of irrevers-
ible blindness worldwide, and in particular, individuals of
Asian ethnicity. In order to identify the genes that underlie
PACG susceptibility, we conducted a two-staged study. We
first conducted a large scale genetic study on a total of
5,308 population-based individuals of Asian descent to
identify the genetic variants that influence ACD. This was
followed by testing for associations between the identified
genetic variant and PACG in another independent collec-
tion of 4,276 PACG cases and 18,801 controls. We found
that a genetic variant within ABCC5 was associated with an
increased risk of having PACG. Our findings suggest that
the increase in PACG risk could in part be mediated by
genetic sequence variants that influence the anterior
chamber dimensions of the eye.
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largely in keeping with the anatomical risk factors of individual
susceptibility to PACG in the eye, whereby shallower ACD is a
cardinal clinical and pathogenic feature, predisposing the eye to
more ‘crowded’ anterior segment and thus increasing the risk of
PACG. Our study provides further clues to genetic mechanisms
underlying this major global cause of blindness.
Materials and Methods
Sample collections analyzed for Anterior Chamber Depth
Anterior chamber depth (ACD) measurements were derived
from three population based samples: the Singapore Malay Eye
Study (SiMES), the Singapore Indian Eye Study (SINDI) and the
Beijing Eye Study (BES).
SiMES. The Singapore Malay Eye Study (SiMES) was a
population-based, cross-sectional study of 3280 Malay adults aged
40 to 79 years. Details of the SiMES design, sampling plan, and
methods have been reported elsewhere [36]. In brief, an age-
stratified random sampling of all Malay adults, aged 40 to 80
years, residing in 15 residential districts in the south- western part
of Singapore was drawn from the computer-generated random list
of 16,069 Malay names provided by the Ministry of Home Affairs.
A total of 1400 names from each decade of age (40–49, 50–59, 60–
69, and 70–79 years), or 5600 names, were selected. Of these,
4168 individuals (74.4%) were determined to be eligible to
participate. A person was considered ineligible if he or she had
moved from the residential address, had not lived there in the past
6 months, was deceased, or was terminally ill. Of the 4168 eligible
individuals, 3280 participants (78.7%) took part in the study. The
study was conducted from August, 2004 to June, 2006.
SINDI. As with SiMES, the Singapore Indian Eye Study
(SINDI) was a population-based, cross-sectional epidemiological
study, but of ethnic Indian adults aged between 40 and 80+ years
residing in Singapore. The Ministry of Home Affairs provided an
initial computer-generated list of Indian names derived from a
simple random sampling of all ethnic Indian adults aged 40–80+
years of age residing in 15 residential districts in south-western
Singapore. From this list, a final sampling frame of 6,350 ethnic
Indian residents was derived using an age-stratified random
sampling strategy similar to SiMES. SINDI was conducted from
March, 2007 to December, 2009 and recruited 3,400 (75%
response rate) participants [37].
BES. The Beijing Eye Study was a population-based, cross-
sectional study of Chinese adults aged 40+ years and residing in 4
communities in the urban district of Haidian in the North of
Central Beijing and in 3 communities in the village area of Yufa of
the Daxing District south of Beijing [38]. At the time of the first
survey in the year 2001, the 7 communities had a total population
of 5324 individuals aged 40 years or older and eligible to take part
in the study. In total, 4439 individuals participated in the eye
examination (83.4% response rate). In the year 2006, when blood
samples were taken, the study was repeated by re-inviting all
participants from the survey from 2001 to be re-examined with
3251 subjects participating (73.3% response
rate).
Measurement and analysis of Anterior Chamber Depth
(ACD). ACD was measured using the IOLMaster (Carl Zeiss
Meditec, Dublin, CA). Five readings were obtained and the
average computed. The signal-to-noise ratio for all readings were
.2.0, which indicate that a clear signal was obtained when
performing the measurement. All the readings were within
0.05 mm of the one with the highest signal-to-noise ratio.
The ACD measurements used in the GWAS excluded any
measurements from any eye which were pseudophakic or
aphakic. For collections with data from two phakic eyes (SiMES,
SINDI), individuals were excluded whose ACD measurements
between the two eyes differed more than 0.2 mm (which
represented the top ,20th percentile of symmetrical data) which
gave a good correlation between the left and the right eye
(r2.0.95 in both SiMES and SINDI). However, given that BES
only had measurements for the right eye; final meta-analysis
used ACD measurements taken from the right eye in all three
cohorts.
PACG case-control cohorts. The subjects for the PACG
case-control study were compiled from 11 independent sample
collections enrolled from 8 different countries; and have been
described previously [6]. Furthermore, we have included an
additional PACG case-control collection from Japan (136 cases
and 419 controls) as well as an additional 436 PACG cases from the
Beijing site. The PACG cases and controls were defined using the
same criteria as described previously [6].
Selection of controls without angle closure. These controls were
selected from within the population-based samples based on
robust clinical criteria. A control was defined as having an
Table 1. Quantitative trait analysis between ABCC5 rs1401999 and anterior chamber depth in SIMES, SINDI, and BES.
Collection N Minor Allele b SE Pgc MAF
SIMES 1752 C 20.056 0.0149 1.7661024 0.15
SINDI 1860 C 20.041 0.0115 3.9761024 0.41
BES1 872 C 20.026 0.0196 0.19 0.16
BES2 824 C 20.058 0.0227 0.011 0.16
All BES 1696 C 20.040 0.0148 0.0075 0.16
Meta-analysis* 5308 C 20.045 0.00775 8.1761029
SIMES: Singapore Malay Eye Study (typed with Illumina 610K GWAS chip).
SINDI: Singapore Indian Eye Study (typed with Illumina 610K GWAS chip).
BES1: Beijing Eye Study typed with Illumina 610K GWAS chip.
BES2: Beijing Eye Study typed with direct sequencing.
b: Per-allele effect size of ABCC5 rs1401999 on anterior chamber depth.
SE: Standard error for b.
Pgc: Genomic control corrected P-value.
MAF: Minor allele frequency.
*: I2-index for heterogeneity = 0%.
doi:10.1371/journal.pgen.1004089.t001
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intraocular pressure (IOP),21 mmHg with open angles (on
gonioscopy) in all quadrants, healthy optic nerves and normal
visual fields, and no previous intraocular surgery.
Ethics. All involved studies were conducted in accordance
with the principles of the Declaration of Helsinki. Study
procedures and protocols were approved by the Institutional
Review Board of each local institution involved in the study, and
all study participants provided written informed consent at the
recruitment into the studies.
Genotyping
ACD GWAS. Genotyping in the following sample collections
(SIMES, N=1752; SINDI, N= 1860; BES1, N=872) was
performed using the Illumina 610K Quad BeadChips following
manufacturer instructions after genomic DNA were extracted
from participants using standard laboratory techniques. Genotyp-
ing of SNP ABCC5 rs1401999 in an additional 824 participants
from the Beijing Eye Study (termed BES2) was performed using
direct capillary sequencing.
PACG sample collections. Genome-wide genotyping was per-
formed for a total of 1,854 PACG cases and 9,608 controls using
Illumina SNP-arrays. A further 1,917 PACG cases and up to 8,943
controls were genotyped using the Sequenom MassArray and
Taqman real-time PCR method (Table S2).
Statistical analysis. Genome-wide per-cohort and meta-
analysis of ACD for all three sample collections was performed
using standard procedures as previously described [39], [40], [41].
A selection of stringent QC filters were applied to remove poorly
performing SNPs and samples using tools implemented in PLINK
version 1.7 [42]. The QC criteria were as follows: SNPs that had
.5% of missing genotypes, gross departure from Hardy-Weinberg
equilibrium (test for HWE showing P,1026) or were of minor
allele frequency below 1% were excluded from downstream
analysis. For sample QC, samples with an overall genotyping call
rate of ,95% were excluded from analysis. Principal component
(PC) analysis was undertaken to account for spurious associations
resulting from ancestral differences of individual SNPs. PC plots
were performed using the R statistical program package (www.r-
project.org/).
For the GWAS on ACD, linear regression was performed to test
for association between SNP genotypes and ACD as implemented
by PLINK (version 1.06). Individual SNP genotypes were coded
according to the number of copies of the minor allele present: 0 for
the wild-type genotype, 1 for heterozygotes, and 2 for homozygote
variants. A trend test using linear regression was used for primary
association testing between genotypes and ACD as a quantitative
trait, adjusting for age, gender, and the significant axes of genetic
stratification. Meta-analysis across SiMES, SINDI and BES was
performed using the inverse-variance, fixed effects model in order
to obtain a combined point estimate of the overall effect size (b)
coefficients and its corresponding standard error (SE). Inter-
cohort heterogeneity was assessed with the Cochran’s Q statistic
and its accompanying I2 index. Quantile-quantile (QQ) and
Manhattan plots were created using the software R (www.r-
project.org). After sample and genotyping QC, a total of 1752,
1860, 872 individuals with complete data for ACD measure-
ments, age and gender were available for SiMES, SINDI and
BES individual GWAS. The overall genomic inflation factor for
the meta-analysis of the three sample collections was minimal
(lgc = 1.036; see Figure S1). We considered P,561028 as
genome-wide significant, and the previously used threshold for
genome-wide significance (P,561027) as ‘highly suggestive
evidence of association [43].
Descriptions of the GWAS datasets used in the current study,
principal component analysis, and adjustment for population
stratification have been described elsewhere (Table S4) [39], [40],
[41].
For the PACG sample collections, the analysis was performed as
previously described, with associations between ABCC5 rs1401999
and PACG modeled using logistic regression.
Power calculations. A power calculation was conducted for
bringing forward genome-wide significant SNPs from the ACD
quantitative trait analysis to the PACG case control analysis (for
4,276 cases and 18,801 controls) (Supplementary Table S5). The
power calculation is consistent with the findings we report in the
current manuscript.
Expression analysis
RT-PCR in human ocular tissues. Expression of ABCC5 was
assessed by semi quantitative reverse transcription PCR (RT-PCR)
using ABCC5 specific primers (forward 59- ATTGG-
CATTGTGGGGCGGAC -39 and reverse 59- CCTCTCC-
AGGGCATCCCAAATC -39) on total RNA extracted from a
variety of ocular tissues (anterior sclera, cornea, iris, ciliary body,
trabecular meshwork, lens, lens capsule, retina and retinal pigment
epithelium, optic nerve head and optic nerve) with TRIzol
Reagent (Invitrogen, Carlsbad, California) in accordance with the
manufacturer’s protocol. First-strand cDNA synthesis was per-
formed with SuperScript First-Strand Synthesis System for RT-
PCR (Invitrogen, Carlsbad, California). Semi quantitative RT-
PCR was performed according to manufacturer’s protocol, with
the SYBR Green Master Mix (Invitrogen, Carlsbad, California)
using the above ABCC5 primers. The resulting PCR products were
Figure 1. Association analysis between ABCC5 rs1401999 and
susceptibility to primary angle closure glaucoma (PACG). The
PACG sample collections have been described elsewhere [6]. The
vertical line represents a per-allele odds ratio of 1.00. The oblongs
represent point estimates (referring to the per-allele odds ratio), with
the height of the oblongs inversely proportional to the standard error
of the point estimates. Horizontal lines indicate the 95% confidence
interval for each point estimate. Meta-analyses of samples are reflected
by blue diamonds. The width of the diamonds indicates their 95%
confidence intervals. All point estimates in Stage 1 have been adjusted
for the top axes of genetic stratification using logistic regression.
doi:10.1371/journal.pgen.1004089.g001
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separated on a 2% agarose gel and visualized by ethidium bromide
staining. The ubiquitously expressed beta-actin (ACTB) gene was
amplified using specific primers (forward 59- CCAACCGCGA-
GAAGATGA -39 and reverse 59- CCAGAGGCGTACAGGGA-
TAG-39) and used as amplification and normalizing control. The
ABCC5 primer sequences were derived from NCBI Reference
Sequence: NM_005688.2.
In situ hybridization. In situ hybridization was performed on 12-
mm-thick 4% paraformaldehyde (PFA) fixed ocular sections using
Dig-labeled riboprobe. Digoxigenin-labeled (DIG-labeled) ribop-
robes for mouse Abcc5 were transcribed from cDNA clones (Open
Biosystems clone ID: 6839816). For anti-sense probe generation,
the plasmid was digested with EcoRI and transcribed with T3
polymerase. While for the sense probe Not1 and T7 were used.
For this procedure, C57BL/6J or A/J mice were perfused
transcardially with 4% PFA in Phosphate buffered saline (PBS).
Eyes were postfixed in 4% PFA overnight, cryoprotected in 30%
sucrose, and embedded in Optimal Cutting Temperature embed-
ding medium (Tissue-Tek O.C.T. Compound, Sakura Finetek
U.S.A., Inc., Torrance, CA). Frozen sections were air dried
(10 min), postfixed (4% PFA; 10 min) and acetylated with 0.25%
acetic anhydride in 0.1 M triethanolamine (TEA). Intercalated
washes were done with PBS and after the last wash the sections
were incubated overnight at 65uC with hybridization solution
[50% formamide, 16 Hybe solution (Sigma-Aldrich, St. Louis,
MO), 1 mg/ml yeast RNA] containing 1 mg/ml Dig-labeled
riboprobes. After hybridization, slides were washed with 0.26SSC
at 72uC for 1 h, and endogenous peroxidases were quenched with
a solution of 0.1% sodium azide and for 10 min. Bound probes
were detected with an POD-conjugated anti-Dig antibody. The
Table 2. Association analysis between ABCC5 rs1401999 and primary angle closure glaucoma in all chip-typed sample collections
(top panel), de-novo genotyped sample collections (middle panel), and PACG cases and clinically certified controls with open
angles (bottom panel).
Stage 1 (Chip-typed sample collections)
Collection MAF case MAF control OR P
Singapore 0.135 0.109 1.27 0.017
Hong Kong 0.147 0.132 1.16 0.38
India 0.493 0.408 1.29 2.8361025
Malaysia* 0.175 0.150 1.21 0.38
Vietnam 0.143 0.121 1.21 0.25
Meta-analysis (Stage 1) 1.23 9.8461025 (I2 = 0.0%)
Stage 2 (De-novo genotyped sample collections)
Collection MAF case MAF control OR P
China (Beijing){ 0.173 0.139 1.29 0.00045
Singapore 0.120 0.143 0.82 0.17
China (Shantou) 0.131 0.150 0.85 0.31
Japan 0.136 0.113 1.23 0.32
India 0.477 0.442 1.15 0.41
Saudi Arabia 0.432 0.484 0.83 0.16
United Kingdom 0.412 0.453 0.85 0.22
Meta-analysis (Stage 2) 1.06 0.23 (I2 = 67.5%)
Meta-analysis (Stages 1 and 2) 1.13 0.00046 (I2 = 60.6%)
ABCC5 rs1401999 genotyped in PACG cases and clinically certified open-angled controls only
Collection MAF case MAF control OR P
Singapore 0.132 0.109 1.24 0.026
Hong Kong 0.159 0.103 1.64 0.012
India 0.489 0.429 1.28 0.0047
Beijing{ 0.173 0.139 1.29 0.00045
Japan 0.136 0.113 1.23 0.32
Meta-analysis 1.30 7.4561029 (I2 = 0.0%)
MAF case: Minor allele frequency in PACG cases.
MAF control: Minor allele frequency in controls.
OR: Odds ratio.
P: P-value for association with PACG.
I2: I-squared index for between-collection heterogeneity.
* Results here are presented based on raw minor allele frequency counts without further adjustment.
{PACG patients were recruited from the Beijing Tongren Hospital and controls were recruited from the Handan Eye Study (HES), a population-based study of eye disease
in rural Chinese aged 30 years and over.
doi:10.1371/journal.pgen.1004089.t002
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detection of hybridized mRNA in sections was performed using
the Cy-3 Tyramide Signal Amplification System (PerkinElmer,
Waltham, MA).
Immunohistochemistry. Enucleated eyes from A/J mice were
embedded in Optimal Cutting Temperature embedding medium
(Tissue-Tek O.C.T. Compound, Sakura Finetek U.S.A., Inc.,
Torrance, CA). The eyes were cryo-sectioned (14 mm) and
transferred to glass slides. Cryosections were air dried for
10 min at room temperature, fixed for 10 min in 4% paraformal-
dehyde, followed by two washes (5 min each) in phosphate
buffered saline (PBS). Sections were blocked 30 min at room
temperature with 10% normal donkey serum. Primary antibodies
were applied for 1 hr at room temperature using polyclonal goat
anti-ABCC5 antibody (diluted 1:300; Catalog No. sc-5781,
Santacruz Biotechnology Inc., Santacruz, CA). Primary antibody
was removed by three washes (5 min each) in PBS and the sections
were treated for 1 hr at room temperature with AlexaFluor
conjugated secondary antibodies (1:200 dilution, Jackson-Immu-
noResearch, West Grove, PA) diluted in 1% normal donkey serum
and 10 mg/mL BSA in PBS. After three washes in PBS, the sections
were mounted (Fluormount, Sigma-Aldrich, St. Louis, MO) and
viewed by fluorescence microscopy. All photomicrographs were
taken with identical camera settings. For peptide blocking experi-
ments, the antibody was preincubated with 106concentration of the
blocking peptide (sc-5781P, Santacruz Biotechnology Inc., Santa-
cruz, CA), incubated for 2 h at room temperature prior to treating it
with the sections.
Supporting Information
Figure S1 Quantile-quantile plot of P-values from the meta-
analysis of ACD across the three independent sample collections
with genome-wide genotyping data (Singapore Malays, N= 1752;
Singapore Indians, N=1860; and Chinese from Beijing, N= 872)
totaling 4,484 individuals.
(DOC)
Figure S2 Manhattan plot for genome-wide meta-analysis of
anterior chamber depth in three populations with genome-wide
genotyping data (Singapore Malays, N= 1752; Singapore Indians,
N= 1860; and Chinese from Beijing, N= 872) totaling 4,484
individuals. A further 824 Chinese samples from Beijing which
were genotyped via direct sequencing for rs1401999 are not
included in this Manhattan plot.
(DOC)
Figure S3 Expression analysis of ABCC5 in human ocular
tissues: The ABCC5 specific 249 bp RT-PCR product was
observed for anterior sclera (AS), cornea (cornea epithelium, CE;
corneal stroma, CS and cornea endothelium, CEn), iris (I),
trabecular meshwork (TM), ciliary body (CB), lens (L), lens capsule
(LC), retina and retinal pigment epithelium (R), optic nerve head
(ONH) and optic nerve (ON). The ubiquitously expressed gene,
ACTB was used as the normalizing control. A no template sample
acted as the negative control (NC) to ensure non-contamination of
the RT-PCR reaction mix. M denotes molecular-weight marker.
(DOC)
Figure S4 Abcc5 is expressed in multiple ocular tissues that may
participate in the pathogenesis of PACG. RNA In situ hybridiza-
tion with an antisense probe (AS) shows that Abcc5 mRNA is
expressed in: A) iris (I), B) ciliary body (CB), C) cornea, and D) in
the outer nuclear layer (ONL) inner nuclear layer (INL) and
ganglion cell layer (GCL) of the retina. The middle panel shows a
merged image of AS staining and DAPI. In situ hybridization with
asense probe (S) control is shown in the right panel. Scale bar,
50 mm.
(DOC)
Figure S5 Immunohistochemical localization of ABCC5 in
ocular tissues: Cryosections of whole eyes from wild-type A/J
mice were imaged using fluorescence microscopy. ABCC5 is
present in: A) iris (I), cornea (C), B) ciliary body (CB), and C)
retina, in the inner segment (IS), inner nuclear layer (INL) and
Muller cell processes in the inner plexifom layer (IPL). The right
panel shows images with immunostaining blocked by a competing
ABCC5 peptide(+ Pep).Scale bar, 50 mm.
(DOC)
Figure S6 Regional linkage disequilibrium (LD) plot for ABCC5
and its flanking region (Chr. 3). This is plotted using the D’
algorithm.ABCC5 rs1401999 is labeled with an arrow. D’ = 1
represents complete LD.
(DOC)
Table S1 Quantitative trait analysis between ABCC5 rs1401999
and axial length.
(DOC)
Table S2 PACG samples collections and genotyping methodol-
ogy for ABCC5 rs1401999.
(DOC)
Table S3 Association analysis between ABCC5 rs1401999 and
PACG in the GWAS collections. Additional adjustments com-
pensating for the allelic dosages at PLEKHA7 rs11024102,
COL11A1 rs3753841, and rs1015213 are also performed in
addition.
(DOC)
Table S4 Baseline characteristics of sample collections used in
quantitative trait analysis for anterior chamber depth (genotyped
individuals passing quality checks from SiMES, SINDI and BES).
(DOC)
Table S5 Study power as a function of minor allele frequency
and per-allele odds ratios. Cells in yellow highlights fulfill .80%
statistical power to achieve P= 161024.
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The Impact of Lens Vault on Visual Acuity and
Refractive Error: Implications for Management
of Primary Angle-Closure Glaucoma
Monisha E. Nongpiur, MD,*w Shweta Singhal, PhD,*
Stephen Stewart, MA, MBBS,z Hla M. Htoon, PhD,*w
Arun K. Narayanaswamy, DO, DNB, MMED,*w Tien Y. Wong, FRCS, PhD,*wy
Shamira A. Perera, BSc (Hons), FRCOphth,* and Tin Aung, FRCS, PhD*wy
Purpose: To investigate the relationship between lens vault (LV),
visual acuity (VA), and refraction.
Methods: This was a cross-sectional study of 2047 subjects aged 50
years and older recruited from a community polyclinic. Anterior
segment optical coherence tomography was performed, and cus-
tomized software was used to measure LV. VA was measured using
a logarithm of minimum angle of resolution chart (logMAR chart;
Lighthouse Inc.), and was classiﬁed as normal (logMAR<0.3),
mild impairment (0.3< logMAR<0.6), and moderate/severe
impairment (logMAR>0.6). Refraction was measured with an
autorefractor machine and spherical equivalent was deﬁned as
sphere plus half cylinder. Angle closure was deﬁned as posterior
trabecular meshwork not visible for Z2 quadrants on non-
indentation gonioscopy.
Results: Complete data were available for 1372 subjects including
295 (21.5%) with angle closure. Angle-closure subjects were sig-
niﬁcantly older (P<0.001), with shorter axial length (P<0.001),
shallower anterior chamber depth (P<0.001), and greater LV
(P<0.001). There was no signiﬁcant diﬀerence in VA (P=0.12)
compared with those without angle closure. After adjusting for age,
sex, axial length, anterior chamber depth, and spherical equivalent,
there was no signiﬁcant association between LV and VA (P=0.35)
or between LV and spherical equivalent (P=0.06).
Conclusions: The magnitude of LV was not associated with VA or
spherical equivalent. Lens extraction may be a consideration in
eyes with angle closure with large LV in the absence of visually
signiﬁcant cataract.
Key Words: lens vault, visual acuity, angle closure
(J Glaucoma 2015;00:000–000)
The lens plays an important role in the pathogenesis ofprimary angle-closure glaucoma (PACG).1–3 In addi-
tion to the thickness and position of the lens, another
parameter, found to be associated with angle closure is the
lens vault (LV).4 The LV, imaged by anterior segment
optical coherence tomography (ASOCT), is a surrogate
measurement of the amount of lens that is located anterior
to the plane of the anterior chamber angles. An increase in
LV may worsen angle crowding in an already predisposed
eye by instigating a more pronounced iris bowing through
relative pupil block, and in more severe cases may also
directly push the peripheral iris towards the angles.4 LV has
been found to distinguish eyes with angle closure from
those with open angles better than biometric parameters
such as anterior chamber depth (ACD), axial length (AL),
lens thickness (LT), and lens position.4 LV is the ASOCT
risk factor for angle closure that is most analogous to the
lens component. Although an increased LV may either
represent an aged lens, an intumescent lens or subluxed
lens, the targeted removal of this component converges to a
lens extraction.
With age, the compaction of crystallins during cata-
ractogenesis may lead to an increase in refractive index and
a yellowing of the lens itself. This is often accompanied by
an increase in LT and a myopic shift related to the devel-
opment of nuclear cataract.5 Studies have shown that for
cases of visually signiﬁcant cataract and PACG, cataract
extraction results in deepening of the anterior chamber and
widening of the angles, and in some cases, may lower
intraocular pressure (IOP) and reduce the likelihood of
progression.6,7 However, there is a lack of consensus on the
role of lens extraction in eyes with PACG or primary angle
closure with good visual acuity (VA). An ongoing multi-
centered randomized-controlled trial, the eﬀectiveness in
Angle Closure Glaucoma of Lens Extraction (EAGLE) is
currently investigating whether early lens extraction in
PACG improves patient-reported outcomes and cost-
eﬀectiveness compared with standard care.8
The relationship of LV with VA or refractive error is
not known, particularly in eyes with angle closure. Whereas
good VA may naturally preclude cataract surgery, an
increased LV may support the decision to proceed with
cataract surgery even with a VA that was considered
“normal” for surgical intervention.
The aim of this study was to investigate the relation-
ship between LV, VA, and refraction in subjects with angle
closure.
METHODS
Approval for the study was granted by the Singapore
Eye Research Institute institutional review board. This
study was conducted in accordance with the Declaration of
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Helsinki, and written informed consent was obtained from
all subjects before enrollment.
Subjects aged 50 years and older were recruited from a
government-run polyclinic that provides primary health
care services for residents living in the area around the
clinic. Details of the study have been described previously.9
Recruited subjects did not have any ophthalmic complaints
and individuals with a history of glaucoma, previous
intraocular surgery, previous laser treatment, or penetrat-
ing eye injury were excluded.
All subjects underwent a detailed eye examination that
included an assessment of VA using a logarithm of mini-
mum angle of resolution chart (logMAR chart; Lighthouse
Inc., Long Island, NY), slit-lamp examination (model BQ
900; Haag-Streit, Bern, Switzerland), stereoscopic optic disc
examination with a 78-D lens (Volk Optical Inc., Mentor,
OH), and measurement of IOP with a Goldmann appla-
nation tonometer (Haag-Streit, Koniz, Switzerland). AL
and ACD were measured by IOLMaster (Carl Zeiss, Jena,
Germany). Refraction was measured with an autorefractor
machine (Topcon Auto K KR7100D; Topcon Corp.,
Tokyo, Japan). Spherical equivalent was deﬁned as sphere
plus half cylinder. Static nonindentation and dynamic
indentation gonioscopy were performed using the Gold-
mann 2-mirror lens and Sussman 4-mirror lens, respec-
tively. The drainage angles were assessed under the lowest
level of ambient illumination that permitted a view of the
angle, and high magniﬁcation (16). An eye was consid-
ered to have angle closure if the posterior pigmented tra-
becular meshwork was not visible for at least 180 degrees
on nonindentation gonioscopy with the eye in the primary
position. Slight tilting of the gonioscopy lens was permitted
in the presence of convex iris proﬁle. Each of the 2 mirrors
of the Goldmann 2-mirror lens was inclined at an angle of
62 degrees towards the front surface. Indentation gonio-
scopy with a Sussman 4-mirror lens was used to establish
the presence or absence of peripheral anterior synechiae
(PAS).
ASOCT
All subjects underwent imaging with ASOCT (Visante;
Carl Zeiss Meditec, Dublin, CA) performed in dark room
conditions (0 lux) by an operator who was masked to the
results of the clinical ophthalmic examination. Scans were
centered on the pupil and taken along the horizontal axis
(nasal-temporal angles at 0 to 180 degrees) using the
standard anterior segment single-scan protocol. The best
quality images were obtained by adjusting the saturation
and noise, and by optimizing the polarization for each scan
during the examination. Care was taken to minimize
motion artefacts, or image artefacts due to the eyelids.
One cross-sectional horizontal ASOCT scan of the
nasal and temporal angle was evaluated for each subject.
These images were processed using customized software,
the Zhongshan Angle Assessment Program (ZAAP,
Guangzhou, China)10 by a single observer, masked to
clinical data. For each image, the only observer input was
to determine the location of the 2 scleral spurs. The algo-
rithm then automatically calculated the LV, deﬁned as the
perpendicular distance between the anterior pole of the
crystalline lens and the horizontal line joining the 2 scleral
spurs (Fig. 1). Positive values indicate that the anterior pole
of lens is located anterior to the sclera spur line, whereas
negative values occur when the anterior pole of the lens is
posterior to the scleral spur line.
Classification of Visual Impairment
For all subjects, their logMAR VA was classiﬁed as
normal vision/minimal visual impairment (logMARr0.3),
mild visual impairment (0.3< logMARr0.6), moderate/
severe (logMAR>0.6) visual impairment. These classes
are based on similar stratiﬁcation used in previous
studies.11,12
Statistical Analysis
Statistical analyses were performed with IBM SPSS
Statistics for Windows (version 21.0., Armonk, NY: IBM
Corp). We examined the relationship between VA and LV,
and that between spherical equivalent and LV. A multiple
linear regression model was constructed with LV as the
dependent variable with age, sex, VA, spherical equivalent,
AL, and ACD as independent variables. The independence
of variables in the linear regression model was assessed by
the Durbin-Watson estimate. Variance inﬂation factor and
tolerance were calculated to test potential multicollinearity
among the independent variables. R2 (coeﬃcient of multiple
determination) was evaluated to examine the adequacy of
the multiple linear regression model. A P-value of <0.05
was considered statistically signiﬁcant.
RESULTS
A total of 2047 community-based subjects were
recruited, of whom 675 were excluded for the following
reasons: 11 subjects could not undergo gonioscopy; 15
subjects could not undergo VA examination; 87 could not
undergo refraction; 62 subjects could not complete ASOCT
examination or had poor-quality ASOCT images; 42 sub-
jects had software delineation errors; and 467 subjects had a
scleral spur that was not clearly visible on ASOCT images.
Of the 1372 subjects (67.0%) who were included for the
ﬁnal analysis, 752 (54.8%) were female subjects, 1233
(89.9%) were Chinese, and 295 (21.5%) had angle closure.
Of the 295 subjects with angle closure, PAS (of at least 1
clock-hour) was present in 62 subjects, and 3 subjects had
IOP>21mm Hg. None of the subjects had corresponding
glaucomatous optic neuropathy.
Table 1 shows the distribution of the various param-
eters among eyes with angle closure and those without
angle closure. Angle-closure eyes were seen more often in
older patients (P<0.001) and had signiﬁcantly shorter AL
(P<0.001), smaller ACD (P<0.001), and greater LV
(P<0.001) but no signiﬁcant diﬀerences were noted in the
VA among the 2 groups (P=0.12). The majority of sub-
jects had normal VA/mild visual impairment (86.3% to
86.8%) in both the groups.
FIGURE 1. Anterior segment optical coherence tomography
images illustrating the measurement of lens vault as determined
by the Zhongshan Angle Assessment Program.
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In the multiple linear regression analysis of the asso-
ciations with LV, the variables that were entered in
regression model included age, sex, VA, spherical equiv-
alent, ACD, and AL. The value of the Durbin-Watson
estimate was 2.06, which indicates fulﬁlment of independent
assumption of the variables in the model. No signiﬁcant
association was found between LV and VA (P=0.35), or
between LV and spherical equivalent (P=0.06) in eyes
with angle closure (Table 2). Figures 2 and 3 are the scatter
plots depicting the bivariate correlation between LV and
VA (coeﬃcient of determination (r2)=0.006), and LV and
spherical equivalent (r2=0.13), respectively. There was
poor correlation between LV and IOP (r2=0.008), and
also between LV and the number of quadrants of PAS
(r2=0.06).
DISCUSSION
Laser peripheral iridotomy (LPI) is the established
ﬁrst-line treatment for angle closure as it eliminates pupil-
lary block. However, LPI does not open up the angle in all
cases, and evidence of progression of PACG in the presence
of a patent iridotomy has been reported.13,14 Plausible
reasons for the persistence of iridotrabecular contact have
been attributed to mechanisms other than pupillary block,
such as plateau iris syndrome, a lens-related element or the
presence of PAS.
Although LT can be biometrically determined and was
initially studied as a possible contributory factor, the data
suggesting an association between LT and angle closure
remains inconsistent.2,15,16 In contrast, we and others have
shown that LV, which represents the magnitude of the lens
anterior to the plane of the anterior chamber angles (ie,
anterior to the level of the scleral spurs), is independently
associated with angle closure.4,17 LV has also been shown
to have a greater ability to diﬀerentiate eyes with angle
closure (AUC, 0.94 to 0.96) compared with LT (AUC, 0.61
to 0.75) or ACD (AUC, 0.75 to 0.90).4,17,18
In light of the importance and strong association of
LV with angle closure supported both by epidemiological
evidence and our understanding of the mechanism of pupil
block, we believe that this aspect of the lens may need to be
considered in the management of the disease. With
advancing age, there is both an increase in thickness as well
as a more anteriorly placed lens19,20; which in predisposed
eyes would worsen angle crowding. This nonpupillary block
component may be recalcitrant to an iridotomy and only
relieved by subsequent lens extraction. Some have even








Age (SD) (y) 61.8 (7.4) 64.6 (7.4) <0.001
Women [n (%)] 559 (51.9) 193 (65.4) <0.001
Race (Chinese) [n (%)] 949 (88.1) 284 (96.3) <0.001
Visual acuity [mean
(SD)] (logMAR)
0.37 (0.22) 0.39 (0.20) 0.12
Axial length [mean
(SD)] (mm)
24.15 (1.37) 23.07 (0.88) <0.001
Spherical equivalent
[mean (SD)] (D)
+0.37 (2.78) +2.04 (1.78) <0.001
ACD [mean (SD)]
(mm)
3.20 (0.33) 2.69 (0.22) <0.001
Lens vault (SD) (mm) 388 (252) 775 (188) <0.001
Visual acuity [n (%)]
Normal vision/mild
visual impairment
929 (86.3) 256 (86.8) 0.41
Moderate/severe
visual impairment
147 (13.7) 39 (13.2)
Normal vision= logMARr0.3; mild visual impairment 0.3< log-
MARr0.6; moderate/severe visual impairment logMAR>0.6
ACD indicates anterior chamber depth.
TABLE 2. Multiple Linear Regression for Associations With Lens Vault (mm) in Eyes With Angle Closure (N=295) (R2 = 0.31)
Measures B 95% CI of B P Tolerance VIF
Visual acuity (logMAR) 33.2 67.7 to 134.2 0.35 0.83 1.21
Spherical equivalent (D) 11.5 23.3 to 0.3 0.06 0.74 1.34
Axial length (mm) 24.5 148.9 to 0.09 0.05 0.72 1.39
Anterior chamber depth (mm) 430 517 to 343 <0.001 0.89 1.13
B=regression estimate.
R=a measurement of the correlation between the observed value of the lens vault and the predicted value based on the regression model.
VIF indicates variance inﬂation factor.
FIGURE 2. Scatter plot showing the bivariate correlation
between visual acuity and lens vault in the study population. The
coefficient of determination (r2) between the variables for all
subjects is 0.006; for open angle is 0.003, and for angle closure it
is 0.014.
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explained the IOP-lowering eﬀect of phacoemulsiﬁcation in
such eyes to be more than just a relief of the anatomic
situation.6,7,21,22
As greater LV carries a higher risk of angle closure, it
follows therefore that lens removal in patients with greater LV
is likely to reduce this risk signiﬁcantly. In this study we
examined a large community-based population group and
found no association between the degree of LV and extent of
visual impairment in subjects with angle closure. In eyes with a
large LV, even if visually asymptomatic, lens extraction may
be of beneﬁt as the lens-related aspect could be refractory to an
iridotomy. In addition to a relief of the anatomic situation,
phacoemulsiﬁcation of the lens in angle closure eyes is known
to have an IOP-lowering eﬀect believed to occur due to better
access for the outﬂow of aqueous through the trabecular
meshwork.6,7,21,22 However, we do not advocate primary lens
extraction in all angle-closure eyes with a large LV. In those
eyes with persistent angle closure and/or progression of disease
despite a patent iridotomy and a large LV, lens extraction can
be considered even in the presence of good VA. In the absence
of visually signiﬁcant cataract, whether to extract the lens in
cases of PACG, is currently being investigated by the
randomized-controlled EAGLE study8 with particular refer-
ence to quality-of-life metrics. Many elderly PACG patients
will develop cataracts in the near future and will require sur-
gery. This includes both those with naturally ageing cataract
and in some cases from the eﬀect of conventional glaucoma
treatment.23–25 Naturally, it can also improve the visual
function in patients with hypermetropia (found in the majority
of PACG patients), by correcting this refractive error.
Although admirable, the remit of the EAGLE study8 does not
address the whole spectrum of angle closure and mainly con-
cerns quality of life rather than long-term glaucoma control.
While it may be tempting to speculate that lens
extraction is preferable to LPI throughout the angle-closure
spectrum in the presence of borderline visually signiﬁcant
cataracts, realistically this scenario depends on each indi-
vidual case. An assessment of LV may be useful in the
education of patients and to guide in the decision-making
process. Of note, this study showed that increasing LV in
angle-closure eyes is not associated with either a myopic
shift in refraction or a decrease in VA. This permits the
ASOCT to be more useful from a mechanistic view rather
than a simple interpretation of whether the angles are open
or closed. An estimation of the LV if available is useful as it
better deﬁnes the role of the lens directly in relation to the
anterior chamber angles. An added advantage is the ability
to visualize the relative positions of the anterior segment
structures from a single ASOCT image.
One of the limitations of our study was the high pro-
portion of undetectable scleral spurs in ASOCT images.
Improvements in ASOCT resolution and fully automated
image analysis techniques should reduce this. Secondly, we
did not have data on the cataract grades of the subjects.
Availability of such data would enhance our understanding
of the eﬀect of cataractogenesis on LV and VA.
In summary, this study suggests that there is a sig-
niﬁcant population of angle-closure individuals with a large
LV but good VA. The clinical relevance of LV may lie in
aiding decision making in those for whom LPI or phacoe-
mulsiﬁcation may be equally acceptable treatment options.
Lens extraction should be a consideration in those cases
with large LV in the absence of visually signiﬁcant cataract.
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